Form 10-Q

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

Table of Contents

0001193125-13-312877.txt : 20130731 0001193125-13-312877.hdr.sgml : 20130731 20130731172325 ACCESSION NUMBER: 0001193125-13-312877 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 10 CONFORMED PERIOD OF REPORT: 20130630 FILED AS OF DATE: 20130731 DATE AS OF CHANGE: 20130731 FILER: COMPANY DATA: COMPANY CONFORMED NAME: QUIDEL CORP /DE/ CENTRAL INDEX KEY: 0000353569 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 942573850 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 000-10961 FILM NUMBER: 131000011 BUSINESS ADDRESS: STREET 1: 10165 MCKELLAR CT CITY: SAN DIEGO STATE: CA ZIP: 92121 BUSINESS PHONE: 8585521100 FORMER COMPANY: FORMER CONFORMED NAME: MONOCLONAL ANTIBODIES INC /DE/ DATE OF NAME CHANGE: 19910210 10-Q 1 d555383d10q.htm FORM 10-Q Form 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

(Mark One)

x	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2013

¨	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

For the transition period from to

Commission File Number: 0-10961

QUIDEL CORPORATION

(Exact name of Registrant as specified in its charter)

Delaware

94-2573850

(State or other jurisdiction

of incorporation or organization)

(I.R.S. Employer

Identification No.)

10165 McKellar Court, San Diego, California 92121

(Address of principal executive offices, including zip code)

(858) 552-1100

(Registrant’s telephone number, including area code)

Not Applicable

(Former name, former address and former fiscal year, if changed since last report)

Indicate by check mark whether the Registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes x No ¨

Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes x No ¨

Indicate by check mark whether the Registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act. (Check one):

Indicate by check mark whether the Registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No x

As of July 25, 2013, 33,904,942 shares of common stock were outstanding.

INDEX


PART I—FINANCIAL INFORMATION			3

ITEM 1. Financial Statements (unaudited)			3

Consolidated Balance Sheets as of June 30, 2013 and December 31, 2012			3

Consolidated Statements of Operations for the three and six months ended June 30, 2013 and 2012			4

Consolidated Statements of Cash Flows for the six months ended June 30, 2013 and 2012			5

Notes to Consolidated Financial Statements			6

ITEM 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations			17

ITEM 3. Quantitative and Qualitative Disclosures About Market Risk			24

ITEM 4. Controls and Procedures			24

PART II—OTHER INFORMATION			26

ITEM 1. Legal Proceedings			26

ITEM 1A. Risk Factors			26

ITEM 2. Unregistered Sales of Equity Securities and Use of Proceeds			26

ITEM 3. Defaults Upon Senior Securities			26

ITEM 4. Mine Safety Disclosures			26

ITEM 5. Other Information			26

ITEM 6. Exhibits			26

Signatures			28

PART I FINANCIAL INFORMATION

ITEM 1.

Financial Statements

QUIDEL CORPORATION

CONSOLIDATED BALANCE SHEETS

(in thousands, except par value; unaudited)


	June 30,		December 31,
	2013		2012
ASSETS
Current assets:
Cash and cash equivalents	$	21,949	$	14,856
Accounts receivable, net		13,595		32,570
Inventories		24,664		15,496
Deferred tax asset—current		4,735		6,622
Prepaid expenses and other current assets		6,058		5,228

Total current assets		71,001		74,772
Property, plant and equipment, net		41,404		34,156
Goodwill		82,716		71,013
Intangible assets, net		68,289		60,341
Other non-current assets		1,691		1,817

Total assets	$	265,101	$	242,099

LIABILITIES AND STOCKHOLDERS’ EQUITY
Current liabilities:
Accounts payable	$	5,286	$	7,864
Accrued payroll and related expenses		5,537		6,016
Current portion of lease obligation		409		380
Current portion of contingent consideration (see Note 13)		1,795		—
Other current liabilities		5,192		8,241

Total current liabilities		18,219		22,501
Long term debt		—		5,000
Lease obligation, net of current portion		5,354		5,567
Contingent consideration—non-current (see Note 13)		10,124		—
Deferred tax liability—non-current		9,465		3,349
Income taxes payable		1,548		4,548
Other non-current liabilities		903		1,354
Commitments and contingencies
Stockholders’ equity:
Preferred stock, $.001 par value per share; 5,000 shares authorized; none issued or outstanding at June 30, 2013 and December 31, 2012		—		—
Common stock, $.001 par value per share; 50,000 shares authorized; 33,868 and 33,452 shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively		34		33
Additional paid-in capital		193,526		184,431
Retained earnings		25,928		15,316

Total stockholders’ equity		219,488		199,780

Total liabilities and stockholders’ equity	$	265,101	$	242,099

See accompanying notes.

QUIDEL CORPORATION

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data; unaudited)


	Three months ended June 30,						Six months ended June 30,
	2013			2012			2013			2012
Total revenues	$	29,706		$	30,858		$	91,701		$	68,818
Costs and expenses
Cost of sales (excludes amortization of intangible assets of $1,511, $1,438, $2,949 and $2,876, respectively)		13,671			14,008			33,218			28,816
Research and development		7,945			6,844			15,469			15,348
Sales and marketing		7,120			7,677			15,562			14,213
General and administrative		6,071			5,129			13,600			11,053
Amortization of intangible assets from acquired businesses and technology		2,022			1,719			3,786			3,437

Total costs and expenses		36,829			35,377			81,635			72,867

Operating (loss) income		(7,123	)		(4,519	)		10,066			(4,049	)
Other (expense) income
Interest income		6			9			12			27
Interest expense		(195	)		(292	)		(399	)		(699	)

Total other expense		(189	)		(283	)		(387	)		(672	)

(Loss) income before taxes		(7,312	)		(4,802	)		9,679			(4,721	)
Benefit for income taxes		(5,557	)		(1,680	)		(933	)		(1,650	)

Net (loss) income	$	(1,755	)	$	(3,122	)	$	10,612		$	(3,071	)

Basic (loss) earnings per share	$	(0.05	)	$	(0.09	)	$	0.31		$	(0.09	)
Diluted (loss) earnings per share	$	(0.05	)	$	(0.09	)	$	0.30		$	(0.09	)
Shares used in basic per share calculation		33,802			32,946			33,658			33,008
Shares used in diluted per share calculation		33,802			32,946			34,716			33,008

See accompanying notes.

QUIDEL CORPORATION

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands; unaudited)


	Six months ended June 30,
	2013			2012
OPERATING ACTIVITIES:
Net income (loss)	$	10,612		$	(3,071	)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, amortization and other		12,123			10,862
Loss on disposal of assets		—			14
Stock-based compensation expense		4,028			3,595
Change in deferred tax assets and liabilities		3,363			(1,679	)
Excess tax benefit from share-based compensation		(937	)		—
Changes in assets and liabilities:
Accounts receivable		19,213			1,865
Inventories		(9,128	)		(2,459	)
Income tax payable		(2,266	)		31
Prepaid expenses and other current and non-current assets		1,491			(764	)
Accounts payable		(1,959	)		(567	)
Accrued payroll and related expenses		(985	)		(152	)
Accrued royalties		(9	)		14
Accrued income taxes payable		(3,803	)		—
Other current and non-current liabilities		(2,427	)		(2,506	)

Net cash provided by operating activities		29,316			5,183

INVESTING ACTIVITIES:
Acquisitions of property and equipment		(11,748	)		(3,985	)
Acquisition of BioHelix, net of cash acquired		(9,150	)		—
Acquisition of intangibles		(1,142	)		(15,165	)
Proceeds from the sale of fixed assets		—			115

Net cash used for investing activities		(22,040	)		(19,035	)

FINANCING ACTIVITIES:
Payments on lease obligation		(184	)		(160	)
Repurchases of common stock		(858	)		(3,387	)
Proceeds from issuance of common stock		4,922			444
Excess tax benefit from share-based compensation		937			—
Payments on line of credit		(5,000	)		(23,000	)
Payment of note payable to state agency		—			(1,498	)

Net cash used for financing activities		(183	)		(27,601	)

Net increase (decrease) in cash and cash equivalents		7,093			(41,453	)
Cash and cash equivalents, beginning of period		14,856			61,332

Cash and cash equivalents, end of period	$	21,949		$	19,879

SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest	$	399		$	699

Cash paid for income taxes	$	1,900		$	—

NON-CASH INVESTING ACTIVITIES:
Purchase of capital equipment by incurring current liabilities	$	1,007		$	300

NON-CASH FINANCING ACTIVITIES:
Reduction of other current liabilities upon issuance of restricted share units	$	456		$	917

See accompanying notes.

Quidel Corporation

Notes to Consolidated Financial Statements

(Unaudited)

Note 1. Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited consolidated financial statements of Quidel Corporation and its subsidiaries (the “Company”) have been prepared in accordance with generally accepted accounting principles in the U.S. for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included.

The information at June 30, 2013, and for the three and six months ended June 30, 2013 and 2012, is unaudited. For further information, refer to the Company’s consolidated financial statements and footnotes thereto for the year ended December 31, 2012 included in the Company’s 2012 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.

For 2013 and 2012, the Company’s fiscal year will or has ended on December 29, 2013 and December 30, 2012, respectively. For 2013 and 2012, the Company’s second quarter ended on June 30, 2013 and July 1, 2012, respectively. For ease of reference, the calendar quarter end dates are used herein. The three and six month periods ended June 30, 2013 and 2012 each included 13 and 26 weeks, respectively.

Comprehensive Income (Loss)

Net (loss) income is equal to comprehensive (loss) income for the three and six months ended June 30, 2013 and 2012, respectively.

Use of Estimates

The preparation of financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, management evaluates its estimates, including those related to revenue recognition, customer programs and incentives, reserve for uncollectible accounts, inventory valuation, intangible assets, software development costs, stock-based compensation, restructuring, contingencies and litigation, contingent consideration, and income taxes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

Revenue Recognition

The Company records revenues primarily from product sales. These revenues are recorded net of rebates and other discounts which are estimated at the time of sale, and are largely driven by various customer program offerings, including special pricing agreements, promotions and other volume-based incentives. Revenue from product sales are recorded upon passage of title and risk of loss to the customer. Change in title to the product and recognition of revenue occurs upon delivery to the customer when sales terms are free on board (“FOB”) destination and at the time of shipment when the sales terms are FOB shipping point and there is no right of return. The Company also earns income from the licensing of technology.

The Company earns income from grants for research and commercialization activities. On November 6, 2012, the Company was awarded a milestone-based grant totaling up to $8.3 million from the Bill and Melinda Gates Foundation to develop, manufacture and validate a quantitative, low-cost, nucleic acid assay for HIV drug treatment monitoring on the integrated Savanna™ MDx platform for use in limited resource settings. Upon execution of the grant agreement, the Company received $2.6 million to fund subsequent research and development activities. The Company expects to receive

milestone payments of $2.5 million in 2013 and $3.2 million in 2014 and will recognize grant revenue on the lesser of the amount recognized on a straight-line basis or the amount that is non-refundable through the end of the agreement, which is December 31, 2015. For the three and six months ended June 30, 2013, the Company recognized $0.7 million and $1.3 million as grant revenue associated with this grant. The Company has included $0.9 million and $2.2 million of restricted cash as a component of prepaid expenses and other current assets and as a component of other current liabilities as of June 30, 2013 and December 31, 2012, respectively.

Collaborative Arrangement

In July 2012, the Company entered into a collaborative arrangement with Life Technologies Corporation for the development of molecular assays. ASC Topic 808, Collaborative Arrangements, defines a collaborative arrangement as an arrangement where the parties are active participants and have exposure to significant risks. The Company is accounting for the joint development and commercialization activities with the third-party as a joint risk sharing collaboration in accordance with ASC Topic 808, Collaborative Arrangements. Payments received or due from Life Technologies Corporation totaled $3.0 million in 2012 and $1.1 million in the six months ended June 30, 2013. The Company expects additional payments of $0.8 million to become due through 2013. The reimbursement represents approximately 50% of project development costs based upon mutually agreed upon project plans for each molecular assay. The reimbursements are recorded as a reduction to research and development expense in the accompanying consolidated financial statements, to the extent that they are less than related expenditures for research and development activities subsequent to the date of the contract. The Company recognized $0 and $1.1 million of such reimbursements as a reduction to research and development expense for the three and six months ended June 30, 2013, respectively. In connection with the collaboration agreement, the Company also entered into a manufacturing and supply agreement with Life Technologies Corporation, which provides for margin sharing.

In March 2013, the Company entered into a six year instrument supply agreement (the “March 2013 Agreement”) with Life Technologies Corporation for $0.8 million to sell Life Technologies Corporation’s QuantStudio™ DX diagnostic laboratory instrument for use in the infectious disease field, along with the assays developed under the collaborative agreement.

Note 2. Computation of (Loss) Earnings Per Share

Diluted net income per share is reported based on the more dilutive of the treasury stock or the two-class method. Under the two-class method, net income is allocated to common stock and participating securities. The Company’s unvested restricted stock awards and certain unvested restricted stock units meet the definition of participating securities. Basic net income per share under the two-class method is computed by dividing net income adjusted for earnings allocated to unvested stockholders for the period by the weighted average number of common shares outstanding during the period. Diluted net income per share under the two-class method is computed by dividing net income adjusted for earnings allocated to unvested stockholders for the period by the weighted average number of common and common equivalent shares outstanding during the period. The Company excludes stock options from the calculation of diluted net income per share when the combined exercise price, unrecognized stock-based compensation and assumed tax benefits upon exercise are greater than the average market price for the Company’s common stock because their effect is anti-dilutive. For the six months ended June 30, 2013, 0.4 million stock options were not included in the calculation of diluted earnings per share (“EPS”) as their effect was anti-dilutive.

For the three months ended June 30, 2013 and the three and six months ended June 30, 2012 there were no differences between the number of common shares used for the basic and diluted EPS computations as they were periods in which the Company incurred a net loss. Due to the fact that the holders of participating securities are not contractually required to share in the Company’s losses, no allocation to participating securities was made for periods in which the Company incurred a net loss in applying the two-class method to compute basic net loss per common share. For the three months ended June 30, 2013 and 2012 and the six months ended June 30, 2012, 1.1 million, 0.7 million, and 0.7 million stock options and shares of restricted stock, respectively, were excluded from diluted loss per share that would have been included if the Company had been in a net income position. Additionally, for the three months ended June 30, 2013 and 2012 and the six months ended June 30, 2012, 0.6 million, 1.3 million, and 1.5 million stock options, respectively, were not included because the exercise of such options would be anti-dilutive.

The following table sets forth the computation of basic and diluted EPS for the six months ended June 30, 2013 (in thousands, except per share amounts):


	2013
Basic net income per share:
Net income	$	10,612
Less: income allocated to participating securities		(32	)

Net income allocated to common stockholders	$	10,580

Weighted average common shares outstanding — basic		33,658

Net income per share — basic	$	0.31

Diluted net income per share:
Net income	$	10,612
Less: income allocated to participating securities		(31	)

Net income allocated to common stockholders	$	10,581

Weighted average common shares outstanding — basic		33,658
Dilutive securities		1,058

Weighted average common shares outstanding — diluted		34,716

Net income per share — diluted	$	0.30

Note 3. Inventories

Inventories are recorded at the lower of cost (first-in, first-out) or market. Inventories consisted of the following, net of reserves of $0.5 million and $0.6 million at June 30, 2013 and December 31, 2012, respectively (in thousands):


	June 30,		December 31,
	2013		2012
Raw materials	$	9,014	$	5,582
Work - in - process (materials, labor and overhead)		8,647		4,686
Finished goods (materials, labor and overhead)		7,003		5,228

	$	24,664	$	15,496

Note 4. Intangible Assets

Intangible assets consist of the following (in thousands):


	Weighted-		June 30, 2013							December 31, 2012
	Average
	Useful Life		Gross		Accumulated					Gross		Accumulated
Description	(years)		Assets		Amortization			Net		Assets		Amortization			Net
Goodwill		Indefinite	$	86,165	$	(3,449	)	$	82,716	$	74,461	$	(3,448	)	$	71,013
Purchased technology		8.3		57,030		(25,371	)		31,659		52,670		(22,308	)		30,362
Customer relationships		7.6		6,852		(2,483	)		4,369		6,322		(2,007	)		4,315
In-process research and development		Indefinite		2,270		—			2,270		1,570		—			1,570
License agreements		4.6		49,778		(33,672	)		16,106		49,378		(29,386	)		19,992
Patent and trademark costs		11.9		14,562		(4,078	)		10,484		5,012		(3,887	)		1,125
Favorable lease		9.0		1,700		(1,627	)		73		1,700		(1,594	)		106
Software development costs		5.2		3,891		(563	)		3,328		3,262		(391	)		2,871

Total goodwill and intangible assets			$	222,248	$	(71,243	)	$	151,005	$	194,375	$	(63,021	)	$	131,354

In 2011, the Company acquired a technology license from Alere Inc. for $28.8 million, which the Company is amortizing over an estimated useful life of 3.5 years based on the higher of the percentage of usage or the straight-line method. This percentage of usage is determined using the revenues generated from products covered by the patents that are subject to the license. The Company recorded $1.1 million, $1.7 million, $4.3 million, and $3.8 million of amortization expense associated with this technology license included as a portion of cost of sales for the three months ended June 30, 2013 and 2012, and the six months ended June 30, 2013 and 2012, respectively.

The Company acquired distribution rights for $0.8 million in conjunction with the March 2013 Agreement with Life Technologies Corporation (see Note 1). The distribution rights will be amortized on a straight-line basis over the contractual term of six years. In May 2013, the Company acquired intangible assets in conjunction with the BioHelix Corporation (“BioHelix”) acquisition as more fully described in Note 13.

The definite lived intangible assets will be amortized on a straight-line basis. The useful life of the in-process research and development is to be determined, and the amortization will commence upon commercialization of the associated product. The following table summarizes the expected future annual amortization expense of intangible assets recorded on the Company’s condensed consolidated balance sheet as of June 30, 2013 (in thousands):


	Amortization
For the years ending December 31,	Expense
2013 (remaining six months)	$	8,434
2014		17,345
2015		9,965
2016		9,087
2017		8,781
Thereafter		12,407

Total expected future amortization	$	66,019

Note 5. Other Current Liabilities

Other current liabilities consist of the following (in thousands):


	June 30,		December 31,
	2013		2012
Customer incentives	$	1,514	$	2,693
Customer prepayments		1,340		450
Unearned grant revenue		872		2,156
Income tax payable		171		955
Accrued liability for technology licenses		—		707
Other		1,295		1,280

	$	5,192	$	8,241

Note 6. Income Taxes

The effective tax rate for the three months ended June 30, 2013 and 2012 was 76% and 35%, respectively. Included in the 76% effective tax rate is a tax benefit of $3.5 million related to the release of certain tax reserves. The Company recognized an income tax benefit of $5.6 million and $1.7 million for the three months ended June 30, 2013 and 2012, respectively. This was related to the Company’s notification by the Internal Revenue Service that the Congressional Joint Committee of Taxation had completed its review and proposed no changes to the Company’s tax returns filed for the tax periods 2008 through 2010. For the six months ended June 30, 2013, the Company recognized an income tax benefit of $0.9 million on pretax income of $9.7 million, which represents an effective tax rate of 10%. For the six months ended June 30, 2012, the Company recognized an income tax benefit of $1.7 million on a pretax loss of $4.7 million, which represents an effective tax rate of 35%. Additionally, on January 3, 2013, the American Taxpayer Relief Act of 2012 was signed into law reinstating the federal research and development credit for the 2012 and 2013 years. Accordingly, the benefit related to the 2012 federal research and development credit of approximately $0.5 million was recorded in the first quarter of 2013 as a discrete item. The benefit related to 2013 research activities is included in the full year effective tax rate.

The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. While the Company believes that it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcome of examinations by tax authorities in determining the adequacy of its provision for income taxes.

The following table summarizes the activity related to the Company’s unrecognized tax benefits (in thousands):


Beginning balance as of December 31, 2012	$	9,051
Increases related to prior year tax positions		300
Decrease due to settlements		(3,078	)
Increases related to current year tax positions		555

Ending balance as of June 30, 2013	$	6,828

Included in the unrecognized tax benefits of $6.8 million at June 30, 2013 was $4.9 million of tax benefits that, if recognized, would reduce the Company’s annual effective tax rate. The Company does not expect the unrealized tax benefits to decrease over the next 12 months. The Company’s policy is to recognize the interest expense and penalties related to income tax matters as a component of income tax expense. For the three and six months ended June 30, 2013, the Company recognized a net benefit from interest and penalties of $0.4 million and $0.3 million as a component of the Company’s benefit for income taxes in the consolidated statements of operations. For both the three and six months ended June 30, 2012, the Company recognized interest and penalties of $0 million. The Company has accrued approximately $0.3 million and $0.7 million of interest and penalties associated with uncertain tax positions as of June 30, 2013 and December 31, 2012, respectively, and there were no repurchases during the six months ended June 30, 2013.

The Company is subject to periodic audits by domestic and foreign tax authorities. The Company’s federal tax years for 2011 and forward are subject to examination by the U.S. authorities. With few exceptions, the Company’s state and foreign tax years for 2000 and forward are subject to examination by tax authorities. The Company believes that it has appropriate support for the income tax positions taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on an assessment of many factors, including past experience and interpretations of tax law applied to the facts of each matter.

Note 7. Line of Credit

On August 10, 2012, the Company entered into an amended and restated $140.0 million senior secured syndicated credit facility (the “Senior Credit Facility”), which matures on August 10, 2017. The Senior Credit Facility amended and restated the Company’s $120.0 million senior secured credit facility dated October 8, 2008. As part of this amendment, the Company incurred an additional $1.0 million in deferred financing costs related to the Senior Credit Facility. The Company had previously recorded $0.6 million related to the original credit facility. Deferred financing costs are amortized on a straight line basis over the term of the Senior Credit Facility. As of June 30, 2013 and December 31, 2012, the Company had

deferred financing costs of $1.3 million and $1.5 million, respectively, included as a portion of other non-current assets. The Senior Credit Facility bears interest at either the London Interbank Offered Rate (“LIBOR”) or the base rate, plus, in each case, the applicable margin. The base rate is equal to the highest of (i) the lender’s prime rate, (ii) the federal funds rate plus one-half of one percent and (iii) LIBOR plus one percent. The applicable margin is generally determined in accordance with a performance pricing grid based on the Company’s leverage ratio and ranges from 1.25% to 2.50% for LIBOR rate loans and from 0.25% to 1.50% for base rate loans. The agreement governing the Senior Credit Facility is subject to certain customary limitations, including among others: limitation on liens; limitation on mergers, consolidations and sales of assets; limitation on debt; limitation on dividends, stock redemptions and the redemption and/or prepayment of other debt; limitation on investments (including loans and advances) and acquisitions; limitation on transactions with affiliates; and limitation on disposition of assets. The Company is also subject to financial covenants which include a funded debt to adjusted EBITDA ratio (as defined in the Senior Credit Facility, with adjusted EBITDA generally calculated as earnings before, among other adjustments, interest, taxes, depreciation, amortization, and stock-based compensation) not to exceed 3:1 as of the end of each fiscal quarter, and an interest coverage ratio of not less than 3:1 as of the end of each fiscal quarter. The Senior Credit Facility is secured by substantially all present and future assets and properties of the Company.

As of June 30, 2013, the Company had $139.3 million available under the Senior Credit Facility. The Company’s ability to borrow under the Senior Credit Facility fluctuates from time to time due to, among other factors, the Company’s borrowings under the facility and its funded debt to adjusted EBITDA ratio. As of June 30, 2013 and December 31, 2012, the Company had $0 and $5.0 million, respectively, outstanding under the Senior Credit Facility. As of June 30, 2013, the Company was in compliance with all financial covenants.

Note 8. Stockholders’ Equity

Issuances and Repurchases of Common Stock

During the six months ended June 30, 2013, 121,375 shares of common stock were issued in conjunction with the vesting and release of restricted stock units, 405,917 shares of common stock were issued due to the exercise of stock options and 24,733 shares of common stock were issued in connection with the Company’s employee stock purchase plan (the “ESPP”), resulting in net proceeds to the Company of approximately $4.9 million. Additionally, during the six months ended June 30, 2013, 38,360 shares of outstanding common stock with a value of $0.9 million were repurchased in connection with payment of minimum tax withholding obligations for certain employees relating to the lapse of restrictions on certain restricted stock awards. As of June 30, 2013, there was $50.0 million remaining under the Company’s share repurchase program.

Stock-Based Compensation

The compensation expense related to the Company’s stock-based compensation plans included in the accompanying Consolidated Statements of Income for the three and six months ended June 30, 2013 and 2012 was as follows (in millions):


	Three months ended June 30,				Six months ended June 30,
	2013		2012		2013		2012
Cost of sales	$	0.2	$	0.1	$	0.4	$	0.3
Research and development		0.3		0.3		0.7		0.6
Sales and marketing		0.2		0.2		0.3		0.2
General and administrative		1.2		1.1		2.6		2.5

	$	1.9	$	1.7	$	4.0	$	3.6

over a weighted-average period of approximately 2.6 years. As of June 30, 2013, total unrecognized compensation expense related to non-vested restricted stock was $1.6 million, which is expected to be recognized over a weighted-average period of approximately 1.5 years. Compensation expense capitalized to inventory and compensation expense related to the Company’s ESPP were not material for the three and six months ended June 30, 2013 and 2012.

The estimated fair value of each stock option award was determined on the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions for the option grants.


	Six months ended June 30,
	2013			2012
Expected option life (in years)		5.53			5.57
Volatility rate		44	%		46	%
Risk-free interest rate		0.86	%		0.74	%
Dividend rate		0	%		0	%

The weighted-average grant date fair value of stock options granted during the six months ended June 30, 2013 and 2012 was $9.19 and $6.51, respectively. The Company granted 529,134 and 621,705 stock options during the six months ended June 30, 2013 and 2012, respectively. The weighted-average grant date fair value of restricted stock granted during the six months ended June 30, 2013 and 2012 was $23.18 and $15.45, respectively. The Company granted 68,994 and 132,205 shares of restricted stock during the six months ended June 30, 2013 and 2012, respectively. The grant date fair value of restricted stock is determined based on the closing market price of the Company’s common stock on the grant date.

Note 9. Industry and Geographic Information

The Company operates in one reportable segment. Sales to customers outside the U.S. represented $12.7 million (14%) and $10.4 million (15%) of total revenue for the six months ended June 30, 2013 and 2012, respectively. As of June 30, 2013 and December 31, 2012, balances due from foreign customers were $3.0 million and $2.8 million, respectively.

The Company had sales to individual customers in excess of 10% of total revenue, as follows:


	Six months ended June 30,
	2013			2012
Customer:
A		15	%		15	%
B		11	%		9	%

		26	%		24	%

As of June 30, 2013, accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $2.0 million while, at December 31, 2012, accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $22.4 million.

Note 10. Commitments and Contingencies

Legal

The Company is involved in various claims and litigation matters from time to time in the ordinary course of business. Management believes that all such current legal actions, in the aggregate, will not have a material adverse effect on the Company. The Company also maintains insurance, including coverage for product liability claims, in amounts which management believes are appropriate given the nature of its business. At June 30, 2013 and December 31, 2012, the Company had $0.3 million accrued as a liability for various legal matters where the Company deemed the liability probable and estimable.

Licensing Arrangements

The Company has entered into various other licensing and royalty agreements, which largely require payments based on specified product sales as well as the achievement of specified milestones. The Company had royalty and license expenses relating to those agreements of $0.3 million, $0.4 million, $0.7 million and $0.8 million for both the three months ended June 30, 2013 and 2012 and the six months ended June 30, 2013 and 2012, respectively.

Research and Development Agreements

The Company has entered into various research and development agreements which provide it with rights to develop, manufacture and market products using the intellectual property and technology of its collaborative partners. Under the terms of certain of these agreements, the Company is required to make periodic payments based on the Company’s achievement of certain milestones or resource expenditures. These milestones generally include achievement of prototype assays, validation lots and clinical trials. At June 30, 2013 and December 31, 2012, total current commitments due under the terms of these agreements are estimated at $0.6 million and $2.1 million, respectively. The commitments will fluctuate as we agree to new phases of development under the existing arrangements.

Contingent Consideration

The Company recorded $11.9 million of contingent consideration in conjunction with the BioHelix acquisition as more fully described in Note 13.

Note 11. Lease Obligation

During 1999, the Company completed a sale and leaseback transaction of its San Diego facility. The facility was sold for $15.0 million, of which $3.8 million was capital contributed by the Company. The sale was an all cash transaction, netting the Company approximately $7.0 million. The Company is a 25% limited partner in the partnership that acquired the facility. The transaction was deemed a financing transaction under the guidance in ASC Topic 840-40, Accounting for Sales of Real Estate. The assets sold remain on the books of the Company and will continue to be depreciated over the estimated useful life. In December 2009, the Company amended the terms of its lease agreement which had no significant impact on the Company’s financial statements. The amended terms include a new ten-year lease term through December 2019, with options to extend the lease for up to three additional five-year periods. The Company will amortize the lease obligation over this new term. The amount of the monthly rental payments remains the same under the amendment. The combined carrying value of the land and building subject to this lease, net of accumulated depreciation, was $2.2 million and $2.3 million as of June 30, 2013 and December 31, 2012, respectively. In addition, the Company has the option to purchase the general partner’s interest in the partnership in January 2015 for a fixed price. The Company has determined that the partnership is a variable interest entity (VIE). The Company is not, however, the primary beneficiary of the VIE as it does not absorb the majority of the partnership’s expected losses or receive a majority of the partnership’s residual returns. The Company made lease payments to the partnership of approximately $0.6 million for each of the six months ended June 30, 2013 and 2012 and $0.3 million for each of the three months ended June 30, 2013 and 2012.

Note 12. Fair Value Measurement

ASC Topic 820, Fair Value Measurements and Disclosures requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed by the Company in one of the following three categories:

Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities;

Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices for identical assets and liabilities in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability;

Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity).

As of June 30, 2013 and December 31, 2012, the carrying amount of the Company’s cash equivalents approximates fair value. Cash equivalents primarily consisted of funds held in a money market account. As of the periods ended June 30, 2013 and December 31, 2012, the carrying value of cash equivalents was $16.0 million and $11.0 million, respectively, and was determined based on Level 1 inputs.

As of December 31, 2012, the carrying amount of the Company’s Senior Credit Facility approximates fair value because it has a variable interest rate that reflects market changes to interest rates and changes in the Company’s leverage ratio. As of December 31, 2012, the Company used Level 2 inputs to determine the fair value of its Senior Credit Facility.

The Company preliminarily measured its contingent consideration liability of $11.9 million arising from its acquisition of BioHelix using level 3 unobservable inputs (see Note 13).

Note 13. Acquisition

In October 2009, the Company entered into a product development and commercialization agreement (the “2009 Agreement”) with BioHelix under which the companies would co-develop a number of hand-held, disposable molecular assays using BioHelix’s proprietary isothermal Helicase Dependent Amplification technology. On May 6, 2013, the Company acquired BioHelix a privately-held, diagnostics company, based in Beverly, Massachusetts.

The acquisition has been accounted for in conformity with ASC Topic 805, Business Combinations. In connection with the acquisition of BioHelix, the Company paid $9.2 million in cash, which represents cash consideration of $10.0 million adjusted for settlement of pre-existing liabilities under the 2009 Agreement and final working capital compared to an agreed upon baseline. Additionally, the Company agreed to contingent consideration ranging from $5.0 million to $13.0 million upon achievement of certain research and development milestones and revenue targets through 2018. The contingent consideration was valued, on a preliminary basis, at $11.9 million, based on probability weighted models.

The preliminary purchase price of BioHelix is allocated to the underlying net assets acquired and liabilities assumed based on their estimated respective fair values as of May 6, 2013 with the excess purchase price allocated to goodwill. The Company’s preliminary allocation of the purchase price to the net tangible and intangible assets acquired and liabilities assumed is as follows (in thousands):


				Weighted-average amortization period (years)

Acquisition consideration
Cash consideration	$	10,000
Settlement of pre-existing liabilities and working capital adjustment		(850	)

Net cash consideration		9,150
Contingent consideration		11,919

Net consideration at closing	$	21,069


Fair market values
Other current and non-current assets	$	375
Property, plant and equipment		179
In-process research and development		700
Purchased technology		4,360		10
Non-compete agreement		700		5
Contractual relationships		530		10
Patents		8,800		12
Goodwill		11,703

Total assets acquired		27,347

Accounts payable and other current liabilities		701
Deferred tax liabilities		5,577

Total liabilities assumed		6,278

Purchase price allocation	$	21,069

The primary areas of the preliminary purchase price allocation that have not been finalized relate to the valuation of contingent consideration and the valuation of intangible assets. Upon completion of the fair value assessment, the Company anticipates that the ultimate contingent consideration and intangible assets may differ from the preliminary assessment outlined above. Any changes to the preliminary estimates of the fair value of the contingent consideration and the intangible assets will be allocated to goodwill during the measurement period, with subsequent changes in estimates recorded in the statement of operations.

The goodwill of $11.7 million reflects the complementary strategic fit that the acquisition of BioHelix brought to the Company. None of the goodwill is expected to be deductible for tax purposes. In-process research and development primarily relates to the future commercialization of BioHelix’s development efforts associated with the potential commercialization of products in development at the time of the acquisition.

The preliminary value assigned to the identifiable intangible assets was determined by discounting the estimated future cash flows associated with these assets to their present value. The preliminary revenue estimates used to value the purchased technology and patents were based on estimates of relevant market sizes and growth factors, expected trends in technology and the nature and expected timing of new product introductions by BioHelix and its competitors. The rates utilized to discount the net cash flows of purchased technology and patents to their present value are based on the risks associated with the respective cash flows taking into consideration the weighted average cost of capital of the Company.

The Company incurred $0.2 million and $0.3 million of transaction costs in conjunction with the BioHelix acquisition included in the consolidated statement of operations for the three and six months ended June 30, 2013, respectively, which impacted both basic and diluted earnings per share by $.01 for both the three and six months ended June 30, 2013.

The following unaudited pro forma financial information shows the combined results of operations of the Company, including BioHelix, as if the acquisition had occurred as of the beginning of the periods presented.


	Six months ended
	June 30,
(in thousands, except per share data)	2013			2012
Pro forma total revenues	$	92,650		$	70,205

Pro forma net income (loss)	$	10,122		$	(3,505	)

Pro forma basic net earnings (loss) per share	$	0.30		$	(0.11	)

Pro forma diluted net earnings (loss) per share	$	0.29		$	(0.11	)


Total revenue included in the consolidated statements of operations	$	188

Net loss included in the consolidated statements of operations	$	(228	)

ITEM 2.

Management’s Discussion and Analysis of Financial Condition and Results of Operations

In this quarterly report, all references to “we,” “our” and “us” refer to Quidel Corporation and its subsidiaries.

Future Uncertainties and Forward-Looking Statements

This Quarterly Report on Form 10-Q contains forward-looking statements within the meaning of the federal securities laws that involve material risks, assumptions and uncertainties. Many possible events or factors could affect our future financial results and performance, such that our actual results and performance may differ materially from those that may be described or implied in the forward-looking statements. As such, no forward-looking statement can be guaranteed. Differences in actual results and performance may arise as a result of a number of factors including, without limitation, fluctuations in our operating results resulting from seasonality; the timing of the onset, length and severity of cold and flu seasons; government and media attention focused on influenza and the related potential impact on humans from novel influenza viruses; adverse changes in competitive conditions in domestic and international markets; the reimbursement system currently in place and future changes to that system; changes in economic conditions in our domestic and international markets; changes in sales levels as it relates to the absorption of our fixed costs; lower than anticipated market penetration of our products; the quantity of our product in our distributors’ inventory or distribution channels and changes in the buying patterns of our distributors; our development of new technologies, products and markets; our development and protection of intellectual property; our reliance on a limited number of key distributors; our reliance on sales of our influenza diagnostics tests; our ability to manage our growth strategy, including our ability to integrate companies or technologies we have acquired or may acquire; intellectual property risks, including but not limited to, infringement litigation; limitations and covenants in our senior credit facility; that we may incur significant additional indebtedness; our need for additional funds to finance our operating needs; volatility and disruption in the global capital and credit markets; acceptance of our products among physicians and other healthcare providers; competition with other providers of POC diagnostic products; changes in government policies; adverse actions or delays in product reviews by the U.S. Food and Drug Administration (the “FDA”); compliance with other government regulations, such as safe working conditions, manufacturing practices, environmental protection, fire hazard and disposal of hazardous substances; third-party reimbursement policies; our ability to meet demand for our products; interruptions in our supply of raw materials; product defects; business risks not covered by insurance; the loss of key personnel; international risks, including but not limited to, compliance with product registration requirements, exposure to currency exchange fluctuations, longer payment cycles, lower selling prices and greater difficulty in collecting accounts receivable, reduced protection of intellectual property rights, political and economic instability, taxes, and diversion of lower priced international products into US markets; our failure to maintain adequate internal control over financial reporting; volatility in our stock price; dilution resulting from future sales of our equity; and provisions in our charter documents and Delaware law that might delay stockholder actions with respect to business combinations or the election of directors. . Forward-looking statements typically are identified by the use of terms such as “may,” “will,” “should,” “might,” “expect,” “anticipate,” “estimate,” and similar words, although some forward-looking statements are expressed differently. Forward-looking statements in this Quarterly Report include, among others, statements concerning: our outlook for the remaining half of fiscal year 2013, including projections about our revenue, gross margins, and expenses including the components thereof; the impact of legal claims and litigation matters and the sufficiency of our accruals for such matters; the sufficiency of our liquidity and capital resources; the sufficiency of our tax positions and the future impact of deferred tax assets or liabilities; the expected vesting periods of unrecognized compensation expense; expected receipts of milestone payments relating to grants and collaborative agreements and expenditures by us relating thereto; that we may enter into foreign currency risk sharing agreements; and our intention to continue to evaluate technology and Company acquisition opportunities. The risks described under “Risk Factors” in Item 1A of this Report on Form 10-Q and our Annual Report on Form 10-K for the year ended December 31, 2012, and elsewhere herein and in reports and registration statements that we file with the Securities and Exchange Commission (the “SEC”) from time to time, should be carefully considered. You are cautioned not to place undue reliance on these forward-looking statements, which reflect management’s analysis only as of the date of this Quarterly Report. The following should be read in conjunction with the Consolidated Financial Statements and Notes thereto beginning on page 3 of this Quarterly Report. We undertake no obligation to publicly release the results of any revision or update of these forward-looking statements, except as required by law.

Overview

We have a leadership position in the development, manufacturing and marketing of rapid diagnostic testing solutions. These diagnostic testing solutions primarily include applications in infectious diseases, women’s health and

gastrointestinal diseases. We sell our products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, public health laboratories, leading universities, retail clinics and wellness screening centers. We market our products in the U.S. through a network of national and regional distributors, and a direct sales force. Internationally, we sell and market primarily in Japan and Europe through distributor arrangements.

Outlook

We continue to expect revenue and earnings growth for fiscal year 2013 as compared to 2012, driven primarily by increased sales of Sofia™ and molecular assays. We anticipate continued investment in research and development, divided relatively equally between the Sofia and molecular programs. In addition, we continue to invest in our U.S. sales organization and related marketing programs both of which are associated with recent product launches. While our main focus is on prudently managing our business and delivering solid financial results, we will continue to evaluate opportunities to acquire new product lines, technologies and companies that would enable us to more quickly build a broader-based diagnostic company.

Three months ended June 30, 2013 compared to the three months ended June 30, 2012

Total Revenues

The following table compares total revenues for the three months ended June 30, 2013 and 2012 (in thousands, except percentages):


	For the three months ended June 30,				Increase (Decrease)
	2013		2012		$			%
Infectious disease net product sales	$	17,322	$	18,758	$	(1,436	)		-8	%
Women’s health net product sales		8,381		8,658		(277	)		-3	%
Gastrointestinal disease net product sales		1,829		1,575		254			16	%
Other net product sales		1,166		1,427		(261	)		-18	%
Royalty, license fees and grant revenue		1,008		440		568			129	%

Total revenues	$	29,706	$	30,858	$	(1,152	)		-4	%

For the three months ended June 30, 2013, total revenue decreased slightly to $29.7 million from $30.9 million for the three months ended June 30, 2012. The decrease in total revenues was largely related to the timing of orders for our pregnancy and Group A Strep products somewhat offset by an increase in influenza sales. Revenues in other product categories remained relatively constant period over period.

Royalty, license fees and grant revenue primarily relates to $0.7 million earned for the three months ended June 30, 2013 in conjunction with the Bill and Melinda Gates Foundation grant as more fully described in Note 1 in the Notes to the Consolidated Financial Statements included in this quarterly report.

Cost of Sales

Cost of sales was $13.7 million, or 46% of total revenues for the three months ended June 30, 2013, and was relatively constant compared to $14.0 million, or 45% of total revenues for the three months ended June 30, 2012.

Operating Expenses

The following table compares operating expenses for the three months ended June 30, 2013 and 2012 (in thousands, except percentages):


	For the three months
	ended June 30,
	2013					2012					Increase (Decrease)
			As a % of					As a % of
	Operating		total			Operating		total
	expenses		revenues			expenses		revenues			$			%
Research and development	$	7,945		27	%	$	6,844		22	%	$	1,101			16	%
Sales and marketing		7,120		24	%		7,677		25	%		(557	)		-7	%
General and administrative		6,071		20	%		5,129		17	%		942			18	%
Amortization of intangible assets from acquired businesses and technology		2,022		7	%		1,719		6	%		303			18	%

Research and Development Expense

Research and development expense for the three months ended June 30, 2013 increased from $6.8 million to $7.9 million primarily due to increased efforts associated with the development of and clinical trials related to molecular assays.

Research and development expenses include direct external costs such as fees paid to consultants, and internal direct and indirect costs such as compensation and other expenses for research and development personnel, supplies and materials, clinical trials and studies, facility costs and depreciation.

Due to the risks inherent in the product development process and given the early-stage of development of certain projects, we are unable to estimate with meaningful certainty the costs we will incur in the continued development of our product candidates for commercialization, and we have not historically tracked research and development costs by individual project. However, we expect our research and development costs to be substantial as we move other product candidates into preclinical and clinical trials and advance our existing product candidates into later stages of development.

Sales and Marketing Expense

Sales and marketing expense for the three months ended June 30, 2013 decreased from $7.7 million to $7.1 million primarily due to reduced commission costs and incentive programs associated with the reduction in total revenue.

General and Administrative Expense

General and administrative expense for the three months ended June 30, 2013 increased from $5.1 million to $6.1 million due to $0.2 million of professional services related to business development activities as well as the 2.3% medical device excise tax that went into effect in 2013, resulting in $0.4 million of expense in the three months ended June 30, 2013.

We expect general and administrative expenses to increase in the remaining six months of 2013 relative to 2012 as a result of the 2.3% medical device excise tax.

Amortization of Intangible Assets from Acquired Businesses and Technology

Amortization of intangible assets from acquired businesses consists of customer relationships, purchased technology and patents and trademarks acquired in connection with our acquisition of Diagnostic Hybrids, Inc. (“DHI”). Amortization of intangible assets from acquired technology consists primarily of expense associated with purchased technology.

We expect amortization of intangible assets from acquired businesses and technology to increase in the remaining six months of 2013 relative to 2012 as a result of the BioHelix acquisition.

Other Income (Expense)

Interest expense primarily relates to interest paid on borrowings under the Senior Credit Facility and interest paid on our lease obligation associated with our San Diego facility. The reduction in the outstanding principal balance under the line of credit from $19.0 million as of June 30, 2012 to $0 as of June 30, 2013 resulted in a reduction to interest expense of $0.1 million for the three months ended June 30, 2013.

Income Taxes

Our effective tax rate for the three months ended June 30, 2013 and 2012 was 76.0% and 35.0%, respectively. We recognized an income tax benefit of $5.6 million and $1.7 million for the three months ended June 30, 2013 and 2012, respectively. Included in the 76% effective tax rate is a tax benefit of $3.5 million related to the release of certain tax reserves. This was related to the notification by the Internal Revenue Service that the Congressional Joint Committee of Taxation had completed its review of and proposed no changes to our tax returns filed for the tax periods 2008 through 2010.

Six months ended June 30, 2013 compared to the six months ended June 30, 2012

Total Revenues

The following table compares total revenues for the six months ended June 30, 2013 and 2012 (in thousands, except percentages):


	For the six months ended June 30,				Increase (Decrease)
	2013		2012		$			%
Infectious disease net product sales	$	66,731	$	45,113	$	21,618			48	%
Women’s health net product sales		16,994		16,917		77			0	%
Gastrointestinal disease net product sales		3,355		3,186		169			5	%
Other net product sales		2,638		2,726		(88	)		-3	%
Royalty, license fees and grant revenue		1,983		876		1,107			126	%

Total revenues	$	91,701	$	68,818	$	22,883			33	%

For the six months ended June 30, 2013, total revenue increased 33% to $91.7 million from $68.8 million for the six months ended June 30, 2012. The increase in total revenues was largely related to a stronger 2012/2013 cold and flu season as compared to the prior season. The increase in total revenues was also driven by sales of Sofia related products in the six months ended June 30, 2013 as compared to minimal Sofia related sales for the six months ended June 30, 2012 as the product had just been recently launched. Revenues in other product categories remained relatively constant period over period.

Royalty, license fees and grant revenue primarily relates to $1.3 million earned for the six months ended June 30, 2013 in conjunction with the Bill and Melinda Gates Foundation grant as more fully described in Note 1 in the Notes to the Consolidated Financial Statements included in this quarterly report.

Cost of Sales

Cost of sales was $33.2 million, or 36% of total revenues for the six months ended June 30, 2013, compared to $28.8 million, or 42% of total revenues for the six months ended June 30, 2012. The absolute dollar increase in cost of sales is primarily related to the variable nature of direct costs (material and labor) associated with the 33% increase in total revenues. The decrease in cost of sales as a percentage of total revenues is primarily driven by a shift in product mix as flu sales, which have higher margins, were higher in the first quarter of 2013 compared to 2012.

Operating Expenses

The following table compares operating expenses for the six months ended June 30, 2013 and 2012 (in thousands, except percentages):


	For the six months
	ended June 30,
	2013					2012					Increase (Decrease)
	Operating expenses		As a % of total revenues			Operating expenses		As a % of total revenues			$		%
Research and development	$	15,469		17	%	$	15,348		22	%	$	121		1	%
Sales and marketing		15,562		17	%		14,213		21	%		1,349		9	%
General and administrative		13,600		15	%		11,053		16	%		2,547		23	%
Amortization of intangible assets from acquired businesses and technology		3,786		4	%		3,437		5	%		349		10	%

Research and Development Expense

Research and development expense for the six months ended June 30, 2013 increased from $15.3 million to $15.5 million. The increase was due to increased development efforts associated with the development of molecular assays including clinical trial costs for these products for the six months ended June 30, 2013, which was mostly offset by the reimbursement of $1.1 million of costs in the first quarter of 2013 associated with our collaboration agreement with Life Technologies Corporation.

Sales and Marketing Expense

Sales and marketing expense for the six months ended June 30, 2013 increased from $14.2 million to $15.6 million. Starting at the end of the first quarter of 2012 and continuing throughout 2012, we made a substantial investment in our sales organization to support new product growth, including an increase in personnel, commissions, travel, and training costs related to new products. Other key components of this expense relate to continued investment in existing products and customer marketing programs.

General and Administrative Expense

General and administrative expense for the six months ended June 30, 2013 increased from $11.1 million to $13.6 million primarily due to the 2.3% medical device excise tax that went into effect in 2013, resulting in $1.2 million of expense in the six months ended June 30, 2013. The increase was also partially due to $0.7 million of professional services related to business development activities and an increase in incentive compensation of $0.4 million for the six months ended June 30, 2013 related to an increase in total revenues and earnings.

We expect general and administrative expenses to increase in the remaining six months of 2013 relative to 2012 as a result of the 2.3% medical device excise tax.

Amortization of Intangible Assets from Acquired Businesses and Technology

We expect amortization of intangible assets from acquired businesses and technology to increase in the remaining six months of 2013 relative to 2012 as a result of the BioHelix acquisition.

Other Income (Expense)

Income Taxes

For the six months ended June 30, 2013 we recognized an income tax benefit of $0.9 million on pretax income of $9.7 million. The effective tax rate for the six months ended June 30, 2013 differs from the statutory tax rate of 35%. During the three months ended June 30, 2013, we were notified by the Internal Revenue Service that the Congressional Joint Committee of Taxation had completed its review of and proposed no changes to our tax returns filed for the tax periods 2008 through 2010. As a result, we released tax reserves and related interest of approximately $3.5 million as a discrete item. Additionally, on January 3, 2013, the American Taxpayer Relief Act of 2012 was signed into law reinstating the federal research and development credit for the 2012 and 2013 years. Accordingly, the benefit related to the 2012 federal research and development credit of approximately $0.5 million was recorded in the first quarter of 2013 as a discrete item. The benefit related to 2013 research activities is included in the full year effective tax rate.

For the six months ended June 30, 2012, we recognized an income tax benefit of $1.7 million on a pretax loss of $4.8 million, which represents an effective tax rate of 35%.

Liquidity and Capital Resources

As of June 30, 2013 and December 31, 2012, our principal sources of liquidity consisted of the following (in thousands):


	June 30, 2013		December 31, 2012
Cash and cash equivalents	$	21,949	$	14,856
Restricted cash included in prepaid expenses and other current assets		870		2,156

Cash, cash equivalents, and restricted cash	$	22,819	$	17,012

Working capital including cash, cash equivalents, and restricted cash	$	52,782	$	52,271

Amount available to borrow under the Senior Credit Facility	$	139,270	$	110,359

During the year ended December 31, 2012, we received cash, pursuant to a grant agreement, which is restricted as to use until expenditures contemplated in the grant are made. As of June 30, 2013 and December 31, 2012, we recorded this restricted cash as a component of prepaid expenses and other current assets as we anticipate making expenditures under the grant in 2013. The amount available to us under our Senior Credit Facility can fluctuate from time to time due to, among other factors, our funded debt to adjusted EBITDA ratio.

Cash provided by operating activities was $29.3 million during the six months ended June 30, 2013. We had net income of $10.6 million and non-cash charges of $16.2 million related to depreciation and amortization of intangible assets and property and equipment, and stock-based compensation. We also had a decrease in accounts receivable of $19.2 million

and an increase in inventories of $9.1 million due to the seasonal nature of our business. Cash provided by operating activities was $5.2 million during the six months ended June 30, 2012. We had a net loss of $3.1 million and non-cash charges of $14.5 million related to depreciation and amortization of intangible assets and property and equipment and stock-based compensation. Other changes in operating assets and liabilities included an increase in inventory of $2.5 million and a decrease in other accrued liabilities of $2.5 million. The changes are related to the seasonal nature of our business.

Our investing activities used $22.0 million during the six months ended June 30, 2013 primarily related to the $9.2 million of net cash used for the acquisition of BioHelix as more fully described in Note 13 in the Notes to the Consolidated Financial Statements included in this quarterly report. In addition, we used cash for investing activities associated with the acquisition of production and scientific equipment, and building improvements during the six months ended June 30, 2013. Our investing activities used $19.0 million during the six months ended June 30, 2012 primarily related to the acquisition of intangibles associated with our exercise of a buyout clause under the Alere Amendment. During the six months ended June 30, 2012, we exercised the buy-out right under the Alere Amendment, which allowed us to buy-out any remaining future royalty obligation for a fixed cash payment in the amount of $15.7 million less $1.0 million of specified third quarter 2011 royalties. In addition, we used cash for investing activities associated with the acquisition of production and scientific equipment, and building improvements during the six months ended June 30, 2012.

Cash used for financing activities of $183,000 during the six months ended June 30, 2013 primarily related to repayments under our Senior Credit Facility of $5.0 million, which were mostly offset by proceeds from issuance of common stock of $4.9 million. Cash used for financing activities of $27.6 million during the six months ended June 30, 2012 was primarily related to repayments under our Senior Credit Facility of $23.0 million, and repurchases of 200,400 shares of our common stock under our share repurchase program at a cost of approximately $2.9 million.

On August 10, 2012, we entered into an amended and restated $139.3 million Senior Credit Facility, which matures on August 10, 2017. The Senior Credit Facility amended and restated our $120.0 million senior secured credit facility dated October 8, 2008. As part of this amendment, we incurred an additional $1.0 million in deferred financing costs related to the Senior Credit Facility. We had previously recorded $0.6 million related to the original credit facility. As of June 30, 2013 and December 31, 2012, we had $1.3 million and $1.5 million of deferred financing costs included as a portion of other non-current assets. The Senior Credit Facility bears interest at either LIBOR or the base rate, plus, in each case, the applicable margin. The base rate is equal to the highest of (i) the lender’s prime rate, (ii) the federal funds rate plus one-half of one percent and (iii) LIBOR plus one percent. The applicable margin is generally determined in accordance with a performance pricing grid based on our leverage ratio and ranges from 1.25% to 2.50% for LIBOR rate loans and from 0.25% to 1.50% for base rate loans. The agreement governing the Senior Credit Facility is subject to certain customary limitations, including among others: limitation on liens; limitation on mergers, consolidations and sales of assets; limitation on debt; limitation on dividends, stock redemptions and the redemption and/or prepayment of other debt; limitation on investments (including loans and advances) and acquisitions; limitation on transactions with affiliates; and limitation on disposition of assets. We are also subject to financial covenants which include a funded debt to adjusted EBITDA ratio (as defined in the Senior Credit Facility) not to exceed 3:1 as of the end of each fiscal quarter, and an interest coverage ratio of not less than 3:1 as of the end of each fiscal quarter. The Senior Credit Facility is secured by substantially all of our present and future assets and properties. Our ability to borrow under the Senior Credit Facility fluctuates from time to time due to, among other factors, our borrowings under the facility and our funded debt to adjusted EBITDA ratio. At June 30, 2013 and December 31, 2012, we had $0 and $5.0 million outstanding under the Senior Credit Facility, respectively. As of June 30, 2013, we were in compliance with all financial covenants.

Our cash requirements fluctuate as a result of numerous factors, such as the extent to which we generate cash from operations, progress in research and development projects, competition and technological developments and the time and expenditures required to obtain governmental approval of our products. In addition, we intend to continue to evaluate candidates for acquisitions or technology licensing. If we determine to proceed with any such transactions, we may need to incur additional debt, or issue additional equity, to successfully complete the transactions. Based on our current cash position and our current assessment of future operating results, we believe that our existing sources of liquidity will be adequate to meet our operating needs during the next 12 months.

Off-Balance Sheet Arrangements

At June 30, 2013, we did not have any relationships or other arrangements with unconsolidated entities or financial partners, such as entities often referred to as structured finance or special purpose entities, which would have been established for the purpose of facilitating off-balance sheet arrangements or other contractually narrow or limited purposes. As such, we are not materially exposed to any financing, liquidity, market or credit risk that could arise if we had engaged in such relationships.

Critical Accounting Policies and Estimates

Our discussion and analysis of our financial condition and results of operations are based on our consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the U.S. The preparation of these financial statements requires us to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates, including those related to revenue recognition, customer programs and incentives, reserve for uncollectible accounts, inventory valuation, intangible assets, software development costs, stock-based compensation, restructuring, contingencies and litigation, contingent consideration, and income taxes. We base our estimates on historical experience and on various other assumptions that we believe are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

A comprehensive discussion of our critical accounting policies and management estimates is included in Management’s Discussion and Analysis of Financial Condition and Results of Operations in our Annual Report on Form 10-K for the year ended December 31, 2012.

ITEM 3.

Quantitative and Qualitative Disclosures About Market Risk

Interest Rate Risk

The fair market value of our floating interest rate debt is subject to interest rate risk. Generally, the fair market value of floating interest rate debt will vary as interest rates increase or decrease. We had $0 outstanding under our Senior Credit Facility at June 30, 2013. Based on our market risk sensitive instruments outstanding at June 30, 2013, we have determined that such instruments do not expose our consolidated financial position, results of operations or cash flows to material market risk as of such date.

Our current investment policy with respect to our cash and cash equivalents focuses on maintaining acceptable levels of interest rate risk and liquidity. Although we continually evaluate our placement of investments, as of June 30, 2013, our cash and cash equivalents were placed in money market or overnight funds that we believe are highly liquid and not subject to material market fluctuation risk.

Foreign Currency Exchange Risk

The majority of our international sales are negotiated for and paid in U.S. dollars. Nonetheless, these sales are subject to currency risks, since changes in the values of foreign currencies relative to the value of the U.S. dollar can render our products comparatively more expensive. These exchange rate fluctuations could negatively affect international sales of our products, as could changes in the general economic conditions in those markets. Continued change in the values of the Euro, the Japanese Yen and other foreign currencies could have a negative impact on our business, financial condition and results of operations. We do not currently hedge against exchange rate fluctuations, which means that we are fully exposed to exchange rate changes. In addition, we have a supply agreement with a foreign vendor whereby we evenly share the foreign currency exchange fluctuation risk. We may, in the future, enter into similar such arrangements.

ITEM 4.

Controls and Procedures

Evaluation of disclosure controls and procedures: We have performed an evaluation under the supervision and with the participation of our management, including our Chief Executive Officer (“CEO”) and Chief Financial Officer (“CFO”), of the effectiveness of our disclosure controls and procedures, as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”). Based on that evaluation, our CEO and CFO concluded that our disclosure controls and procedures were effective as of June 30, 2013 to provide reasonable assurance that information required to be disclosed by us in the reports filed or submitted by us under the Exchange Act is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms.

Changes in internal control over financial reporting: There was no change in our internal control over financial reporting during the quarter ended June 30, 2013 that materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II OTHER INFORMATION

ITEM 1.

Legal Proceedings

The information set forth in the section entitled Legal under Note 10 of Notes to Consolidated Financial Statements, included in Part I, Item I of this Report, is incorporated herein by reference.

ITEM 1A.

Risk Factors

There has been no material change in our risk factors as previously disclosed in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. For a detailed description of our risk factors, refer to Item 1A, “Risk Factors” of our Annual Report on Form 10-K for the year ended December 31, 2012.

ITEM 2.

Unregistered Sales of Equity Securities and Use of Proceeds

The table below sets forth information regarding repurchases of our common stock by us during the three months ended June 30, 2013:


Period	Total number of shares purchased(1)		Average price paid per share		Total number of shares purchased as part of publicly announced plans or programs		Approximate dollar value of shares that may yet be purchased under the plans or programs (2)
April		9,014	$	22.60		—	$	50,000,000
May		4,034		23.00		—		50,000,000
June		—		—		—		50,000,000

Total		13,048	$	22.15		—	$	50,000,000

(1)	We withheld 13,048 shares of common stock from employees in connection with payment of minimum tax withholding obligations relating to the lapse of restrictions on certain restricted stock awards during the three months ended June 30, 2013.

(2)

On April 23, 2013, we announced that our Board of Directors authorized us to repurchase up to an aggregate of $50.0 million in shares of our common stock under our stock repurchase program. Any shares of common stock repurchased under this program will no longer be deemed outstanding upon repurchase and will be returned to the pool of authorized shares. The repurchase program will expire on April 22, 2015 unless extended by our Board of Directors.

ITEM 3.

Defaults Upon Senior Securities

None.

ITEM 4.

Mine Safety Disclosures

Not applicable.

ITEM 5.

Other Information

None.

ITEM 6.

Exhibits


Exhibit Number
3.1		Restated Certificate of Incorporation of Quidel Corporation. (Incorporated by reference to Exhibit 3.1 to the Registrant’s Form 10-Q for the quarter ended September 30, 2010.)

3.2		Amended and Restated Bylaws of Quidel Corporation. (Incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed on May 21, 2012.)

4.1		Certificate of Designations of Series C Junior Participating Preferred Stock. (Incorporated by reference to Exhibit 4.1 to the Registrant’s Form 10-Q for the quarter ended September 30, 2010.)

31.1*		Certification by Principal Executive Officer of Registrant pursuant to Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification by Principal Financial and Accounting Officer of Registrant pursuant to Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certifications by Principal Executive Officer and Principal Financial and Accounting Officer of Registrant pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101		XBRL Instance Document

101		XBRL Taxonomy Extension Schema Document

101		XBRL Taxonomy Calculation Linkbase Document

101		XBRL Taxonomy Extension Definition Linkbase Document

101		XBRL Taxonomy Label Linkbase Document

101		XBRL Taxonomy Presentation Linkbase Document

*	Filed herewith.

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.


Date: July 31, 2013				QUIDEL CORPORATION

				/s/ DOUGLAS C. BRYANT
				Douglas C. Bryant
				President and Chief Executive Officer (Principal Executive Officer)

				/s/ RANDALL J. STEWARD
				Randall J. Steward
				Chief Financial Officer (Principal Financial Officer and Accounting Officer)

Exhibit Index


Exhibit Number
3.1		Restated Certificate of Incorporation of Quidel Corporation. (Incorporated by reference to Exhibit 3.1 to the Registrant’s Form 10-Q for the quarter ended September 30, 2010.)

3.2		Amended and Restated Bylaws of Quidel Corporation. (Incorporated by reference to Exhibit 3.1 to the Registrant’s Form 8-K filed on May 21, 2012.)

4.1		Certificate of Designations of Series C Junior Participating Preferred Stock. (Incorporated by reference to Exhibit 4.1 to the Registrant’s Form 10-Q for the quarter ended September 30, 2010.)

31.1*		Certification by Principal Executive Officer of Registrant pursuant to Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification by Principal Financial and Accounting Officer of Registrant pursuant to Rules 13a-14 and 15d-14, as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certifications by Principal Executive Officer and Principal Financial and Accounting Officer of Registrant pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101		XBRL Instance Document

101		XBRL Taxonomy Extension Schema Document

101		XBRL Taxonomy Calculation Linkbase Document

101		XBRL Taxonomy Extension Definition Linkbase Document

101		XBRL Taxonomy Label Linkbase Document

101		XBRL Taxonomy Presentation Linkbase Document

*	Filed herewith.

EX-31.1 2 d555383dex311.htm EX-31.1 EX-31.1

Exhibit 31.1

CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Douglas C. Bryant, certify that:

I have reviewed this quarterly report on Form 10-Q of Quidel Corporation;

Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

(a)

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

(b)

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

(c)

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

(d)

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

(a)

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: July 31, 2013
				/s/ DOUGLAS C. BRYANT
				Douglas C. Bryant
				President and Chief Executive Officer (Principal Executive Officer)

EX-31.2 3 d555383dex312.htm EX-31.2 EX-31.2

Exhibit 31.2

CERTIFICATION OF PRINCIPAL FINANCIAL AND ACCOUNTING OFFICER

PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Randall J. Steward, certify that:

I have reviewed this quarterly report on Form 10-Q of Quidel Corporation;

(a)

(b)

(c)

(d)

(a)

(b)

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.


Date: July 31, 2013
		/s/ RANDALL J. STEWARD
		Randall J. Steward
		Chief Financial Officer (Principal Financial Officer and Accounting Officer)

EX-32.1 4 d555383dex321.htm EX-32.1 EX-32.1

Exhibit 32.1

Certifications by the Principal Executive Officer and Principal Financial and Accounting Officer of Registrant

pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

Each of the undersigned hereby certifies, in his capacity as an officer of Quidel Corporation, a Delaware corporation (the “Company”), for purposes of 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of his knowledge:

•

the Company’s Quarterly Report on Form 10-Q for the period ended June 30, 2013 (the “Report”), as filed with the Securities and Exchange Commission on the date hereof, fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and

•

the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: July 31, 2013

/s/ DOUGLAS C. BRYANT

Douglas C. Bryant

President and Chief Executive Officer

(Principal Executive Officer)

/s/ RANDALL J. STEWARD

Randall J. Steward

Chief Financial Officer

(Principal Financial Officer and Accounting Officer)

EX-101.INS 5 qdel-20130630.xml XBRL INSTANCE DOCUMENT

140000000

33904942

120000000

19879000

33868000

5000000

50000000

0.001

300000

1295000

500000

193526000

5286000

5577000

18219000

1548000

6828000

5537000

903000

219488000

11919000

6278000

139300000

25928000

3449000

71243000

1340000

34000

265101000

9465000

171000

5192000

4900000

12407000

71001000

82716000

68289000

1691000

17345000

900000

265101000

21069000

21949000

13595000

24664000

9965000

7003000

151005000

222248000

27347000

6058000

8647000

9087000

179000

86165000

8781000

4735000

9014000

8434000

41404000

701000 2200000 0.10 11703000 872000 1300000 5354000 409000 3200000 10000000 66019000 2000000 2500000 1514000 1795000 10124000 375000

1000000

600000

0.0150

0.0025

0.0250

0.0125

13000000 5000000

3000000

16000000

10000000 11900000 11900000

1600000

6100000

2270000

700000

2270000

300000

600000

4078000

10484000

14562000

25371000

31659000

57030000

530000

4360000

33672000

16106000

49778000

8800000

700000

1627000

73000

1700000

563000

3328000

3891000

2483000

4369000

6852000

61332000

28800000

33452000

5000000

50000000

0.001

700000

1280000

5000000

707000

600000

184431000

7864000

22501000

4548000

9051000

6016000

1354000

199780000

15316000

3448000

63021000

450000

33000

242099000

3349000

5000000

955000

8241000

74772000

71013000

60341000

1817000

2200000

242099000

14856000

32570000

15496000

5228000

131354000

194375000

5228000

4686000

74461000

6622000

5582000

34156000

2300000 0.10 2156000 1500000 5567000 380000 22400000 2693000

2800000

11000000

1570000

300000

2100000

3887000

1125000

5012000

22308000

30362000

52670000

29386000

19992000

49378000

1594000

106000

1700000

391000

2871000

3262000

2007000

4315000

6322000

QDEL QUIDEL CORP /DE/ false Accelerated Filer 2013 10-Q 2013-06-30 0000353569 --12-31 Q2

<div> Note 10. Commitments and Contingencies Legal The Company is involved in various claims and litigation matters from time to time in the ordinary course of business. Management believes that all such current legal actions, in the aggregate, will not have a material adverse effect on the Company. The Company also maintains insurance, including coverage for product liability claims, in amounts which management believes are appropriate given the nature of its business. At June 30, 2013 and December 31, 2012, the Company had $0.3 million accrued as a liability for various legal matters where the Company deemed the liability probable and estimable. Licensing Arrangements The Company has entered into various other licensing and royalty agreements, which largely require payments based on specified product sales as well as the achievement of specified milestones. The Company had royalty and license expenses relating to those agreements of $0.3 million, $0.4 million, $0.7 million and $0.8 million for both the three months ended June 30, 2013 and 2012 and the six months ended June 30, 2013 and 2012, respectively. Research and Development Agreements The Company has entered into various research and development agreements which provide it with rights to develop, manufacture and market products using the intellectual property and technology of its collaborative partners. Under the terms of certain of these agreements, the Company is required to make periodic payments based on the Company’s achievement of certain milestones or resource expenditures. These milestones generally include achievement of prototype assays, validation lots and clinical trials. At June 30, 2013 and December 31, 2012, total current commitments due under the terms of these agreements are estimated at $0.6 million and $2.1 million, respectively. The commitments will fluctuate as we agree to new phases of development under the existing arrangements. Contingent Consideration The Company recorded $11.9 million of contingent consideration in conjunction with the BioHelix acquisition as more fully described in Note 13. </div>

<div> Revenue Recognition The Company records revenues primarily from product sales. These revenues are recorded net of rebates and other discounts which are estimated at the time of sale, and are largely driven by various customer program offerings, including special pricing agreements, promotions and other volume-based incentives. Revenue from product sales are recorded upon passage of title and risk of loss to the customer. Change in title to the product and recognition of revenue occurs upon delivery to the customer when sales terms are free on board (“FOB”) destination and at the time of shipment when the sales terms are FOB shipping point and there is no right of return. The Company also earns income from the licensing of technology. The Company earns income from grants for research and commercialization activities. On November 6, 2012, the Company was awarded a milestone-based grant totaling up to $8.3 million from the Bill and Melinda Gates Foundation to develop, manufacture and validate a quantitative, low-cost, nucleic acid assay for HIV drug treatment monitoring on the integrated Savanna™ MDx platform for use in limited resource settings. Upon execution of the grant agreement, the Company received $2.6 million to fund subsequent research and development activities. The Company expects to receive milestone payments of $2.5 million in 2013 and $3.2 million in 2014 and will recognize grant revenue on the lesser of the amount recognized on a straight-line basis or the amount that is non-refundable through the end of the agreement, which is December 31, 2015. For the three and six months ended June 30, 2013, the Company recognized $0.7 million and $1.3 million as grant revenue associated with this grant. The Company has included $0.9 million and $2.2 million of restricted cash as a component of prepaid expenses and other current assets and as a component of other current liabilities as of June 30, 2013 and December 31, 2012, respectively. </div>

0.30

0.44

34716000

<div> Comprehensive Income (Loss) Net (loss) income is equal to comprehensive (loss) income for the three and six months ended June 30, 2013 and 2012, respectively. </div>

1058000

121375

<div> Note 11. Lease Obligation During 1999, the Company completed a sale and leaseback transaction of its San Diego facility. The facility was sold for $15.0 million, of which $3.8 million was capital contributed by the Company. The sale was an all cash transaction, netting the Company approximately $7.0 million. The Company is a 25% limited partner in the partnership that acquired the facility. The transaction was deemed a financing transaction under the guidance in ASC Topic 840-40, Accounting for Sales of Real Estate. The assets sold remain on the books of the Company and will continue to be depreciated over the estimated useful life. In December 2009, the Company amended the terms of its lease agreement which had no significant impact on the Company’s financial statements. The amended terms include a new ten-year lease term through December 2019, with options to extend the lease for up to three additional five-year periods. The Company will amortize the lease obligation over this new term. The amount of the monthly rental payments remains the same under the amendment. The combined carrying value of the land and building subject to this lease, net of accumulated depreciation, was $2.2 million and $2.3 million as of June 30, 2013 and December 31, 2012, respectively. In addition, the Company has the option to purchase the general partner’s interest in the partnership in January 2015 for a fixed price. The Company has determined that the partnership is a variable interest entity (VIE). The Company is not, however, the primary beneficiary of the VIE as it does not absorb the majority of the partnership’s expected losses or receive a majority of the partnership’s residual returns. The Company made lease payments to the partnership of approximately $0.6 million for each of the six months ended June 30, 2013 and 2012 and $0.3 million for each of the three months ended June 30, 2013 and 2012. </div>

<div> The following table summarizes the expected future annual amortization expense of intangible assets recorded on the Company’s condensed consolidated balance sheet as of June 30, 2013 (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="85%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom">For the years ending December 31,</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Expense</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2013 (remaining six months) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,434</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,345</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,965</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2016 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,087</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,781</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Thereafter </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,407</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total expected future amortization </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">66,019</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

0.31

<div> The Company had sales to individual customers in excess of 10% of total revenue, as follows:   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> A </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> B </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">24</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> Note 7. Line of Credit On August 10, 2012, the Company entered into an amended and restated $140.0 million senior secured syndicated credit facility (the “Senior Credit Facility”), which matures on August 10, 2017. The Senior Credit Facility amended and restated the Company’s $120.0 million senior secured credit facility dated October 8, 2008. As part of this amendment, the Company incurred an additional $1.0 million in deferred financing costs related to the Senior Credit Facility. The Company had previously recorded $0.6 million related to the original credit facility. Deferred financing costs are amortized on a straight line basis over the term of the Senior Credit Facility. As of June 30, 2013 and December 31, 2012, the Company had deferred financing costs of $1.3 million and $1.5 million, respectively, included as a portion of other non-current assets. The Senior Credit Facility bears interest at either the London Interbank Offered Rate (“LIBOR”) or the base rate, plus, in each case, the applicable margin. The base rate is equal to the highest of (i) the lender’s prime rate, (ii) the federal funds rate plus one-half of one percent and (iii) LIBOR plus one percent. The applicable margin is generally determined in accordance with a performance pricing grid based on the Company’s leverage ratio and ranges from 1.25% to 2.50% for LIBOR rate loans and from 0.25% to 1.50% for base rate loans. The agreement governing the Senior Credit Facility is subject to certain customary limitations, including among others: limitation on liens; limitation on mergers, consolidations and sales of assets; limitation on debt; limitation on dividends, stock redemptions and the redemption and/or prepayment of other debt; limitation on investments (including loans and advances) and acquisitions; limitation on transactions with affiliates; and limitation on disposition of assets. The Company is also subject to financial covenants which include a funded debt to adjusted EBITDA ratio (as defined in the Senior Credit Facility, with adjusted EBITDA generally calculated as earnings before, among other adjustments, interest, taxes, depreciation, amortization, and stock-based compensation) not to exceed 3:1 as of the end of each fiscal quarter, and an interest coverage ratio of not less than 3:1 as of the end of each fiscal quarter. The Senior Credit Facility is secured by substantially all present and future assets and properties of the Company. As of June 30, 2013, the Company had $139.3 million available under the Senior Credit Facility. The Company’s ability to borrow under the Senior Credit Facility fluctuates from time to time due to, among other factors, the Company’s borrowings under the facility and its funded debt to adjusted EBITDA ratio. As of June 30, 2013 and December 31, 2012, the Company had $0 and $5.0 million, respectively, outstanding under the Senior Credit Facility. As of June 30, 2013, the Company was in compliance with all financial covenants. </div>

0.30

<div> Note 12. Fair Value Measurement ASC Topic 820, Fair Value Measurements and Disclosures requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed by the Company in one of the following three categories: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices for identical assets and liabilities in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity). As of June 30, 2013 and December 31, 2012, the carrying amount of the Company’s cash equivalents approximates fair value. Cash equivalents primarily consisted of funds held in a money market account. As of the periods ended June 30, 2013 and December 31, 2012, the carrying value of cash equivalents was $16.0 million and $11.0 million, respectively, and was determined based on Level 1 inputs. As of December 31, 2012, the carrying amount of the Company’s Senior Credit Facility approximates fair value because it has a variable interest rate that reflects market changes to interest rates and changes in the Company’s leverage ratio. As of December 31, 2012, the Company used Level 2 inputs to determine the fair value of its Senior Credit Facility. The Company preliminarily measured its contingent consideration liability of $11.9 million arising from its acquisition of BioHelix using level 3 unobservable inputs (see Note 13). </div>

<div> Other current liabilities consist of the following (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">December 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer incentives </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,514</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,693</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Customer prepayments </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,340</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">450</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Unearned grant revenue </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">872</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,156</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Income tax payable </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">171</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">955</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Accrued liability for technology licenses </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">707</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Other </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,295</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,280</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,192</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,241</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

0.10

P5Y6M11D

<div> The estimated fair value of each stock option award was determined on the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions for the option grants.   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="86%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Expected option life (in years) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.53</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.57</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Volatility rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">44</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">46</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Risk-free interest rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.86</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.74</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr> <td valign="top"> Dividend rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> </table> </div>

<div> Note 3. Inventories Inventories are recorded at the lower of cost (first-in, first-out) or market. Inventories consisted of the following, net of reserves of $0.5 million and $0.6 million at June 30, 2013 and December 31, 2012, respectively (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">December 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Raw materials </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,014</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,582</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Work - in - process (materials, labor and overhead) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,647</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,686</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Finished goods (materials, labor and overhead) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,003</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,228</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">24,664</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">15,496</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> The following table sets forth the computation of basic and diluted EPS for the six months ended June 30, 2013 (in thousands, except per share amounts):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Basic net income per share: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net income </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,612</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Less: income allocated to participating securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(32</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income allocated to common stockholders </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,580</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — basic </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">33,658</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income per share — basic </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.31</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Diluted net income per share: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net income </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,612</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Less: income allocated to participating securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(31</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income allocated to common stockholders </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,581</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — basic </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">33,658</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Dilutive securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,058</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — diluted </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">34,716</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income per share — diluted </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.30</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> Note 8. Stockholders’ Equity Issuances and Repurchases of Common Stock During the six months ended June 30, 2013, 121,375 shares of common stock were issued in conjunction with the vesting and release of restricted stock units, 405,917 shares of common stock were issued due to the exercise of stock options and 24,733 shares of common stock were issued in connection with the Company’s employee stock purchase plan (the “ESPP”), resulting in net proceeds to the Company of approximately $4.9 million. Additionally, during the six months ended June 30, 2013, 38,360 shares of outstanding common stock with a value of $0.9 million were repurchased in connection with payment of minimum tax withholding obligations for certain employees relating to the lapse of restrictions on certain restricted stock awards. As of June 30, 2013, there was $50.0 million remaining under the Company’s share repurchase program. Stock-Based Compensation The compensation expense related to the Company’s stock-based compensation plans included in the accompanying Consolidated Statements of Income for the three and six months ended June 30, 2013 and 2012 was as follows (in millions):   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="80%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Cost of sales </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.1</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.4</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.7</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.6</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Sales and marketing </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> General and administrative </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.1</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.6</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.5</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.9</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.7</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4.0</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.6</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> Total compensation expense recognized for the three months ended June 30, 2013 and 2012 includes $1.0 million and $1.1 million related to stock options and $0.9 million and $0.6 million related to restricted stock, respectively. Total compensation expense recognized for the six months ended June 30, 2013 and 2012 includes $2.3 million and $2.1 million related to stock options and $1.7 million and $1.5 million related to restricted stock, respectively. As of June 30, 2013, total unrecognized compensation expense related to non-vested stock options was $6.1 million, which is expected to be recognized over a weighted-average period of approximately 2.6 years. As of June 30, 2013, total unrecognized compensation expense related to non-vested restricted stock was $1.6 million, which is expected to be recognized over a weighted-average period of approximately 1.5 years. Compensation expense capitalized to inventory and compensation expense related to the Company’s ESPP were not material for the three and six months ended June 30, 2013 and 2012. The estimated fair value of each stock option award was determined on the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions for the option grants.   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="86%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Expected option life (in years) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.53</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.57</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Volatility rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">44</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">46</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Risk-free interest rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.86</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.74</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr> <td valign="top"> Dividend rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> </table> The weighted-average grant date fair value of stock options granted during the six months ended June 30, 2013 and 2012 was $9.19 and $6.51, respectively. The Company granted 529,134 and 621,705 stock options during the six months ended June 30, 2013 and 2012, respectively. The weighted-average grant date fair value of restricted stock granted during the six months ended June 30, 2013 and 2012 was $23.18 and $15.45, respectively. The Company granted 68,994 and 132,205 shares of restricted stock during the six months ended June 30, 2013 and 2012, respectively. The grant date fair value of restricted stock is determined based on the closing market price of the Company’s common stock on the grant date. </div>

The Company was in compliance with all financial covenants.

<div> Inventories consisted of the following, net of reserves of $0.5 million and $0.6 million at June 30, 2013 and December 31, 2012, respectively (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">December 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Raw materials </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,014</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,582</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Work - in - process (materials, labor and overhead) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,647</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,686</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Finished goods (materials, labor and overhead) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,003</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,228</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">24,664</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">15,496</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

38360

0.29

<div> Intangible assets consist of the following (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="45%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Weighted-</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Average</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Useful Life</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Gross</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Accumulated</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Gross</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Accumulated</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> Description </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">(years)</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Assets</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Net</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Assets</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Net</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Goodwill </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">Indefinite</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">86,165</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,449</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">82,716</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">74,461</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,448</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">71,013</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Purchased technology </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">57,030</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(25,371</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">31,659</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,670</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(22,308</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">30,362</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,852</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,483</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,369</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,322</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,007</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,315</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> In-process research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">Indefinite</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,270</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,270</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,570</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,570</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> License agreements </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">49,778</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(33,672</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">16,106</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">49,378</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(29,386</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">19,992</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Patent and trademark costs </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11.9</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14,562</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,078</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,484</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,012</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,887</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,125</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Favorable lease </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9.0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,627</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">73</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,594</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">106</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Software development costs </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.2</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,891</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(563</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,328</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,262</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(391</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,871</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total goodwill and intangible assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">222,248</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(71,243</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">151,005</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">194,375</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(63,021</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">131,354</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

9.19

<div> The Company’s preliminary allocation of the purchase price to the net tangible and intangible assets acquired and liabilities assumed is as follows (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="73%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center">Weighted-average amortization period (years)</td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Acquisition consideration </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Cash consideration </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Settlement of pre-existing liabilities and working capital adjustment </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(850</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net cash consideration </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,150</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Contingent consideration </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,919</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net consideration at closing </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21,069</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Fair market values </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Other current and non-current assets </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">375</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Property, plant and equipment </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">179</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> In-process research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Purchased technology </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,360</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">10</td> </tr> <tr> <td valign="top"> Non-compete agreement </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">5</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Contractual relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">530</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">10</td> </tr> <tr> <td valign="top"> Patents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,800</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">12</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Goodwill </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,703</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Total assets acquired </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">27,347</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Accounts payable and other current liabilities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">701</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Deferred tax liabilities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,577</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total liabilities assumed </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,278</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Purchase price allocation </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21,069</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> </table> </div>

0.00

<div> Note 13. Acquisition In October 2009, the Company entered into a product development and commercialization agreement (the “2009 Agreement”) with BioHelix under which the companies would co-develop a number of hand-held, disposable molecular assays using BioHelix’s proprietary isothermal Helicase Dependent Amplification technology. On May 6, 2013, the Company acquired BioHelix a privately-held, diagnostics company, based in Beverly, Massachusetts. The acquisition has been accounted for in conformity with ASC Topic 805, Business Combinations. In connection with the acquisition of BioHelix, the Company paid $9.2 million in cash, which represents cash consideration of $10.0 million adjusted for settlement of pre-existing liabilities under the 2009 Agreement and final working capital compared to an agreed upon baseline. Additionally, the Company agreed to contingent consideration ranging from $5.0 million to $13.0 million upon achievement of certain research and development milestones and revenue targets through 2018. The contingent consideration was valued, on a preliminary basis, at $11.9 million, based on probability weighted models.   The preliminary purchase price of BioHelix is allocated to the underlying net assets acquired and liabilities assumed based on their estimated respective fair values as of May 6, 2013 with the excess purchase price allocated to goodwill. The Company’s preliminary allocation of the purchase price to the net tangible and intangible assets acquired and liabilities assumed is as follows (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="73%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center">Weighted-average amortization period (years)</td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Acquisition consideration </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Cash consideration </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Settlement of pre-existing liabilities and working capital adjustment </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(850</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net cash consideration </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,150</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Contingent consideration </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,919</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net consideration at closing </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21,069</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Fair market values </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Other current and non-current assets </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">375</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Property, plant and equipment </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">179</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> In-process research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Purchased technology </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,360</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">10</td> </tr> <tr> <td valign="top"> Non-compete agreement </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">5</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Contractual relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">530</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">10</td> </tr> <tr> <td valign="top"> Patents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,800</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">12</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Goodwill </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,703</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Total assets acquired </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">27,347</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Accounts payable and other current liabilities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">701</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Deferred tax liabilities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,577</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total liabilities assumed </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,278</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Purchase price allocation </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21,069</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> </table> The primary areas of the preliminary purchase price allocation that have not been finalized relate to the valuation of contingent consideration and the valuation of intangible assets. Upon completion of the fair value assessment, the Company anticipates that the ultimate contingent consideration and intangible assets may differ from the preliminary assessment outlined above. Any changes to the preliminary estimates of the fair value of the contingent consideration and the intangible assets will be allocated to goodwill during the measurement period, with subsequent changes in estimates recorded in the statement of operations. The goodwill of $11.7 million reflects the complementary strategic fit that the acquisition of BioHelix brought to the Company. None of the goodwill is expected to be deductible for tax purposes. In-process research and development primarily relates to the future commercialization of BioHelix’s development efforts associated with the potential commercialization of products in development at the time of the acquisition. The preliminary value assigned to the identifiable intangible assets was determined by discounting the estimated future cash flows associated with these assets to their present value. The preliminary revenue estimates used to value the purchased technology and patents were based on estimates of relevant market sizes and growth factors, expected trends in technology and the nature and expected timing of new product introductions by BioHelix and its competitors. The rates utilized to discount the net cash flows of purchased technology and patents to their present value are based on the risks associated with the respective cash flows taking into consideration the weighted average cost of capital of the Company. The Company incurred $0.2 million and $0.3 million of transaction costs in conjunction with the BioHelix acquisition included in the consolidated statement of operations for the three and six months ended June 30, 2013, respectively, which impacted both basic and diluted earnings per share by $.01 for both the three and six months ended June 30, 2013.   The following unaudited pro forma financial information shows the combined results of operations of the Company, including BioHelix, as if the acquisition had occurred as of the beginning of the periods presented.   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="80%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"> Six months ended </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom">(in thousands, except per share data)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Pro forma total revenues </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">92,650</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">70,205</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Pro forma net income (loss) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,122</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,505</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Pro forma basic net earnings (loss) per share </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.30</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.11</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Pro forma diluted net earnings (loss) per share </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.29</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.11</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total revenue included in the consolidated statements of operations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">188</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net loss included in the consolidated statements of operations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(228</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> </div>

<div> Note 1. Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited consolidated financial statements of Quidel Corporation and its subsidiaries (the “Company”) have been prepared in accordance with generally accepted accounting principles in the U.S. for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included. The information at June 30, 2013, and for the three and six months ended June 30, 2013 and 2012, is unaudited. For further information, refer to the Company’s consolidated financial statements and footnotes thereto for the year ended December 31, 2012 included in the Company’s 2012 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year. For 2013 and 2012, the Company’s fiscal year will or has ended on December 29, 2013 and December 30, 2012, respectively. For 2013 and 2012, the Company’s second quarter ended on June 30, 2013 and July 1, 2012, respectively. For ease of reference, the calendar quarter end dates are used herein. The three and six month periods ended June 30, 2013 and 2012 each included 13 and 26 weeks, respectively. Comprehensive Income (Loss) Net (loss) income is equal to comprehensive (loss) income for the three and six months ended June 30, 2013 and 2012, respectively. Use of Estimates The preparation of financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, management evaluates its estimates, including those related to revenue recognition, customer programs and incentives, reserve for uncollectible accounts, inventory valuation, intangible assets, software development costs, stock-based compensation, restructuring, contingencies and litigation, contingent consideration, and income taxes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. Revenue Recognition The Company records revenues primarily from product sales. These revenues are recorded net of rebates and other discounts which are estimated at the time of sale, and are largely driven by various customer program offerings, including special pricing agreements, promotions and other volume-based incentives. Revenue from product sales are recorded upon passage of title and risk of loss to the customer. Change in title to the product and recognition of revenue occurs upon delivery to the customer when sales terms are free on board (“FOB”) destination and at the time of shipment when the sales terms are FOB shipping point and there is no right of return. The Company also earns income from the licensing of technology. The Company earns income from grants for research and commercialization activities. On November 6, 2012, the Company was awarded a milestone-based grant totaling up to $8.3 million from the Bill and Melinda Gates Foundation to develop, manufacture and validate a quantitative, low-cost, nucleic acid assay for HIV drug treatment monitoring on the integrated Savanna™ MDx platform for use in limited resource settings. Upon execution of the grant agreement, the Company received $2.6 million to fund subsequent research and development activities. The Company expects to receive milestone payments of $2.5 million in 2013 and $3.2 million in 2014 and will recognize grant revenue on the lesser of the amount recognized on a straight-line basis or the amount that is non-refundable through the end of the agreement, which is December 31, 2015. For the three and six months ended June 30, 2013, the Company recognized $0.7 million and $1.3 million as grant revenue associated with this grant. The Company has included $0.9 million and $2.2 million of restricted cash as a component of prepaid expenses and other current assets and as a component of other current liabilities as of June 30, 2013 and December 31, 2012, respectively. Collaborative Arrangement In July 2012, the Company entered into a collaborative arrangement with Life Technologies Corporation for the development of molecular assays. ASC Topic 808, Collaborative Arrangements, defines a collaborative arrangement as an arrangement where the parties are active participants and have exposure to significant risks. The Company is accounting for the joint development and commercialization activities with the third-party as a joint risk sharing collaboration in accordance with ASC Topic 808, Collaborative Arrangements. Payments received or due from Life Technologies Corporation totaled $3.0 million in 2012 and $1.1 million in the six months ended June 30, 2013. The Company expects additional payments of $0.8 million to become due through 2013. The reimbursement represents approximately 50% of project development costs based upon mutually agreed upon project plans for each molecular assay. The reimbursements are recorded as a reduction to research and development expense in the accompanying consolidated financial statements, to the extent that they are less than related expenditures for research and development activities subsequent to the date of the contract. The Company recognized $0 and $1.1 million of such reimbursements as a reduction to research and development expense for the three and six months ended June 30, 2013, respectively. In connection with the collaboration agreement, the Company also entered into a manufacturing and supply agreement with Life Technologies Corporation, which provides for margin sharing. In March 2013, the Company entered into a six year instrument supply agreement (the “March 2013 Agreement”) with Life Technologies Corporation for $0.8 million to sell Life Technologies Corporation’s QuantStudio™ DX diagnostic laboratory instrument for use in the infectious disease field, along with the assays developed under the collaborative agreement. </div>

<div> The following table summarizes the activity related to the Company’s unrecognized tax benefits (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Beginning balance as of December 31, 2012 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,051</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Increases related to prior year tax positions </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">300</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Decrease due to settlements </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,078</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr> <td valign="top"> Increases related to current year tax positions </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">555</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Ending balance as of June 30, 2013 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,828</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

29316000

24733

2019-12-01

33658000

<div> Note 6. Income Taxes The effective tax rate for the three months ended June 30, 2013 and 2012 was 76% and 35%, respectively. Included in the 76% effective tax rate is a tax benefit of $3.5 million related to the release of certain tax reserves. The Company recognized an income tax benefit of $5.6 million and $1.7 million for the three months ended June 30, 2013 and 2012, respectively. This was related to the Company’s notification by the Internal Revenue Service that the Congressional Joint Committee of Taxation had completed its review and proposed no changes to the Company’s tax returns filed for the tax periods 2008 through 2010. For the six months ended June 30, 2013, the Company recognized an income tax benefit of $0.9 million on pretax income of $9.7 million, which represents an effective tax rate of 10%. For the six months ended June 30, 2012, the Company recognized an income tax benefit of $1.7 million on a pretax loss of $4.7 million, which represents an effective tax rate of 35%. Additionally, on January 3, 2013, the American Taxpayer Relief Act of 2012 was signed into law reinstating the federal research and development credit for the 2012 and 2013 years. Accordingly, the benefit related to the 2012 federal research and development credit of approximately $0.5 million was recorded in the first quarter of 2013 as a discrete item. The benefit related to 2013 research activities is included in the full year effective tax rate. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. While the Company believes that it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcome of examinations by tax authorities in determining the adequacy of its provision for income taxes. The following table summarizes the activity related to the Company’s unrecognized tax benefits (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Beginning balance as of December 31, 2012 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,051</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Increases related to prior year tax positions </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">300</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Decrease due to settlements </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,078</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr> <td valign="top"> Increases related to current year tax positions </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">555</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Ending balance as of June 30, 2013 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,828</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> Included in the unrecognized tax benefits of $6.8 million at June 30, 2013 was $4.9 million of tax benefits that, if recognized, would reduce the Company’s annual effective tax rate. The Company does not expect the unrealized tax benefits to decrease over the next 12 months. The Company’s policy is to recognize the interest expense and penalties related to income tax matters as a component of income tax expense. For the three and six months ended June 30, 2013, the Company recognized a net benefit from interest and penalties of $0.4 million and $0.3 million as a component of the Company’s benefit for income taxes in the consolidated statements of operations. For both the three and six months ended June 30, 2012, the Company recognized interest and penalties of $0 million. The Company has accrued approximately $0.3 million and $0.7 million of interest and penalties associated with uncertain tax positions as of June 30, 2013 and December 31, 2012, respectively, and there were no repurchases during the six months ended June 30, 2013. The Company is subject to periodic audits by domestic and foreign tax authorities. The Company’s federal tax years for 2011 and forward are subject to examination by the U.S. authorities. With few exceptions, the Company’s state and foreign tax years for 2000 and forward are subject to examination by tax authorities. The Company believes that it has appropriate support for the income tax positions taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on an assessment of many factors, including past experience and interpretations of tax law applied to the facts of each matter. </div>

<div> Basis of Presentation The accompanying unaudited consolidated financial statements of Quidel Corporation and its subsidiaries (the “Company”) have been prepared in accordance with generally accepted accounting principles in the U.S. for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included. The information at June 30, 2013, and for the three and six months ended June 30, 2013 and 2012, is unaudited. For further information, refer to the Company’s consolidated financial statements and footnotes thereto for the year ended December 31, 2012 included in the Company’s 2012 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year. For 2013 and 2012, the Company’s fiscal year will or has ended on December 29, 2013 and December 30, 2012, respectively. For 2013 and 2012, the Company’s second quarter ended on June 30, 2013 and July 1, 2012, respectively. For ease of reference, the calendar quarter end dates are used herein. The three and six month periods ended June 30, 2013 and 2012 each included 13 and 26 weeks, respectively. </div>

0.0086

<div> The following unaudited pro forma financial information shows the combined results of operations of the Company, including BioHelix, as if the acquisition had occurred as of the beginning of the periods presented.   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="80%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"> Six months ended </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom">(in thousands, except per share data)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Pro forma total revenues </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">92,650</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">70,205</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Pro forma net income (loss) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,122</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,505</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Pro forma basic net earnings (loss) per share </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.30</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.11</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Pro forma diluted net earnings (loss) per share </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.29</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.11</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total revenue included in the consolidated statements of operations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">188</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net loss included in the consolidated statements of operations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(228</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> </div>

<div> Note 2. Computation of (Loss) Earnings Per Share Diluted net income per share is reported based on the more dilutive of the treasury stock or the two-class method. Under the two-class method, net income is allocated to common stock and participating securities. The Company’s unvested restricted stock awards and certain unvested restricted stock units meet the definition of participating securities. Basic net income per share under the two-class method is computed by dividing net income adjusted for earnings allocated to unvested stockholders for the period by the weighted average number of common shares outstanding during the period. Diluted net income per share under the two-class method is computed by dividing net income adjusted for earnings allocated to unvested stockholders for the period by the weighted average number of common and common equivalent shares outstanding during the period. The Company excludes stock options from the calculation of diluted net income per share when the combined exercise price, unrecognized stock-based compensation and assumed tax benefits upon exercise are greater than the average market price for the Company’s common stock because their effect is anti-dilutive. For the six months ended June 30, 2013, 0.4 million stock options were not included in the calculation of diluted earnings per share (“EPS”) as their effect was anti-dilutive. For the three months ended June 30, 2013 and the three and six months ended June 30, 2012 there were no differences between the number of common shares used for the basic and diluted EPS computations as they were periods in which the Company incurred a net loss. Due to the fact that the holders of participating securities are not contractually required to share in the Company’s losses, no allocation to participating securities was made for periods in which the Company incurred a net loss in applying the two-class method to compute basic net loss per common share. For the three months ended June 30, 2013 and 2012 and the six months ended June 30, 2012, 1.1 million, 0.7 million, and 0.7 million stock options and shares of restricted stock, respectively, were excluded from diluted loss per share that would have been included if the Company had been in a net income position. Additionally, for the three months ended June 30, 2013 and 2012 and the six months ended June 30, 2012, 0.6 million, 1.3 million, and 1.5 million stock options, respectively, were not included because the exercise of such options would be anti-dilutive.   The following table sets forth the computation of basic and diluted EPS for the six months ended June 30, 2013 (in thousands, except per share amounts):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Basic net income per share: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net income </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,612</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Less: income allocated to participating securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(32</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income allocated to common stockholders </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,580</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — basic </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">33,658</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income per share — basic </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.31</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Diluted net income per share: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net income </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,612</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Less: income allocated to participating securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(31</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income allocated to common stockholders </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,581</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — basic </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">33,658</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Dilutive securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,058</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — diluted </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">34,716</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income per share — diluted </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.30</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

405917

<div> Note 4. Intangible Assets Intangible assets consist of the following (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="45%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Weighted-</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Average</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Useful Life</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Gross</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Accumulated</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Gross</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Accumulated</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> Description </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">(years)</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Assets</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Net</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Assets</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Net</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Goodwill </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">Indefinite</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">86,165</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,449</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">82,716</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">74,461</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,448</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">71,013</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Purchased technology </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">57,030</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(25,371</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">31,659</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,670</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(22,308</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">30,362</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,852</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,483</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,369</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,322</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,007</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,315</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> In-process research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">Indefinite</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,270</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,270</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,570</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,570</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> License agreements </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">49,778</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(33,672</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">16,106</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">49,378</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(29,386</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">19,992</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Patent and trademark costs </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11.9</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14,562</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,078</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,484</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,012</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,887</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,125</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Favorable lease </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9.0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,627</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">73</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,594</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">106</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Software development costs </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.2</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,891</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(563</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,328</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,262</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(391</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,871</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total goodwill and intangible assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">222,248</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(71,243</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">151,005</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">194,375</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(63,021</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">131,354</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> In 2011, the Company acquired a technology license from Alere Inc. for $28.8 million, which the Company is amortizing over an estimated useful life of 3.5 years based on the higher of the percentage of usage or the straight-line method. This percentage of usage is determined using the revenues generated from products covered by the patents that are subject to the license. The Company recorded $1.1 million, $1.7 million, $4.3 million, and $3.8 million of amortization expense associated with this technology license included as a portion of cost of sales for the three months ended June 30, 2013 and 2012, and the six months ended June 30, 2013 and 2012, respectively. The Company acquired distribution rights for $0.8 million in conjunction with the March 2013 Agreement with Life Technologies Corporation (see Note 1). The distribution rights will be amortized on a straight-line basis over the contractual term of six years. In May 2013, the Company acquired intangible assets in conjunction with the BioHelix Corporation (“BioHelix”) acquisition as more fully described in Note 13. The definite lived intangible assets will be amortized on a straight-line basis. The useful life of the in-process research and development is to be determined, and the amortization will commence upon commercialization of the associated product. The following table summarizes the expected future annual amortization expense of intangible assets recorded on the Company’s condensed consolidated balance sheet as of June 30, 2013 (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="85%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom">For the years ending December 31,</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Expense</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2013 (remaining six months) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,434</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,345</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,965</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2016 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,087</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,781</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Thereafter </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,407</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total expected future amortization </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">66,019</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

The agreement governing the Senior Credit Facility is subject to certain customary limitations, including among others limitation on liens; limitation on mergers, consolidations and sales of assets; limitation on debt; limitation on dividends, stock redemptions and the redemption and/or prepayment of other debt; limitation on investments (including loans and advances) and acquisitions; limitation on transactions with affiliates; and limitation on disposition of assets.

400000

<div> The compensation expense related to the Company’s stock-based compensation plans included in the accompanying Consolidated Statements of Income for the three and six months ended June 30, 2013 and 2012 was as follows (in millions):   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="80%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Cost of sales </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.1</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.4</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.7</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.6</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Sales and marketing </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> General and administrative </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.1</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.6</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.5</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.9</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.7</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4.0</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.6</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>

<div> Use of Estimates The preparation of financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, management evaluates its estimates, including those related to revenue recognition, customer programs and incentives, reserve for uncollectible accounts, inventory valuation, intangible assets, software development costs, stock-based compensation, restructuring, contingencies and litigation, contingent consideration, and income taxes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. </div>

<div> Collaborative Arrangement In July 2012, the Company entered into a collaborative arrangement with Life Technologies Corporation for the development of molecular assays. ASC Topic 808, Collaborative Arrangements, defines a collaborative arrangement as an arrangement where the parties are active participants and have exposure to significant risks. The Company is accounting for the joint development and commercialization activities with the third-party as a joint risk sharing collaboration in accordance with ASC Topic 808, Collaborative Arrangements. Payments received or due from Life Technologies Corporation totaled $3.0 million in 2012 and $1.1 million in the six months ended June 30, 2013. The Company expects additional payments of $0.8 million to become due through 2013. The reimbursement represents approximately 50% of project development costs based upon mutually agreed upon project plans for each molecular assay. The reimbursements are recorded as a reduction to research and development expense in the accompanying consolidated financial statements, to the extent that they are less than related expenditures for research and development activities subsequent to the date of the contract. The Company recognized $0 and $1.1 million of such reimbursements as a reduction to research and development expense for the three and six months ended June 30, 2013, respectively. In connection with the collaboration agreement, the Company also entered into a manufacturing and supply agreement with Life Technologies Corporation, which provides for margin sharing. In March 2013, the Company entered into a six year instrument supply agreement (the “March 2013 Agreement”) with Life Technologies Corporation for $0.8 million to sell Life Technologies Corporation’s QuantStudio™ DX diagnostic laboratory instrument for use in the infectious disease field, along with the assays developed under the collaborative agreement. </div>

300000

5000000

555000

600000

91701000

10580000

9150000

1900000

12000

31000

937000

10581000

1300000

10066000

10122000

1142000

92650000

399000

9679000

-19213000

-387000

10612000

9128000

50000000

858000

11748000

4900000

2949000

81635000

-985000

13600000

-183000

-9000

33218000

3363000

4028000

7093000

15562000

399000

-3803000

-1959000

4922000

-22040000

15469000

-2427000

32000

12123000

937000

3078000

3786000

4000000

300000

-933000

800000 -1491000 188000 1100000 1007000 3 -228000 0.25 1100000 184000 P10Y 700000 -2266000 0.50 2015-01 3 P5Y <div> Note 5. Other Current Liabilities Other current liabilities consist of the following (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">December 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer incentives </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,514</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,693</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Customer prepayments </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,340</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">450</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Unearned grant revenue </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">872</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,156</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Income tax payable </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">171</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">955</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Accrued liability for technology licenses </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">707</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Other </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,295</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,280</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,192</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,241</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div> 456000 0.50 <div> Note 9. Industry and Geographic Information The Company operates in one reportable segment. Sales to customers outside the U.S. represented $12.7 million (14%) and $10.4 million (15%) of total revenue for the six months ended June 30, 2013 and 2012, respectively. As of June 30, 2013 and December 31, 2012, balances due from foreign customers were $3.0 million and $2.8 million, respectively. The Company had sales to individual customers in excess of 10% of total revenue, as follows:   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> A </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> B </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">24</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> As of June 30, 2013, accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $2.0 million while, at December 31, 2012, accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $22.4 million. </div> 3 850000 0.01 21069000

0.005

0.010

0.15

0.11

15000000

7000000

3800000

2600000

400000

700000

300000

0.14

12700000

9150000

300000

68994

23.18

P1Y6M

1700000

529134

P2Y7M6D

2300000

0.26

P11Y10M24D

P8Y3M18D

P10Y

P4Y7M6D

P12Y

P5Y

P9Y

P5Y2M12D

P7Y7M6D

-0.09

0.46

33008000

-0.09

-0.11

0.35

P5Y6M26D

-0.11

6.51

0.00

5183000

33008000

0.0074

1500000

23000000

600000

68818000

27000

-4049000

-3505000

15165000

70205000

-14000

699000

-4721000

-1865000

-672000

-3071000

2459000

3387000

3985000

2876000

72867000

-152000

11053000

-27601000

14000

28816000

-1679000

3595000

-41453000

14213000

699000

-567000

444000

115000

-19035000

15348000

-2506000

10862000

3437000

3600000

-1650000

1498000 764000 300000 160000 800000 31000 917000

0.15

0.09

2500000

300000

600000

200000

0.15

10400000

700000

132205

15.45

1500000

621705

2100000

0.24

2600000 8300000

2017-08-10

P6Y

800000

P3Y6M

3000000

500000

-0.09

32946000

-0.09

0.35

32946000

1300000

300000

30858000

9000

-4519000

-4802000

-283000

-3122000

1438000

35377000

5129000

14008000

7677000

292000

6844000

1719000

1700000

-1680000

400000

1100000

100000

300000

200000

700000

600000

1100000

-0.05

33802000

-0.05

0.76

33802000

600000

300000

29706000

6000

700000

-7123000

-7312000

-189000

-1755000

1511000

36829000

6071000

13671000

7120000

195000

7945000

2022000

1900000

400000

-5557000

0 3500000 300000 0.01

1200000

200000

300000

200000

1100000

200000

900000

1000000

0000353569 us-gaap:EmployeeStockOptionMember 2013-04-01 2013-06-30 0000353569 us-gaap:RestrictedStockMember 2013-04-01 2013-06-30 0000353569 qdel:BioHelixMember 2013-04-01 2013-06-30 0000353569 us-gaap:StockOptionMember 2013-04-01 2013-06-30 0000353569 us-gaap:SellingAndMarketingExpenseMember 2013-04-01 2013-06-30 0000353569 us-gaap:ResearchAndDevelopmentExpenseMember 2013-04-01 2013-06-30 0000353569 us-gaap:CostOfSalesMember 2013-04-01 2013-06-30 0000353569 us-gaap:GeneralAndAdministrativeExpenseMember 2013-04-01 2013-06-30 0000353569 2013-04-01 2013-06-30 0000353569 us-gaap:EmployeeStockOptionMember 2012-04-01 2012-06-30 0000353569 us-gaap:RestrictedStockMember 2012-04-01 2012-06-30 0000353569 us-gaap:StockOptionMember 2012-04-01 2012-06-30 0000353569 us-gaap:SellingAndMarketingExpenseMember 2012-04-01 2012-06-30 0000353569 us-gaap:ResearchAndDevelopmentExpenseMember 2012-04-01 2012-06-30 0000353569 us-gaap:CostOfSalesMember 2012-04-01 2012-06-30 0000353569 us-gaap:GeneralAndAdministrativeExpenseMember 2012-04-01 2012-06-30 0000353569 2012-04-01 2012-06-30 0000353569 2013-01-01 2013-03-31 0000353569 2012-01-01 2012-12-31 0000353569 2011-01-01 2011-12-31 0000353569 us-gaap:DistributionRightsMember 2013-03-01 2013-03-31 0000353569 2013-03-01 2013-03-31 0000353569 2012-08-01 2012-08-31 0000353569 2012-11-01 2012-11-30 0000353569 us-gaap:SalesMember 2012-01-01 2012-06-30 0000353569 us-gaap:EmployeeStockOptionMember 2012-01-01 2012-06-30 0000353569 us-gaap:RestrictedStockMember 2012-01-01 2012-06-30 0000353569 us-gaap:RestrictedStockMember 2012-01-01 2012-06-30 0000353569 us-gaap:SalesMemberqdel:NonUsCustomersMember 2012-01-01 2012-06-30 0000353569 us-gaap:SellingAndMarketingExpenseMember 2012-01-01 2012-06-30 0000353569 us-gaap:ResearchAndDevelopmentExpenseMember 2012-01-01 2012-06-30 0000353569 us-gaap:CostOfSalesMember 2012-01-01 2012-06-30 0000353569 us-gaap:GeneralAndAdministrativeExpenseMember 2012-01-01 2012-06-30 0000353569 us-gaap:SalesMemberus-gaap:OperatingSegmentsMemberqdel:CustomerTwoMember 2012-01-01 2012-06-30 0000353569 us-gaap:SalesMemberus-gaap:OperatingSegmentsMemberqdel:CustomerOneMember 2012-01-01 2012-06-30 0000353569 2012-01-01 2012-06-30 0000353569 us-gaap:CustomerRelationshipsMember 2013-01-01 2013-06-30 0000353569 us-gaap:ComputerSoftwareIntangibleAssetMember 2013-01-01 2013-06-30 0000353569 us-gaap:LeaseAgreementsMember 2013-01-01 2013-06-30 0000353569 us-gaap:NoncompeteAgreementsMember 2013-01-01 2013-06-30 0000353569 us-gaap:PatentsMember 2013-01-01 2013-06-30 0000353569 us-gaap:LicensingAgreementsMember 2013-01-01 2013-06-30 0000353569 qdel:TechnologyPurchasedMember 2013-01-01 2013-06-30 0000353569 qdel:ContractualRelationshipsMember 2013-01-01 2013-06-30 0000353569 qdel:PurchasedTechnologyMember 2013-01-01 2013-06-30 0000353569 qdel:PatentsAndTrademarksMember 2013-01-01 2013-06-30 0000353569 us-gaap:SalesMember 2013-01-01 2013-06-30 0000353569 us-gaap:EmployeeStockOptionMember 2013-01-01 2013-06-30 0000353569 us-gaap:RestrictedStockMember 2013-01-01 2013-06-30 0000353569 qdel:BioHelixMember 2013-01-01 2013-06-30 0000353569 us-gaap:SalesMemberqdel:NonUsCustomersMember 2013-01-01 2013-06-30 0000353569 us-gaap:SellingAndMarketingExpenseMember 2013-01-01 2013-06-30 0000353569 us-gaap:ResearchAndDevelopmentExpenseMember 2013-01-01 2013-06-30 0000353569 us-gaap:CostOfSalesMember 2013-01-01 2013-06-30 0000353569 us-gaap:GeneralAndAdministrativeExpenseMember 2013-01-01 2013-06-30 0000353569 qdel:SanDiegoFacilityMember 2013-01-01 2013-06-30 0000353569 us-gaap:SalesMemberus-gaap:OperatingSegmentsMemberqdel:CustomerTwoMember 2013-01-01 2013-06-30 0000353569 us-gaap:SalesMemberus-gaap:OperatingSegmentsMemberqdel:CustomerOneMember 2013-01-01 2013-06-30 0000353569 qdel:LondonInterbankOfferRateLoansMember 2013-01-01 2013-06-30 0000353569 qdel:FederalFundsRateMember 2013-01-01 2013-06-30 0000353569 2013-01-01 2013-06-30 0000353569 us-gaap:CustomerRelationshipsMember 2012-12-31 0000353569 us-gaap:ComputerSoftwareIntangibleAssetMember 2012-12-31 0000353569 us-gaap:LeaseAgreementsMember 2012-12-31 0000353569 us-gaap:LicensingAgreementsMember 2012-12-31 0000353569 qdel:PurchasedTechnologyMember 2012-12-31 0000353569 qdel:PatentsAndTrademarksMember 2012-12-31 0000353569 qdel:ResearchAndDevelopmentCollaborationAgreementsMember 2012-12-31 0000353569 qdel:ClaimsAndLitigationMember 2012-12-31 0000353569 us-gaap:InProcessResearchAndDevelopmentMember 2012-12-31 0000353569 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member 2012-12-31 0000353569 qdel:NonUsCustomersMember 2012-12-31 0000353569 2012-12-31 0000353569 us-gaap:PatentedTechnologyMember 2011-12-31 0000353569 2011-12-31 0000353569 us-gaap:CustomerRelationshipsMember 2013-06-30 0000353569 us-gaap:ComputerSoftwareIntangibleAssetMember 2013-06-30 0000353569 us-gaap:LeaseAgreementsMember 2013-06-30 0000353569 us-gaap:NoncompeteAgreementsMember 2013-06-30 0000353569 us-gaap:PatentsMember 2013-06-30 0000353569 us-gaap:LicensingAgreementsMember 2013-06-30 0000353569 qdel:TechnologyPurchasedMember 2013-06-30 0000353569 qdel:ContractualRelationshipsMember 2013-06-30 0000353569 qdel:PurchasedTechnologyMember 2013-06-30 0000353569 qdel:PatentsAndTrademarksMember 2013-06-30 0000353569 qdel:ResearchAndDevelopmentCollaborationAgreementsMember 2013-06-30 0000353569 qdel:ClaimsAndLitigationMember 2013-06-30 0000353569 us-gaap:InProcessResearchAndDevelopmentMember 2013-06-30 0000353569 us-gaap:EmployeeStockOptionMember 2013-06-30 0000353569 us-gaap:RestrictedStockMember 2013-06-30 0000353569 qdel:BioHelixMemberus-gaap:FairValueInputsLevel3Member 2013-06-30 0000353569 qdel:BioHelixMember 2013-06-30 0000353569 us-gaap:MoneyMarketFundsMemberus-gaap:FairValueInputsLevel1Member 2013-06-30 0000353569 qdel:NonUsCustomersMember 2013-06-30 0000353569 qdel:BioHelixMemberus-gaap:MinimumMember 2013-06-30 0000353569 qdel:BioHelixMemberus-gaap:MaximumMember 2013-06-30 0000353569 qdel:LondonInterbankOfferRateLoansMemberus-gaap:MinimumMember 2013-06-30 0000353569 qdel:LondonInterbankOfferRateLoansMemberus-gaap:MaximumMember 2013-06-30 0000353569 us-gaap:BaseRateMemberus-gaap:MinimumMember 2013-06-30 0000353569 us-gaap:BaseRateMemberus-gaap:MaximumMember 2013-06-30 0000353569 qdel:SeniorCreditFacilityMemberus-gaap:ScenarioPreviouslyReportedMember 2013-06-30 0000353569 qdel:SeniorCreditFacilityMember 2013-06-30 0000353569 2013-06-30 0000353569 2012-06-30 0000353569 qdel:SeniorSecuredCreditFacilityMember 2008-10-08 0000353569 2013-07-25 0000353569 2012-08-10 iso4217:USD shares iso4217:USD shares pure qdel:Segment qdel:Lease

EX-101.SCH 6 qdel-20130630.xsd XBRL TAXONOMY EXTENSION SCHEMA 101 - Document - Document and Entity Information link:calculationLink link:presentationLink link:definitionLink 103 - Statement - CONSOLIDATED BALANCE SHEETS link:calculationLink link:presentationLink link:definitionLink 104 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 105 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS link:calculationLink link:presentationLink link:definitionLink 106 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) link:calculationLink link:presentationLink link:definitionLink 107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS link:calculationLink link:presentationLink link:definitionLink 108 - Disclosure - Summary of Significant Accounting Policies link:calculationLink link:presentationLink link:definitionLink 109 - Disclosure - Computation of (Loss) Earnings Per Share link:calculationLink link:presentationLink link:definitionLink 110 - Disclosure - Inventories link:calculationLink link:presentationLink link:definitionLink 111 - Disclosure - Intangible Assets link:calculationLink link:presentationLink link:definitionLink 112 - Disclosure - Other Current Liabilities link:calculationLink link:presentationLink link:definitionLink 113 - Disclosure - Income Taxes link:calculationLink link:presentationLink link:definitionLink 114 - Disclosure - Line of Credit link:calculationLink link:presentationLink link:definitionLink 115 - Disclosure - Stockholders' Equity link:calculationLink link:presentationLink link:definitionLink 116 - Disclosure - Industry and Geographic Information link:calculationLink link:presentationLink link:definitionLink 117 - Disclosure - Commitments and Contingencies link:calculationLink link:presentationLink link:definitionLink 118 - Disclosure - Lease Obligation link:calculationLink link:presentationLink link:definitionLink 119 - Disclosure - Fair Value Measurement link:calculationLink link:presentationLink link:definitionLink 120 - Disclosure - Acquisition link:calculationLink link:presentationLink link:definitionLink 121 - Disclosure - Summary of Significant Accounting Policies (Policies) link:calculationLink link:presentationLink link:definitionLink 122 - Disclosure - Computation of (Loss) Earnings Per Share (Tables) link:calculationLink link:presentationLink link:definitionLink 123 - Disclosure - Inventories (Tables) link:calculationLink link:presentationLink link:definitionLink 124 - Disclosure - Intangible Assets (Tables) link:calculationLink link:presentationLink link:definitionLink 125 - Disclosure - Other Current Liabilities (Tables) link:calculationLink link:presentationLink link:definitionLink 126 - Disclosure - Income Taxes (Tables) link:calculationLink link:presentationLink link:definitionLink 127 - Disclosure - Stockholders' Equity (Tables) link:calculationLink link:presentationLink link:definitionLink 128 - Disclosure - Industry and Geographic Information (Tables) link:calculationLink link:presentationLink link:definitionLink 129 - Disclosure - Acquisition (Tables) link:calculationLink link:presentationLink link:definitionLink 130 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 131 - Disclosure - Computation of (Loss) Earnings Per Share - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 132 - Disclosure - Computation of (Loss) Earnings Per Share - Basic and Diluted EPS (Detail) link:calculationLink link:presentationLink link:definitionLink 133 - Disclosure - Inventories - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 134 - Disclosure - Inventories - Summary of Inventories (Detail) link:calculationLink link:presentationLink link:definitionLink 135 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Detail) link:calculationLink link:presentationLink link:definitionLink 136 - Disclosure - Intangible Assets - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 137 - Disclosure - Intangible Assets - Summary of Expected Future Annual Amortization Expense of Intangible Assets (Detail) link:calculationLink link:presentationLink link:definitionLink 138 - Disclosure - Other Current Liabilities - Other Current Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 139 - Disclosure - Income Taxes - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 140 - Disclosure - Income Taxes - Summary of Unrecognized Tax Benefits (Detail) link:calculationLink link:presentationLink link:definitionLink 141 - Disclosure - Line of Credit - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 142 - Disclosure - Stockholders' Equity - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 143 - Disclosure - Stockholders' Equity - Compensation Expense Related to Stock-Based Compensation Plans (Detail) link:calculationLink link:presentationLink link:definitionLink 144 - Disclosure - Stockholders' Equity - Estimated Fair Value of Each Stock Option Award (Detail) link:calculationLink link:presentationLink link:definitionLink 145 - Disclosure - Industry and Geographic Information - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 146 - Disclosure - Industry and Geographic Information - Sales to Individual Customers in Excess of 10% of Total Revenue (Detail) link:calculationLink link:presentationLink link:definitionLink 147 - Disclosure - Commitments and Contingencies - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 148 - Disclosure - Lease Obligation - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 149 - Disclosure - Fair Value Measurement - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 150 - Disclosure - Acquisition - Additional Information (Detail) link:calculationLink link:presentationLink link:definitionLink 151 - Disclosure - Acquisition - Allocation of Purchase Price to Net Tangible and Intangible Assets Acquired and Liabilities (Detail) link:calculationLink link:presentationLink link:definitionLink 152 - Disclosure - Acquisition - Schedule of Pro Forma Financial Information (Detail) link:calculationLink link:presentationLink link:definitionLink EX-101.CAL 7 qdel-20130630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 8 qdel-20130630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 9 qdel-20130630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Accounting Policies [Abstract] Accounting Policies [Abstract] Accounts Payable Current Accounts payable Accounts receivable from major customers. Accounts Receivable From Major Customers Accounts receivable due in excess of 10% Accounts Receivable Net Balances due from foreign customers Accounts Receivable Net Current Accounts receivable, net Accrued Income Taxes Current Income tax payable Accrued Income Taxes Noncurrent Income taxes payable Acquired Finite Lived Intangible Assets [Line Items] Acquired Finite-Lived Intangible Assets [Line Items] Acquired Finite Lived Intangible Assets Weighted Average Useful Life Weighted-average amortization period Additional Paid In Capital Additional paid-in capital Adjustments To Reconcile Net Income Loss To Cash Provided By Used In Operating Activities [Abstract] Adjustments to reconcile net income (loss) to net cash provided by operating activities: Allocated Share Based Compensation Expense Share-based compensation expense recognized Stock-based compensation expense The amended terms. Amended Terms Amended terms Amendment Flag Amendment Flag Amortization Of Intangible Assets Amortization expense Amortization of intangible assets from acquired businesses and technology Amount of fund received for subsequent research and commercialization activities. Amount Of Fund Received For Subsequent Research And Commercialization Activities Fund received for research and development activities Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount Shares excluded from calculation of diluted (loss) earnings per share ("EPS") Antidilutive Securities Excluded From Computation Of Earnings Per Share By Antidilutive Securities [Axis] Antidilutive Securities [Axis] Antidilutive Securities Name [Domain] Antidilutive Securities, Name [Domain] Assets Total assets Assets [Abstract] ASSETS Assets Current Total current assets Assets Current [Abstract] Current assets: Award Type [Axis] Award Type [Axis] Base Rate [Member] Base rate loans [Member] Basis Of Accounting Policy Policy [Text Block] Basis of Presentation Basis Of Presentation And Significant Accounting Policies [Text Block] Summary of Significant Accounting Policies Bio Helix [Member] Bio Helix [Member] BioHelix [Member] Business Acquisition Acquiree [Domain] Business Acquisition, Acquiree [Domain] Business Acquisition [Axis] Business Acquisition [Axis] Business Acquisition Contingent Consideration Fair Value Business Acquisition Contingent Consideration Fair Value Contingent consideration Contingent consideration, fair value of goal Business Acquisition Cost Of Acquired Entity Transaction Cost Business Acquisition Cost Of Acquired Entity Transaction Cost Transaction costs in conjunction with acquisition Business Acquisition, Cost of Acquired Entity Transaction Costs, Impact on Basic and Diluted Earnings Per Share Business Acquisition Cost Of Acquired Entity Transaction Costs Impact On Basic And Diluted Earnings Per Share Impacted on basic and diluted earnings per share Business Acquisition [Line Items] Business Acquisition [Line Items] Business Acquisition Pro Forma Earnings Per Share Basic Pro forma basic net earnings (loss) per share Business Acquisition Pro Forma Earnings Per Share Diluted Pro forma diluted net earnings (loss) per share Business Acquisition Pro Forma Gross Profit Business Acquisition Pro Forma Gross Profit Total revenue included in the consolidated statements of operations Business Acquisition Pro Forma Information [Text Block] Schedule of Pro Forma Financial Information Business Acquisition Pro Forma Net Income Loss Attributable To Parent Business Acquisition Pro Forma Net Income Loss Attributable To Parent Net loss included in the consolidated statements of operations Business Acquisition Purchase Price Allocation Current Liabilities Accounts Payable And Other Liabilities Business Acquisition Purchase Price Allocation Current Liabilities Accounts Payable And Other Liabilities Accounts payable and other current liabilities Business Acquisition Purchase Price Allocation Goodwill Business Acquisition Purchase Price Allocation Goodwill Goodwill Business Acquisitions Pro Forma Net Income Loss Pro forma net income (loss) Business Acquisitions Pro Forma Revenue Pro forma total revenues Business Combination Cash Consideration Business Combination Cash Consideration Cash consideration Business Combination, Cash Consideration Paid to Settle Pre-Existing Liability Business Combination Cash Consideration Paid To Settle Pre Existing Liability Settlement of pre-existing liabilities and working capital adjustment Business Combination Contingent Consideration Liability Contingent consideration Business Combination, Contingent Consideration, Liability Current Business Combination Contingent Consideration Liability Current Current portion of contingent consideration (see Note 13) Business Combination, Contingent Consideration, Liability Non Current Business Combination Contingent Consideration Liability Non Current Contingent consideration-non-current (see Note 13) Business Combination Contingent Consideration Net Business Combination Contingent Consideration Net Net consideration at closing Business Combination Disclosure [Text Block] Acquisition Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Assets Total assets acquired Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Deferred Tax Liabilities Noncurrent Deferred tax liabilities Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Intangible Assets Other Than Goodwill Contractual relationships Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Liabilities Total liabilities assumed Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Assets Current And Non Current Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Assets Current And Non Current Other current and non-current assets Business Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Property Plant And Equipment Property, plant and equipment Business Combination Recognized Identifiable Assets Acquired Goodwill And Liabilities Assumed Net Purchase price allocation Business Combinations [Abstract] Business Combinations [Abstract] Capital contributed by company sale and lease back transaction. Capital Contributed By Company Sale And Lease Back Transaction Capital contributed Cash And Cash Equivalents At Carrying Value Cash and cash equivalents, end of period Cash and cash equivalents, beginning of period Cash and cash equivalents Cash And Cash Equivalents Period Increase Decrease Net increase (decrease) in cash and cash equivalents Cash Equivalents At Carrying Value Carrying value of cash equivalents Change In Income Taxes Payable Change In Income Taxes Payable Income tax payable Claims and litigation. Claims And Litigation [Member] Claims and litigation [Member] Collaborative Arrangement Accounting Policy Collaborative Arrangement Commitments And Contingencies Commitments and contingencies Commitments And Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Abstract] Commitments And Contingencies Disclosure [Text Block] Commitments and Contingencies Common Stock Par Or Stated Value Per Share Common stock, par value per share Common Stock Shares Authorized Common stock, shares authorized Common Stock Shares Issued Common stock, shares issued Common Stock Shares Outstanding Common stock, shares outstanding Common Stock Value Common stock, $.001 par value per share; 50,000 shares authorized; 33,868 and 33,452 shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively Comprehensive Income Policy Policy [Text Block] Comprehensive Income (Loss) Computer Software Intangible Asset [Member] Software development costs [Member] Concentration Risk Benchmark [Domain] Concentration Risk Benchmark [Domain] Concentration Risk By Benchmark [Axis] Concentration Risk Benchmark [Axis] Concentration Risk Percentage 1 Sales percentage Consolidation Items [Axis] Consolidation Items [Axis] Consolidation Items [Domain] Consolidation Items [Domain] Contractual Relationships [Member] Contractual Relationships [Member] Contractual relationships [Member] Cost Of Goods Sold Cost of sales (excludes amortization of intangible assets of $1,511, $1,438, $2,949 and $2,876, respectively) Cost Of Goods Sold Amortization Amortization of intangible assets Cost Of Sales [Member] Cost of sales [Member] Costs And Expenses Total costs and expenses Costs And Expenses [Abstract] Costs and expenses Credit Facilities [Line Items] Credit Facilities [Line Items] Credit Facilities [Line Items] Credit Facility [Axis] Credit Facility [Axis] Credit Facility [Domain] Credit Facility [Domain] Current commitments. Current Commitments Current commitments Current Fiscal Year End Date Current Fiscal Year End Date Current portion of lease obligation. Current Portion Of Lease Obligation Current portion of lease obligation Customer Advances Current Customer prepayments Customer incentives. Customer Incentives Customer incentives Customer one. Customer One [Member] Customer A [Member] Customer Relationships [Member] Customer relationships [Member] Customer two. Customer Two [Member] Customer B [Member] Debt Disclosure [Abstract] Debt Disclosure [Abstract] Debt Disclosure [Text Block] Line of Credit Debt Instrument Basis Spread On Variable Rate 1 Base rate Debt Instrument Interest Rate Stated Percentage Senior Credit Facility, applicable margin Debt Instrument Restrictive Covenants Line of credit facility restrictive covenants Deferred Finance Costs Net Deferred financing costs Deferred Income Tax Expense Benefit Change in deferred tax assets and liabilities Deferred Tax Assets Net Current Deferred tax asset-current Deferred Tax Liabilities Noncurrent Deferred tax liability-non-current Depreciation Depletion And Amortization Depreciation, amortization and other Distribution Rights [Member] Distribution rights [Member] Document Document and Entity Information [Abstract] Document Document And Entity Information [Abstract] Document Documentand Entity Information [Abstract] Document Fiscal Period Focus Document Fiscal Period Focus Document Fiscal Year Focus Document Fiscal Year Focus Document Period End Date Document Period End Date Document Type Document Type Earnings Per Share [Abstract] Earnings Per Share [Abstract] Earnings Per Share Basic Basic (loss) earnings per share Net income per share - basic Earnings Per Share Basic [Abstract] Basic net income per share: Earnings Per Share Diluted Diluted (loss) earnings per share Net income per share - diluted Earnings Per Share Diluted [Abstract] Diluted net income per share: Earnings Per Share [Text Block] Computation of (Loss) Earnings Per Share Effective Income Tax Rate Continuing Operations Effective tax rate Eligible Item Or Group For Fair Value Option [Axis] Eligible Item or Group for Fair Value Option [Axis] Employee Related Liabilities Current Accrued payroll and related expenses Employee Service Share Based Compensation Allocation Of Recognized Period Costs [Line Items] Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items] Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition 1 Expected weighted-average period of recognition for unrecognized compensation expense Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Share Based Awards Other Than Options Total unrecognized compensation expense related to non-vested restricted stock Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options Total unrecognized compensation expense related to non-vested stock options Employee Stock Option [Member] Stock options [Member] Entity Central Index Key Entity Central Index Key Entity Common Stock Shares Outstanding Entity Common Stock, Shares Outstanding Entity Filer Category Entity Filer Category Entity Registrant Name Entity Registrant Name Entity Wide Revenue Major Customer [Line Items] Revenue, Major Customer [Line Items] Equity [Abstract] Equity [Abstract] Excess Tax Benefit From Share Based Compensation Financing Activities Excess tax benefit from share-based compensation Excess Tax Benefit From Share Based Compensation Operating Activities Excess tax benefit from share-based compensation Expected additional reimbursement related to research and development expense. Expected Additional Reimbursement Related To Research And Development Expense Expected additional reimbursement related to research and development expense Expected Future Amortization Expense Expected Future Amortization Expense Total expected future amortization Expected milestone payments amount receivable year one. Expected Milestone Payments Amount Receivable Year One Company's expectation to receive milestone payment in 2013 Expected milestone payments amount receivable year two. Expected Milestone Payments Amount Receivable Year Two Company's expectation to receive milestone payment in 2014 Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items] Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items] Fair Value By Balance Sheet Grouping [Table] Fair Value, by Balance Sheet Grouping [Table] Fair Value By Fair Value Hierarchy Level [Axis] Fair Value, Hierarchy [Axis] Fair Value By Measurement Frequency [Axis] Measurement Frequency [Axis] Fair Value Disclosures [Abstract] Fair Value Disclosures [Abstract] Fair Value Disclosures [Text Block] Fair Value Measurement Fair Value Inputs Level 1 [Member] Fair Value, Inputs, Level 1 [Member] Fair Value Inputs Level 3 [Member] Fair Value, Inputs, Level 3 [Member] Fair Value Measurement Frequency [Domain] Fair Value, Measurement Frequency [Domain] Fair Value Measurements Fair Value Hierarchy [Domain] Fair Value Hierarchy [Domain] Fair Value Option Eligible Item Or Group [Domain] Fair Value, Option, Eligible Item or Group [Domain] Federal funds rate. Federal Funds Rate [Member] Federal funds rate [Member] Finite Lived Intangible Assets Accumulated Amortization Accumulated Amortization Finitelived Intangible Assets Acquired 1 Acquisition of distribution rights Finite Lived Intangible Assets Amortization Expense After Year Five Thereafter Finite Lived Intangible Assets Amortization Expense Next Twelve Months 2014 Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year 2013 (remaining six months) Finite Lived Intangible Assets Amortization Expense Year Four 2017 Finite Lived Intangible Assets Amortization Expense Year Three 2016 Finite Lived Intangible Assets Amortization Expense Year Two 2015 Finite Lived Intangible Assets By Major Class [Axis] Finite-Lived Intangible Assets by Major Class [Axis] Finite Lived Intangible Assets Fair Value Disclosure Assigned licensed technology Finite Lived Intangible Assets Gross Gross Assets Finite Lived Intangible Assets [Line Items] Finite-Lived Intangible Assets [Line Items] Finite Lived Intangible Assets Major Class Name [Domain] Finite-Lived Intangible Assets, Major Class Name [Domain] Finite Lived Intangible Assets Net Net Finite Lived Intangible Asset Useful Life Weighted - Average Useful Life (Years) Expected life for amortization of distribution rights Period of instrument supply agreement with Life Technologies Corporation Gain Loss On Disposition Of Assets Loss on disposal of assets General And Administrative Expense General and administrative General And Administrative Expense [Member] General and administrative [Member] General partners interest. General Partners Interest General partner's interest Goodwill Goodwill Goodwill Net Goodwill And Intangible Assets Disclosure [Abstract] Goodwill and Intangible Assets Disclosure [Abstract] Goodwill Gross Goodwill Gross Goodwill Impaired Accumulated Impairment Loss Accumulated Amortization on Goodwill Income Loss From Continuing Operations Before Income Taxes Minority Interest And Income Loss From Equity Method Investments Pretax income (loss) (Loss) income before taxes Income Statement [Abstract] Income Statement [Abstract] Income Statement Location [Axis] Income Statement Location [Axis] Income Statement Location [Domain] Income Statement Location [Domain] Income Tax Disclosure [Abstract] Income Tax Disclosure [Abstract] Income Tax Disclosure [Text Block] Income Taxes Income Taxes Paid Cash paid for income taxes Income Tax Examination Penalties And Interest Accrued Interest and penalties with uncertain tax positions Income Tax Examination Penalties And Interest Expense Recognized net benefit from interest and penalties Income Tax Expense Benefit Benefit for income taxes Income tax benefit Income Tax Reconciliation Nondeductible Expense Research And Development Benefit related to the federal research and development credit Income Tax Reserve Release Income Tax Reserve Release Income tax reserve release Increase Decrease In Accounts Payable Accounts payable Increase Decrease In Accounts Receivable Accounts receivable Increase Decrease In Accrued Income Taxes Payable Accrued income taxes payable Increase Decrease In Employee Related Liabilities Accrued payroll and related expenses Increase Decrease In Inventories Inventories Increase Decrease In Operating Capital [Abstract] Changes in assets and liabilities: Increase Decrease In Other Operating Liabilities Other current and non-current liabilities Prepaid expenses and other current and non-current assets. Increase Decrease In Prepaid Expenses And Other Current And Non Current Assets Prepaid expenses and other current and non-current assets EX-101.PRE 10 qdel-20130630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 11 R8.xml IDEA: Computation of (Loss) Earnings Per Share 2.4.0.8109 - Disclosure - Computation of (Loss) Earnings Per Sharetruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_EarningsPerShareAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Earnings Per Share [Abstract]2false 2us-gaap_EarningsPerShareTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 2. Computation of (Loss) Earnings Per Share Diluted net income per share is reported based on the more dilutive of the treasury stock or the two-class method. Under the two-class method, net income is allocated to common stock and participating securities. The Company’s unvested restricted stock awards and certain unvested restricted stock units meet the definition of participating securities. Basic net income per share under the two-class method is computed by dividing net income adjusted for earnings allocated to unvested stockholders for the period by the weighted average number of common shares outstanding during the period. Diluted net income per share under the two-class method is computed by dividing net income adjusted for earnings allocated to unvested stockholders for the period by the weighted average number of common and common equivalent shares outstanding during the period. The Company excludes stock options from the calculation of diluted net income per share when the combined exercise price, unrecognized stock-based compensation and assumed tax benefits upon exercise are greater than the average market price for the Company’s common stock because their effect is anti-dilutive. For the six months ended June 30, 2013, 0.4 million stock options were not included in the calculation of diluted earnings per share (“EPS”) as their effect was anti-dilutive. For the three months ended June 30, 2013 and the three and six months ended June 30, 2012 there were no differences between the number of common shares used for the basic and diluted EPS computations as they were periods in which the Company incurred a net loss. Due to the fact that the holders of participating securities are not contractually required to share in the Company’s losses, no allocation to participating securities was made for periods in which the Company incurred a net loss in applying the two-class method to compute basic net loss per common share. For the three months ended June 30, 2013 and 2012 and the six months ended June 30, 2012, 1.1 million, 0.7 million, and 0.7 million stock options and shares of restricted stock, respectively, were excluded from diluted loss per share that would have been included if the Company had been in a net income position. Additionally, for the three months ended June 30, 2013 and 2012 and the six months ended June 30, 2012, 0.6 million, 1.3 million, and 1.5 million stock options, respectively, were not included because the exercise of such options would be anti-dilutive.   The following table sets forth the computation of basic and diluted EPS for the six months ended June 30, 2013 (in thousands, except per share amounts):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Basic net income per share: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net income </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,612</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Less: income allocated to participating securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(32</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income allocated to common stockholders </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,580</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — basic </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">33,658</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income per share — basic </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.31</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Diluted net income per share: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net income </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,612</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Less: income allocated to participating securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(31</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income allocated to common stockholders </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,581</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — basic </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">33,658</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Dilutive securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,058</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — diluted </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">34,716</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income per share — diluted </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.30</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for earnings per share.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1278-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false0Computation of (Loss) Earnings Per SharefalseComputation of (Loss) Earnings Per ShareUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlock12 XML 12 R6.xml IDEA: CONSOLIDATED STATEMENTS OF CASH FLOWS 2.4.0.8107 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWStruefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_NetCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0OPERATING ACTIVITIES:2false 3us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse1061200010612USD$falsetruefalse2truefalsefalse-3071000-3071USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false2Net income (loss)3true 3us-gaap_AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Adjustments to reconcile net income (loss) to net cash provided by operating activities:4false 4us-gaap_DepreciationDepletionAndAmortizationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1212300012123falsefalsefalse2truefalsefalse1086200010862falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate expense recognized in the current period that allocates the cost of tangible assets, intangible assets, or depleting assets to periods that benefit from use of the assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Depreciation, amortization and other5false 4us-gaap_GainLossOnDispositionOfAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00falsefalsefalse2truefalsefalse1400014falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of gain (loss) on sale or disposal of property, plant and equipment assets, excluding oil and gas property and timber property.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6391110&loc=d3e2941-110230 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 205 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6360339&loc=d3e1361-107760 false2Loss on disposal of assets6false 4us-gaap_ShareBasedCompensationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse40280004028falsefalsefalse2truefalsefalse35950003595falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate amount of noncash, equity-based employee remuneration. This may include the value of stock or unit options, amortization of restricted stock or units, and adjustment for officers' compensation. As noncash, this element is an add back when calculating net cash generated by operating activities using the indirect method.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Stock-based compensation expense7false 4us-gaap_DeferredIncomeTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse33630003363falsefalsefalse2truefalsefalse-1679000-1679falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of deferred income tax expense (benefit) pertaining to income (loss) from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 6.I.7) -URI http://asc.fasb.org/extlink&oid=34349781&loc=d3e330036-122817 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 6 -Section I -Subsection 7 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Deferred Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6510177 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 false2Change in deferred tax assets and liabilities8false 4us-gaap_ExcessTaxBenefitFromShareBasedCompensationOperatingActivitiesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-937000-937falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash outflow for realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 20 -Section 55 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11374-113907 false2Excess tax benefit from share-based compensation9true 3us-gaap_IncreaseDecreaseInOperatingCapitalAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Changes in assets and liabilities:10false 4us-gaap_IncreaseDecreaseInAccountsReceivableus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse1921300019213falsefalsefalse2truefalsefalse18650001865falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in amount due within one year (or one business cycle) from customers for the credit sale of goods and services.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Accounts receivable11false 4us-gaap_IncreaseDecreaseInInventoriesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-9128000-9128falsefalsefalse2truefalsefalse-2459000-2459falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate value of all inventory held by the reporting entity, associated with underlying transactions that are classified as operating activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Inventories12false 4qdel_ChangeInIncomeTaxesPayableqdel_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-2266000-2266falsefalsefalse2truefalsefalse3100031falsefalsefalsexbrli:monetaryItemTypemonetaryChange In Income Taxes PayableNo definition available.false2Income tax payable13false 4qdel_IncreaseDecreaseInPrepaidExpensesAndOtherCurrentAndNonCurrentAssetsqdel_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse14910001491falsefalsefalse2truefalsefalse-764000-764falsefalsefalsexbrli:monetaryItemTypemonetaryPrepaid expenses and other current and non-current assets.No definition available.false2Prepaid expenses and other current and non-current assets14false 4us-gaap_IncreaseDecreaseInAccountsPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-1959000-1959falsefalsefalse2truefalsefalse-567000-567falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Accounts payable15false 4us-gaap_IncreaseDecreaseInEmployeeRelatedLiabilitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-985000-985falsefalsefalse2truefalsefalse-152000-152falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the aggregate amount of obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Accrued payroll and related expenses16false 4us-gaap_IncreaseDecreaseInRoyaltiesPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-9000-9falsefalsefalse2truefalsefalse1400014falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in the obligations due for compensation payments related to the use of copyrights, patents, trade names, licenses, technology. Royalty payments are also paid by the lease holders for oil, gas, and mineral extraction.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Accrued royalties17false 4us-gaap_IncreaseDecreaseInAccruedIncomeTaxesPayableus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-3803000-3803falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the period in the amount due for taxes based on the reporting entity's earnings or attributable to the entity's income earning process (business presence) within a given jurisdiction.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Accrued income taxes payable18false 4us-gaap_IncreaseDecreaseInOtherOperatingLiabilitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-2427000-2427falsefalsefalse2truefalsefalse-2506000-2506falsefalsefalsexbrli:monetaryItemTypemonetaryThe increase (decrease) during the reporting period in other liabilities used in operating activities not separately disclosed in the statement of cash flows. May include changes in other current liabilities, other noncurrent liabilities, or a combination of other current and noncurrent liabilities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 false2Other current and non-current liabilities19false 3us-gaap_NetCashProvidedByUsedInOperatingActivitiesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse2931600029316falsefalsefalse2truefalsefalse51830005183falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 true2Net cash provided by operating activities20true 2us-gaap_NetCashProvidedByUsedInInvestingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0INVESTING ACTIVITIES:21false 3us-gaap_PaymentsToAcquirePropertyPlantAndEquipmentus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-11748000-11748falsefalsefalse2truefalsefalse-3985000-3985falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale; includes cash outflows to pay for construction of self-constructed assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Acquisitions of property and equipment22false 3us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-9150000-9150falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Acquisition of BioHelix, net of cash acquired23false 3us-gaap_PaymentsToAcquireIntangibleAssetsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-1142000-1142falsefalsefalse2truefalsefalse-15165000-15165falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow to acquire asset without physical form usually arising from contractual or other legal rights, excluding goodwill.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Acquisition of intangibles24false 3us-gaap_ProceedsFromSaleOfPropertyPlantAndEquipmentus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse115000115falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow from the sale of long-lived, physical assets that are used in the normal conduct of business to produce goods and services and not intended for resale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 12 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3179-108585 false2Proceeds from the sale of fixed assets25false 3us-gaap_NetCashProvidedByUsedInInvestingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-22040000-22040falsefalsefalse2truefalsefalse-19035000-19035falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from investing activities, including discontinued operations. Investing activity cash flows include making and collecting loans and acquiring and disposing of debt or equity instruments and property, plant, and equipment and other productive assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 true2Net cash used for investing activities26true 2us-gaap_NetCashProvidedByUsedInFinancingActivitiesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0FINANCING ACTIVITIES:27false 3qdel_PaymentsOnLeaseObligationqdel_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-184000-184falsefalsefalse2truefalsefalse-160000-160falsefalsefalsexbrli:monetaryItemTypemonetaryPayments on lease obligation.No definition available.false2Payments on lease obligation28false 3us-gaap_PaymentsForRepurchaseOfCommonStockus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-858000-858falsefalsefalse2truefalsefalse-3387000-3387falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow to reacquire common stock during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585 false2Repurchases of common stock29false 3us-gaap_ProceedsFromIssuanceOfCommonStockus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse49220004922falsefalsefalse2truefalsefalse444000444falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash inflow from the additional capital contribution to the entity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585 false2Proceeds from issuance of common stock30false 3us-gaap_ExcessTaxBenefitFromShareBasedCompensationFinancingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse937000937falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow from realized tax benefit related to deductible compensation cost reported on the entity's tax return for equity instruments in excess of the compensation cost for those instruments recognized for financial reporting purposes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 20 -Section 55 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=32706628&loc=d3e11374-113907 false2Excess tax benefit from share-based compensation31false 3us-gaap_RepaymentsOfLongTermLinesOfCreditus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-5000000-5000falsefalsefalse2truefalsefalse-23000000-23000falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow for the settlement of obligation drawn from a contractual arrangement with the lender, including letter of credit, standby letter of credit and revolving credit arrangements, under which borrowings can be made up to a specific amount at any point in time with maturities due beyond one year or the operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 false2Payments on line of credit32false 3qdel_PaymentOfNotePayableToStateAgencyqdel_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00falsefalsefalse2truefalsefalse-1498000-1498falsefalsefalsexbrli:monetaryItemTypemonetaryPayment of note payable to state agency.No definition available.false2Payment of note payable to state agency33false 3us-gaap_NetCashProvidedByUsedInFinancingActivitiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse-183000-183falsefalsefalse2truefalsefalse-27601000-27601falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 26 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3574-108585 true2Net cash used for financing activities34false 2us-gaap_CashAndCashEquivalentsPeriodIncreaseDecreaseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse70930007093falsefalsefalse2truefalsefalse-41453000-41453falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase (decrease) in cash and cash equivalents. Cash and cash equivalents are the amount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Includes effect from exchange rate changes.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 24 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3521-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 830 -SubTopic 230 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6450594&loc=d3e33268-110906 true2Net increase (decrease) in cash and cash equivalents35false 2us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsetruefalsefalseperiodStartLabel1truefalsefalse1485600014856falsefalsefalse2truefalsefalse6133200061332falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false2Cash and cash equivalents, beginning of period36false 2us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsetruefalseperiodEndLabel1truefalsefalse2194900021949falsefalsefalse2truefalsefalse1987900019879falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false2Cash and cash equivalents, end of period37true 2us-gaap_SupplementalCashFlowInformationAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:38false 3us-gaap_InterestPaidus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse399000399falsefalsefalse2truefalsefalse699000699falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of cash paid for interest during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (e) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 false2Cash paid for interest39false 3us-gaap_IncomeTaxesPaidus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse19000001900falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of cash paid during the current period to foreign, federal, state, and local authorities as taxes on income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6367179&loc=d3e4297-108586 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 25 -Subparagraph (f) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3536-108585 false2Cash paid for income taxes40true 2qdel_NoncashInvestingActivitiesAbstractqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0NON-CASH INVESTING ACTIVITIES:41false 3qdel_PurchaseOfCapitalEquipmentByIncurringCurrentLiabilitiesqdel_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse10070001007falsefalsefalse2truefalsefalse300000300falsefalsefalsexbrli:monetaryItemTypemonetaryPurchase of capital equipment by incurring current liabilities.No definition available.false2Purchase of capital equipment by incurring current liabilities42true 2qdel_NonCashFinancingActivitiesAbstractqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0NON-CASH FINANCING ACTIVITIES:43false 3qdel_ReductionOfOtherCurrentLiabilitiesUponIssuanceOfRestrictedShareUnitsqdel_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse456000456USD$falsetruefalse2truefalsefalse917000917USD$falsetruefalsexbrli:monetaryItemTypemonetaryReduction of other current liabilities upon issuance of restricted share units.No definition available.false2Reduction of other current liabilities upon issuance of restricted share unitsfalseCONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/StatementOfCashFlowsIndirect243 XML 13 R17.htm IDEA: XBRL DOCUMENT

Lease Obligation	6 Months Ended
Lease Obligation	Jun. 30, 2013
Leases [Abstract]
Lease Obligation	Note 11. Lease Obligation During 1999, the Company completed a sale and leaseback transaction of its San Diego facility. The facility was sold for $15.0 million, of which $3.8 million was capital contributed by the Company. The sale was an all cash transaction, netting the Company approximately $7.0 million. The Company is a 25% limited partner in the partnership that acquired the facility. The transaction was deemed a financing transaction under the guidance in ASC Topic 840-40, Accounting for Sales of Real Estate. The assets sold remain on the books of the Company and will continue to be depreciated over the estimated useful life. In December 2009, the Company amended the terms of its lease agreement which had no significant impact on the Company’s financial statements. The amended terms include a new ten-year lease term through December 2019, with options to extend the lease for up to three additional five-year periods. The Company will amortize the lease obligation over this new term. The amount of the monthly rental payments remains the same under the amendment. The combined carrying value of the land and building subject to this lease, net of accumulated depreciation, was $2.2 million and $2.3 million as of June 30, 2013 and December 31, 2012, respectively. In addition, the Company has the option to purchase the general partner’s interest in the partnership in January 2015 for a fixed price. The Company has determined that the partnership is a variable interest entity (VIE). The Company is not, however, the primary beneficiary of the VIE as it does not absorb the majority of the partnership’s expected losses or receive a majority of the partnership’s residual returns. The Company made lease payments to the partnership of approximately $0.6 million for each of the six months ended June 30, 2013 and 2012 and $0.3 million for each of the three months ended June 30, 2013 and 2012.

- Definition

The entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.

+ References+ Details

XML 14 R4.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Income Statement [Abstract]
Total revenues	$ 29,706	$ 30,858	$ 91,701	$ 68,818
Costs and expenses
Cost of sales (excludes amortization of intangible assets of $1,511, $1,438, $2,949 and $2,876, respectively)	13,671	14,008	33,218	28,816
Research and development	7,945	6,844	15,469	15,348
Sales and marketing	7,120	7,677	15,562	14,213
General and administrative	6,071	5,129	13,600	11,053
Amortization of intangible assets from acquired businesses and technology	2,022	1,719	3,786	3,437
Total costs and expenses	36,829	35,377	81,635	72,867
Operating (loss) income	(7,123)	(4,519)	10,066	(4,049)
Other (expense) income
Interest income	6	9	12	27
Interest expense	(195)	(292)	(399)	(699)
Total other expense	(189)	(283)	(387)	(672)
(Loss) income before taxes	(7,312)	(4,802)	9,679	(4,721)
Benefit for income taxes	(5,557)	(1,680)	(933)	(1,650)
Net (loss) income	$ (1,755)	$ (3,122)	$ 10,612	$ (3,071)
Basic (loss) earnings per share	$ (0.05)	$ (0.09)	$ 0.31	$ (0.09)
Diluted (loss) earnings per share	$ (0.05)	$ (0.09)	$ 0.30	$ (0.09)
Shares used in basic per share calculation	33,802	32,946	33,658	33,008
Shares used in diluted per share calculation	33,802	32,946	34,716	33,008

XML 15 R10.htm IDEA: XBRL DOCUMENT

Intangible Assets

6 Months Ended

Jun. 30, 2013

Goodwill And Intangible Assets Disclosure [Abstract]

Intangible Assets

Note 4. Intangible Assets

Intangible assets consist of the following (in thousands):


	Weighted-		June 30, 2013							December 31, 2012
	Average
	Useful Life		Gross		Accumulated					Gross		Accumulated
Description	(years)		Assets		Amortization			Net		Assets		Amortization			Net
Goodwill		Indefinite	$	86,165	$	(3,449	)	$	82,716	$	74,461	$	(3,448	)	$	71,013
Purchased technology		8.3		57,030		(25,371	)		31,659		52,670		(22,308	)		30,362
Customer relationships		7.6		6,852		(2,483	)		4,369		6,322		(2,007	)		4,315
In-process research and development		Indefinite		2,270		—			2,270		1,570		—			1,570
License agreements		4.6		49,778		(33,672	)		16,106		49,378		(29,386	)		19,992
Patent and trademark costs		11.9		14,562		(4,078	)		10,484		5,012		(3,887	)		1,125
Favorable lease		9.0		1,700		(1,627	)		73		1,700		(1,594	)		106
Software development costs		5.2		3,891		(563	)		3,328		3,262		(391	)		2,871

Total goodwill and intangible assets			$	222,248	$	(71,243	)	$	151,005	$	194,375	$	(63,021	)	$	131,354


	Amortization
For the years ending December 31,	Expense
2013 (remaining six months)	$	8,434
2014		17,345
2015		9,965
2016		9,087
2017		8,781
Thereafter		12,407

Total expected future amortization	$	66,019

XML 16 Show.js IDEA: XBRL DOCUMENT /** * Rivet Software Inc. * * @copyright Copyright (c) 2006-2011 Rivet Software, Inc. All rights reserved. * Version 2.4.0.3 * */ var Show = {}; Show.LastAR = null, Show.hideAR = function(){ Show.LastAR.style.display = 'none'; }; Show.showAR = function ( link, id, win ){ if( Show.LastAR ){ Show.hideAR(); } var ref = link; do { ref = ref.nextSibling; } while (ref && ref.nodeName != 'TABLE'); if (!ref || ref.nodeName != 'TABLE') { var tmp = win ? win.document.getElementById(id) : document.getElementById(id); if( tmp ){ ref = tmp.cloneNode(true); ref.id = ''; link.parentNode.appendChild(ref); } } if( ref ){ ref.style.display = 'block'; Show.LastAR = ref; } }; Show.toggleNext = function( link ){ var ref = link; do{ ref = ref.nextSibling; }while( ref.nodeName != 'DIV' ); if( ref.style && ref.style.display && ref.style.display == 'none' ){ ref.style.display = 'block'; if( link.textContent ){ link.textContent = link.textContent.replace( '+', '-' ); }else{ link.innerText = link.innerText.replace( '+', '-' ); } }else{ ref.style.display = 'none'; if( link.textContent ){ link.textContent = link.textContent.replace( '-', '+' ); }else{ link.innerText = link.innerText.replace( '-', '+' ); } } }; XML 17 R24.htm IDEA: XBRL DOCUMENT

Other Current Liabilities (Tables)

6 Months Ended

Jun. 30, 2013

Text Block [Abstract]

Other Current Liabilities

Other current liabilities consist of the following (in thousands):


	June 30,		December 31,
	2013		2012
Customer incentives	$	1,514	$	2,693
Customer prepayments		1,340		450
Unearned grant revenue		872		2,156
Income tax payable		171		955
Accrued liability for technology licenses		—		707
Other		1,295		1,280

	$	5,192	$	8,241

XML 18 R29.xml IDEA: Summary of Significant Accounting Policies - Additional Information (Detail) 2.4.0.8130 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_31_20130331_0http://www.sec.gov/CIK0000353569duration2013-03-01T00:00:002013-03-31T00:00:002false USDfalsefalse$eol_PE8142----1310-Q0005_STD_30_20121130_0http://www.sec.gov/CIK0000353569duration2012-11-01T00:00:002012-11-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$eol_PE8142----1310-Q0005_STD_366_20121231_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-12-31T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false falsefalseeol_PE8142----1310-Q0005_STD_365_20111231_0http://www.sec.gov/CIK0000353569duration2011-01-01T00:00:002011-12-31T00:00:001true 3us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Acquired Finite-Lived Intangible Assets [Line Items]2false 4qdel_MaximumAmountOfMilestoneBasedGrantRelatedToResearchAndCommercializationActivitiesqdel_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse83000008300000USD$falsetruefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryMaximum amount of milestone based grant related to research and commercialization activities.No definition available.false2Company's milestone-based grant3false 4qdel_AmountOfFundReceivedForSubsequentResearchAndCommercializationActivitiesqdel_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse26000002600000falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of fund received for subsequent research and commercialization activities.No definition available.false2Fund received for research and development activities4false 4qdel_ExpectedMilestonePaymentsAmountReceivableYearOneqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse25000002500000falsefalsefalse4truefalsefalse25000002500000falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryExpected milestone payments amount receivable year one.No definition available.false2Company's expectation to receive milestone payment in 20135false 4qdel_ExpectedMilestonePaymentsAmountReceivableYearTwoqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse32000003200000falsefalsefalse4truefalsefalse32000003200000falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryExpected milestone payments amount receivable year two.No definition available.false2Company's expectation to receive milestone payment in 20146false 4us-gaap_RevenueFromGrantsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse700000700000falsefalsefalse4truefalsefalse13000001300000falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRevenue earned during the period from non-repayable sum of money awarded to an entity to carry out a specific purpose as provided in grant agreements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1(e)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false2Company's grant revenue7false 4us-gaap_RestrictedCashAndCashEquivalentsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse900000900000falsefalsefalse4truefalsefalse900000900000falsefalsefalse5truefalsefalse22000002200000falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe carrying amounts of cash and cash equivalent items which are restricted as to withdrawal or usage. Restrictions may include legally restricted deposits held as compensating balances against borrowing arrangements, contracts entered into with others, or entity statements of intention with regard to particular deposits; however, time deposits and short-term certificates of deposit are not generally included in legally restricted deposits. Excludes compensating balance arrangements that are not agreements which legally restrict the use of cash amounts shown on the balance sheet. This element is for unclassified presentations; for classified presentations there is a separate and distinct element.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Restricted cash as a component of prepaid expenses8false 4qdel_ReimbursementRelatedToResearchAndDevelopmentExpenseqdel_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse11000001100000falsefalsefalse5truefalsefalse30000003000000falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryReimbursement related to research and development expense.No definition available.false2Reimbursement related to research and development expense9false 4qdel_ReimbursementPercentageUponProjectDevelopmentCostqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truetruefalse0.500.50falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsenum:percentItemTypepureReimbursement percentage upon project development cost.No definition available.false0Reimbursement percentage upon project development cost10false 4qdel_ExpectedAdditionalReimbursementRelatedToResearchAndDevelopmentExpenseqdel_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse800000800000falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryExpected additional reimbursement related to research and development expense.No definition available.false2Expected additional reimbursement related to research and development expense11false 4qdel_ReimbursementsRecognizedAsReductionToResearchAndDevelopmentExpenseqdel_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00falsefalsefalse4truefalsefalse11000001100000falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryReimbursements recognized as a reduction to research and development expense.No definition available.false2Reimbursements recognized as a reduction to research and development expense12false 4us-gaap_FiniteLivedIntangibleAssetUsefulLifeus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse006 yearsfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse003 years 6 monthsfalsefalsefalsexbrli:durationItemTypenaUseful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.No definition available.false0Period of instrument supply agreement with Life Technologies Corporation13false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7false USDtruefalse$eol_PE8142----1310-Q0005_STD_31_20130331_0_931868x927273http://www.sec.gov/CIK0000353569duration2013-03-01T00:00:002013-03-31T00:00:00falsefalseDistribution rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_DistributionRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Distribution rights [Member]14true 3us-gaap_AcquiredFiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Acquired Finite-Lived Intangible Assets [Line Items]15false 4us-gaap_FiniteLivedIntangibleAssetUsefulLifeus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1falsefalsefalse006 yearsfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaUseful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.No definition available.false0Period of instrument supply agreement with Life Technologies Corporation16false 4us-gaap_FinitelivedIntangibleAssetsAcquired1us-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse800000800000USD$falsetruefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase in assets, excluding financial assets, lacking physical substance with a definite life, resulting from a business combination.No definition available.false2Acquisition of distribution rightsfalseSummary of Significant Accounting Policies - Additional Information (Detail) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureSummaryOfSignificantAccountingPoliciesAdditionalInformation616 XML 19 R18.htm IDEA: XBRL DOCUMENT

Fair Value Measurement	6 Months Ended
Fair Value Measurement	Jun. 30, 2013
Fair Value Disclosures [Abstract]
Fair Value Measurement	Note 12. Fair Value Measurement ASC Topic 820, Fair Value Measurements and Disclosures requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed by the Company in one of the following three categories: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices for identical assets and liabilities in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity). As of June 30, 2013 and December 31, 2012, the carrying amount of the Company’s cash equivalents approximates fair value. Cash equivalents primarily consisted of funds held in a money market account. As of the periods ended June 30, 2013 and December 31, 2012, the carrying value of cash equivalents was $16.0 million and $11.0 million, respectively, and was determined based on Level 1 inputs. As of December 31, 2012, the carrying amount of the Company’s Senior Credit Facility approximates fair value because it has a variable interest rate that reflects market changes to interest rates and changes in the Company’s leverage ratio. As of December 31, 2012, the Company used Level 2 inputs to determine the fair value of its Senior Credit Facility. The Company preliminarily measured its contingent consideration liability of $11.9 million arising from its acquisition of BioHelix using level 3 unobservable inputs (see Note 13).

- Definition

The entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.

+ References+ Details

XML 20 R34.xml IDEA: Intangible Assets - Schedule of Intangible Assets (Detail) 2.4.0.8135 - Disclosure - Intangible Assets - Schedule of Intangible Assets (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false falsefalseeol_PE8142----1310-Q0005_STD_31_20130331_0http://www.sec.gov/CIK0000353569duration2013-03-01T00:00:002013-03-31T00:00:002false falsefalseeol_PE8142----1310-Q0005_STD_365_20111231_0http://www.sec.gov/CIK0000353569duration2011-01-01T00:00:002011-12-31T00:00:003false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDtruefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931868x1064150http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalsePurchased technology [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_PurchasedTechnologyMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$6false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0_931868x1064150http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00falsefalsePurchased technology [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_PurchasedTechnologyMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$7false USDtruefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931868x931765http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseCustomer relationships [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CustomerRelationshipsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$8false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0_931868x931765http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseCustomer relationships [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CustomerRelationshipsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$9false USDtruefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931868x925806http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseLicense agreements [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_LicensingAgreementsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$10false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0_931868x925806http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseLicense agreements [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_LicensingAgreementsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$11false USDtruefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931868x1006215http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalsePatent and trademark costs [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_PatentsAndTrademarksMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$12false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0_931868x1006215http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00falsefalsePatent and trademark costs [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_PatentsAndTrademarksMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$13false USDtruefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931868x929485http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseFavorable lease [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_LeaseAgreementsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$14false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0_931868x929485http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseFavorable lease [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_LeaseAgreementsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$15false USDtruefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931868x931666http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseSoftware development costs [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_ComputerSoftwareIntangibleAssetMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$16false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0_931868x931666http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseSoftware development costs [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_ComputerSoftwareIntangibleAssetMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$17false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0_931701x931972http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseIn-process research and development [Member]us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_InProcessResearchAndDevelopmentMemberus-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$18false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0_931701x931972http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseIn-process research and development [Member]us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_InProcessResearchAndDevelopmentMemberus-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_FiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Finite-Lived Intangible Assets [Line Items]2false 4us-gaap_GoodwillGrossus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse8616500086165USD$falsetruefalse4truefalsefalse7446100074461USD$falsetruefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a,h) -URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267 false2Goodwill Gross3false 4us-gaap_GoodwillImpairedAccumulatedImpairmentLossus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse-3449000-3449falsefalsefalse4truefalsefalse-3448000-3448falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of accumulated impairment loss for an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (a,h) -URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267 false2Accumulated Amortization on Goodwill4false 4us-gaap_Goodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse8271600082716falsefalsefalse4truefalsefalse7101300071013falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266 true2Goodwill Net5false 4us-gaap_FiniteLivedIntangibleAssetUsefulLifeus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalsepositiveLabel1falsefalsefalse006 yearsfalsefalsefalse2falsefalsefalse003 years 6 monthsfalsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse008 years 3 months 18 daysfalsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse007 years 7 months 6 daysfalsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse004 years 7 months 6 daysfalsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse0011 years 10 months 24 daysfalsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse009 yearsfalsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse005 years 2 months 12 daysfalsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaUseful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.No definition available.false0Weighted - Average Useful Life (Years)6false 4us-gaap_FiniteLivedIntangibleAssetsGrossus-gaap_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:monetaryItemTypemonetaryAmount before amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 false2Gross Assets7false 4us-gaap_FiniteLivedIntangibleAssetsAccumulatedAmortizationus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse-71243000-71243falsefalsefalse4truefalsefalse-63021000-63021falsefalsefalse5truefalsefalse-25371000-25371falsefalsefalse6truefalsefalse-22308000-22308falsefalsefalse7truefalsefalse-2483000-2483falsefalsefalse8truefalsefalse-2007000-2007falsefalsefalse9truefalsefalse-33672000-33672falsefalsefalse10truefalsefalse-29386000-29386falsefalsefalse11truefalsefalse-4078000-4078falsefalsefalse12truefalsefalse-3887000-3887falsefalsefalse13truefalsefalse-1627000-1627falsefalsefalse14truefalsefalse-1594000-1594falsefalsefalse15truefalsefalse-563000-563falsefalsefalse16truefalsefalse-391000-391falsefalsefalse17falsefalsefalse00falsefalsefalse18falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAccumulated amount of amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 false2Accumulated Amortization8false 4us-gaap_FiniteLivedIntangibleAssetsNetus-gaap_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:monetaryItemTypemonetaryAmount after amortization of assets, excluding financial assets and goodwill, lacking physical substance with a finite life.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(1) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 true2Net9false 4us-gaap_IntangibleAssetsGrossExcludingGoodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17truefalsefalse22700002270falsefalsefalse18truefalsefalse15700001570falsefalsefalsexbrli:monetaryItemTypemonetaryAmount before accumulated amortization of intangible assets, excluding goodwill.No definition available.false2Gross intangible asset excluding Goodwill10false 4qdel_IndefiniteLivedIntangibleAssetsAccumulatedAmortizationqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17falsefalsefalse00  falsefalsefalse18falsefalsefalse00  falsefalsefalsexbrli:monetaryItemTypemonetaryIndefinite Lived Intangible Assets Accumulated AmortizationNo definition available.false2Intangible asset excluding Goodwill Accumulated amortization11false 4us-gaap_IndefiniteLivedIntangibleAssetsExcludingGoodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalse14falsefalsefalse00falsefalsefalse15falsefalsefalse00falsefalsefalse16falsefalsefalse00falsefalsefalse17truefalsefalse22700002270USD$falsetruefalse18truefalsefalse15700001570USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of assets, excluding financial assets and goodwill, lacking physical substance and having a projected indefinite period of benefit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 true2Net intangible asset excluding GoodwillfalseIntangible Assets - Schedule of Intangible Assets (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureIntangibleAssetsScheduleOfIntangibleAssets1811 XML 21 R44.xml IDEA: Industry and Geographic Information - Additional Information (Detail) 2.4.0.8145 - Disclosure - Industry and Geographic Information - Additional Information (Detail)truefalseIn Millions, unless otherwise specifiedfalse1false USDfalsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00SegmentStandardhttp://www.quidel.com/20130630Segmentqdel0pureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0_927195x982945http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseNon-U.S. Customers [Member]us-gaap_MajorCustomersAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_NonUsCustomersMemberus-gaap_MajorCustomersAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0_927195x982945http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00falsefalseNon-U.S. Customers [Member]us-gaap_MajorCustomersAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_NonUsCustomersMemberus-gaap_MajorCustomersAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false truefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931007x926597http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseSales [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_SalesMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure06false truefalseeol_PE8142----1310-Q0005_STD_182_20120630_0_931007x926597http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00falsefalseSales [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_SalesMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure07false USDtruefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0_927195x982945_931007x926597http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseSales [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_SalesMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberfalsefalseNon-U.S. Customers [Member]us-gaap_MajorCustomersAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_NonUsCustomersMemberus-gaap_MajorCustomersAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$8false USDtruefalse$eol_PE8142----1310-Q0005_STD_182_20120630_0_927195x982945_931007x926597http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00falsefalseSales [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_SalesMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberfalsefalseNon-U.S. Customers [Member]us-gaap_MajorCustomersAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_NonUsCustomersMemberus-gaap_MajorCustomersAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_EntityWideRevenueMajorCustomerLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenue, Major Customer [Line Items]2false 4us-gaap_ConcentrationRiskPercentage1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsetruefalse00falsefalsefalse2falsetruefalse00falsefalsefalse3falsetruefalse00falsefalsefalse4falsetruefalse00falsefalsefalse5truetruefalse0.260.26falsefalsefalse6truetruefalse0.240.24falsefalsefalse7truetruefalse0.140.14falsefalsefalse8truetruefalse0.150.15falsefalsefalsenum:percentItemTypepureFor an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592 false0Sales percentage3false 4us-gaap_Revenuesus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7truefalsefalse1270000012.7USD$falsetruefalse8truefalsefalse1040000010.4USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of revenue recognized from goods sold, services rendered, insurance premiums, or other activities that constitute an earning process. Includes, but is not limited to, investment and interest income before deduction of interest expense when recognized as a component of revenue, and sales and trading gain (loss).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 1 -Article 5 false2Sales to customers outside the U.S.4false 4us-gaap_AccountsReceivableNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse30000003.0falsefalsefalse4truefalsefalse28000002.8falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryFor an unclassified balance sheet, the amount due from customers or clients for goods or services that have been delivered or sold in the normal course of business, reduced to their estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.9) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.5) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 false2Balances due from foreign customers5false 4us-gaap_NumberOfReportableSegmentsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse11falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalsexbrli:integerItemTypeintegerNumber of segments reported by the entity. A reportable segment is a component of an entity for which there is an accounting requirement to report separate financial information on that component in the entity's financial statements.No definition available.false256Number of reportable segments6false 4qdel_AccountsReceivableFromMajorCustomersqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse20000002.0USD$falsetruefalse2truefalsefalse2240000022.4USD$falsetruefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAccounts receivable from major customers.No definition available.false2Accounts receivable due in excess of 10%7false 4qdel_MinimumPercentageOfAccountsReceivableFromMajorCustomersqdel_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.100.10falsefalsefalse2truetruefalse0.100.10falsefalsefalse3falsetruefalse00falsefalsefalse4falsetruefalse00falsefalsefalse5falsetruefalse00falsefalsefalse6falsetruefalse00falsefalsefalse7falsetruefalse00falsefalsefalse8falsetruefalse00falsefalsefalsenum:percentItemTypepureMinimum percentage of accounts receivable from major customers.No definition available.false0Minimum percentage of accounts receivable from major customersfalseIndustry and Geographic Information - Additional Information (Detail) (USD $)HundredThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureIndustryAndGeographicInformationAdditionalInformation87 XML 22 R32.xml IDEA: Inventories - Additional Information (Detail) 2.4.0.8133 - Disclosure - Inventories - Additional Information (Detail)truefalseIn Millions, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_InventoryDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Inventory Disclosure [Abstract]2false 2us-gaap_InventoryAdjustmentsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse5000000.5USD$falsetruefalse2truefalsefalse6000000.6USD$falsetruefalsexbrli:monetaryItemTypemonetaryCertain changes made in the current period to the value and amount of inventory reported.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Subparagraph b -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=28360613&loc=d3e4492-108314 false2Net of reserves, inventoriesfalseInventories - Additional Information (Detail) (USD $)HundredThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureInventoriesAdditionalInformation22 XML 23 R25.xml IDEA: Income Taxes (Tables) 2.4.0.8126 - Disclosure - Income Taxes (Tables)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_IncomeTaxDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Income Tax Disclosure [Abstract]2false 2us-gaap_ScheduleOfUnrecognizedTaxBenefitsRollForwardTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The following table summarizes the activity related to the Company’s unrecognized tax benefits (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Beginning balance as of December 31, 2012 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,051</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Increases related to prior year tax positions </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">300</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Decrease due to settlements </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,078</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr> <td valign="top"> Increases related to current year tax positions </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">555</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Ending balance as of June 30, 2013 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,828</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the change in unrecognized tax benefits.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 55 -Paragraph 217 -URI http://asc.fasb.org/extlink&oid=32707879&loc=d3e36027-109320 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15A -URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319 false0Summary of Unrecognized Tax BenefitsfalseIncome Taxes (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlockTables12 XML 24 R48.htm IDEA: XBRL DOCUMENT

Fair Value Measurement - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
BioHelix [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Contingent consideration, fair value of goal	$ 11.9
BioHelix [Member] \| Fair Value, Inputs, Level 3 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Contingent consideration, fair value of goal	11.9
Money Market Funds [Member] \| Fair Value, Inputs, Level 1 [Member]
Fair Value, Balance Sheet Grouping, Financial Statement Captions [Line Items]
Carrying value of cash equivalents	$ 16.0	$ 11.0

XML 25 R38.htm IDEA: XBRL DOCUMENT

Income Taxes - Additional Information (Detail) (USD $)	3 Months Ended			6 Months Ended
Income Taxes - Additional Information (Detail) (USD $)	Jun. 30, 2013	Mar. 31, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Income Tax Disclosure [Abstract]
Income tax benefit	$ 5,557,000		$ 1,680,000	$ 933,000	$ 1,650,000
Pretax income (loss)	(7,312,000)		(4,802,000)	9,679,000	(4,721,000)
Effective tax rate	76.00%		35.00%	10.00%	35.00%
Benefit related to the federal research and development credit		500,000
Recognized net benefit from interest and penalties	400,000		0	300,000	0
Income tax reserve release	3,500,000
Realized upon settlement				50.00%
Unrecognized tax benefits	6,828,000			6,828,000		9,051,000
Unrecognized tax benefits that would impact effective tax rate	4,900,000			4,900,000
Interest and penalties with uncertain tax positions	$ 300,000			$ 300,000		$ 700,000

XML 26 R27.htm IDEA: XBRL DOCUMENT

Industry and Geographic Information (Tables)

6 Months Ended

Jun. 30, 2013

Text Block [Abstract]

Sales to Individual Customers in Excess of 10% of Total Revenue

The Company had sales to individual customers in excess of 10% of total revenue, as follows:


	Six months ended June 30,
	2013			2012
Customer:
A		15	%		15	%
B		11	%		9	%

		26	%		24	%

XML 27 R26.htm IDEA: XBRL DOCUMENT

Stockholders' Equity (Tables)

6 Months Ended

Jun. 30, 2013

Equity [Abstract]

Compensation Expense Related to Stock-Based Compensation Plans


	Three months ended June 30,				Six months ended June 30,
	2013		2012		2013		2012
Cost of sales	$	0.2	$	0.1	$	0.4	$	0.3
Research and development		0.3		0.3		0.7		0.6
Sales and marketing		0.2		0.2		0.3		0.2
General and administrative		1.2		1.1		2.6		2.5

	$	1.9	$	1.7	$	4.0	$	3.6

Estimated Fair Value of Each Stock Option Award


	Six months ended June 30,
	2013			2012
Expected option life (in years)		5.53			5.57
Volatility rate		44	%		46	%
Risk-free interest rate		0.86	%		0.74	%
Dividend rate		0	%		0	%

XML 28 R46.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies - Additional Information (Detail) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2012
Loss Contingencies [Line Items]
Accrued in other current liabilities	$ 5,192,000		$ 5,192,000		$ 8,241,000
Company had royalty and license expenses relating to those agreements	300,000	400,000	700,000	800,000
BioHelix [Member]
Loss Contingencies [Line Items]
Contingent consideration	11,900,000		11,900,000
Claims and litigation [Member]
Loss Contingencies [Line Items]
Accrued in other current liabilities	300,000		300,000		300,000
Research and Development Collaboration Agreements [Member]
Loss Contingencies [Line Items]
Current commitments	$ 600,000		$ 600,000		$ 2,100,000

- Definition

Aggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.

+ References+ Details

XML 29 R34.htm IDEA: XBRL DOCUMENT

Intangible Assets - Schedule of Intangible Assets (Detail) (USD $) In Thousands, unless otherwise specified	1 Months Ended	12 Months Ended			6 Months Ended		6 Months Ended		6 Months Ended		6 Months Ended		6 Months Ended		6 Months Ended
	Mar. 31, 2013	Dec. 31, 2011	Jun. 30, 2013	Dec. 31, 2012	Jun. 30, 2013 Purchased technology [Member]	Dec. 31, 2012 Purchased technology [Member]	Jun. 30, 2013 Customer relationships [Member]	Dec. 31, 2012 Customer relationships [Member]	Jun. 30, 2013 License agreements [Member]	Dec. 31, 2012 License agreements [Member]	Jun. 30, 2013 Patent and trademark costs [Member]	Dec. 31, 2012 Patent and trademark costs [Member]	Jun. 30, 2013 Favorable lease [Member]	Dec. 31, 2012 Favorable lease [Member]	Jun. 30, 2013 Software development costs [Member]	Dec. 31, 2012 Software development costs [Member]	Jun. 30, 2013 In-process research and development [Member]	Dec. 31, 2012 In-process research and development [Member]
Finite-Lived Intangible Assets [Line Items]
Goodwill Gross			$ 86,165	$ 74,461
Accumulated Amortization on Goodwill			(3,449)	(3,448)
Goodwill Net			82,716	71,013
Weighted - Average Useful Life (Years)	6 years	3 years 6 months			8 years 3 months 18 days		7 years 7 months 6 days		4 years 7 months 6 days		11 years 10 months 24 days		9 years		5 years 2 months 12 days
Gross Assets			222,248	194,375	57,030	52,670	6,852	6,322	49,778	49,378	14,562	5,012	1,700	1,700	3,891	3,262
Accumulated Amortization			(71,243)	(63,021)	(25,371)	(22,308)	(2,483)	(2,007)	(33,672)	(29,386)	(4,078)	(3,887)	(1,627)	(1,594)	(563)	(391)
Net			151,005	131,354	31,659	30,362	4,369	4,315	16,106	19,992	10,484	1,125	73	106	3,328	2,871
Gross intangible asset excluding Goodwill																	2,270	1,570
Intangible asset excluding Goodwill Accumulated amortization
Net intangible asset excluding Goodwill																	$ 2,270	$ 1,570

XML 30 R19.xml IDEA: Acquisition 2.4.0.8120 - Disclosure - Acquisitiontruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_BusinessCombinationsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Business Combinations [Abstract]2false 2us-gaap_BusinessCombinationDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 13. Acquisition In October 2009, the Company entered into a product development and commercialization agreement (the “2009 Agreement”) with BioHelix under which the companies would co-develop a number of hand-held, disposable molecular assays using BioHelix’s proprietary isothermal Helicase Dependent Amplification technology. On May 6, 2013, the Company acquired BioHelix a privately-held, diagnostics company, based in Beverly, Massachusetts. The acquisition has been accounted for in conformity with ASC Topic 805, Business Combinations. In connection with the acquisition of BioHelix, the Company paid $9.2 million in cash, which represents cash consideration of $10.0 million adjusted for settlement of pre-existing liabilities under the 2009 Agreement and final working capital compared to an agreed upon baseline. Additionally, the Company agreed to contingent consideration ranging from $5.0 million to $13.0 million upon achievement of certain research and development milestones and revenue targets through 2018. The contingent consideration was valued, on a preliminary basis, at $11.9 million, based on probability weighted models.   The preliminary purchase price of BioHelix is allocated to the underlying net assets acquired and liabilities assumed based on their estimated respective fair values as of May 6, 2013 with the excess purchase price allocated to goodwill. The Company’s preliminary allocation of the purchase price to the net tangible and intangible assets acquired and liabilities assumed is as follows (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="73%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center">Weighted-average amortization period (years)</td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Acquisition consideration </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Cash consideration </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Settlement of pre-existing liabilities and working capital adjustment </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(850</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net cash consideration </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,150</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Contingent consideration </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,919</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net consideration at closing </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21,069</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Fair market values </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Other current and non-current assets </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">375</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Property, plant and equipment </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">179</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> In-process research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Purchased technology </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,360</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">10</td> </tr> <tr> <td valign="top"> Non-compete agreement </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">5</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Contractual relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">530</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">10</td> </tr> <tr> <td valign="top"> Patents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,800</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">12</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Goodwill </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,703</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Total assets acquired </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">27,347</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Accounts payable and other current liabilities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">701</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Deferred tax liabilities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,577</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total liabilities assumed </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,278</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Purchase price allocation </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21,069</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> </table> The primary areas of the preliminary purchase price allocation that have not been finalized relate to the valuation of contingent consideration and the valuation of intangible assets. Upon completion of the fair value assessment, the Company anticipates that the ultimate contingent consideration and intangible assets may differ from the preliminary assessment outlined above. Any changes to the preliminary estimates of the fair value of the contingent consideration and the intangible assets will be allocated to goodwill during the measurement period, with subsequent changes in estimates recorded in the statement of operations. The goodwill of $11.7 million reflects the complementary strategic fit that the acquisition of BioHelix brought to the Company. None of the goodwill is expected to be deductible for tax purposes. In-process research and development primarily relates to the future commercialization of BioHelix’s development efforts associated with the potential commercialization of products in development at the time of the acquisition. The preliminary value assigned to the identifiable intangible assets was determined by discounting the estimated future cash flows associated with these assets to their present value. The preliminary revenue estimates used to value the purchased technology and patents were based on estimates of relevant market sizes and growth factors, expected trends in technology and the nature and expected timing of new product introductions by BioHelix and its competitors. The rates utilized to discount the net cash flows of purchased technology and patents to their present value are based on the risks associated with the respective cash flows taking into consideration the weighted average cost of capital of the Company. The Company incurred $0.2 million and $0.3 million of transaction costs in conjunction with the BioHelix acquisition included in the consolidated statement of operations for the three and six months ended June 30, 2013, respectively, which impacted both basic and diluted earnings per share by $.01 for both the three and six months ended June 30, 2013.   The following unaudited pro forma financial information shows the combined results of operations of the Company, including BioHelix, as if the acquisition had occurred as of the beginning of the periods presented.   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="80%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"> Six months ended </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom">(in thousands, except per share data)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Pro forma total revenues </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">92,650</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">70,205</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Pro forma net income (loss) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,122</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,505</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Pro forma basic net earnings (loss) per share </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.30</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.11</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Pro forma diluted net earnings (loss) per share </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.29</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.11</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total revenue included in the consolidated statements of operations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">188</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net loss included in the consolidated statements of operations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(228</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1383-128463 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1486-128463 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1497-128463 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1490-128463 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1500-128463 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 7 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1524-128463 false0AcquisitionfalseAcquisitionUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlock12 XML 31 R40.htm IDEA: XBRL DOCUMENT

Line of Credit - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	1 Months Ended	6 Months Ended						6 Months Ended
	Aug. 31, 2012	Jun. 30, 2013	Dec. 31, 2012	Aug. 10, 2012	Oct. 08, 2008 Senior secured credit facility [Member]	Jun. 30, 2013 Senior Credit Facility [Member]	Jun. 30, 2013 Senior Credit Facility [Member] Scenario, previously reported [Member]	Jun. 30, 2013 Federal funds rate [Member]	Jun. 30, 2013 LIBOR [Member]	Jun. 30, 2013 LIBOR [Member] Maximum [Member]	Jun. 30, 2013 LIBOR [Member] Minimum [Member]	Jun. 30, 2013 Base rate loans [Member] Maximum [Member]	Jun. 30, 2013 Base rate loans [Member] Minimum [Member]
Credit Facilities [Line Items]
Senior Credit Facility				$ 140.0	$ 120.0
Deferred financing costs						1.0	0.6
Portion of deferred financing costs included in non-current assets		1.3	1.5
Senior Credit Facility, maturity date	Aug. 10, 2017
Base rate								0.50%	1.00%
Senior Credit Facility, applicable margin										2.50%	1.25%	1.50%	0.25%
Senior Credit Facility, adjusted EBITDA ratio		3
Senior Credit Facility, interest coverage ratio		3
Line of credit facility restrictive covenants		The agreement governing the Senior Credit Facility is subject to certain customary limitations, including among others limitation on liens; limitation on mergers, consolidations and sales of assets; limitation on debt; limitation on dividends, stock redemptions and the redemption and/or prepayment of other debt; limitation on investments (including loans and advances) and acquisitions; limitation on transactions with affiliates; and limitation on disposition of assets.
Amount available under the senior credit facility		139.3
Amount outstanding under the senior credit facility		$ 0	$ 5.0
Line of credit facility covenant compliance		The Company was in compliance with all financial covenants.

XML 32 R49.htm IDEA: XBRL DOCUMENT

Acquisition - Additional Information (Detail) (USD $)	3 Months Ended	6 Months Ended
Acquisition - Additional Information (Detail) (USD $)	Jun. 30, 2013	Jun. 30, 2013
Business Acquisition [Line Items]
Cash consideration	$ 10,000,000	$ 10,000,000
Net cash consideration		9,150,000
Goodwill	11,703,000	11,703,000
Impacted on basic and diluted earnings per share	$ 0.01	$ 0.01
BioHelix [Member]
Business Acquisition [Line Items]
Cash consideration	10,000,000	10,000,000
Net cash consideration		9,150,000
Contingent consideration, fair value of goal	11,900,000	11,900,000
Transaction costs in conjunction with acquisition	200,000	300,000
BioHelix [Member] \| Minimum [Member]
Business Acquisition [Line Items]
Contingent consideration, fair value of goal	5,000,000	5,000,000
BioHelix [Member] \| Maximum [Member]
Business Acquisition [Line Items]
Contingent consideration, fair value of goal	$ 13,000,000	$ 13,000,000

XML 33 R31.htm IDEA: XBRL DOCUMENT

Computation of (Loss) Earnings Per Share - Basic and Diluted EPS (Detail) (USD $) In Thousands, except Per Share data, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Basic net income per share:
Net income	$ (1,755)	$ (3,122)	$ 10,612	$ (3,071)
Less: income allocated to participating securities			(32)
Net income allocated to common stockholders			10,580
Weighted average common shares outstanding - basic	33,802	32,946	33,658	33,008
Net income per share - basic	$ (0.05)	$ (0.09)	$ 0.31	$ (0.09)
Diluted net income per share:
Net income	(1,755)	(3,122)	10,612	(3,071)
Less: income allocated to participating securities			(31)
Net income allocated to common stockholders			$ 10,581
Weighted average common shares outstanding - basic	33,802	32,946	33,658	33,008
Dilutive securities			1,058
Weighted average common shares outstanding - diluted	33,802	32,946	34,716	33,008
Net income per share - diluted	$ (0.05)	$ (0.09)	$ 0.30	$ (0.09)

XML 34 R49.xml IDEA: Acquisition - Additional Information (Detail) 2.4.0.8150 - Disclosure - Acquisition - Additional Information (Detail)truefalsefalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_BusinessAcquisitionLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Business Acquisition [Line Items]2false 4qdel_BusinessCombinationCashConsiderationqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1000000010000000USD$falsetruefalse2truefalsefalse1000000010000000USD$falsetruefalsexbrli:monetaryItemTypemonetaryBusiness Combination Cash ConsiderationNo definition available.false2Cash consideration3false 4us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse91500009150000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Net cash consideration4false 4qdel_BusinessAcquisitionPurchasePriceAllocationGoodwillqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1170300011703000USD$falsefalsefalse2truefalsefalse1170300011703000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Acquisition Purchase Price Allocation GoodwillNo definition available.false2Goodwill5false 4qdel_BusinessAcquisitionCostOfAcquiredEntityTransactionCostsImpactOnBasicAndDilutedEarningsPerShareqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse0.010.01USD$falsetruefalse2truefalsefalse0.010.01USD$falsetruefalsenum:perShareItemTypedecimalBusiness Acquisition, Cost of Acquired Entity Transaction Costs, Impact on Basic and Diluted Earnings Per ShareNo definition available.false3Impacted on basic and diluted earnings per share6false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3false USDtruefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0_928576x1165746http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseBioHelix [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_BioHelixMemberus-gaap_BusinessAcquisitionAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0BioHelix [Member]7true 3us-gaap_BusinessAcquisitionLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Business Acquisition [Line Items]8false 4qdel_BusinessCombinationCashConsiderationqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1000000010000000USD$falsefalsefalse2truefalsefalse1000000010000000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Combination Cash ConsiderationNo definition available.false2Cash consideration9false 4us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse91500009150000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Net cash consideration10false 4qdel_BusinessAcquisitionContingentConsiderationFairValueqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse1190000011900000USD$falsefalsefalse2truefalsefalse1190000011900000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Acquisition Contingent Consideration Fair ValueNo definition available.false2Contingent consideration, fair value of goal11false 4qdel_BusinessAcquisitionCostOfAcquiredEntityTransactionCostqdel_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse200000200000USD$falsefalsefalse2truefalsefalse300000300000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Acquisition Cost Of Acquired Entity Transaction CostNo definition available.false2Transaction costs in conjunction with acquisition12false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse5false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0_926437x932953_928576x1165746http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseBioHelix [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_BioHelixMemberus-gaap_BusinessAcquisitionAxisexplicitMemberfalsefalseMinimum [Member]us-gaap_RangeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MinimumMemberus-gaap_RangeAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0BioHelix [Member] | Minimum [Member]13true 3us-gaap_BusinessAcquisitionLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Business Acquisition [Line Items]14false 4qdel_BusinessAcquisitionContingentConsiderationFairValueqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse50000005000000USD$falsefalsefalse2truefalsefalse50000005000000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Acquisition Contingent Consideration Fair ValueNo definition available.false2Contingent consideration, fair value of goal15false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse6false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0_926437x923140_928576x1165746http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseBioHelix [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_BioHelixMemberus-gaap_BusinessAcquisitionAxisexplicitMemberfalsefalseMaximum [Member]us-gaap_RangeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MaximumMemberus-gaap_RangeAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0BioHelix [Member] | Maximum [Member]16true 3us-gaap_BusinessAcquisitionLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Business Acquisition [Line Items]17false 4qdel_BusinessAcquisitionContingentConsiderationFairValueqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse1300000013000000USD$falsetruefalse2truefalsefalse1300000013000000USD$falsetruefalsexbrli:monetaryItemTypemonetaryBusiness Acquisition Contingent Consideration Fair ValueNo definition available.false2Contingent consideration, fair value of goalfalseAcquisition - Additional Information (Detail) (USD $)NoRoundingUnKnownNoRoundingUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureAcquisitionAdditionalInformation217 XML 35 R51.xml IDEA: Acquisition - Schedule of Pro Forma Financial Information (Detail) 2.4.0.8152 - Disclosure - Acquisition - Schedule of Pro Forma Financial Information (Detail)truefalseIn Thousands, except Per Share data, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_BusinessCombinationsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Business Combinations [Abstract]2false 2us-gaap_BusinessAcquisitionsProFormaRevenueus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse9265000092650USD$falsetruefalse2truefalsefalse7020500070205USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe pro forma revenue for a period as if the business combination or combinations had been completed at the beginning of the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 false2Pro forma total revenues3false 2us-gaap_BusinessAcquisitionsProFormaNetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1012200010122falsefalsefalse2truefalsefalse-3505000-3505falsefalsefalsexbrli:monetaryItemTypemonetaryThe pro forma net Income or Loss for the period as if the business combination or combinations had been completed at the beginning of a period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 false2Pro forma net income (loss)4false 2us-gaap_BusinessAcquisitionProFormaEarningsPerShareBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse0.300.30USD$falsetruefalse2truefalsefalse-0.11-0.11USD$falsetruefalsenum:perShareItemTypedecimalThe pro forma basic net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 false3Pro forma basic net earnings (loss) per share5false 2us-gaap_BusinessAcquisitionProFormaEarningsPerShareDilutedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse0.290.29USD$falsetruefalse2truefalsefalse-0.11-0.11USD$falsetruefalsenum:perShareItemTypedecimalThe pro forma diluted net income per share for a period as if the business combination or combinations had been completed at the beginning of a period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 false3Pro forma diluted net earnings (loss) per share6false 2qdel_BusinessAcquisitionProFormaGrossProfitqdel_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse188000188falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Acquisition Pro Forma Gross ProfitNo definition available.false2Total revenue included in the consolidated statements of operations7false 2qdel_BusinessAcquisitionProFormaNetIncomeLossAttributableToParentqdel_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-228000-228USD$falsetruefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Acquisition Pro Forma Net Income Loss Attributable To ParentNo definition available.false2Net loss included in the consolidated statements of operationsfalseAcquisition - Schedule of Pro Forma Financial Information (Detail) (USD $)ThousandsUnKnownNoRoundingUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureAcquisitionScheduleOfProFormaFinancialInformation27 XML 36 R9.xml IDEA: Inventories 2.4.0.8110 - Disclosure - Inventoriestruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_InventoryDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Inventory Disclosure [Abstract]2false 2us-gaap_InventoryDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 3. Inventories Inventories are recorded at the lower of cost (first-in, first-out) or market. Inventories consisted of the following, net of reserves of $0.5 million and $0.6 million at June 30, 2013 and December 31, 2012, respectively (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">December 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Raw materials </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,014</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,582</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Work - in - process (materials, labor and overhead) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,647</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,686</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Finished goods (materials, labor and overhead) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,003</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,228</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">24,664</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">15,496</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6361739&loc=d3e7789-107766 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Subparagraph a, b, c -Article 5 false0InventoriesfalseInventoriesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlock12 XML 37 R43.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Estimated Fair Value of Each Stock Option Award (Detail)	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Equity [Abstract]
Expected option life (in years)	5 years 6 months 11 days	5 years 6 months 26 days
Volatility rate	44.00%	46.00%
Risk-free interest rate	0.86%	0.74%
Dividend rate	0.00%	0.00%

XML 38 R12.xml IDEA: Income Taxes 2.4.0.8113 - Disclosure - Income Taxestruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_IncomeTaxDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Income Tax Disclosure [Abstract]2false 2us-gaap_IncomeTaxDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 6. Income Taxes The effective tax rate for the three months ended June 30, 2013 and 2012 was 76% and 35%, respectively. Included in the 76% effective tax rate is a tax benefit of $3.5 million related to the release of certain tax reserves. The Company recognized an income tax benefit of $5.6 million and $1.7 million for the three months ended June 30, 2013 and 2012, respectively. This was related to the Company’s notification by the Internal Revenue Service that the Congressional Joint Committee of Taxation had completed its review and proposed no changes to the Company’s tax returns filed for the tax periods 2008 through 2010. For the six months ended June 30, 2013, the Company recognized an income tax benefit of $0.9 million on pretax income of $9.7 million, which represents an effective tax rate of 10%. For the six months ended June 30, 2012, the Company recognized an income tax benefit of $1.7 million on a pretax loss of $4.7 million, which represents an effective tax rate of 35%. Additionally, on January 3, 2013, the American Taxpayer Relief Act of 2012 was signed into law reinstating the federal research and development credit for the 2012 and 2013 years. Accordingly, the benefit related to the 2012 federal research and development credit of approximately $0.5 million was recorded in the first quarter of 2013 as a discrete item. The benefit related to 2013 research activities is included in the full year effective tax rate. The Company recognizes liabilities for uncertain tax positions based on a two-step process. The first step is to evaluate the tax position for recognition by determining if the weight of available evidence indicates that it is more likely than not that the position will be sustained on audit, including resolution of related appeals or litigation processes, if any. The second step is to measure the tax benefit as the largest amount that is more than 50% likely of being realized upon settlement. While the Company believes that it has appropriate support for the positions taken on its tax returns, the Company regularly assesses the potential outcome of examinations by tax authorities in determining the adequacy of its provision for income taxes. The following table summarizes the activity related to the Company’s unrecognized tax benefits (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Beginning balance as of December 31, 2012 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,051</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Increases related to prior year tax positions </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">300</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Decrease due to settlements </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,078</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr> <td valign="top"> Increases related to current year tax positions </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">555</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Ending balance as of June 30, 2013 </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">6,828</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> Included in the unrecognized tax benefits of $6.8 million at June 30, 2013 was $4.9 million of tax benefits that, if recognized, would reduce the Company’s annual effective tax rate. The Company does not expect the unrealized tax benefits to decrease over the next 12 months. The Company’s policy is to recognize the interest expense and penalties related to income tax matters as a component of income tax expense. For the three and six months ended June 30, 2013, the Company recognized a net benefit from interest and penalties of $0.4 million and $0.3 million as a component of the Company’s benefit for income taxes in the consolidated statements of operations. For both the three and six months ended June 30, 2012, the Company recognized interest and penalties of $0 million. The Company has accrued approximately $0.3 million and $0.7 million of interest and penalties associated with uncertain tax positions as of June 30, 2013 and December 31, 2012, respectively, and there were no repurchases during the six months ended June 30, 2013. The Company is subject to periodic audits by domestic and foreign tax authorities. The Company’s federal tax years for 2011 and forward are subject to examination by the U.S. authorities. With few exceptions, the Company’s state and foreign tax years for 2000 and forward are subject to examination by tax authorities. The Company believes that it has appropriate support for the income tax positions taken on its tax returns and that its accruals for tax liabilities are adequate for all open years based on an assessment of many factors, including past experience and interpretations of tax law applied to the facts of each matter. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32559-109319 false0Income TaxesfalseIncome TaxesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsIncomeTaxDisclosureTextBlock12 XML 39 R46.xml IDEA: Commitments and Contingencies - Additional Information (Detail) 2.4.0.8147 - Disclosure - Commitments and Contingencies - Additional Information (Detail)truefalsefalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20120630_0http://www.sec.gov/CIK0000353569duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_LossContingenciesLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Loss Contingencies [Line Items]2false 4us-gaap_OtherLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse51920005192000USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse51920005192000USD$falsetruefalse4falsefalsefalse00falsefalsefalse5truefalsefalse82410008241000USD$falsetruefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6904-107765 false2Accrued in other current liabilities3false 4qdel_RoyaltyAndLicenseExpenseqdel_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse300000300000USD$falsefalsefalse2truefalsefalse400000400000USD$falsefalsefalse3truefalsefalse700000700000USD$falsefalsefalse4truefalsefalse800000800000USD$falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryRoyalty and license expense.No definition available.false2Company had royalty and license expenses relating to those agreements4false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0_928576x1165746http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseBioHelix [Member]us-gaap_BusinessAcquisitionAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_BioHelixMemberus-gaap_BusinessAcquisitionAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0BioHelix [Member]5true 3us-gaap_LossContingenciesLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Loss Contingencies [Line Items]6false 4qdel_BusinessAcquisitionContingentConsiderationFairValueqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1190000011900000USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1190000011900000USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Acquisition Contingent Consideration Fair ValueNo definition available.false2Contingent consideration7false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse7false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0_931737x1056325http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseClaims and litigation [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_ClaimsAndLitigationMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Claims and litigation [Member]8true 3us-gaap_LossContingenciesLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Loss Contingencies [Line Items]9false 4us-gaap_OtherLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse300000300000USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse300000300000USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5truefalsefalse300000300000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6904-107765 false2Accrued in other current liabilities10false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse9false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0_931737x982946http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseResearch and Development Collaboration Agreements [Member]us-gaap_LossContingenciesByNatureOfContingencyAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_ResearchAndDevelopmentCollaborationAgreementsMemberus-gaap_LossContingenciesByNatureOfContingencyAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Research and Development Collaboration Agreements [Member]11true 3us-gaap_LossContingenciesLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Loss Contingencies [Line Items]12false 4qdel_CurrentCommitmentsqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse600000600000USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse600000600000USD$falsetruefalse4falsefalsefalse00falsefalsefalse5truefalsefalse21000002100000USD$falsetruefalsexbrli:monetaryItemTypemonetaryCurrent commitments.No definition available.false2Current commitmentsfalseCommitments and Contingencies - Additional Information (Detail) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureCommitmentsAndContingenciesAdditionalInformation512 XML 40 R25.htm IDEA: XBRL DOCUMENT

Income Taxes (Tables)

6 Months Ended

Jun. 30, 2013

Income Tax Disclosure [Abstract]

Summary of Unrecognized Tax Benefits

The following table summarizes the activity related to the Company’s unrecognized tax benefits (in thousands):


Beginning balance as of December 31, 2012	$	9,051
Increases related to prior year tax positions		300
Decrease due to settlements		(3,078	)
Increases related to current year tax positions		555

Ending balance as of June 30, 2013	$	6,828

XML 41 R6.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
OPERATING ACTIVITIES:
Net income (loss)	$ 10,612	$ (3,071)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:
Depreciation, amortization and other	12,123	10,862
Loss on disposal of assets		14
Stock-based compensation expense	4,028	3,595
Change in deferred tax assets and liabilities	3,363	(1,679)
Excess tax benefit from share-based compensation	(937)
Changes in assets and liabilities:
Accounts receivable	19,213	1,865
Inventories	(9,128)	(2,459)
Income tax payable	(2,266)	31
Prepaid expenses and other current and non-current assets	1,491	(764)
Accounts payable	(1,959)	(567)
Accrued payroll and related expenses	(985)	(152)
Accrued royalties	(9)	14
Accrued income taxes payable	(3,803)
Other current and non-current liabilities	(2,427)	(2,506)
Net cash provided by operating activities	29,316	5,183
INVESTING ACTIVITIES:
Acquisitions of property and equipment	(11,748)	(3,985)
Acquisition of BioHelix, net of cash acquired	(9,150)
Acquisition of intangibles	(1,142)	(15,165)
Proceeds from the sale of fixed assets		115
Net cash used for investing activities	(22,040)	(19,035)
FINANCING ACTIVITIES:
Payments on lease obligation	(184)	(160)
Repurchases of common stock	(858)	(3,387)
Proceeds from issuance of common stock	4,922	444
Excess tax benefit from share-based compensation	937
Payments on line of credit	(5,000)	(23,000)
Payment of note payable to state agency		(1,498)
Net cash used for financing activities	(183)	(27,601)
Net increase (decrease) in cash and cash equivalents	7,093	(41,453)
Cash and cash equivalents, beginning of period	14,856	61,332
Cash and cash equivalents, end of period	21,949	19,879
SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION:
Cash paid for interest	399	699
Cash paid for income taxes	1,900
NON-CASH INVESTING ACTIVITIES:
Purchase of capital equipment by incurring current liabilities	1,007	300
NON-CASH FINANCING ACTIVITIES:
Reduction of other current liabilities upon issuance of restricted share units	$ 456	$ 917

XML 42 R40.xml IDEA: Line of Credit - Additional Information (Detail) 2.4.0.8141 - Disclosure - Line of Credit - Additional Information (Detail)truefalseIn Millions, unless otherwise specifiedfalse1false falsefalseeol_PE8142----1310-Q0005_STD_31_20120831_0http://www.sec.gov/CIK0000353569duration2012-08-01T00:00:002012-08-31T00:00:002false USDfalsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$3false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20120810_0http://www.sec.gov/CIK0000353569instant2012-08-10T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20081008_0_924420x1066348http://www.sec.gov/CIK0000353569instant2008-10-08T00:00:000001-01-01T00:00:00falsefalseSenior secured credit facility [Member]us-gaap_CreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_SeniorSecuredCreditFacilityMemberus-gaap_CreditFacilityAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0_924420x1103433http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseSenior Credit Facility [Member]us-gaap_CreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_SeniorCreditFacilityMemberus-gaap_CreditFacilityAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$7false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0_924420x1103433_924791x926313http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseSenior Credit Facility [Member]us-gaap_CreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_SeniorCreditFacilityMemberus-gaap_CreditFacilityAxisexplicitMemberfalsefalseScenario, previously reported [Member]us-gaap_StatementScenarioAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_ScenarioPreviouslyReportedMemberus-gaap_StatementScenarioAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$8false truefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_924420x1047471http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseFederal funds rate [Member]us-gaap_CreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_FederalFundsRateMemberus-gaap_CreditFacilityAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure09false truefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_924420x942140http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseLIBOR [Member]us-gaap_CreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_LondonInterbankOfferRateLoansMemberus-gaap_CreditFacilityAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure010false truefalseeol_PE8142----1310-Q0005_STD_0_20130630_0_924420x942140_926437x923140http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLIBOR [Member]us-gaap_CreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_LondonInterbankOfferRateLoansMemberus-gaap_CreditFacilityAxisexplicitMemberfalsefalseMaximum [Member]us-gaap_RangeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MaximumMemberus-gaap_RangeAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure011false truefalseeol_PE8142----1310-Q0005_STD_0_20130630_0_924420x942140_926437x932953http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseLIBOR [Member]us-gaap_CreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_LondonInterbankOfferRateLoansMemberus-gaap_CreditFacilityAxisexplicitMemberfalsefalseMinimum [Member]us-gaap_RangeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MinimumMemberus-gaap_RangeAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure012false truefalseeol_PE8142----1310-Q0005_STD_0_20130630_0_924420x930272_926437x923140http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseBase rate loans [Member]us-gaap_CreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_BaseRateMemberus-gaap_CreditFacilityAxisexplicitMemberfalsefalseMaximum [Member]us-gaap_RangeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MaximumMemberus-gaap_RangeAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure013false truefalseeol_PE8142----1310-Q0005_STD_0_20130630_0_924420x930272_926437x932953http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseBase rate loans [Member]us-gaap_CreditFacilityAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_BaseRateMemberus-gaap_CreditFacilityAxisexplicitMemberfalsefalseMinimum [Member]us-gaap_RangeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_MinimumMemberus-gaap_RangeAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure01true 3qdel_CreditFacilitiesLineItemsqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Credit Facilities [Line Items]2false 4us-gaap_LineOfCreditFacilityMaximumBorrowingCapacityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse140000000140.0USD$falsetruefalse5truefalsefalse120000000120.0USD$falsetruefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryMaximum borrowing capacity under the credit facility without consideration of any current restrictions on the amount that could be borrowed or the amounts currently outstanding under the facility.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false2Senior Credit Facility3false 4us-gaap_DeferredFinanceCostsNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6truefalsefalse10000001.0falsefalsefalse7truefalsefalse6000000.6falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryFor an unclassified balance sheet, the carrying amount (net of accumulated amortization) as of the balance sheet date of capitalized costs associated with the issuance of debt instruments (for example, legal, accounting, underwriting, printing, and registration costs) that will be charged against earnings over the life of the debt instruments to which such costs pertain.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 835 -SubTopic 30 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6451184&loc=d3e28555-108399 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.17) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 false2Deferred financing costs4false 4qdel_PortionOfDeferredFinancingCostsIncludedInNonCurrentAssetsqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse13000001.3falsefalsefalse3truefalsefalse15000001.5falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryPortion of deferred financing costs included in non current assets.No definition available.false2Portion of deferred financing costs included in non-current assets5false 4us-gaap_LineOfCreditFacilityExpirationDate1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse002017-08-10falsefalsetrue2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:dateItemTypedateDate the credit facility terminates, in CCYY-MM-DD format.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false0Senior Credit Facility, maturity date6false 4us-gaap_DebtInstrumentBasisSpreadOnVariableRate1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsetruefalse00falsefalsefalse2falsetruefalse00falsefalsefalse3falsetruefalse00falsefalsefalse4falsetruefalse00falsefalsefalse5falsetruefalse00falsefalsefalse6falsetruefalse00falsefalsefalse7falsetruefalse00falsefalsefalse8truetruefalse0.0050.005falsefalsefalse9truetruefalse0.0100.010falsefalsefalse10falsetruefalse00falsefalsefalse11falsetruefalse00falsefalsefalse12falsetruefalse00falsefalsefalse13falsetruefalse00falsefalsefalsenum:percentItemTypepurePercentage points added to the reference rate to compute the variable rate on the debt instrument.No definition available.false0Base rate7false 4us-gaap_DebtInstrumentInterestRateStatedPercentageus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsetruefalse00falsefalsefalse2falsetruefalse00falsefalsefalse3falsetruefalse00falsefalsefalse4falsetruefalse00falsefalsefalse5falsetruefalse00falsefalsefalse6falsetruefalse00falsefalsefalse7falsetruefalse00falsefalsefalse8falsetruefalse00falsefalsefalse9falsetruefalse00falsefalsefalse10truetruefalse0.02500.0250falsefalsefalse11truetruefalse0.01250.0125falsefalsefalse12truetruefalse0.01500.0150falsefalsefalse13truetruefalse0.00250.0025falsefalsefalsenum:percentItemTypepureContractual interest rate for funds borrowed, under the debt agreement.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false0Senior Credit Facility, applicable margin8false 4qdel_SeniorCreditFacilityAdjustedEbitdaRatioqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse33falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:pureItemTypepureSenior credit facility, adjusted EBITDA ratio.No definition available.false0Senior Credit Facility, adjusted EBITDA ratio9false 4qdel_SeniorCreditFacilityInterestCoverageRatioqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse33falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:pureItemTypepureSenior credit facility, interest coverage ratio.No definition available.false0Senior Credit Facility, interest coverage ratio10false 4us-gaap_DebtInstrumentRestrictiveCovenantsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00The agreement governing the Senior Credit Facility is subject to certain customary limitations, including among others limitation on liens; limitation on mergers, consolidations and sales of assets; limitation on debt; limitation on dividends, stock redemptions and the redemption and/or prepayment of other debt; limitation on investments (including loans and advances) and acquisitions; limitation on transactions with affiliates; and limitation on disposition of assets.falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringDescription of covenants that limit or prohibit certain actions or activities without the lender's prior consent within a specified period of time or until certain specified targets are achieved for example, reduction of the debt or an increase in net worth to a specified amount).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(e)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph e -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 470 -Section 50 -Paragraph 3 -Subparagraph (g) -URI http://asc.fasb.org/extlink&oid=6479336&loc=d3e64711-112823 false0Line of credit facility restrictive covenants11false 4us-gaap_LineOfCreditFacilityRemainingBorrowingCapacityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse139300000139.3falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of borrowing capacity currently available under the credit facility (current borrowing capacity less the amount of borrowings outstanding).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(b),22(b)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false2Amount available under the senior credit facility12false 4us-gaap_LineOfCreditFacilityAmountOutstandingus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse00USD$falsetruefalse3truefalsefalse50000005.0USD$falsetruefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount borrowed under the credit facility as of the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false2Amount outstanding under the senior credit facility13false 4us-gaap_LineOfCreditFacilityCovenantComplianceus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00The Company was in compliance with all financial covenants.falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7falsefalsefalse00falsefalsefalse8falsefalsefalse00falsefalsefalse9falsefalsefalse00falsefalsefalse10falsefalsefalse00falsefalsefalse11falsefalsefalse00falsefalsefalse12falsefalsefalse00falsefalsefalse13falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringIdentification of whether the entity has been in compliance with any credit facility debt covenants during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 22 -Article 5 false0Line of credit facility covenant compliancefalseLine of Credit - Additional Information (Detail) (USD $)HundredThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureLineOfCreditAdditionalInformation1313 XML 43 R8.htm IDEA: XBRL DOCUMENT

Computation of (Loss) Earnings Per Share

6 Months Ended

Jun. 30, 2013

Earnings Per Share [Abstract]

Computation of (Loss) Earnings Per Share

Note 2. Computation of (Loss) Earnings Per Share

The following table sets forth the computation of basic and diluted EPS for the six months ended June 30, 2013 (in thousands, except per share amounts):


	2013
Basic net income per share:
Net income	$	10,612
Less: income allocated to participating securities		(32	)

Net income allocated to common stockholders	$	10,580

Weighted average common shares outstanding — basic		33,658

Net income per share — basic	$	0.31

Diluted net income per share:
Net income	$	10,612
Less: income allocated to participating securities		(31	)

Net income allocated to common stockholders	$	10,581

Weighted average common shares outstanding — basic		33,658
Dilutive securities		1,058

Weighted average common shares outstanding — diluted		34,716

Net income per share — diluted	$	0.30

- Definition

The entire disclosure for earnings per share.

+ References+ Details

XML 44 R11.xml IDEA: Other Current Liabilities 2.4.0.8112 - Disclosure - Other Current Liabilitiestruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_TextBlockAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Text Block [Abstract]2false 2qdel_OtherCurrentLiabilitiesTextBlockqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 5. Other Current Liabilities Other current liabilities consist of the following (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">December 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer incentives </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,514</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,693</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Customer prepayments </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,340</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">450</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Unearned grant revenue </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">872</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,156</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Income tax payable </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">171</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">955</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Accrued liability for technology licenses </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">707</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Other </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,295</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,280</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,192</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,241</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaOther current liabilities.No definition available.false0Other Current LiabilitiesfalseOther Current LiabilitiesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsOtherCurrentLiabilitiesTextBlock12 XML 45 R11.htm IDEA: XBRL DOCUMENT

Other Current Liabilities

6 Months Ended

Jun. 30, 2013

Text Block [Abstract]

Other Current Liabilities

Note 5. Other Current Liabilities

Other current liabilities consist of the following (in thousands):


	June 30,		December 31,
	2013		2012
Customer incentives	$	1,514	$	2,693
Customer prepayments		1,340		450
Unearned grant revenue		872		2,156
Income tax payable		171		955
Accrued liability for technology licenses		—		707
Other		1,295		1,280

	$	5,192	$	8,241

XML 46 R14.xml IDEA: Stockholders' Equity 2.4.0.8115 - Disclosure - Stockholders' Equitytruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_EquityAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Equity [Abstract]2false 2us-gaap_StockholdersEquityNoteDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 8. Stockholders’ Equity Issuances and Repurchases of Common Stock During the six months ended June 30, 2013, 121,375 shares of common stock were issued in conjunction with the vesting and release of restricted stock units, 405,917 shares of common stock were issued due to the exercise of stock options and 24,733 shares of common stock were issued in connection with the Company’s employee stock purchase plan (the “ESPP”), resulting in net proceeds to the Company of approximately $4.9 million. Additionally, during the six months ended June 30, 2013, 38,360 shares of outstanding common stock with a value of $0.9 million were repurchased in connection with payment of minimum tax withholding obligations for certain employees relating to the lapse of restrictions on certain restricted stock awards. As of June 30, 2013, there was $50.0 million remaining under the Company’s share repurchase program. Stock-Based Compensation The compensation expense related to the Company’s stock-based compensation plans included in the accompanying Consolidated Statements of Income for the three and six months ended June 30, 2013 and 2012 was as follows (in millions):   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="80%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Cost of sales </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.1</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.4</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.7</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.6</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Sales and marketing </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> General and administrative </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.1</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.6</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.5</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.9</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.7</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4.0</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.6</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> Total compensation expense recognized for the three months ended June 30, 2013 and 2012 includes $1.0 million and $1.1 million related to stock options and $0.9 million and $0.6 million related to restricted stock, respectively. Total compensation expense recognized for the six months ended June 30, 2013 and 2012 includes $2.3 million and $2.1 million related to stock options and $1.7 million and $1.5 million related to restricted stock, respectively. As of June 30, 2013, total unrecognized compensation expense related to non-vested stock options was $6.1 million, which is expected to be recognized over a weighted-average period of approximately 2.6 years. As of June 30, 2013, total unrecognized compensation expense related to non-vested restricted stock was $1.6 million, which is expected to be recognized over a weighted-average period of approximately 1.5 years. Compensation expense capitalized to inventory and compensation expense related to the Company’s ESPP were not material for the three and six months ended June 30, 2013 and 2012. The estimated fair value of each stock option award was determined on the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions for the option grants.   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="86%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Expected option life (in years) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.53</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.57</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Volatility rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">44</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">46</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Risk-free interest rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.86</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.74</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr> <td valign="top"> Dividend rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> </table> The weighted-average grant date fair value of stock options granted during the six months ended June 30, 2013 and 2012 was $9.19 and $6.51, respectively. The Company granted 529,134 and 621,705 stock options during the six months ended June 30, 2013 and 2012, respectively. The weighted-average grant date fair value of restricted stock granted during the six months ended June 30, 2013 and 2012 was $23.18 and $15.45, respectively. The Company granted 68,994 and 132,205 shares of restricted stock during the six months ended June 30, 2013 and 2012, respectively. The grant date fair value of restricted stock is determined based on the closing market price of the Company’s common stock on the grant date. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 4.E) -URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 4 -Subparagraph (SAB TOPIC 4.C) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Article 4 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section C Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(d),(e)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Preferred Stock -URI http://asc.fasb.org/extlink&oid=6521494 Reference 11: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 12: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 13: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 14: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644 Reference 15: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644 Reference 16: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644 Reference 17: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644 Reference 18: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph d -Article 4 Reference 19: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656 false0Stockholders' EquityfalseStockholders' EquityUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlock12 XML 47 R2.xml IDEA: CONSOLIDATED BALANCE SHEETS 2.4.0.8103 - Statement - CONSOLIDATED BALANCE SHEETStruefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_AssetsCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Current assets:2false 4us-gaap_CashAndCashEquivalentsAtCarryingValueus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2194900021949USD$falsetruefalse2truefalsefalse1485600014856USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of currency on hand as well as demand deposits with banks or financial institutions. Includes other kinds of accounts that have the general characteristics of demand deposits. Also includes short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates. Excludes cash and cash equivalents within disposal group and discontinued operation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash -URI http://asc.fasb.org/extlink&oid=6506951 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Cash Equivalents -URI http://asc.fasb.org/extlink&oid=6507016 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 1 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.1) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3044-108585 false2Cash and cash equivalents3false 4us-gaap_AccountsReceivableNetCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1359500013595falsefalsefalse2truefalsefalse3257000032570falsefalsefalsexbrli:monetaryItemTypemonetaryAmount due from customers or clients, within one year of the balance sheet date (or the normal operating cycle, whichever is longer), for goods or services (including trade receivables) that have been delivered or sold in the normal course of business, reduced to the estimated net realizable fair value by an allowance established by the entity of the amount it deems uncertain of collection.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.3-4) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 3 -Subparagraph a(1) -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 4 -Article 5 false2Accounts receivable, net4false 4us-gaap_InventoryNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2466400024664falsefalsefalse2truefalsefalse1549600015496falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 false2Inventories5false 4us-gaap_DeferredTaxAssetsNetCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse47350004735falsefalsefalse2truefalsefalse66220006622falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards expected to be realized or consumed within one year or operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31917-109318 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32537-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31931-109318 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31928-109318 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31958-109318 false2Deferred tax asset-current6false 4us-gaap_PrepaidExpenseAndOtherAssetsCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse60580006058falsefalsefalse2truefalsefalse52280005228falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of asset related to consideration paid in advance for costs that provide economic benefits in future periods, and amount of other assets that are expected to be realized or consumed within one year or the normal operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 8 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 false2Prepaid expenses and other current assets7false 4us-gaap_AssetsCurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse7100100071001falsefalsefalse2truefalsefalse7477200074772falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are expected to be realized in cash, sold, or consumed within one year (or the normal operating cycle, if longer). Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.9) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6801-107765 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 9 -Article 5 true2Total current assets8false 3us-gaap_PropertyPlantAndEquipmentNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse4140400041404falsefalsefalse2truefalsefalse3415600034156falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after accumulated depreciation, depletion and amortization of physical assets used in the normal conduct of business to produce goods and services and not intended for resale. Examples include, but are not limited to, land, buildings, machinery and equipment, office equipment, and furniture and fixtures.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 360 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6391035&loc=d3e2868-110229 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.13) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 13 -Subparagraph a -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 8 -Article 7 false2Property, plant and equipment, net9false 3us-gaap_Goodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse8271600082716falsefalsefalse2truefalsefalse7101300071013falsefalsefalsexbrli:monetaryItemTypemonetaryAmount after accumulated impairment loss of an asset representing future economic benefits arising from other assets acquired in a business combination that are not individually identified and separately recognized.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388280&loc=d3e13770-109266 false2Goodwill10false 3us-gaap_IntangibleAssetsNetExcludingGoodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse6828900068289falsefalsefalse2truefalsefalse6034100060341falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts of all intangible assets, excluding goodwill, as of the balance sheet date, net of accumulated amortization and impairment charges.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16212-109274 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph ((a)(1),(b)) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 false2Intangible assets, net11false 3us-gaap_OtherAssetsNoncurrentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse16910001691falsefalsefalse2truefalsefalse18170001817falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of noncurrent assets not separately disclosed in the balance sheet. Noncurrent assets are expected to be realized or consumed after one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.17) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 17 -Article 5 false2Other non-current assets12false 3us-gaap_Assetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse265101000265101falsefalsefalse2truefalsefalse242099000242099falsefalsefalsexbrli:monetaryItemTypemonetarySum of the carrying amounts as of the balance sheet date of all assets that are recognized. Assets are probable future economic benefits obtained or controlled by an entity as a result of past transactions or events.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.18) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 12 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 18 -Article 5 true2Total assets13true 3us-gaap_LiabilitiesCurrentAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Current liabilities:14false 4us-gaap_AccountsPayableCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse52860005286falsefalsefalse2truefalsefalse78640007864falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19 -Subparagraph a -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Accounts payable15false 4us-gaap_EmployeeRelatedLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse55370005537falsefalsefalse2truefalsefalse60160006016falsefalsefalsexbrli:monetaryItemTypemonetaryTotal of the carrying values as of the balance sheet date of obligations incurred through that date and payable for obligations related to services received from employees, such as accrued salaries and bonuses, payroll taxes and fringe benefits. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Accrued payroll and related expenses16false 4qdel_CurrentPortionOfLeaseObligationqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse409000409falsefalsefalse2truefalsefalse380000380falsefalsefalsexbrli:monetaryItemTypemonetaryCurrent portion of lease obligation.No definition available.false2Current portion of lease obligation17false 4qdel_BusinessCombinationContingentConsiderationLiabilityCurrentqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse17950001795falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Combination, Contingent Consideration, Liability CurrentNo definition available.false2Current portion of contingent consideration (see Note 13)18false 4us-gaap_OtherLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse51920005192falsefalsefalse2truefalsefalse82410008241falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6904-107765 false2Other current liabilities19false 4us-gaap_LiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse1821900018219falsefalsefalse2truefalsefalse2250100022501falsefalsefalsexbrli:monetaryItemTypemonetaryTotal obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.21) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 21 -Article 5 true2Total current liabilities20false 3us-gaap_LongTermDebtNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse50000005000falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying amount of long-term debt, net of unamortized discount or premium, excluding amounts to be repaid within one year or the normal operating cycle, if longer (current maturities). Includes, but not limited to, notes payable, bonds payable, debentures, mortgage loans and commercial paper. Excludes capital lease obligations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 22 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Long term debt21false 3qdel_LeaseObligationNetOfCurrentPortionqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse53540005354falsefalsefalse2truefalsefalse55670005567falsefalsefalsexbrli:monetaryItemTypemonetaryLease obligation, net of current portion.No definition available.false2Lease obligation, net of current portion22false 3qdel_BusinessCombinationContingentConsiderationLiabilityNonCurrentqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1012400010124falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Combination, Contingent Consideration, Liability Non CurrentNo definition available.false2Contingent consideration-non-current (see Note 13)23false 3us-gaap_DeferredTaxLiabilitiesNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse94650009465falsefalsefalse2truefalsefalse33490003349falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of deferred tax liability attributable to taxable temporary differences, net of deferred tax asset attributable to deductible temporary differences and carryforwards net of valuation allowances expected to be realized or consumed after one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31917-109318 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31931-109318 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=21917399&loc=d3e31958-109318 false2Deferred tax liability-non-current24false 3us-gaap_AccruedIncomeTaxesNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse15480001548falsefalsefalse2truefalsefalse45480004548falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all domestic and foreign income tax obligations due beyond one year or the operating cycle, whichever is longer. Alternate captions include income taxes payable, noncurrent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 24 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 15 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 15 -Subparagraph b(1) -Article 7 false2Income taxes payable25false 3us-gaap_OtherLiabilitiesNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse903000903falsefalsefalse2truefalsefalse13540001354falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount, as of the balance sheet date, of noncurrent obligations not separately disclosed in the balance sheet. Noncurrent liabilities are expected to be paid after one year (or the normal operating cycle, if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.24) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 24 -Article 5 false2Other non-current liabilities26false 3us-gaap_CommitmentsAndContingenciesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00  falsefalsefalse2falsefalsefalse00  falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the caption on the face of the balance sheet to indicate that the entity has entered into (1) purchase or supply arrangements that will require expending a portion of its resources to meet the terms thereof, and (2) is exposed to potential losses or, less frequently, gains, arising from (a) possible claims against a company's resources due to future performance under contract terms, and (b) possible losses or likely gains from uncertainties that will ultimately be resolved when one or more future events that are deemed likely to occur do occur or fail to occur.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14326-108349 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 25 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 7 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 17 -Article 9 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-03.17) -URI http://asc.fasb.org/extlink&oid=6876686&loc=d3e534808-122878 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 210 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-03.(a),19) -URI http://asc.fasb.org/extlink&oid=6879938&loc=d3e572229-122910 false2Commitments and contingencies27true 3us-gaap_StockholdersEquityAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Stockholders' equity:28false 4us-gaap_PreferredStockValueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00  falsefalsefalse2falsefalsefalse00  falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate par or stated value of issued nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable preferred shares, par value and other disclosure concepts are in another section within stockholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false2Preferred stock, $.001 par value per share; 5,000 shares authorized; none issued or outstanding at June 30, 2013 and December 31, 201229false 4us-gaap_CommonStockValueus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse3400034falsefalsefalse2truefalsefalse3300033falsefalsefalsexbrli:monetaryItemTypemonetaryAggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false2Common stock, $.001 par value per share; 50,000 shares authorized; 33,868 and 33,452 shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively30false 4us-gaap_AdditionalPaidInCapitalus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse193526000193526falsefalsefalse2truefalsefalse184431000184431falsefalsefalsexbrli:monetaryItemTypemonetaryExcess of issue price over par or stated value of the entity's capital stock and amounts received from other transactions involving the entity's stock or stockholders. Includes adjustments to additional paid in capital. Some examples of such adjustments include recording the issuance of debt with a beneficial conversion feature and certain tax consequences of equity instruments awarded to employees. Use this element for the aggregate amount of additional paid-in capital associated with common and preferred stock. For additional paid-in capital associated with only common stock, use the element additional paid in capital, common stock. For additional paid-in capital associated with only preferred stock, use the element additional paid in capital, preferred stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.30(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Additional paid-in capital31false 4us-gaap_RetainedEarningsAccumulatedDeficitus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2592800025928falsefalsefalse2truefalsefalse1531600015316falsefalsefalsexbrli:monetaryItemTypemonetaryThe cumulative amount of the reporting entity's undistributed earnings or deficit.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 31 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.31(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Retained earnings32false 4us-gaap_StockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse219488000219488falsefalsefalse2truefalsefalse199780000199780falsefalsefalsexbrli:monetaryItemTypemonetaryTotal of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 310 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 4.E) -URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 4 -Section E Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29-31) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30, 31 -Article 5 true2Total stockholders' equity33false 3us-gaap_LiabilitiesAndStockholdersEquityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse265101000265101USD$falsetruefalse2truefalsefalse242099000242099USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of liabilities and equity items, including the portion of equity attributable to noncontrolling interests, if any.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.32) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 25 -Article 7 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 32 -Article 5 true2Total liabilities and stockholders' equityfalseCONSOLIDATED BALANCE SHEETS (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/StatementOfFinancialPositionClassified233 XML 48 R9.htm IDEA: XBRL DOCUMENT

Inventories

6 Months Ended

Jun. 30, 2013

Inventory Disclosure [Abstract]

Inventories

Note 3. Inventories


	June 30,		December 31,
	2013		2012
Raw materials	$	9,014	$	5,582
Work - in - process (materials, labor and overhead)		8,647		4,686
Finished goods (materials, labor and overhead)		7,003		5,228

	$	24,664	$	15,496

- Definition

The entire disclosure for inventory. This may include, but is not limited to, the basis of stating inventory, the method of determining inventory cost, the major classes of inventory, and the nature of the cost elements included in inventory. If inventory is stated above cost, accrued net losses on firm purchase commitments for inventory and losses resulting from valuing inventory at the lower-of-cost-or-market may also be included. For LIFO inventory, may disclose the amount and basis for determining the excess of replacement or current cost over stated LIFO value and the effects of a LIFO quantities liquidation that impacts net income.

+ References+ Details

XML 49 R41.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Additional Information (Detail) (USD $)	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Common stock issued in conjunction with the vesting and release of restricted stock			121,375
Common stock issued due to exercise of stock options			405,917
Common stock issued in connection with employee stock purchase plan			24,733
Employee stock purchase plan, net proceeds			$ 4,900,000
Repurchase of Common stock shares			38,360
Repurchases of common stock			858,000	3,387,000
Amount available under the share repurchase program			50,000,000
Share-based compensation expense recognized	1,900,000	1,700,000	4,000,000	3,600,000
Weighted-average grant date fair value of stock options granted			$ 9.19	$ 6.51
Stock options [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense recognized	1,000,000	1,100,000	2,300,000	2,100,000
Total unrecognized compensation expense related to non-vested stock options	6,100,000		6,100,000
Expected weighted-average period of recognition for unrecognized compensation expense			2 years 7 months 6 days
Stock options granted			529,134	621,705
Restricted stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Share-based compensation expense recognized	900,000	600,000	1,700,000	1,500,000
Expected weighted-average period of recognition for unrecognized compensation expense			1 year 6 months
Total unrecognized compensation expense related to non-vested restricted stock	$ 1,600,000		$ 1,600,000
Weighted-average grant date fair value of restricted stock granted			$ 23.18	$ 15.45
Restricted stock granted			68,994	132,205

XML 50 R28.htm IDEA: XBRL DOCUMENT

Acquisition (Tables)

6 Months Ended

Jun. 30, 2013

Business Combinations [Abstract]

Allocation of Purchase Price to Net Tangible and Intangible Assets Acquired and Liabilities

The Company’s preliminary allocation of the purchase price to the net tangible and intangible assets acquired and liabilities assumed is as follows (in thousands):


				Weighted-average amortization period (years)

Acquisition consideration
Cash consideration	$	10,000
Settlement of pre-existing liabilities and working capital adjustment		(850	)

Net cash consideration		9,150
Contingent consideration		11,919

Net consideration at closing	$	21,069


Fair market values
Other current and non-current assets	$	375
Property, plant and equipment		179
In-process research and development		700
Purchased technology		4,360		10
Non-compete agreement		700		5
Contractual relationships		530		10
Patents		8,800		12
Goodwill		11,703

Total assets acquired		27,347

Accounts payable and other current liabilities		701
Deferred tax liabilities		5,577

Total liabilities assumed		6,278

Purchase price allocation	$	21,069

Schedule of Pro Forma Financial Information


	Six months ended
	June 30,
(in thousands, except per share data)	2013			2012
Pro forma total revenues	$	92,650		$	70,205

Pro forma net income (loss)	$	10,122		$	(3,505	)

Pro forma basic net earnings (loss) per share	$	0.30		$	(0.11	)

Pro forma diluted net earnings (loss) per share	$	0.29		$	(0.11	)


Total revenue included in the consolidated statements of operations	$	188

Net loss included in the consolidated statements of operations	$	(228	)

XML 51 R32.htm IDEA: XBRL DOCUMENT

Inventories - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Inventory Disclosure [Abstract]
Net of reserves, inventories	$ 0.5	$ 0.6

XML 52 R24.xml IDEA: Other Current Liabilities (Tables) 2.4.0.8125 - Disclosure - Other Current Liabilities (Tables)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_TextBlockAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Text Block [Abstract]2false 2us-gaap_OtherCurrentLiabilitiesTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Other current liabilities consist of the following (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="7%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">December 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer incentives </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1,514</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">2,693</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Customer prepayments </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,340</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">450</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Unearned grant revenue </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">872</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,156</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Income tax payable </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">171</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">955</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Accrued liability for technology licenses </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">707</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Other </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,295</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,280</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,192</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,241</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of other current liabilities.No definition available.false0Other Current LiabilitiesfalseOther Current Liabilities (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsOtherCurrentLiabilitiesTextBlockTables12 XML 53 R10.xml IDEA: Intangible Assets 2.4.0.8111 - Disclosure - Intangible Assetstruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Goodwill And Intangible Assets Disclosure [Abstract]2false 2us-gaap_IntangibleAssetsDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 4. Intangible Assets Intangible assets consist of the following (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="45%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Weighted-</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Average</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Useful Life</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Gross</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Accumulated</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Gross</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Accumulated</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> Description </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">(years)</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Assets</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Net</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Assets</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Net</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Goodwill </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">Indefinite</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">86,165</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,449</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">82,716</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">74,461</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,448</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">71,013</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Purchased technology </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">57,030</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(25,371</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">31,659</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,670</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(22,308</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">30,362</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,852</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,483</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,369</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,322</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,007</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,315</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> In-process research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">Indefinite</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,270</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,270</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,570</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,570</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> License agreements </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">49,778</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(33,672</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">16,106</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">49,378</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(29,386</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">19,992</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Patent and trademark costs </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11.9</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14,562</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,078</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,484</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,012</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,887</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,125</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Favorable lease </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9.0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,627</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">73</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,594</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">106</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Software development costs </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.2</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,891</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(563</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,328</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,262</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(391</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,871</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total goodwill and intangible assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">222,248</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(71,243</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">151,005</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">194,375</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(63,021</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">131,354</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> In 2011, the Company acquired a technology license from Alere Inc. for $28.8 million, which the Company is amortizing over an estimated useful life of 3.5 years based on the higher of the percentage of usage or the straight-line method. This percentage of usage is determined using the revenues generated from products covered by the patents that are subject to the license. The Company recorded $1.1 million, $1.7 million, $4.3 million, and $3.8 million of amortization expense associated with this technology license included as a portion of cost of sales for the three months ended June 30, 2013 and 2012, and the six months ended June 30, 2013 and 2012, respectively. The Company acquired distribution rights for $0.8 million in conjunction with the March 2013 Agreement with Life Technologies Corporation (see Note 1). The distribution rights will be amortized on a straight-line basis over the contractual term of six years. In May 2013, the Company acquired intangible assets in conjunction with the BioHelix Corporation (“BioHelix”) acquisition as more fully described in Note 13. The definite lived intangible assets will be amortized on a straight-line basis. The useful life of the in-process research and development is to be determined, and the amortization will commence upon commercialization of the associated product. The following table summarizes the expected future annual amortization expense of intangible assets recorded on the Company’s condensed consolidated balance sheet as of June 30, 2013 (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="85%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom">For the years ending December 31,</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Expense</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2013 (remaining six months) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,434</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,345</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,965</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2016 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,087</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,781</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Thereafter </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,407</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total expected future amortization </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">66,019</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for all or part of the information related to intangible assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16373-109275 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275 false0Intangible AssetsfalseIntangible AssetsUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsIntangibleAssetsDisclosureTextBlock12 XML 54 R37.htm IDEA: XBRL DOCUMENT

Other Current Liabilities - Other Current Liabilities (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Other Liabilities Disclosure [Abstract]
Customer incentives	$ 1,514	$ 2,693
Customer prepayments	1,340	450
Unearned grant revenue	872	2,156
Income tax payable	171	955
Accrued liability for technology licenses		707
Other	1,295	1,280
Total other current liabilities	$ 5,192	$ 8,241

- Definition

Carrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

+ References+ Details

- Definition

+ References+ Details

XML 55 R5.xml IDEA: CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) 2.4.0.8106 - Statement - CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20120630_0http://www.sec.gov/CIK0000353569duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_IncomeStatementAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Income Statement [Abstract]2false 2us-gaap_CostOfGoodsSoldAmortizationus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse15110001511USD$falsetruefalse2truefalsefalse14380001438USD$falsetruefalse3truefalsefalse29490002949USD$falsetruefalse4truefalsefalse28760002876USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe amount of expense recognized in the current period that reflects the allocation of the costs of intangible assets over the expected benefit period of such assets. This element applies only to intangible assets used in the production of goods.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.2(a)) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 false2Amortization of intangible assetsfalseCONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/StatementOfIncomeAlternativeParenthetical42 EXCEL 56 Financial_Report.xls IDEA: XBRL DOCUMENT begin 644 Financial_Report.xls M[[N_34E-12U697)S:6]N.B`Q+C`-"E@M1&]C=6UE;G0M5'EP93H@5V]R:V)O M;VL-"D-O;G1E;G0M5'EP93H@;75L=&EP87)T+W)E;&%T960[(&)O=6YD87)Y M/2(M+2TM/5].97AT4&%R=%\X83@P9#)A-5\T9C)E7S1C9#=?835B,%\S8C4P M865E9#`P8F0B#0H-"E1H:7,@9&]C=6UE;G0@:7,@82!3:6YG;&4@1FEL92!7 M96(@4&%G92P@86QS;R!K;F]W;B!A'!L;W)E&UL;G,Z=CTS1")U&UL;G,Z;STS1")U&UL/@T*(#QX.D5X8V5L5V]R:V)O;VL^#0H@(#QX M.D5X8V5L5V]R:W-H965T5]);F9O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/E-U;6UA#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/DEN=F5N=&]R:65S/"]X.DYA;64^#0H@("`@ M/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O#I%>&-E;%=O&5S/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H M965T4V]U#I%>&-E;%=O#I7;W)K#I%>&-E;%=O#I%>&-E;%=O#I%>&-E M;%=O#I.86UE/@T*("`@(#QX.E=O M#I%>&-E;%=O#I.86UE/D%C<75I#I%>&-E;%=O5]O9E]3:6=N:69I8V%N M=%]!8V-O=6YT,3PO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I. M86UE/D-O;7!U=&%T:6]N7V]F7TQO#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I% M>&-E;%=O5]486)L97,\+W@Z3F%M93X-"B`@ M("`\>#I7;W)K5]A;F1?1V5O9W)A M<&AI8U]);F9O#I% M>&-E;%=O#I%>&-E;%=O5]O9E]3:6=N:69I8V%N=%]!8V-O M=6YT,CPO>#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE/D-O M;7!U=&%T:6]N7V]F7TQO#I7;W)K#I%>&-E M;%=O#I%>&-E;%=O5]O9E]);G9E;G1O/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I% M>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O#I%>&-E;%=O&5S7T%D9&ET:6]N86Q?26YF;W)M/"]X M.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O&5S7U-U;6UA#I%>&-E;%=O#I%>&-E;%=O5]!9&1I=&EO;F%L/"]X.DYA;64^#0H@("`@/'@Z5V]R M:W-H965T4V]U#I%>&-E;%=O5]#;VUP96YS M871I/"]X.DYA;64^#0H@("`@/'@Z5V]R:W-H965T4V]U#I%>&-E;%=O5]%#I%>&-E;%=O#I.86UE/@T*("`@(#QX.E=O#I%>&-E;%=O#I.86UE M/DEN9'5S=')Y7V%N9%]'96]G#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I7;W)K#I3='EL97-H965T($A2968] M,T0B5V]R:W-H965T&-E;"!84"!O3X-"CPO:'1M;#X-"@T* M+2TM+2TM/5].97AT4&%R=%\X83@P9#)A-5\T9C)E7S1C9#=?835B,%\S8C4P M865E9#`P8F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&$X,&0R M835?-&8R95\T8V0W7V$U8C!?,V(U,&%E960P,&)D+U=O'0O:'1M;#L@8VAA7!E(&-O;G1E;G0],T0G=&5X="]H=&UL.R!C M:&%R2!);F9O2!);F9O'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$6UB;VP\ M+W1D/@T*("`@("`@("`\=&0@8VQA2!2 M96=I2!#96YT3PO M=&0^#0H@("`@("`@(#QT9"!C;&%S'0^,#`P,#,U,S4V.3QS<&%N M/CPO'0^+2TQ,BTS,3QS<&%N/CPO3X-"CPO:'1M;#X-"@T*+2TM+2TM/5].97AT4&%R=%\X83@P9#)A-5\T M9C)E7S1C9#=?835B,%\S8C4P865E9#`P8F0-"D-O;G1E;G0M3&]C871I;VXZ M(&9I;&4Z+R\O0SHO.&$X,&0R835?-&8R95\T8V0W7V$U8C!?,V(U,&%E960P M,&)D+U=O'0O:'1M;#L@8VAA"!A6%B;&4\+W1D/@T*("`@("`@("`\=&0@8VQA'!E;G-E'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@ M/'1R(&-L87-S/3-$'0^)FYB'0^)FYB'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@ M(#QT9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\ M+W1R/@T*("`@("`@/'1R(&-L87-S/3-$F5D.R!N M;VYE(&ES'0^)FYB'0^)FYB3PO=&0^#0H@("`@("`@(#QT9"!C;&%S'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA&-E<'0@4&5R(%-H87)E(&1A=&$L('5N;&5S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$F5D M/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M<#XU+#`P,#QS<&%N/CPO M7!E.B!T97AT M+VAT;6P[(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^ M#0H@("`@/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT M/3-$)W1E>'0O:'1M;#L@8VAA'!E;G-E&5S/"]T9#X-"B`@("`@("`@/'1D(&-L87-S/3-$;G5M/B@W+#,Q,BD\3X-"CPO:'1M;#X- M"@T*+2TM+2TM/5].97AT4&%R=%\X83@P9#)A-5\T9C)E7S1C9#=?835B,%\S M8C4P865E9#`P8F0-"D-O;G1E;G0M3&]C871I;VXZ(&9I;&4Z+R\O0SHO.&$X M,&0R835?-&8R95\T8V0W7V$U8C!?,V(U,&%E960P,&)D+U=O'0O:'1M;#L@8VAA'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT M9"!C;&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R M/@T*("`@("`@/'1R(&-L87-S/3-$'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^ M/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L M87-S/3-$"!A"!B96YE9FET(&9R;VT@'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$7)O;&P@86YD(')E;&%T960@97AP M96YS97,\+W1D/@T*("`@("`@("`\=&0@8VQA6%L=&EE'0^/'-P86X^/"]S<&%N M/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@ M("`@/'1R(&-L87-S/3-$&5D(&%S'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S M'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^/"]S M<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^ M#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$'0^/'-P86X^/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R M(&-L87-S/3-$'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`@(#QT9"!C;&%S'0^/'-P86X^ M/"]S<&%N/CPO=&0^#0H@("`@("`\+W1R/@T*("`@("`@/'1R(&-L87-S/3-$ M2!I;F-U7!E.B!T97AT+VAT;6P[ M(&-H87)S970](G5S+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@ M/$U%5$$@:'1T<"UE<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E M>'0O:'1M;#L@8VAA2!O9B!3:6=N:69I8V%N="!!8V-O=6YT:6YG(%!O;&EC:65S/"]T9#X-"B`@ M("`@("`@/'1D(&-L87-S/3-$=&5X=#X\9&EV/@T*/'`@#L@34%21TE.+4)/5%1/33H@,'!X)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\ M8CY.;W1E(#$N(%-U;6UA6QE/3-$)TU!4D=)3BU4 M3U`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`Q,RP@86YD(&9O"!M;VYT:',@96YD960-"DIU;F4F(WA!,#LS,"P@,C`Q,R!A;F0@,C`Q,BP@ M:7,@=6YA=61I=&5D+B!&;W(@9G5R=&AE65A$$P.S,Q+"`R,#$R#0II;F-L=61E9"!I M;B!T:&4@0V]M<&%N>28C>#(P,3D[$$P M.S$P+4LN/"]F;VYT/B!/<&5R871I;F<@2!Q=6%R M=&5R(&%R92!H:7-T;W)I8V%L;'D@2!I;F1I8V%T:79E(&]F('1H92!R97-U;'1S M(&5X<&5C=&5D(&9O65A#L@5$585"U)3D1%3E0Z(#0E.R!- M05)'24XM0D]45$]-.B`P<'@G/@T*/&9O;G0@28C>#(P,3D[65A"!M;VYT:"!P97)I;V1S(&5N9&5D)B-X M03`[2G5N92`S,"P@,C`Q,R!A;F0@,C`Q,B!E86-H#0II;F-L=61E9"`Q,R!A M;F0@,C8@=V5E:W,L(')E2X\+V9O;G0^/"]P/@T*/'`@#L@34%21TE.+4)/5%1/33H@,'!X)SX\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CX\8CY#;VUP6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/DYE M="`H;&]S"!M;VYT:',@96YD M960@2G5N928C>$$P.S,P+"`R,#$S(&%N9"`R,#$R+`T*6QE/3-$)T9/3E0M1D%-24Q9 M.B!4:6UEF4],T0R/CQB/E5S92!O9@T*17-T:6UA M=&5S/"]B/CPO9F]N=#X\+W`^#0H\<"!S='EL93TS1"=-05)'24XM5$]0.B`V M<'@[(%1%6%0M24Y$14Y4.B`T)3L@34%21TE.+4)/5%1/33H@,'!X)SX-"CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!P'!E;G-E M2!V86QU871I;VXL(&EN=&%N M9VEB;&4@87-S971S+"!S;V9T=V%R92!D979E;&]P;65N="!C;W-T2!A<'!A0T*9&EF9F5R M(&9R;VT@=&AE6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/CQB/E)E=F5N=64-"E)E8V]G;FET:6]N/"]B/CPO9F]N=#X\+W`^#0H\ M<"!S='EL93TS1"=-05)'24XM5$]0.B`V<'@[(%1%6%0M24Y$14Y4.B`T)3L@ M34%21TE.+4)/5%1/33H@,'!X)SX-"CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/E1H92!#;VUP86YY#0IR M96-O2!F2!A;'-O(&5A6QE/3-$)TU!4D=) M3BU43U`Z(#$R<'@[(%1%6%0M24Y$14Y4.B`T)3L@34%21TE.+4)/5%1/33H@ M,'!X)SX-"CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/E1H92!#;VUP86YY#0IE87)N2!W87,@87=A2!F;W(@2$E6(&1R=6<@=')E871M96YT#0IM;VYI M=&]R:6YG(&]N('1H92!I;G1E9W)A=&5D(%-A=F%N;F$F(W@R,3(R.R!-1'@@ M<&QA=&9O&5C=71I;VX@;V8@=&AE(&=R86YT(&%GF5D(&]N(&$-"G-T M"!M;VYT:',@96YD960@2G5N928C>$$P.S,P+"`R,#$S+"!T M:&4@0V]M<&%N>0T*6QE/3-$)TU!4D=)3BU43U`Z(#$X<'@[($U!4D=)3BU"3U14 M3TTZ(#!P>"<^/&9O;G0@6QE/3-$)TU!4D=)3BU43U`Z(#9P M>#L@5$585"U)3D1%3E0Z(#0E.R!-05)'24XM0D]45$]-.B`P<'@G/@T*/&9O M;G0@2`R,#$R+`T*=&AE($-O;7!A;GD@96YT97)E9"!I;G1O M(&$@8V]L;&%B;W)A=&EV92!A7,N#0I!4T,@5&]P:6,@.#`X+"!#;VQL86)O'!O"!M;VYT:',@96YD960@ M2G5N928C>$$P.S,P+"`R,#$S+B!4:&4@0V]M<&%N>2!E>'!E8W1S(&%D9&ET M:6]N86P-"G!A>6UE;G1S(&]F("0P+C@@;6EL;&EO;B!T;R!B96-O;64@9'5E M('1H2`U,"4@;V8@<')O:F5C="!D979E;&]P;65N=`T*8V]S M=',@8F%S960@=7!O;B!M=71U86QL>2!A9W)E960@=7!O;B!P'!E;F1I M='5R97,@9F]R(')E2X@26X@8V]N;F5C=&EO;B!W:71H('1H90T*8V]L;&%B;W)A=&EO;B!A M9W)E96UE;G0L('1H92!#;VUP86YY(&%L2!A9W)E96UE;G0@=VET:"!,:69E(%1E M8VAN;VQO9VEE#L@5$585"U)3D1%3E0Z(#0E.R!-05)'24XM0D]45$]-.B`P M<'@G/@T*/&9O;G0@"!Y96%R(&EN7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S M+6%S8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE M<75I=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA M'0^/&1I=CX-"CQP('-T>6QE/3-$)TU!4D=)3BU43U`Z(#$X<'@[($U! M4D=)3BU"3U143TTZ(#!P>"<^/&9O;G0@$$P.S(N($-O M;7!U=&%T:6]N#0IO9B`H3&]S6QE M/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D1I M;'5T960@;F5T#0II;F-O;64@<&5R('-H87)E(&ES(')E<&]R=&5D(&)A28C>#(P,3D[2!D:79I9&EN9R!N970@:6YC M;VUE(&%D:G5S=&5D(&9O<@T*96%R;FEN9W,@86QL;V-A=&5D('1O('5N=F5S M=&5D('-T;V-K:&]L9&5R2!T:&4-"G=E:6=H M=&5D(&%V97)A9V4@;G5M8F5R(&]F(&-O;6UO;B!S:&%R97,@;W5T2!D:79I9&EN9R!N970@:6YC;VUE(&%D:G5S=&5D(&9O2!T:&4@=V5I9VAT960@879E&5R8VES M92!P"!M;VYT M:',@96YD960@2G5N928C>$$P.S,P+"`R,#$S+"`P+C0F(WA!,#MM:6QL:6]N M('-T;V-K#0IO<'1I;VYS('=E#(P M,4,[15!3)B-X,C`Q1#LI(&%S('1H96ER(&5F9F5C="!W87,-"F%N=&DM9&EL M=71I=F4N/"]F;VYT/CPO<#X-"CQP('-T>6QE/3-$)TU!4D=)3BU43U`Z(#$R M<'@[(%1%6%0M24Y$14Y4.B`T)3L@34%21TE.+4)/5%1/33H@,'!X)SX-"CQF M;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/D9O"!M;VYT:',@96YD960-"DIU;F4F M(WA!,#LS,"P@,C`Q,B!T:&5R92!W97)E(&YO(&1I9F9E2!W M97)E('!E2!I;F-U$$P.VUI;&QI;VXL(#`N M-R8C>$$P.VUI;&QI;VXL(&%N9`T*,"XW)B-X03`[;6EL;&EO;B!S=&]C:R!O M<'1I;VYS(&%N9"!S:&%R97,@;V8@2P@=V5R92!E>&-L=61E9"!F2P@9F]R('1H92!T:')E92!M;VYT:',@96YD960@2G5N928C M>$$P.S,P+`T*,C`Q,R!A;F0@,C`Q,B!A;F0@=&AE('-I>"!M;VYT:',@96YD M960@2G5N928C>$$P.S,P+"`R,#$R+`T*,"XV)B-X03`[;6EL;&EO;BP@,2XS M)B-X03`[;6EL;&EO;BP@86YD(#$N-28C>$$P.VUI;&QI;VX@2P@=V5R92!N;W0@:6YC;'5D960@8F5C875S M92!T:&4@97AE$$P.SPO<#X-"CQP('-T>6QE/3-$)TU!4D=)3BU43U`Z(#!P>#L@5$58 M5"U)3D1%3E0Z(#0E.R!-05)'24XM0D]45$]-.B`P<'@G/@T*/&9O;G0@"!M;VYT M:',@96YD960@2G5N928C>$$P.S,P+"`R,#$S("AI;B!T:&]U#L@1D]. M5"U325I%.B`Q,G!X)SX-"B8C>$$P.SPO<#X-"CQT86)L92!S='EL93TS1"=" M3U)$15(M0T],3$%04T4Z(&-O;&QA<'-E)R!B;W)D97(],T0P(&-E;&QS<&%C M:6YG/3-$,"!C96QL<&%D9&EN9STS1#`@=VED=&@],T0V."4@86QI9VX],T1C M96YT97(^#0H\='(^#0H\=&0@=VED=&@],T0X."4^/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT@=VED=&@],T0V)3X\+W1D/@T*/'1D/CPO=&0^#0H\=&0^ M/"]T9#X-"CQT9#X\+W1D/@T*/"]TF4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1%4BU"3U143TTZ(",P,#`P M,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M M.R!-05)'24XM3$5&5#H@,65M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY"87-I8R!N970@:6YC;VUE M('!E<@T*F4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;3X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\+W1D/@T*/"]T6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/C$P+#8Q,CPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R M87`^/&9O;G0@6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!-05)'24XM3$5&5#H@,V5M M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N M)R!S:7IE/3-$,CY,97-S.B!I;F-O;64@86QL;V-A=&5D('1O#0IP87)T:6-I M<&%T:6YG('-E8W5R:71I97,\+V9O;G0^/"]P/@T*/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/B@S,CPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D M/@T*/"]T"<^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.R8C>$$P.SPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@$$P.SPO M<#X-"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@$$P.SPO<#X-"CPO M=&0^#0H\=&0^)B-X03`[/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N M/3-$=&]P/@T*/'`@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/DYE="!I;F-O;64@86QL;V-A=&5D('1O M#0IC;VUM;VX@F4],T0Q/B8C>$$P.R8C>$$P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXD/"]F M;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"CPO=&0^#0H\=&0^)B-X03`[/"]T9#X-"CPO='(^#0H\='(@8F=C M;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/E=E:6=H=&5D(&%V97)A9V4@8V]M;6]N#0IS:&%R97,@;W5T6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C,S+#8U.#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/3E0M4TE:13H@,7!X M)SX-"CQT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^ M#0H\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@ M$$P.SPO=&0^#0H\+W1R/@T*/'1R/@T* M/'1D('9A;&EG;CTS1'1O<#X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`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`Z(",P,#`P,#`@,W!X(&1O=6)L92<^ M)B-X03`[/"]P/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S M='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P M.SPO<#X-"CPO=&0^#0H\=&0^)B-X03`[/"]T9#X-"CPO='(^#0H\='(@8F=C M;VQO6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/D1I;'5T960@;F5T(&EN8V]M92!P97(-"G-H87)E.CPO9F]N=#X\+W`^ M#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF M(WA!,#LF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"CQT9"!V86QI9VX] M,T1B;W1T;VT^/"]T9#X-"CPO='(^#0H\='(^#0H\=&0@=F%L:6=N/3-$=&]P M/@T*/'`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`Z(",P,#`P M,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X-"CQP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X M('-O;&ED)SXF(WA!,#L\+W`^#0H\+W1D/@T*/'1D/B8C>$$P.SPO=&0^#0H\ M+W1R/@T*/'1R/@T*/'1D('9A;&EG;CTS1'1O<#X-"CQP('-T>6QE/3-$)U1% M6%0M24Y$14Y4.B`M,65M.R!-05)'24XM3$5&5#H@,V5M)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY. M970@:6YC;VUE(&%L;&]C871E9"!T;PT*8V]M;6]N('-T;V-K:&]L9&5R6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/C$P+#4X,3PO9F]N=#X\ M+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O M;G0@6QE/3-$)T9/3E0M4TE:13H@,7!X)SX-"CQT9"!V86QI9VX],T1B;W1T;VT^ M/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X- M"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"="3U)$15(M5$]0 M.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO<#X-"CPO=&0^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M/@T*/'`@$$P M.SPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C0T-%149&/@T*/'1D('9A M;&EG;CTS1'1O<#X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`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`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^ M#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)T)/ M4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H\+W1D M/@T*/'1D/B8C>$$P.SPO=&0^#0H\+W1R/@T*/'1R(&)G8V]L;W(],T0C0T-% M149&/@T*/'1D('9A;&EG;CTS1'1O<#X-"CQP('-T>6QE/3-$)U1%6%0M24Y$ M14Y4.B`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`[)B-X03`[/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^#0H\<"!S='EL M93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G/B8C>$$P.SPO M<#X-"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@$$P.SPO=&0^#0H\+W1R/@T*/'1R/@T*/'1D('9A;&EG M;CTS1'1O<#X-"CQP('-T>6QE/3-$)U1%6%0M24Y$14Y4.B`M,65M.R!-05)' M24XM3$5&5#H@,V5M)SX\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY.970@:6YC;VUE('!E6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4] M,T0R/C`N,S`\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@;F]W M6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0R/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D M/@T*/"]T"<^#0H\=&0@ M=F%L:6=N/3-$8F]T=&]M/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/B8C M>$$P.R8C>$$P.SPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M/@T*/'`@6QE/3-$ M)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O=6)L92<^)B-X03`[/"]P/@T* M/"]T9#X-"CQT9#XF(WA!,#L\+W1D/@T*/"]T'1087)T7SAA M.#!D,F$U7S1F,F5?-&-D-U]A-6(P7S-B-3!A965D,#!B9`T*0V]N=&5N="U, M;V-A=&EO;CH@9FEL93HO+R]#.B\X83@P9#)A-5\T9C)E7S1C9#=?835B,%\S M8C4P865E9#`P8F0O5V]R:W-H965T'0O:F%V87-C3X-"B`@("`\=&%B;&4@8VQA#L@34%21TE.+4)/5%1/33H@,'!X)SX\9F]N="!S='EL M93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CX\ M8CY.;W1E)B-X03`[,RX-"DEN=F5N=&]R:65S/"]B/CPO9F]N=#X\+W`^#0H\ M<"!S='EL93TS1"=-05)'24XM5$]0.B`V<'@[(%1%6%0M24Y$14Y4.B`T)3L@ M34%21TE.+4)/5%1/33H@,'!X)SX-"CQF;VYT('-T>6QE/3-$)T9/3E0M1D%- M24Q9.B!4:6UEF4],T0R/DEN=F5N=&]R:65S(&%R M90T*$$P.S,P+"`R M,#$S(&%N9`T*1&5C96UB97(F(WA!,#LS,2P@,C`Q,BP@#L@1D].5"U325I%.B`Q M,G!X)SX-"B8C>$$P.SPO<#X-"CQT86)L92!S='EL93TS1"="3U)$15(M0T], M3$%04T4Z(&-O;&QA<'-E)R!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C M96QL<&%D9&EN9STS1#`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`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]LF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$ M)T)/4D1%4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B M;W1T;VT@8V]L6QE M/3-$)U1%6%0M24Y$14Y4.B`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`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`P,SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!N M;W=R87`],T1N;W=R87`^/&9O;G0@F4],T0Q/B8C>$$P M.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N M="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE M/3-$,CXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@ M86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXU+#(R.#PO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;2!N;W=R87`],T1N;W=R87`^/&9O;G0@6QE/3-$)T9/ M3E0M4TE:13H@,7!X)SX-"CQT9"!V86QI9VX],T1B;W1T;VT^/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT^#0H\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P M(#%P>"!S;VQI9"<^)B-X03`[/"]P/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT^#0H\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#%P>"!S M;VQI9"<^)B-X03`[/"]P/@T*/"]T9#X-"CQT9#XF(WA!,#L\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;3XF(WA!,#LF(WA!,#L\+W1D/@T*/'1D('9A;&EG M;CTS1&)O='1O;3X-"CQP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@ M,7!X('-O;&ED)SXF(WA!,#L\+W`^#0H\+W1D/@T*/'1D('9A;&EG;CTS1&)O M='1O;3X-"CQP('-T>6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,7!X('-O M;&ED)SXF(WA!,#L\+W`^#0H\+W1D/@T*/'1D/B8C>$$P.SPO=&0^#0H\+W1R M/@T*/'1R/@T*/'1D('9A;&EG;CTS1'1O<#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\+V9O;G0^/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R M/C(T+#8V-#PO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!N;W=R M87`],T1N;W=R87`^/&9O;G0@F4],T0Q/B8C>$$P.R8C M>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXD/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&%L:6=N/3-$ M6QE/3-$)T)/4D1%4BU43U`Z(",P,#`P,#`@,W!X(&1O M=6)L92<^)B-X03`[/"]P/@T*/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T;VT^ M#0H\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D;W5B;&4G M/B8C>$$P.SPO<#X-"CPO=&0^#0H\=&0^)B-X03`[/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT^)B-X03`[)B-X03`[/"]T9#X-"CQT9"!V86QI9VX],T1B M;W1T;VT^#0H\<"!S='EL93TS1"="3U)$15(M5$]0.B`C,#`P,#`P(#-P>"!D M;W5B;&4G/B8C>$$P.SPO<#X-"CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M M/@T*/'`@$$P.SPO=&0^#0H\+W1R/@T* M/"]T86)L93X-"CPO9&EV/CQS<&%N/CPO7!E.B!T97AT+VAT;6P[(&-H87)S970](G5S+6%S M8VEI(@T*#0H\:'1M;#X-"B`@/&AE860^#0H@("`@/$U%5$$@:'1T<"UE<75I M=CTS1$-O;G1E;G0M5'EP92!C;VYT96YT/3-$)W1E>'0O:'1M;#L@8VAA7!E/3-$=&5X="]J879A"<^/&9O;G0@$$P.S0N($EN=&%N9VEB;&4-"D%S"<^#0H\9F]N="!S='EL93TS1"=& M3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY);G1A;F=I M8FQE#0IA#L@1D].5"U325I%.B`Q,G!X)SX-"B8C M>$$P.SPO<#X-"CQT86)L92!S='EL93TS1"="3U)$15(M0T],3$%04T4Z(&-O M;&QA<'-E)R!B;W)D97(],T0P(&-E;&QS<&%C:6YG/3-$,"!C96QL<&%D9&EN M9STS1#`@=VED=&@],T0Q,#`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`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@8V]L M6QE/3-$)T9/3E0M M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D1E8V5M8F5R M)B-X03`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`C,#`P,#`P M(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L:6=N M/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0Q/CQB/D%SF4],T0Q M/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/4D1% M4BU"3U143TTZ(",P,#`P,#`@,7!X('-O;&ED)R!V86QI9VX],T1B;W1T;VT@ M8V]LF%T:6]N/"]B/CPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX] M,T1B;W1T;VT^/&9O;G0@F4],T0Q/B8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D M('9A;&EG;CTS1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#LF(WA!,#L\ M+V9O;G0^/"]T9#X-"CQT9"!S='EL93TS1"="3U)$15(M0D]45$]-.B`C,#`P M,#`P(#%P>"!S;VQI9"<@=F%L:6=N/3-$8F]T=&]M(&-O;'-P86X],T0R(&%L M:6=N/3-$8V5N=&5R/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UE MF4],T0Q/CQB/D%SF4] M,T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('-T>6QE/3-$)T)/ M4D1%4BU"3U143TTZ(",P,#`P,#`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`],T1N;W=R M87`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`],T1N;W=R M87`^/&9O;G0@$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS M1&)O='1O;3X\9F]N="!S:7IE/3-$,3XF(WA!,#L\+V9O;G0^/"]T9#X-"CQT M9"!V86QI9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$ M)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C6QE/3-$)U1%6%0M M24Y$14Y4.B`M,65M.R!-05)'24XM3$5&5#H@,65M)SX\9F]N="!S='EL93TS M1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CY0=7)C M:&%S960-"G1E8VAN;VQO9WD\+V9O;G0^/"]P/@T*/"]T9#X-"CQT9"!V86QI M9VX],T1B;W1T;VT^/&9O;G0@6QE/3-$)T9/ M3E0M1D%-24Q9.B!4:6UEF4],T0R/B8C>$$P.SPO M9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;2!A;&EG;CTS1')I9VAT M/CQF;VYT('-T>6QE/3-$)T9/3E0M1D%-24Q9.B!4:6UEF4],T0R/C@N,SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O M;2!N;W=R87`],T1N;W=R87`^/&9O;G0@F4],T0Q/B8C M>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T*/'1D('9A;&EG;CTS1&)O='1O;3X\ M9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S M:7IE/3-$,CXF(WA!,#L\+V9O;G0^/"]T9#X-"CQT9"!V86QI9VX],T1B;W1T M;VT@86QI9VX],T1R:6=H=#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@ M5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXU-RPP,S`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`],T1N;W=R87`^/&9O;G0@ MF4],T0Q/B8C>$$P.R8C>$$P.SPO9F]N=#X\+W1D/@T* M/'1D('9A;&EG;CTS1&)O='1O;3X\9F]N="!S='EL93TS1"=&3TY4+49!34E, M63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXF(WA!,#L\+V9O;G0^/"]T M9#X-"CQT9"!V86QI9VX],T1B;W1T;VT@86QI9VX],T1R:6=H=#X\9F]N="!S M='EL93TS1"=&3TY4+49!34E,63H@5&EM97,@3F5W(%)O;6%N)R!S:7IE/3-$ M,CXH,C(L,S`X/"]F;VYT/CPO=&0^#0H\=&0@=F%L:6=N/3-$8F]T=&]M(&YO M=W)A<#TS1&YO=W)A<#X\9F]N="!S='EL93TS1"=&3TY4+49!34E,63H@5&EM M97,@3F5W(%)O;6%N)R!S:7IE/3-$,CXI)B-X03`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`],T1N;W=R87`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htm IDEA: XBRL DOCUMENT

Industry and Geographic Information - Sales to Individual Customers in Excess of 10% of Total Revenue (Detail) (Sales [Member])	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Revenue, Major Customer [Line Items]
Sales percentage	26.00%	24.00%
Operating Segments [Member] \| Customer A [Member]
Revenue, Major Customer [Line Items]
Sales percentage	15.00%	15.00%
Operating Segments [Member] \| Customer B [Member]
Revenue, Major Customer [Line Items]
Sales percentage	11.00%	9.00%

XML 63 R3.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $) In Thousands, except Per Share data, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Statement Of Financial Position [Abstract]
Preferred stock, par value per share	$ 0.001	$ 0.001
Preferred stock, shares authorized	5,000	5,000
Preferred stock, shares issued
Preferred stock, shares outstanding
Common stock, par value per share	$ 0.001	$ 0.001
Common stock, shares authorized	50,000	50,000
Common stock, shares issued	33,868	33,452
Common stock, shares outstanding	33,868	33,452

XML 64 R14.htm IDEA: XBRL DOCUMENT

Stockholders' Equity

6 Months Ended

Jun. 30, 2013

Equity [Abstract]

Stockholders' Equity

Note 8. Stockholders’ Equity

Issuances and Repurchases of Common Stock

Stock-Based Compensation


	Three months ended June 30,				Six months ended June 30,
	2013		2012		2013		2012
Cost of sales	$	0.2	$	0.1	$	0.4	$	0.3
Research and development		0.3		0.3		0.7		0.6
Sales and marketing		0.2		0.2		0.3		0.2
General and administrative		1.2		1.1		2.6		2.5

	$	1.9	$	1.7	$	4.0	$	3.6

Total compensation expense recognized for the three months ended June 30, 2013 and 2012 includes $1.0 million and $1.1 million related to stock options and $0.9 million and $0.6 million related to restricted stock, respectively. Total compensation expense recognized for the six months ended June 30, 2013 and 2012 includes $2.3 million and $2.1 million related to stock options and $1.7 million and $1.5 million related to restricted stock, respectively. As of June 30, 2013, total unrecognized compensation expense related to non-vested stock options was $6.1 million, which is expected to be recognized over a weighted-average period of approximately 2.6 years. As of June 30, 2013, total unrecognized compensation expense related to non-vested restricted stock was $1.6 million, which is expected to be recognized over a weighted-average period of approximately 1.5 years. Compensation expense capitalized to inventory and compensation expense related to the Company’s ESPP were not material for the three and six months ended June 30, 2013 and 2012.


	Six months ended June 30,
	2013			2012
Expected option life (in years)		5.53			5.57
Volatility rate		44	%		46	%
Risk-free interest rate		0.86	%		0.74	%
Dividend rate		0	%		0	%

- Definition

The entire disclosure for shareholders' equity comprised of portions attributable to the parent entity and noncontrolling interest, including other comprehensive income. Includes, but is not limited to, balances of common stock, preferred stock, additional paid-in capital, other capital and retained earnings, accumulated balance for each classification of other comprehensive income and amount of comprehensive income.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 210

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.5-02.29-31)

-URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21506-112644

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 02

-Paragraph 29, 30, 31

-Article 5

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 310

-SubTopic 10

-Section S99

-Paragraph 2

-Subparagraph (SAB TOPIC 4.E)

-URI http://asc.fasb.org/extlink&oid=27010918&loc=d3e74512-122707

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 4

-Subparagraph (SAB TOPIC 4.C)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187143-122770

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Article 4

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section C

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 4

-Section E

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.4-08.(d),(e))

-URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Glossary Preferred Stock

-URI http://asc.fasb.org/extlink&oid=6521494

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 04

-Article 3

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SX 210.3-04)

-URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 11

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21564-112644

Reference 16: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21488-112644

Reference 17: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21484-112644

Reference 18: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 08

-Paragraph d

-Article 4

Reference 19: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 505

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6405834&loc=d3e23285-112656

+ Details

XML 65 R20.xml IDEA: Summary of Significant Accounting Policies (Policies) 2.4.0.8121 - Disclosure - Summary of Significant Accounting Policies (Policies)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_AccountingPoliciesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Accounting Policies [Abstract]2false 2us-gaap_BasisOfAccountingPolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Basis of Presentation The accompanying unaudited consolidated financial statements of Quidel Corporation and its subsidiaries (the “Company”) have been prepared in accordance with generally accepted accounting principles in the U.S. for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included. The information at June 30, 2013, and for the three and six months ended June 30, 2013 and 2012, is unaudited. For further information, refer to the Company’s consolidated financial statements and footnotes thereto for the year ended December 31, 2012 included in the Company’s 2012 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year. For 2013 and 2012, the Company’s fiscal year will or has ended on December 29, 2013 and December 30, 2012, respectively. For 2013 and 2012, the Company’s second quarter ended on June 30, 2013 and July 1, 2012, respectively. For ease of reference, the calendar quarter end dates are used herein. The three and six month periods ended June 30, 2013 and 2012 each included 13 and 26 weeks, respectively. </div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).No definition available.false0Basis of Presentation3false 2us-gaap_ComprehensiveIncomePolicyPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Comprehensive Income (Loss) Net (loss) income is equal to comprehensive (loss) income for the three and six months ended June 30, 2013 and 2012, respectively. </div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for comprehensive income.No definition available.false0Comprehensive Income (Loss)4false 2us-gaap_UseOfEstimatesus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Use of Estimates The preparation of financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, management evaluates its estimates, including those related to revenue recognition, customer programs and incentives, reserve for uncollectible accounts, inventory valuation, intangible assets, software development costs, stock-based compensation, restructuring, contingencies and litigation, contingent consideration, and income taxes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. </div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6143-108592 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6132-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6061-108592 false0Use of Estimates5false 2us-gaap_RevenueRecognitionPolicyTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Revenue Recognition The Company records revenues primarily from product sales. These revenues are recorded net of rebates and other discounts which are estimated at the time of sale, and are largely driven by various customer program offerings, including special pricing agreements, promotions and other volume-based incentives. Revenue from product sales are recorded upon passage of title and risk of loss to the customer. Change in title to the product and recognition of revenue occurs upon delivery to the customer when sales terms are free on board (“FOB”) destination and at the time of shipment when the sales terms are FOB shipping point and there is no right of return. The Company also earns income from the licensing of technology. The Company earns income from grants for research and commercialization activities. On November 6, 2012, the Company was awarded a milestone-based grant totaling up to $8.3 million from the Bill and Melinda Gates Foundation to develop, manufacture and validate a quantitative, low-cost, nucleic acid assay for HIV drug treatment monitoring on the integrated Savanna™ MDx platform for use in limited resource settings. Upon execution of the grant agreement, the Company received $2.6 million to fund subsequent research and development activities. The Company expects to receive milestone payments of $2.5 million in 2013 and $3.2 million in 2014 and will recognize grant revenue on the lesser of the amount recognized on a straight-line basis or the amount that is non-refundable through the end of the agreement, which is December 31, 2015. For the three and six months ended June 30, 2013, the Company recognized $0.7 million and $1.3 million as grant revenue associated with this grant. The Company has included $0.9 million and $2.2 million of restricted cash as a component of prepaid expenses and other current assets and as a component of other current liabilities as of June 30, 2013 and December 31, 2012, respectively. </div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 13 -Section B -Paragraph Question 1 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 605 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 13.B.Q1) -URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18823-107790 false0Revenue Recognition6false 2us-gaap_CollaborativeArrangementAccountingPolicyus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Collaborative Arrangement In July 2012, the Company entered into a collaborative arrangement with Life Technologies Corporation for the development of molecular assays. ASC Topic 808, Collaborative Arrangements, defines a collaborative arrangement as an arrangement where the parties are active participants and have exposure to significant risks. The Company is accounting for the joint development and commercialization activities with the third-party as a joint risk sharing collaboration in accordance with ASC Topic 808, Collaborative Arrangements. Payments received or due from Life Technologies Corporation totaled $3.0 million in 2012 and $1.1 million in the six months ended June 30, 2013. The Company expects additional payments of $0.8 million to become due through 2013. The reimbursement represents approximately 50% of project development costs based upon mutually agreed upon project plans for each molecular assay. The reimbursements are recorded as a reduction to research and development expense in the accompanying consolidated financial statements, to the extent that they are less than related expenditures for research and development activities subsequent to the date of the contract. The Company recognized $0 and $1.1 million of such reimbursements as a reduction to research and development expense for the three and six months ended June 30, 2013, respectively. In connection with the collaboration agreement, the Company also entered into a manufacturing and supply agreement with Life Technologies Corporation, which provides for margin sharing. In March 2013, the Company entered into a six year instrument supply agreement (the “March 2013 Agreement”) with Life Technologies Corporation for $0.8 million to sell Life Technologies Corporation’s QuantStudio™ DX diagnostic laboratory instrument for use in the infectious disease field, along with the assays developed under the collaborative agreement. </div>falsefalsefalsenonnum:textBlockItemTypenaDisclosure of accounting policy for collaborative arrangements.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 808 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434 false0Collaborative ArrangementfalseSummary of Significant Accounting Policies (Policies)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsBasisOfPresentationAndSignificantAccountingPoliciesTextBlockPolicies16 XML 66 R5.htm IDEA: XBRL DOCUMENT

CONSOLIDATED STATEMENTS OF OPERATIONS (Parenthetical) (USD $) In Thousands, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Income Statement [Abstract]
Amortization of intangible assets	$ 1,511	$ 1,438	$ 2,949	$ 2,876

XML 67 R2.htm IDEA: XBRL DOCUMENT

CONSOLIDATED BALANCE SHEETS (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Current assets:
Cash and cash equivalents	$ 21,949	$ 14,856
Accounts receivable, net	13,595	32,570
Inventories	24,664	15,496
Deferred tax asset-current	4,735	6,622
Prepaid expenses and other current assets	6,058	5,228
Total current assets	71,001	74,772
Property, plant and equipment, net	41,404	34,156
Goodwill	82,716	71,013
Intangible assets, net	68,289	60,341
Other non-current assets	1,691	1,817
Total assets	265,101	242,099
Current liabilities:
Accounts payable	5,286	7,864
Accrued payroll and related expenses	5,537	6,016
Current portion of lease obligation	409	380
Current portion of contingent consideration (see Note 13)	1,795
Other current liabilities	5,192	8,241
Total current liabilities	18,219	22,501
Long term debt		5,000
Lease obligation, net of current portion	5,354	5,567
Contingent consideration-non-current (see Note 13)	10,124
Deferred tax liability-non-current	9,465	3,349
Income taxes payable	1,548	4,548
Other non-current liabilities	903	1,354
Commitments and contingencies
Stockholders' equity:
Preferred stock, $.001 par value per share; 5,000 shares authorized; none issued or outstanding at June 30, 2013 and December 31, 2012
Common stock, $.001 par value per share; 50,000 shares authorized; 33,868 and 33,452 shares issued and outstanding at June 30, 2013 and December 31, 2012, respectively	34	33
Additional paid-in capital	193,526	184,431
Retained earnings	25,928	15,316
Total stockholders' equity	219,488	199,780
Total liabilities and stockholders' equity	$ 265,101	$ 242,099

XML 68 R47.xml IDEA: Lease Obligation - Additional Information (Detail) 2.4.0.8148 - Disclosure - Lease Obligation - Additional Information (Detail)truefalseIn Millions, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20120630_0http://www.sec.gov/CIK0000353569duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00LeaseStandardhttp://www.quidel.com/20130630Leaseqdel0pureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_SaleLeasebackTransactionLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Sale Leaseback Transaction [Line Items]2false 4qdel_PartnershipPercentageThatAcquiredRealEstateqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truetruefalse0.250.25falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsenum:percentItemTypepurePartnership percentage that acquired real estate.No definition available.false0Partnership that acquired the facility3false 4qdel_AmendedTermsqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse0010 yearsfalsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaThe amended terms.No definition available.false0Amended terms4false 4us-gaap_LeaseExpirationDate1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse002019-12-01falsefalsetrue4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:dateItemTypedateDate which lease or group of leases is set to expire, in CCYY-MM-DD format.No definition available.false0Amended term lease extended ending date5false 4qdel_NumberOfExtensionqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse33falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:integerItemTypeintegerNumber of extension.No definition available.false256Number of extension6false 4qdel_SaleLeaseBackTermOptionsForPeriodOfExtensionqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse005 yearsfalsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaSale lease back term, options for period of extension.No definition available.false0Extend the lease options7false 4qdel_LandAndBuildingNetOfAccumulatedDepreciationqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse22000002.2USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse22000002.2USD$falsetruefalse4falsefalsefalse00falsefalsefalse5truefalsefalse23000002.3USD$falsetruefalsexbrli:monetaryItemTypemonetaryLand and building net of accumulated depreciation.No definition available.false2Land and building, net of accumulated depreciation8false 4qdel_GeneralPartnersInterestqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse002015-01falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:gYearMonthItemTypeyearmonthGeneral partners interest.No definition available.false0General partner's interest9false 4us-gaap_SaleLeasebackTransactionMonthlyRentalPaymentsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse3000000.3USD$falsefalsefalse2truefalsefalse3000000.3USD$falsefalsefalse3truefalsefalse6000000.6USD$falsefalsefalse4truefalsefalse6000000.6USD$falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of the monthly rental payments due under the lease entered into in connection with the transactions involving the sale of property to another party and the lease of the property back to the seller.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 40 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6456341&loc=d3e50796-112755 false2Lease payments10false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6false USDtruefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0_925378x1038636http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseSan Diego facility [Member]us-gaap_SaleLeasebackTransactionDescriptionAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_SanDiegoFacilityMemberus-gaap_SaleLeasebackTransactionDescriptionAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0San Diego facility [Member]11true 3us-gaap_SaleLeasebackTransactionLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Sale Leaseback Transaction [Line Items]12false 4us-gaap_SaleLeasebackTransactionGrossProceedsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1500000015.0USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe gross proceeds received from the asset(s) sold in connection with the transaction involving the sale of property to another party and the lease back to the seller.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 40 -Section 55 -Paragraph 51 -URI http://asc.fasb.org/extlink&oid=28365400&loc=d3e51840-112757 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 40 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=28365400&loc=d3e51843-112757 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 40 -Section 55 -Paragraph 50 -URI http://asc.fasb.org/extlink&oid=28365400&loc=d3e51831-112757 false2Facility sold13false 4qdel_CapitalContributedByCompanySaleAndLeaseBackTransactionqdel_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse38000003.8USD$falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryCapital contributed by company sale and lease back transaction.No definition available.false2Capital contributed14false 4us-gaap_SaleLeasebackTransactionNetProceedsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse70000007.0USD$falsetruefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe gross proceeds received from the asset(s) sold in connection with the transaction involving the sale of property to another party and the lease of the property back to the seller less the costs incurred in connection with the transaction, such as closing and deferred financing costs.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 40 -Section 55 -Paragraph 51 -URI http://asc.fasb.org/extlink&oid=28365400&loc=d3e51840-112757 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 40 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=28365400&loc=d3e51843-112757 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 40 -Section 55 -Paragraph 50 -URI http://asc.fasb.org/extlink&oid=28365400&loc=d3e51831-112757 false2Cash transaction, nettingfalseLease Obligation - Additional Information (Detail) (USD $)HundredThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureLeaseObligationAdditionalInformation514 XML 69 R7.xml IDEA: Summary of Significant Accounting Policies 2.4.0.8108 - Disclosure - Summary of Significant Accounting Policiestruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_AccountingPoliciesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Accounting Policies [Abstract]2false 2us-gaap_BasisOfPresentationAndSignificantAccountingPoliciesTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 1. Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited consolidated financial statements of Quidel Corporation and its subsidiaries (the “Company”) have been prepared in accordance with generally accepted accounting principles in the U.S. for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included. The information at June 30, 2013, and for the three and six months ended June 30, 2013 and 2012, is unaudited. For further information, refer to the Company’s consolidated financial statements and footnotes thereto for the year ended December 31, 2012 included in the Company’s 2012 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year. For 2013 and 2012, the Company’s fiscal year will or has ended on December 29, 2013 and December 30, 2012, respectively. For 2013 and 2012, the Company’s second quarter ended on June 30, 2013 and July 1, 2012, respectively. For ease of reference, the calendar quarter end dates are used herein. The three and six month periods ended June 30, 2013 and 2012 each included 13 and 26 weeks, respectively. Comprehensive Income (Loss) Net (loss) income is equal to comprehensive (loss) income for the three and six months ended June 30, 2013 and 2012, respectively. Use of Estimates The preparation of financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, management evaluates its estimates, including those related to revenue recognition, customer programs and incentives, reserve for uncollectible accounts, inventory valuation, intangible assets, software development costs, stock-based compensation, restructuring, contingencies and litigation, contingent consideration, and income taxes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. Revenue Recognition The Company records revenues primarily from product sales. These revenues are recorded net of rebates and other discounts which are estimated at the time of sale, and are largely driven by various customer program offerings, including special pricing agreements, promotions and other volume-based incentives. Revenue from product sales are recorded upon passage of title and risk of loss to the customer. Change in title to the product and recognition of revenue occurs upon delivery to the customer when sales terms are free on board (“FOB”) destination and at the time of shipment when the sales terms are FOB shipping point and there is no right of return. The Company also earns income from the licensing of technology. The Company earns income from grants for research and commercialization activities. On November 6, 2012, the Company was awarded a milestone-based grant totaling up to $8.3 million from the Bill and Melinda Gates Foundation to develop, manufacture and validate a quantitative, low-cost, nucleic acid assay for HIV drug treatment monitoring on the integrated Savanna™ MDx platform for use in limited resource settings. Upon execution of the grant agreement, the Company received $2.6 million to fund subsequent research and development activities. The Company expects to receive milestone payments of $2.5 million in 2013 and $3.2 million in 2014 and will recognize grant revenue on the lesser of the amount recognized on a straight-line basis or the amount that is non-refundable through the end of the agreement, which is December 31, 2015. For the three and six months ended June 30, 2013, the Company recognized $0.7 million and $1.3 million as grant revenue associated with this grant. The Company has included $0.9 million and $2.2 million of restricted cash as a component of prepaid expenses and other current assets and as a component of other current liabilities as of June 30, 2013 and December 31, 2012, respectively. Collaborative Arrangement In July 2012, the Company entered into a collaborative arrangement with Life Technologies Corporation for the development of molecular assays. ASC Topic 808, Collaborative Arrangements, defines a collaborative arrangement as an arrangement where the parties are active participants and have exposure to significant risks. The Company is accounting for the joint development and commercialization activities with the third-party as a joint risk sharing collaboration in accordance with ASC Topic 808, Collaborative Arrangements. Payments received or due from Life Technologies Corporation totaled $3.0 million in 2012 and $1.1 million in the six months ended June 30, 2013. The Company expects additional payments of $0.8 million to become due through 2013. The reimbursement represents approximately 50% of project development costs based upon mutually agreed upon project plans for each molecular assay. The reimbursements are recorded as a reduction to research and development expense in the accompanying consolidated financial statements, to the extent that they are less than related expenditures for research and development activities subsequent to the date of the contract. The Company recognized $0 and $1.1 million of such reimbursements as a reduction to research and development expense for the three and six months ended June 30, 2013, respectively. In connection with the collaboration agreement, the Company also entered into a manufacturing and supply agreement with Life Technologies Corporation, which provides for margin sharing. In March 2013, the Company entered into a six year instrument supply agreement (the “March 2013 Agreement”) with Life Technologies Corporation for $0.8 million to sell Life Technologies Corporation’s QuantStudio™ DX diagnostic laboratory instrument for use in the infectious disease field, along with the assays developed under the collaborative agreement. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for the basis of presentation and significant accounting policies concepts. Basis of presentation describes the underlying basis used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS). Accounting policies describe all significant accounting policies of the reporting entity.No definition available.false0Summary of Significant Accounting PoliciesfalseSummary of Significant Accounting PoliciesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsBasisOfPresentationAndSignificantAccountingPoliciesTextBlock12 XML 70 R17.xml IDEA: Lease Obligation 2.4.0.8118 - Disclosure - Lease Obligationtruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_LeasesAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Leases [Abstract]2false 2us-gaap_LeasesOfLesseeDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 11. Lease Obligation During 1999, the Company completed a sale and leaseback transaction of its San Diego facility. The facility was sold for $15.0 million, of which $3.8 million was capital contributed by the Company. The sale was an all cash transaction, netting the Company approximately $7.0 million. The Company is a 25% limited partner in the partnership that acquired the facility. The transaction was deemed a financing transaction under the guidance in ASC Topic 840-40, Accounting for Sales of Real Estate. The assets sold remain on the books of the Company and will continue to be depreciated over the estimated useful life. In December 2009, the Company amended the terms of its lease agreement which had no significant impact on the Company’s financial statements. The amended terms include a new ten-year lease term through December 2019, with options to extend the lease for up to three additional five-year periods. The Company will amortize the lease obligation over this new term. The amount of the monthly rental payments remains the same under the amendment. The combined carrying value of the land and building subject to this lease, net of accumulated depreciation, was $2.2 million and $2.3 million as of June 30, 2013 and December 31, 2012, respectively. In addition, the Company has the option to purchase the general partner’s interest in the partnership in January 2015 for a fixed price. The Company has determined that the partnership is a variable interest entity (VIE). The Company is not, however, the primary beneficiary of the VIE as it does not absorb the majority of the partnership’s expected losses or receive a majority of the partnership’s residual returns. The Company made lease payments to the partnership of approximately $0.6 million for each of the six months ended June 30, 2013 and 2012 and $0.3 million for each of the three months ended June 30, 2013 and 2012. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for lessee entity's leasing arrangements including, but not limited to, all of the following: (a.) The basis on which contingent rental payments are determined, (b.) The existence and terms of renewal or purchase options and escalation clauses, (c.) Restrictions imposed by lease agreements, such as those concerning dividends, additional debt, and further leasing.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=6851643&loc=d3e12069-110248 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 30 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6455398&loc=d3e45280-112737 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6452660&loc=d3e36991-112694 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41499-112717 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 10 -Section 55 -Paragraph 40 -Subparagraph (Note 1,3) -URI http://asc.fasb.org/extlink&oid=6584154&loc=d3e38371-112697 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 840 -SubTopic 20 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6453985&loc=d3e41502-112717 false0Lease ObligationfalseLease ObligationUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsLeasesOfLesseeDisclosureTextBlock12 XML 71 R51.htm IDEA: XBRL DOCUMENT

Acquisition - Schedule of Pro Forma Financial Information (Detail) (USD $) In Thousands, except Per Share data, unless otherwise specified	6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012
Business Combinations [Abstract]
Pro forma total revenues	$ 92,650	$ 70,205
Pro forma net income (loss)	10,122	(3,505)
Pro forma basic net earnings (loss) per share	$ 0.30	$ (0.11)
Pro forma diluted net earnings (loss) per share	$ 0.29	$ (0.11)
Total revenue included in the consolidated statements of operations	188
Net loss included in the consolidated statements of operations	$ (228)

XML 72 R45.xml IDEA: Industry and Geographic Information - Sales to Individual Customers in Excess of 10% of Total Revenue (Detail) 2.4.0.8146 - Disclosure - Industry and Geographic Information - Sales to Individual Customers in Excess of 10% of Total Revenue (Detail)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931007x926597http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure02false falsefalseeol_PE8142----1310-Q0005_STD_182_20120630_0_931007x926597http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure01true 3us-gaap_EntityWideRevenueMajorCustomerLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenue, Major Customer [Line Items]2false 4us-gaap_ConcentrationRiskPercentage1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.260.26falsefalsefalse2truetruefalse0.240.24falsefalsefalsenum:percentItemTypepureFor an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592 false0Sales percentage3false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3false truefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_925274x1079477_929479x927462_931007x926597http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseSales [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_SalesMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberfalsefalseOperating Segments [Member]us-gaap_ConsolidationItemsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_OperatingSegmentsMemberus-gaap_ConsolidationItemsAxisexplicitMemberfalsefalseCustomer A [Member]us-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_CustomerOneMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure0nanafalse0Operating Segments [Member] | Customer A [Member]4true 3us-gaap_EntityWideRevenueMajorCustomerLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenue, Major Customer [Line Items]5false 4us-gaap_ConcentrationRiskPercentage1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.150.15falsefalsefalse2truetruefalse0.150.15falsefalsefalsenum:percentItemTypepureFor an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592 false0Sales percentage6false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse5false truefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_925274x991975_929479x927462_931007x926597http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseSales [Member]us-gaap_ConcentrationRiskByBenchmarkAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_SalesMemberus-gaap_ConcentrationRiskByBenchmarkAxisexplicitMemberfalsefalseOperating Segments [Member]us-gaap_ConsolidationItemsAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_OperatingSegmentsMemberus-gaap_ConsolidationItemsAxisexplicitMemberfalsefalseCustomer B [Member]us-gaap_StatementBusinessSegmentsAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_CustomerTwoMemberus-gaap_StatementBusinessSegmentsAxisexplicitMemberpureStandardhttp://www.xbrl.org/2003/instancepure0nanafalse0Operating Segments [Member] | Customer B [Member]7true 3us-gaap_EntityWideRevenueMajorCustomerLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Revenue, Major Customer [Line Items]8false 4us-gaap_ConcentrationRiskPercentage1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.110.11falsefalsefalse2truetruefalse0.090.09falsefalsefalsenum:percentItemTypepureFor an entity that discloses a concentration risk in relation to quantitative amount, which serves as the "benchmark" (or denominator) in the equation, this concept represents the concentration percentage derived from the division.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6404-108592 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 20 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13531-108611 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 275 -SubTopic 10 -Section 50 -Paragraph 18 -URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6351-108592 false0Sales percentagefalseIndustry and Geographic Information - Sales to Individual Customers in Excess of 10% of Total Revenue (Detail) (Sales [Member])UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureIndustryAndGeographicInformationSalesToIndividualCustomersInExcessOf10OfTotalRevenue28 XML 73 R16.xml IDEA: Commitments and Contingencies 2.4.0.8117 - Disclosure - Commitments and Contingenciestruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_CommitmentsAndContingenciesDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Commitments And Contingencies Disclosure [Abstract]2false 2us-gaap_CommitmentsAndContingenciesDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 10. Commitments and Contingencies Legal The Company is involved in various claims and litigation matters from time to time in the ordinary course of business. Management believes that all such current legal actions, in the aggregate, will not have a material adverse effect on the Company. The Company also maintains insurance, including coverage for product liability claims, in amounts which management believes are appropriate given the nature of its business. At June 30, 2013 and December 31, 2012, the Company had $0.3 million accrued as a liability for various legal matters where the Company deemed the liability probable and estimable. Licensing Arrangements The Company has entered into various other licensing and royalty agreements, which largely require payments based on specified product sales as well as the achievement of specified milestones. The Company had royalty and license expenses relating to those agreements of $0.3 million, $0.4 million, $0.7 million and $0.8 million for both the three months ended June 30, 2013 and 2012 and the six months ended June 30, 2013 and 2012, respectively. Research and Development Agreements The Company has entered into various research and development agreements which provide it with rights to develop, manufacture and market products using the intellectual property and technology of its collaborative partners. Under the terms of certain of these agreements, the Company is required to make periodic payments based on the Company’s achievement of certain milestones or resource expenditures. These milestones generally include achievement of prototype assays, validation lots and clinical trials. At June 30, 2013 and December 31, 2012, total current commitments due under the terms of these agreements are estimated at $0.6 million and $2.1 million, respectively. The commitments will fluctuate as we agree to new phases of development under the existing arrangements. Contingent Consideration The Company recorded $11.9 million of contingent consideration in conjunction with the BioHelix acquisition as more fully described in Note 13. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for commitments and contingencies.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.25) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6449706&loc=d3e16207-108621 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 460 -SubTopic 10 -Section 50 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=6398077&loc=d3e12565-110249 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 450 -SubTopic 20 -Section 50 -Paragraph 4 -URI http://asc.fasb.org/extlink&oid=25496072&loc=d3e14435-108349 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 440 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6394976&loc=d3e25287-109308 false0Commitments and ContingenciesfalseCommitments and ContingenciesUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsCommitmentsAndContingenciesDisclosureTextBlock12 XML 74 R27.xml IDEA: Industry and Geographic Information (Tables) 2.4.0.8128 - Disclosure - Industry and Geographic Information (Tables)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_TextBlockAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Text Block [Abstract]2false 2us-gaap_ScheduleOfRevenueByMajorCustomersByReportingSegmentsTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The Company had sales to individual customers in excess of 10% of total revenue, as follows:   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> A </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> B </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">24</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the extent of the entity's reliance on its major customers, if revenues from transactions with a single external customer amount to 10 percent or more of entity revenues, including the disclosure of that fact, the total amount of revenues from each such customer, and the identity of the reportable segment or segments reporting the revenues. The entity need not disclose the identity of a major customer or the amount of revenues that each segment reports from that customer. For these purposes, a group of companies known to the entity to be under common control is considered a single customer, and the federal government, a state government, a local government such as a county or municipality, or a foreign government is each considered a single customer.No definition available.false0Sales to Individual Customers in Excess of 10% of Total RevenuefalseIndustry and Geographic Information (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsIndustryAndGeographicInformationTextBlockTables12 XML 75 R18.xml IDEA: Fair Value Measurement 2.4.0.8119 - Disclosure - Fair Value Measurementtruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_FairValueDisclosuresAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Fair Value Disclosures [Abstract]2false 2us-gaap_FairValueDisclosuresTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 12. Fair Value Measurement ASC Topic 820, Fair Value Measurements and Disclosures requires the valuation of assets and liabilities subject to fair value measurements using a three tiered approach and fair value measurement be classified and disclosed by the Company in one of the following three categories: Level 1: Unadjusted quoted prices in active markets that are accessible at the measurement date for identical, unrestricted assets or liabilities; Level 2: Quoted prices for similar assets and liabilities in active markets, quoted prices for identical assets and liabilities in markets that are not active, or inputs which are observable, either directly or indirectly, for substantially the full term of the asset or liability; Level 3: Prices or valuation techniques that require inputs that are both significant to the fair value measurement and unobservable (i.e. supported by little or no market activity). As of June 30, 2013 and December 31, 2012, the carrying amount of the Company’s cash equivalents approximates fair value. Cash equivalents primarily consisted of funds held in a money market account. As of the periods ended June 30, 2013 and December 31, 2012, the carrying value of cash equivalents was $16.0 million and $11.0 million, respectively, and was determined based on Level 1 inputs. As of December 31, 2012, the carrying amount of the Company’s Senior Credit Facility approximates fair value because it has a variable interest rate that reflects market changes to interest rates and changes in the Company’s leverage ratio. As of December 31, 2012, the Company used Level 2 inputs to determine the fair value of its Senior Credit Facility. The Company preliminarily measured its contingent consideration liability of $11.9 million arising from its acquisition of BioHelix using level 3 unobservable inputs (see Note 13). </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for the fair value of financial instruments (as defined), including financial assets and financial liabilities (collectively, as defined), and the measurements of those instruments as well as disclosures related to the fair value of non-financial assets and liabilities. Such disclosures about the financial instruments, assets, and liabilities would include: (1) the fair value of the required items together with their carrying amounts (as appropriate); (2) for items for which it is not practicable to estimate fair value, disclosure would include: (a) information pertinent to estimating fair value (including, carrying amount, effective interest rate, and maturity, and (b) the reasons why it is not practicable to estimate fair value; (3) significant concentrations of credit risk including: (a) information about the activity, region, or economic characteristics identifying a concentration, (b) the maximum amount of loss the entity is exposed to based on the gross fair value of the related item, (c) policy for requiring collateral or other security and information as to accessing such collateral or security, and (d) the nature and brief description of such collateral or security; (4) quantitative information about market risks and how such risks are managed; (5) for items measured on both a recurring and nonrecurring basis information regarding the inputs used to develop the fair value measurement; and (6) for items presented in the financial statement for which fair value measurement is elected: (a) information necessary to understand the reasons for the election, (b) discussion of the effect of fair value changes on earnings, (c) a description of [similar groups] items for which the election is made and the relation thereof to the balance sheet, the aggregate carrying value of items included in the balance sheet that are not eligible for the election; (7) all other required (as defined) and desired information.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 21 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13537-108611 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13433-108611 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14064-108612 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19207-110258 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 30 -URI http://asc.fasb.org/extlink&oid=6957238&loc=d3e14172-108612 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 825 -SubTopic 10 -Section 50 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=28364263&loc=d3e13504-108611 false0Fair Value MeasurementfalseFair Value MeasurementUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsFairValueDisclosuresTextBlock12 XML 76 R3.xml IDEA: CONSOLIDATED BALANCE SHEETS (Parenthetical) 2.4.0.8104 - Statement - CONSOLIDATED BALANCE SHEETS (Parenthetical)truefalseIn Thousands, except Per Share data, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0USDUSD$1true 1us-gaap_StatementOfFinancialPositionAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Statement Of Financial Position [Abstract]2false 2us-gaap_PreferredStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse0.0010.001USD$falsetruefalse2truefalsefalse0.0010.001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value per share of preferred stock nonredeemable or redeemable solely at the option of the issuer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false3Preferred stock, par value per share3false 2us-gaap_PreferredStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse50000005000falsefalsefalse2truefalsefalse50000005000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false1Preferred stock, shares authorized4false 2us-gaap_PreferredStockSharesIssuedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00  falsefalsefalse2falsefalsefalse00  falsefalsefalsexbrli:sharesItemTypesharesTotal number of nonredeemable preferred shares (or preferred stock redeemable solely at the option of the issuer) issued to shareholders (includes related preferred shares that were issued, repurchased, and remain in the treasury). May be all or portion of the number of preferred shares authorized. Excludes preferred shares that are classified as debt.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false1Preferred stock, shares issued5false 2us-gaap_PreferredStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00  falsefalsefalse2falsefalsefalse00  falsefalsefalsexbrli:sharesItemTypesharesAggregate share number for all nonredeemable preferred stock (or preferred stock redeemable solely at the option of the issuer) held by stockholders. Does not include preferred shares that have been repurchased.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29 -Article 5 false1Preferred stock, shares outstanding6false 2us-gaap_CommonStockParOrStatedValuePerShareus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse0.0010.001USD$falsetruefalse2truefalsefalse0.0010.001USD$falsetruefalsenum:perShareItemTypedecimalFace amount or stated value per share of common stock.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false3Common stock, par value per share7false 2us-gaap_CommonStockSharesAuthorizedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse5000000050000falsefalsefalse2truefalsefalse5000000050000falsefalsefalsexbrli:sharesItemTypesharesThe maximum number of common shares permitted to be issued by an entity's charter and bylaws.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1Common stock, shares authorized8false 2us-gaap_CommonStockSharesIssuedus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse3386800033868falsefalsefalse2truefalsefalse3345200033452falsefalsefalsexbrli:sharesItemTypesharesTotal number of common shares of an entity that have been sold or granted to shareholders (includes common shares that were issued, repurchased and remain in the treasury). These shares represent capital invested by the firm's shareholders and owners, and may be all or only a portion of the number of shares authorized. Shares issued include shares outstanding and shares held in the treasury.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1Common stock, shares issued9false 2us-gaap_CommonStockSharesOutstandingus-gaap_truenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse3386800033868falsefalsefalse2truefalsefalse3345200033452falsefalsefalsexbrli:sharesItemTypesharesNumber of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 30 -Article 5 false1Common stock, shares outstandingfalseCONSOLIDATED BALANCE SHEETS (Parenthetical) (USD $)UnKnownThousandsNoRoundingUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/StatementOfFinancialPositionClassifiedParenthetical29 XML 77 R29.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Additional Information (Detail) (USD $)	1 Months Ended		3 Months Ended	6 Months Ended	12 Months Ended
	Mar. 31, 2013	Nov. 30, 2012	Jun. 30, 2013	Jun. 30, 2013	Dec. 31, 2012	Dec. 31, 2011
Acquired Finite-Lived Intangible Assets [Line Items]
Company's milestone-based grant		$ 8,300,000
Fund received for research and development activities		2,600,000
Company's expectation to receive milestone payment in 2013			2,500,000	2,500,000
Company's expectation to receive milestone payment in 2014			3,200,000	3,200,000
Company's grant revenue			700,000	1,300,000
Restricted cash as a component of prepaid expenses			900,000	900,000	2,200,000
Reimbursement related to research and development expense				1,100,000	3,000,000
Reimbursement percentage upon project development cost				50.00%
Expected additional reimbursement related to research and development expense				800,000
Reimbursements recognized as a reduction to research and development expense			0	1,100,000
Period of instrument supply agreement with Life Technologies Corporation	6 years					3 years 6 months
Distribution rights [Member]
Acquired Finite-Lived Intangible Assets [Line Items]
Period of instrument supply agreement with Life Technologies Corporation	6 years
Acquisition of distribution rights	$ 800,000

XML 78 R23.htm IDEA: XBRL DOCUMENT

Intangible Assets (Tables)

6 Months Ended

Jun. 30, 2013

Goodwill And Intangible Assets Disclosure [Abstract]

Schedule of Intangible Assets

Intangible assets consist of the following (in thousands):


	Weighted-		June 30, 2013							December 31, 2012
	Average
	Useful Life		Gross		Accumulated					Gross		Accumulated
Description	(years)		Assets		Amortization			Net		Assets		Amortization			Net
Goodwill		Indefinite	$	86,165	$	(3,449	)	$	82,716	$	74,461	$	(3,448	)	$	71,013
Purchased technology		8.3		57,030		(25,371	)		31,659		52,670		(22,308	)		30,362
Customer relationships		7.6		6,852		(2,483	)		4,369		6,322		(2,007	)		4,315
In-process research and development		Indefinite		2,270		—			2,270		1,570		—			1,570
License agreements		4.6		49,778		(33,672	)		16,106		49,378		(29,386	)		19,992
Patent and trademark costs		11.9		14,562		(4,078	)		10,484		5,012		(3,887	)		1,125
Favorable lease		9.0		1,700		(1,627	)		73		1,700		(1,594	)		106
Software development costs		5.2		3,891		(563	)		3,328		3,262		(391	)		2,871

Total goodwill and intangible assets			$	222,248	$	(71,243	)	$	151,005	$	194,375	$	(63,021	)	$	131,354

Summary of Expected Future Annual Amortization Expense of Intangible Assets

The following table summarizes the expected future annual amortization expense of intangible assets recorded on the Company’s condensed consolidated balance sheet as of June 30, 2013 (in thousands):


	Amortization
For the years ending December 31,	Expense
2013 (remaining six months)	$	8,434
2014		17,345
2015		9,965
2016		9,087
2017		8,781
Thereafter		12,407

Total expected future amortization	$	66,019

XML 79 R44.htm IDEA: XBRL DOCUMENT

Industry and Geographic Information - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	6 Months Ended				6 Months Ended
	Jun. 30, 2013 Segment	Dec. 31, 2012	Jun. 30, 2013 Non-U.S. Customers [Member]	Dec. 31, 2012 Non-U.S. Customers [Member]	Jun. 30, 2013 Sales [Member]	Jun. 30, 2012 Sales [Member]	Jun. 30, 2013 Sales [Member] Non-U.S. Customers [Member]	Jun. 30, 2012 Sales [Member] Non-U.S. Customers [Member]
Revenue, Major Customer [Line Items]
Sales percentage					26.00%	24.00%	14.00%	15.00%
Sales to customers outside the U.S.							$ 12.7	$ 10.4
Balances due from foreign customers			3.0	2.8
Number of reportable segments	1
Accounts receivable due in excess of 10%	$ 2.0	$ 22.4
Minimum percentage of accounts receivable from major customers	10.00%	10.00%

XML 80 R50.xml IDEA: Acquisition - Allocation of Purchase Price to Net Tangible and Intangible Assets Acquired and Liabilities (Detail) 2.4.0.8151 - Disclosure - Acquisition - Allocation of Purchase Price to Net Tangible and Intangible Assets Acquired and Liabilities (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_FiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Finite-Lived Intangible Assets [Line Items]2false 4qdel_BusinessCombinationCashConsiderationqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1000000010000USD$falsetruefalsexbrli:monetaryItemTypemonetaryBusiness Combination Cash ConsiderationNo definition available.false2Cash consideration3false 4qdel_BusinessCombinationCashConsiderationPaidToSettlePreExistingLiabilityqdel_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse-850000-850USD$falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Combination, Cash Consideration Paid to Settle Pre-Existing LiabilityNo definition available.false2Settlement of pre-existing liabilities and working capital adjustment4false 4us-gaap_PaymentsToAcquireBusinessesNetOfCashAcquiredus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse91500009150USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow associated with the acquisition of a business, net of the cash acquired from the purchase.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Investing Activities -URI http://asc.fasb.org/extlink&oid=6516133 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 13 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3213-108585 false2Net cash consideration5false 4us-gaap_BusinessCombinationContingentConsiderationLiabilityus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1191900011919USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of liability recognized arising from contingent consideration in a business combination.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 35 -Paragraph 1 -Subparagraph b -URI http://asc.fasb.org/extlink&oid=6911338&loc=d3e6819-128478 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 30 -Section 25 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=6911189&loc=d3e6408-128476 false2Contingent consideration6false 4qdel_BusinessCombinationContingentConsiderationNetqdel_falsecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2106900021069USD$falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Combination Contingent Consideration NetNo definition available.false2Net consideration at closing7false 4qdel_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedOtherAssetsCurrentAndNonCurrentqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse375000375USD$falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Combination Recognized Identifiable Assets Acquired And Liabilities Assumed Other Assets Current And Non CurrentNo definition available.false2Other current and non-current assets8false 4us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedPropertyPlantAndEquipmentus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse179000179USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe amount of property, plant, and equipment recognized as of the acquisition date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 55 -Paragraph 37 -URI http://asc.fasb.org/extlink&oid=25498275&loc=d3e2207-128464 false2Property, plant and equipment9false 4qdel_BusinessAcquisitionPurchasePriceAllocationGoodwillqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1170300011703USD$falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Acquisition Purchase Price Allocation GoodwillNo definition available.false2Goodwill10false 4us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedAssetsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse2734700027347USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of assets acquired at the acquisition date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 false2Total assets acquired11false 4qdel_BusinessAcquisitionPurchasePriceAllocationCurrentLiabilitiesAccountsPayableAndOtherLiabilitiesqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse701000701USD$falsefalsefalsexbrli:monetaryItemTypemonetaryBusiness Acquisition Purchase Price Allocation Current Liabilities Accounts Payable And Other LiabilitiesNo definition available.false2Accounts payable and other current liabilities12false 4us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedDeferredTaxLiabilitiesNoncurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse55770005577USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of deferred tax liability attributable to taxable temporary differences due after one year or the normal operating cycle, if longer, assumed at the acquisition date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 false2Deferred tax liabilities13false 4us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedLiabilitiesus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse62780006278USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of liabilities assumed at the acquisition date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 true2Total liabilities assumed14false 4us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse2106900021069USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount recognized for assets, including goodwill, in excess of (less than) the aggregate liabilities assumed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 true2Purchase price allocation15false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0_931701x931972http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00falsefalseIn-process research and development [Member]us-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_InProcessResearchAndDevelopmentMemberus-gaap_IndefiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0In-process research and development [Member]16true 3us-gaap_FiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Finite-Lived Intangible Assets [Line Items]17false 4us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse700000700USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of intangible assets, excluding goodwill, acquired at the acquisition date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 false2Contractual relationships18false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse3false USDtruefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931868x1092745http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalsePurchased technology [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_TechnologyPurchasedMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$nanafalse0Purchased technology [Member]19true 3us-gaap_FiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Finite-Lived Intangible Assets [Line Items]20false 4us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse43600004360USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of intangible assets, excluding goodwill, acquired at the acquisition date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 false2Contractual relationships21false 4us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse0010 yearsfalsefalsefalsexbrli:durationItemTypenaWeighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275 false0Weighted-average amortization period22false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse4false USDtruefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931868x927135http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseNon-compete agreement [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_NoncompeteAgreementsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$nanafalse0Non-compete agreement [Member]23true 3us-gaap_FiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Finite-Lived Intangible Assets [Line Items]24false 4us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse700000700USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of intangible assets, excluding goodwill, acquired at the acquisition date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 false2Contractual relationships25false 4us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse005 yearsfalsefalsefalsexbrli:durationItemTypenaWeighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275 false0Weighted-average amortization period26false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse5false USDtruefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931868x1087116http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalseContractual relationships [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldiqdel_ContractualRelationshipsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$nanafalse0Contractual relationships [Member]27true 3us-gaap_FiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Finite-Lived Intangible Assets [Line Items]28false 4us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse530000530USD$falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of intangible assets, excluding goodwill, acquired at the acquisition date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 false2Contractual relationships29false 4us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse0010 yearsfalsefalsefalsexbrli:durationItemTypenaWeighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275 false0Weighted-average amortization period30false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse6false USDtruefalseeol_PE8142----1310-Q0005_STD_181_20130630_0_931868x926240http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00falsefalsePatents [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PatentsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170$nanafalse0Patents [Member]31true 3us-gaap_FiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Finite-Lived Intangible Assets [Line Items]32false 4us-gaap_BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIntangibleAssetsOtherThanGoodwillus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse88000008800USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of intangible assets, excluding goodwill, acquired at the acquisition date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 20 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472 false2Contractual relationships33false 4us-gaap_AcquiredFiniteLivedIntangibleAssetsWeightedAverageUsefulLifeus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse0012 yearsfalsefalsefalsexbrli:durationItemTypenaWeighted average amortization period of finite-lived intangible assets acquired either individually or as part of a group of assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 1 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16265-109275 false0Weighted-average amortization periodfalseAcquisition - Allocation of Purchase Price to Net Tangible and Intangible Assets Acquired and Liabilities (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureAcquisitionAllocationOfPurchasePriceToNetTangibleAndIntangibleAssetsAcquiredAndLiabilities133 XML 81 R39.htm IDEA: XBRL DOCUMENT

Income Taxes - Summary of Unrecognized Tax Benefits (Detail) (USD $) In Thousands, unless otherwise specified	6 Months Ended
	Jun. 30, 2013
Income Tax Disclosure [Abstract]
Beginning balance as of December 31, 2012	$ 9,051
Increases related to prior year tax positions	300
Decrease due to settlements	(3,078)
Increases related to current year tax positions	555
Ending balance as of June 30, 2013	$ 6,828

XML 82 R42.xml IDEA: Stockholders' Equity - Compensation Expense Related to Stock-Based Compensation Plans (Detail) 2.4.0.8143 - Disclosure - Stockholders' Equity - Compensation Expense Related to Stock-Based Compensation Plans (Detail)truefalseIn Millions, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20120630_0http://www.sec.gov/CIK0000353569duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]2false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse19000001.9USD$falsetruefalse2truefalsefalse17000001.7USD$falsetruefalse3truefalsefalse40000004.0USD$falsetruefalse4truefalsefalse36000003.6USD$falsetruefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false2Stock-based compensation expense3false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false USDtruefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0_927015x928619http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseCost of sales [Member]us-gaap_IncomeStatementLocationAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_CostOfSalesMemberus-gaap_IncomeStatementLocationAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Cost of sales [Member]4true 3us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]5false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse2000000.2USD$falsefalsefalse2truefalsefalse1000000.1USD$falsefalsefalse3truefalsefalse4000000.4USD$falsefalsefalse4truefalsefalse3000000.3USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false2Stock-based compensation expense6false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse9false USDtruefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0_927015x928963http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseResearch and development [Member]us-gaap_IncomeStatementLocationAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_ResearchAndDevelopmentExpenseMemberus-gaap_IncomeStatementLocationAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Research and development [Member]7true 3us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]8false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse3000000.3USD$falsefalsefalse2truefalsefalse3000000.3USD$falsefalsefalse3truefalsefalse7000000.7USD$falsefalsefalse4truefalsefalse6000000.6USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false2Stock-based compensation expense9false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse13false USDtruefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0_927015x932732http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseSales and marketing [Member]us-gaap_IncomeStatementLocationAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_SellingAndMarketingExpenseMemberus-gaap_IncomeStatementLocationAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Sales and marketing [Member]10true 3us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]11false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse2000000.2USD$falsefalsefalse2truefalsefalse2000000.2USD$falsefalsefalse3truefalsefalse3000000.3USD$falsefalsefalse4truefalsefalse2000000.2USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false2Stock-based compensation expense12false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse17false USDtruefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0_927015x925832http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseGeneral and administrative [Member]us-gaap_IncomeStatementLocationAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_GeneralAndAdministrativeExpenseMemberus-gaap_IncomeStatementLocationAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0General and administrative [Member]13true 3us-gaap_EmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]14false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse12000001.2USD$falsetruefalse2truefalsefalse11000001.1USD$falsetruefalse3truefalsefalse26000002.6USD$falsetruefalse4truefalsefalse25000002.5USD$falsetruefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false2Stock-based compensation expensefalseStockholders' Equity - Compensation Expense Related to Stock-Based Compensation Plans (Detail) (USD $)HundredThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureStockholdersEquityCompensationExpenseRelatedToStockBasedCompensationPlans414 XML 83 R31.xml IDEA: Computation of (Loss) Earnings Per Share - Basic and Diluted EPS (Detail) 2.4.0.8132 - Disclosure - Computation of (Loss) Earnings Per Share - Basic and Diluted EPS (Detail)truefalseIn Thousands, except Per Share data, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20120630_0http://www.sec.gov/CIK0000353569duration2012-04-01T00:00:002012-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 2us-gaap_EarningsPerShareBasicAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Basic net income per share:2false 3us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-1755000-1755USD$falsetruefalse2truefalsefalse-3122000-3122USD$falsetruefalse3truefalsefalse1061200010612USD$falsetruefalse4truefalsefalse-3071000-3071USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false2Net income3false 3us-gaap_UndistributedEarningsAllocatedToParticipatingSecuritiesus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse-32000-32falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryEarnings allocated (not distributed) to participating securities under the two-class method to the extent that participating securities may share in earnings as if all of the earnings for the period had been distributed.No definition available.false2Less: income allocated to participating securities4false 3us-gaap_NetIncomeLossAvailableToCommonStockholdersBasicus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1058000010580falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryNet income after adjustments for dividends on preferred stock (declared in the period) and/or cumulative preferred stock (accumulated for the period).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256 true2Net income allocated to common stockholders5false 3us-gaap_WeightedAverageNumberOfSharesOutstandingBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse3380200033802falsefalsefalse2truefalsefalse3294600032946falsefalsefalse3truefalsefalse3365800033658falsefalsefalse4truefalsefalse3300800033008falsefalsefalsexbrli:sharesItemTypesharesNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Weighted-Average Number of Common Shares Outstanding -URI http://asc.fasb.org/extlink&oid=6528421 false1Weighted average common shares outstanding - basic6false 3us-gaap_EarningsPerShareBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-0.05-0.05USD$falsetruefalse2truefalsefalse-0.09-0.09USD$falsetruefalse3truefalsefalse0.310.31USD$falsetruefalse4truefalsefalse-0.09-0.09USD$falsetruefalsenum:perShareItemTypedecimalThe amount of net income (loss) for the period per each share of common stock or unit outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 55 -Paragraph 52 -URI http://asc.fasb.org/extlink&oid=32703322&loc=d3e4984-109258 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 942 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.9-04.23) -URI http://asc.fasb.org/extlink&oid=6879574&loc=d3e536633-122882 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false3Net income per share - basic7true 2us-gaap_EarningsPerShareDilutedAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Diluted net income per share:8false 3us-gaap_NetIncomeLossus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-1755000-1755falsefalsefalse2truefalsefalse-3122000-3122falsefalsefalse3truefalsefalse1061200010612falsefalsefalse4truefalsefalse-3071000-3071falsefalsefalsexbrli:monetaryItemTypemonetaryThe portion of profit or loss for the period, net of income taxes, which is attributable to the parent.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 20 -Article 9 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Other Comprehensive Income -URI http://asc.fasb.org/extlink&oid=6519514 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Net Income -URI http://asc.fasb.org/extlink&oid=6518256 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.19) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 7: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.18) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 8: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 944 -SubTopic 225 -Section S99 -Paragraph 1 -Subparagraph (SX 210.7-04.22) -URI http://asc.fasb.org/extlink&oid=6879464&loc=d3e573970-122913 Reference 9: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358780&loc=d3e565-108580 Reference 10: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 19 -Article 5 false2Net income9false 3us-gaap_UndistributedEarningsDilutedus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse-31000-31falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe earnings that is allocated to common stock and participating securities to the extent that each security may share in earnings as if all of the earnings for the period had been distributed. Includes the adjustments resulting from the assumption that dilutive securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.No definition available.false2Less: income allocated to participating securities10false 3us-gaap_NetIncomeLossAvailableToCommonStockholdersDilutedus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse1058100010581USD$falsetruefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryNet Income or Loss Available to Common Stockholders plus adjustments resulting from the assumption that dilutive convertible securities were converted, options or warrants were exercised, or that other shares were issued upon the satisfaction of certain conditions.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 11 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1377-109256 true2Net income allocated to common stockholders11false 3us-gaap_WeightedAverageNumberOfSharesOutstandingBasicus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse3380200033802falsefalsefalse2truefalsefalse3294600032946falsefalsefalse3truefalsefalse3365800033658falsefalsefalse4truefalsefalse3300800033008falsefalsefalsexbrli:sharesItemTypesharesNumber of [basic] shares or units, after adjustment for contingently issuable shares or units and other shares or units not deemed outstanding, determined by relating the portion of time within a reporting period that common shares or units have been outstanding to the total time in that period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1448-109256 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Weighted-Average Number of Common Shares Outstanding -URI http://asc.fasb.org/extlink&oid=6528421 false1Weighted average common shares outstanding - basic12false 3us-gaap_WeightedAverageNumberDilutedSharesOutstandingAdjustmentus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse10580001058falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesThe sum of dilutive potential common shares or units used in the calculation of the diluted per-share or per-unit computation.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 false1Dilutive securities13false 3us-gaap_WeightedAverageNumberOfDilutedSharesOutstandingus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse3380200033802falsefalsefalse2truefalsefalse3294600032946falsefalsefalse3truefalsefalse3471600034716falsefalsefalse4truefalsefalse3300800033008falsefalsefalsexbrli:sharesItemTypesharesThe average number of shares or units issued and outstanding that are used in calculating diluted EPS or earnings per unit (EPU), determined based on the timing of issuance of shares or units in the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 16 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1505-109256 true1Weighted average common shares outstanding - diluted14false 3us-gaap_EarningsPerShareDilutedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseverboseLabel1truefalsefalse-0.05-0.05USD$falsetruefalse2truefalsefalse-0.09-0.09USD$falsetruefalse3truefalsefalse0.300.30USD$falsetruefalse4truefalsefalse-0.09-0.09USD$falsetruefalsenum:perShareItemTypedecimalThe amount of net income (loss) for the period available to each share of common stock or common unit outstanding during the reporting period and to each share or unit that would have been outstanding assuming the issuance of common shares or units for all dilutive potential common shares or units outstanding during the reporting period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=7655603&loc=d3e1252-109256 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 225 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.21) -URI http://asc.fasb.org/extlink&oid=26872669&loc=d3e20235-122688 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 18 -Article 7 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 20 -Article 5 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Paragraph 21 -Article 9 false3Net income per share - dilutedfalseComputation of (Loss) Earnings Per Share - Basic and Diluted EPS (Detail) (USD $)ThousandsThousandsNoRoundingUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureComputationOfLossEarningsPerShareBasicAndDilutedEPS414 XML 84 R35.htm IDEA: XBRL DOCUMENT

Intangible Assets - Additional Information (Detail) (USD $)	1 Months Ended	3 Months Ended		6 Months Ended		12 Months Ended
	Mar. 31, 2013	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012	Dec. 31, 2011
Finite-Lived Intangible Assets [Line Items]
Expected life for amortization of distribution rights	6 years					3 years 6 months
Amortization expense		$ 2,022,000	$ 1,719,000	$ 3,786,000	$ 3,437,000
Distribution rights [Member]
Finite-Lived Intangible Assets [Line Items]
Expected life for amortization of distribution rights	6 years
Acquisition of distribution rights	800,000
Patented technology [Member]
Finite-Lived Intangible Assets [Line Items]
Assigned licensed technology						$ 28,800,000

XML 85 R36.htm IDEA: XBRL DOCUMENT

Intangible Assets - Summary of Expected Future Annual Amortization Expense of Intangible Assets (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013
Goodwill And Intangible Assets Disclosure [Abstract]
2013 (remaining six months)	$ 8,434
2014	17,345
2015	9,965
2016	9,087
2017	8,781
Thereafter	12,407
Total expected future amortization	$ 66,019

XML 86 R30.xml IDEA: Computation of (Loss) Earnings Per Share - Additional Information (Detail) 2.4.0.8131 - Disclosure - Computation of (Loss) Earnings Per Share - Additional Information (Detail)truefalseIn Millions, unless otherwise specifiedfalse1false falsefalseeol_PE8142----1310-Q0005_STD_91_20130630_0http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares02false falsefalseeol_PE8142----1310-Q0005_STD_91_20120630_0http://www.sec.gov/CIK0000353569duration2012-04-01T00:00:002012-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares03false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares04false falsefalseeol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares01true 3qdel_ScheduleOfEarningsPerShareBasicAndDilutedLineItemsqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Schedule Of Earnings Per Share Basic And Diluted [Line Items]2false 4us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse6000000.6falsefalsefalse2truefalsefalse13000001.3falsefalsefalse3truefalsefalse4000000.4falsefalsefalse4truefalsefalse15000001.5falsefalsefalsexbrli:sharesItemTypesharesSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Antidilution -URI http://asc.fasb.org/extlink&oid=6505113 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Diluted Earnings Per Share -URI http://asc.fasb.org/extlink&oid=6510752 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Contingent Stock Agreement -URI http://asc.fasb.org/extlink&oid=6508534 false1Shares excluded from calculation of diluted (loss) earnings per share ("EPS")3false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false truefalseeol_PE8142----1310-Q0005_STD_91_20130630_0_928305x926520http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseEquity Option [Member]us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_StockOptionMemberus-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisexplicitMembersharesStandardhttp://www.xbrl.org/2003/instanceshares0nanafalse0Equity Option [Member]4true 3qdel_ScheduleOfEarningsPerShareBasicAndDilutedLineItemsqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Schedule Of Earnings Per Share Basic And Diluted [Line Items]5false 4us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse11000001.1falsefalsefalse2truefalsefalse7000000.7falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Antidilution -URI http://asc.fasb.org/extlink&oid=6505113 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Diluted Earnings Per Share -URI http://asc.fasb.org/extlink&oid=6510752 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Contingent Stock Agreement -URI http://asc.fasb.org/extlink&oid=6508534 false1Shares excluded from calculation of diluted (loss) earnings per share ("EPS")6false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse7false truefalseeol_PE8142----1310-Q0005_STD_182_20120630_0_928305x923936http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00falsefalseRestricted stock [Member]us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_RestrictedStockMemberus-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareByAntidilutiveSecuritiesAxisexplicitMembersharesStandardhttp://www.xbrl.org/2003/instanceshares0nanafalse0Restricted stock [Member]7true 3qdel_ScheduleOfEarningsPerShareBasicAndDilutedLineItemsqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Schedule Of Earnings Per Share Basic And Diluted [Line Items]8false 4us-gaap_AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmountus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse7000000.7falsefalsefalsexbrli:sharesItemTypesharesSecurities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Antidilution -URI http://asc.fasb.org/extlink&oid=6505113 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Diluted Earnings Per Share -URI http://asc.fasb.org/extlink&oid=6510752 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Contingent Stock Agreement -URI http://asc.fasb.org/extlink&oid=6508534 false1Shares excluded from calculation of diluted (loss) earnings per share ("EPS")falseComputation of (Loss) Earnings Per Share - Additional Information (Detail)UnKnownHundredThousandsUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureComputationOfLossEarningsPerShareAdditionalInformation48 XML 87 R13.htm IDEA: XBRL DOCUMENT

Line of Credit	6 Months Ended
Line of Credit	Jun. 30, 2013
Debt Disclosure [Abstract]
Line of Credit	Note 7. Line of Credit On August 10, 2012, the Company entered into an amended and restated $140.0 million senior secured syndicated credit facility (the “Senior Credit Facility”), which matures on August 10, 2017. The Senior Credit Facility amended and restated the Company’s $120.0 million senior secured credit facility dated October 8, 2008. As part of this amendment, the Company incurred an additional $1.0 million in deferred financing costs related to the Senior Credit Facility. The Company had previously recorded $0.6 million related to the original credit facility. Deferred financing costs are amortized on a straight line basis over the term of the Senior Credit Facility. As of June 30, 2013 and December 31, 2012, the Company had deferred financing costs of $1.3 million and $1.5 million, respectively, included as a portion of other non-current assets. The Senior Credit Facility bears interest at either the London Interbank Offered Rate (“LIBOR”) or the base rate, plus, in each case, the applicable margin. The base rate is equal to the highest of (i) the lender’s prime rate, (ii) the federal funds rate plus one-half of one percent and (iii) LIBOR plus one percent. The applicable margin is generally determined in accordance with a performance pricing grid based on the Company’s leverage ratio and ranges from 1.25% to 2.50% for LIBOR rate loans and from 0.25% to 1.50% for base rate loans. The agreement governing the Senior Credit Facility is subject to certain customary limitations, including among others: limitation on liens; limitation on mergers, consolidations and sales of assets; limitation on debt; limitation on dividends, stock redemptions and the redemption and/or prepayment of other debt; limitation on investments (including loans and advances) and acquisitions; limitation on transactions with affiliates; and limitation on disposition of assets. The Company is also subject to financial covenants which include a funded debt to adjusted EBITDA ratio (as defined in the Senior Credit Facility, with adjusted EBITDA generally calculated as earnings before, among other adjustments, interest, taxes, depreciation, amortization, and stock-based compensation) not to exceed 3:1 as of the end of each fiscal quarter, and an interest coverage ratio of not less than 3:1 as of the end of each fiscal quarter. The Senior Credit Facility is secured by substantially all present and future assets and properties of the Company. As of June 30, 2013, the Company had $139.3 million available under the Senior Credit Facility. The Company’s ability to borrow under the Senior Credit Facility fluctuates from time to time due to, among other factors, the Company’s borrowings under the facility and its funded debt to adjusted EBITDA ratio. As of June 30, 2013 and December 31, 2012, the Company had $0 and $5.0 million, respectively, outstanding under the Senior Credit Facility. As of June 30, 2013, the Company was in compliance with all financial covenants.

- Definition

The entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.

+ References+ Details

XML 88 R21.xml IDEA: Computation of (Loss) Earnings Per Share (Tables) 2.4.0.8122 - Disclosure - Computation of (Loss) Earnings Per Share (Tables)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_EarningsPerShareAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Earnings Per Share [Abstract]2false 2us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The following table sets forth the computation of basic and diluted EPS for the six months ended June 30, 2013 (in thousands, except per share amounts):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Basic net income per share: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net income </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,612</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Less: income allocated to participating securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(32</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income allocated to common stockholders </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,580</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — basic </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">33,658</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income per share — basic </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.31</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Diluted net income per share: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net income </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,612</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Less: income allocated to participating securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(31</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income allocated to common stockholders </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,581</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — basic </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">33,658</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Dilutive securities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,058</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Weighted average common shares outstanding — diluted </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">34,716</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Net income per share — diluted </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.30</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 260 -SubTopic 10 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257 false0Basic and Diluted EPSfalseComputation of (Loss) Earnings Per Share (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsEarningsPerShareTextBlockTables12 XML 89 R30.htm IDEA: XBRL DOCUMENT

Computation of (Loss) Earnings Per Share - Additional Information (Detail) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Shares excluded from calculation of diluted (loss) earnings per share ("EPS")	0.6	1.3	0.4	1.5
Equity Option [Member]
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Shares excluded from calculation of diluted (loss) earnings per share ("EPS")	1.1	0.7
Restricted stock [Member]
Schedule Of Earnings Per Share Basic And Diluted [Line Items]
Shares excluded from calculation of diluted (loss) earnings per share ("EPS")				0.7

- Definition

Securities (including those issuable pursuant to contingent stock agreements) that could potentially dilute basic earnings per share (EPS) or earnings per unit (EPU) in the future that were not included in the computation of diluted EPS or EPU because to do so would increase EPS or EPU amounts or decrease loss per share or unit amounts for the period presented.

+ References+ Details

XML 90 R42.htm IDEA: XBRL DOCUMENT

Stockholders' Equity - Compensation Expense Related to Stock-Based Compensation Plans (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013	Jun. 30, 2012
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 1.9	$ 1.7	$ 4.0	$ 3.6
Cost of sales [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	0.2	0.1	0.4	0.3
Research and development [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	0.3	0.3	0.7	0.6
Sales and marketing [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	0.2	0.2	0.3	0.2
General and administrative [Member]
Employee Service Share-based Compensation, Allocation of Recognized Period Costs [Line Items]
Stock-based compensation expense	$ 1.2	$ 1.1	$ 2.6	$ 2.5

XML 91 R16.htm IDEA: XBRL DOCUMENT

Commitments and Contingencies	6 Months Ended
Commitments and Contingencies	Jun. 30, 2013
Commitments And Contingencies Disclosure [Abstract]
Commitments and Contingencies	Note 10. Commitments and Contingencies Legal The Company is involved in various claims and litigation matters from time to time in the ordinary course of business. Management believes that all such current legal actions, in the aggregate, will not have a material adverse effect on the Company. The Company also maintains insurance, including coverage for product liability claims, in amounts which management believes are appropriate given the nature of its business. At June 30, 2013 and December 31, 2012, the Company had $0.3 million accrued as a liability for various legal matters where the Company deemed the liability probable and estimable. Licensing Arrangements The Company has entered into various other licensing and royalty agreements, which largely require payments based on specified product sales as well as the achievement of specified milestones. The Company had royalty and license expenses relating to those agreements of $0.3 million, $0.4 million, $0.7 million and $0.8 million for both the three months ended June 30, 2013 and 2012 and the six months ended June 30, 2013 and 2012, respectively. Research and Development Agreements The Company has entered into various research and development agreements which provide it with rights to develop, manufacture and market products using the intellectual property and technology of its collaborative partners. Under the terms of certain of these agreements, the Company is required to make periodic payments based on the Company’s achievement of certain milestones or resource expenditures. These milestones generally include achievement of prototype assays, validation lots and clinical trials. At June 30, 2013 and December 31, 2012, total current commitments due under the terms of these agreements are estimated at $0.6 million and $2.1 million, respectively. The commitments will fluctuate as we agree to new phases of development under the existing arrangements. Contingent Consideration The Company recorded $11.9 million of contingent consideration in conjunction with the BioHelix acquisition as more fully described in Note 13.

- Definition

The entire disclosure for commitments and contingencies.

+ References+ Details

XML 92 R22.xml IDEA: Inventories (Tables) 2.4.0.8123 - Disclosure - Inventories (Tables)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_InventoryDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Inventory Disclosure [Abstract]2false 2us-gaap_ScheduleOfInventoryCurrentTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Inventories consisted of the following, net of reserves of $0.5 million and $0.6 million at June 30, 2013 and December 31, 2012, respectively (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="76%"></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="6%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">December 31,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Raw materials </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">9,014</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">5,582</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Work - in - process (materials, labor and overhead) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,647</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,686</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Finished goods (materials, labor and overhead) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7,003</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,228</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">24,664</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">15,496</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 2 -Paragraph 6 -Subparagraph a,b,c -Article 5 false0Summary of InventoriesfalseInventories (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsInventoryDisclosureTextBlockTables12 XML 93 R12.htm IDEA: XBRL DOCUMENT

Income Taxes

6 Months Ended

Jun. 30, 2013

Income Tax Disclosure [Abstract]

Income Taxes

Note 6. Income Taxes

The following table summarizes the activity related to the Company’s unrecognized tax benefits (in thousands):


Beginning balance as of December 31, 2012	$	9,051
Increases related to prior year tax positions		300
Decrease due to settlements		(3,078	)
Increases related to current year tax positions		555

Ending balance as of June 30, 2013	$	6,828

- Definition

The entire disclosure for income taxes. Disclosures may include net deferred tax liability or asset recognized in an enterprise's statement of financial position, net change during the year in the total valuation allowance, approximate tax effect of each type of temporary difference and carryforward that gives rise to a significant portion of deferred tax liabilities and deferred tax assets, utilization of a tax carryback, and tax uncertainties information.

+ References+ Details

XML 94 R7.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies	6 Months Ended
Summary of Significant Accounting Policies	Jun. 30, 2013
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Note 1. Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited consolidated financial statements of Quidel Corporation and its subsidiaries (the “Company”) have been prepared in accordance with generally accepted accounting principles in the U.S. for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included. The information at June 30, 2013, and for the three and six months ended June 30, 2013 and 2012, is unaudited. For further information, refer to the Company’s consolidated financial statements and footnotes thereto for the year ended December 31, 2012 included in the Company’s 2012 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year. For 2013 and 2012, the Company’s fiscal year will or has ended on December 29, 2013 and December 30, 2012, respectively. For 2013 and 2012, the Company’s second quarter ended on June 30, 2013 and July 1, 2012, respectively. For ease of reference, the calendar quarter end dates are used herein. The three and six month periods ended June 30, 2013 and 2012 each included 13 and 26 weeks, respectively. Comprehensive Income (Loss) Net (loss) income is equal to comprehensive (loss) income for the three and six months ended June 30, 2013 and 2012, respectively. Use of Estimates The preparation of financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, management evaluates its estimates, including those related to revenue recognition, customer programs and incentives, reserve for uncollectible accounts, inventory valuation, intangible assets, software development costs, stock-based compensation, restructuring, contingencies and litigation, contingent consideration, and income taxes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates. Revenue Recognition The Company records revenues primarily from product sales. These revenues are recorded net of rebates and other discounts which are estimated at the time of sale, and are largely driven by various customer program offerings, including special pricing agreements, promotions and other volume-based incentives. Revenue from product sales are recorded upon passage of title and risk of loss to the customer. Change in title to the product and recognition of revenue occurs upon delivery to the customer when sales terms are free on board (“FOB”) destination and at the time of shipment when the sales terms are FOB shipping point and there is no right of return. The Company also earns income from the licensing of technology. The Company earns income from grants for research and commercialization activities. On November 6, 2012, the Company was awarded a milestone-based grant totaling up to $8.3 million from the Bill and Melinda Gates Foundation to develop, manufacture and validate a quantitative, low-cost, nucleic acid assay for HIV drug treatment monitoring on the integrated Savanna™ MDx platform for use in limited resource settings. Upon execution of the grant agreement, the Company received $2.6 million to fund subsequent research and development activities. The Company expects to receive milestone payments of $2.5 million in 2013 and $3.2 million in 2014 and will recognize grant revenue on the lesser of the amount recognized on a straight-line basis or the amount that is non-refundable through the end of the agreement, which is December 31, 2015. For the three and six months ended June 30, 2013, the Company recognized $0.7 million and $1.3 million as grant revenue associated with this grant. The Company has included $0.9 million and $2.2 million of restricted cash as a component of prepaid expenses and other current assets and as a component of other current liabilities as of June 30, 2013 and December 31, 2012, respectively. Collaborative Arrangement In July 2012, the Company entered into a collaborative arrangement with Life Technologies Corporation for the development of molecular assays. ASC Topic 808, Collaborative Arrangements, defines a collaborative arrangement as an arrangement where the parties are active participants and have exposure to significant risks. The Company is accounting for the joint development and commercialization activities with the third-party as a joint risk sharing collaboration in accordance with ASC Topic 808, Collaborative Arrangements. Payments received or due from Life Technologies Corporation totaled $3.0 million in 2012 and $1.1 million in the six months ended June 30, 2013. The Company expects additional payments of $0.8 million to become due through 2013. The reimbursement represents approximately 50% of project development costs based upon mutually agreed upon project plans for each molecular assay. The reimbursements are recorded as a reduction to research and development expense in the accompanying consolidated financial statements, to the extent that they are less than related expenditures for research and development activities subsequent to the date of the contract. The Company recognized $0 and $1.1 million of such reimbursements as a reduction to research and development expense for the three and six months ended June 30, 2013, respectively. In connection with the collaboration agreement, the Company also entered into a manufacturing and supply agreement with Life Technologies Corporation, which provides for margin sharing. In March 2013, the Company entered into a six year instrument supply agreement (the “March 2013 Agreement”) with Life Technologies Corporation for $0.8 million to sell Life Technologies Corporation’s QuantStudio™ DX diagnostic laboratory instrument for use in the infectious disease field, along with the assays developed under the collaborative agreement.

XML 95 R37.xml IDEA: Other Current Liabilities - Other Current Liabilities (Detail) 2.4.0.8138 - Disclosure - Other Current Liabilities - Other Current Liabilities (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_OtherLiabilitiesDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Other Liabilities Disclosure [Abstract]2false 2qdel_CustomerIncentivesqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse15140001514USD$falsetruefalse2truefalsefalse26930002693USD$falsetruefalsexbrli:monetaryItemTypemonetaryCustomer incentives.No definition available.false2Customer incentives3false 2us-gaap_CustomerAdvancesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse13400001340falsefalsefalse2truefalsefalse450000450falsefalsefalsexbrli:monetaryItemTypemonetaryThe current portion of prepayments received from customers for goods or services to be provided in the future.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Customer prepayments4false 2qdel_UnearnedGrantRevenueqdel_falsecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse872000872falsefalsefalse2truefalsefalse21560002156falsefalsefalsexbrli:monetaryItemTypemonetaryUnearned grant revenue.No definition available.false2Unearned grant revenue5false 2us-gaap_AccruedIncomeTaxesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse171000171falsefalsefalse2truefalsefalse955000955falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying amount as of the balance sheet date of the unpaid sum of the known and estimated amounts payable to satisfy all currently due domestic and foreign income tax obligations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 15 -Article 9 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 03 -Paragraph 15 -Subparagraph b(1) -Article 7 false2Income tax payable6false 2us-gaap_OtherAccruedLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse707000707falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying value as of the balance sheet date of obligations incurred through that date and payable arising from transactions not otherwise specified in the taxonomy. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Liabilities -URI http://asc.fasb.org/extlink&oid=6509677 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 8 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6935-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 9 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e7018-107765 false2Accrued liability for technology licenses7false 2us-gaap_OtherSundryLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse12950001295falsefalsefalse2truefalsefalse12800001280falsefalsefalsexbrli:monetaryItemTypemonetaryObligations not otherwise itemized or categorized in the footnotes to the financial statements that are due within one year or operating cycle, if longer, from the balance sheet date.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Current Liabilities -URI http://asc.fasb.org/extlink&oid=6509677 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 470 -SubTopic 10 -Section 45 -Paragraph 10 -URI http://asc.fasb.org/extlink&oid=28361426&loc=d3e1243-112600 false2Other8false 2us-gaap_OtherLiabilitiesCurrentus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse51920005192USD$falsetruefalse2truefalsefalse82410008241USD$falsetruefalsexbrli:monetaryItemTypemonetaryAggregate carrying amount of current liabilities (due within one year or within the normal operating cycle if longer) not separately disclosed in the balance sheet. Includes costs that are statutory in nature, are incurred on contractual obligations, or accumulate over time and for which invoices have not yet been received or will not be rendered and of liabilities not separately disclosed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 20 -Article 5 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.20) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 6 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6911-107765 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 5 -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6904-107765 true2Total other current liabilitiesfalseOther Current Liabilities - Other Current Liabilities (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureOtherCurrentLiabilitiesOtherCurrentLiabilities28 XML 96 report.css IDEA: XBRL DOCUMENT /* Updated 2009-11-04 */ /* v2.2.0.24 */ /* DefRef Styles */ ..report table.authRefData{ background-color: #def; border: 2px solid #2F4497; font-size: 1em; position: absolute; } ..report table.authRefData a { display: block; font-weight: bold; } ..report table.authRefData p { margin-top: 0px; } ..report table.authRefData .hide { background-color: #2F4497; padding: 1px 3px 0px 0px; text-align: right; } ..report table.authRefData .hide a:hover { background-color: #2F4497; } ..report table.authRefData .body { height: 150px; overflow: auto; width: 400px; } ..report table.authRefData table{ font-size: 1em; } /* Report Styles */ ..pl a, .pl a:visited { color: black; text-decoration: none; } /* table */ ..report { background-color: white; border: 2px solid #acf; clear: both; color: black; font: normal 8pt Helvetica, Arial, san-serif; margin-bottom: 2em; } ..report hr { border: 1px solid #acf; } /* Top labels */ ..report th { background-color: #acf; color: black; font-weight: bold; text-align: center; } ..report th.void { background-color: transparent; color: #000000; font: bold 10pt Helvetica, Arial, san-serif; text-align: left; } ..report .pl { text-align: left; vertical-align: top; white-space: normal; width: 200px; word-wrap: break-word; } ..report td.pl a.a { cursor: pointer; display: block; width: 200px; overflow: hidden; } ..report td.pl div.a { width: 200px; } ..report td.pl a:hover { background-color: #ffc; } /* Header rows... */ ..report tr.rh { background-color: #acf; color: black; font-weight: bold; } /* Calendars... */ ..report .rc { background-color: #f0f0f0; } /* Even rows... */ ..report .re, .report .reu { background-color: #def; } ..report .reu td { border-bottom: 1px solid black; } /* Odd rows... */ ..report .ro, .report .rou { background-color: white; } ..report .rou td { border-bottom: 1px solid black; } ..report .rou table td, .report .reu table td { border-bottom: 0px solid black; } /* styles for footnote marker */ ..report .fn { white-space: nowrap; } /* styles for numeric types */ ..report .num, .report .nump { text-align: right; white-space: nowrap; } ..report .nump { padding-left: 2em; } ..report .nump { padding: 0px 0.4em 0px 2em; } /* styles for text types */ ..report .text { text-align: left; white-space: normal; } ..report .text .big { margin-bottom: 1em; width: 17em; } ..report .text .more { display: none; } ..report .text .note { font-style: italic; font-weight: bold; } ..report .text .small { width: 10em; } ..report sup { font-style: italic; } ..report .outerFootnotes { font-size: 1em; } XML 97 R47.htm IDEA: XBRL DOCUMENT

Lease Obligation - Additional Information (Detail) (USD $) In Millions, unless otherwise specified	3 Months Ended		6 Months Ended
	Jun. 30, 2013	Jun. 30, 2012	Jun. 30, 2013 Lease	Jun. 30, 2012	Dec. 31, 2012
Sale Leaseback Transaction [Line Items]
Partnership that acquired the facility			25.00%
Amended terms			10 years
Amended term lease extended ending date			Dec. 01, 2019
Number of extension			3
Extend the lease options			5 years
Land and building, net of accumulated depreciation	$ 2.2		$ 2.2		$ 2.3
General partner's interest			2015-01
Lease payments	0.3	0.3	0.6	0.6
San Diego facility [Member]
Sale Leaseback Transaction [Line Items]
Facility sold			15.0
Capital contributed			3.8
Cash transaction, netting			$ 7.0

XML 98 R13.xml IDEA: Line of Credit 2.4.0.8114 - Disclosure - Line of Credittruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_DebtDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Debt Disclosure [Abstract]2false 2us-gaap_DebtDisclosureTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 7. Line of Credit On August 10, 2012, the Company entered into an amended and restated $140.0 million senior secured syndicated credit facility (the “Senior Credit Facility”), which matures on August 10, 2017. The Senior Credit Facility amended and restated the Company’s $120.0 million senior secured credit facility dated October 8, 2008. As part of this amendment, the Company incurred an additional $1.0 million in deferred financing costs related to the Senior Credit Facility. The Company had previously recorded $0.6 million related to the original credit facility. Deferred financing costs are amortized on a straight line basis over the term of the Senior Credit Facility. As of June 30, 2013 and December 31, 2012, the Company had deferred financing costs of $1.3 million and $1.5 million, respectively, included as a portion of other non-current assets. The Senior Credit Facility bears interest at either the London Interbank Offered Rate (“LIBOR”) or the base rate, plus, in each case, the applicable margin. The base rate is equal to the highest of (i) the lender’s prime rate, (ii) the federal funds rate plus one-half of one percent and (iii) LIBOR plus one percent. The applicable margin is generally determined in accordance with a performance pricing grid based on the Company’s leverage ratio and ranges from 1.25% to 2.50% for LIBOR rate loans and from 0.25% to 1.50% for base rate loans. The agreement governing the Senior Credit Facility is subject to certain customary limitations, including among others: limitation on liens; limitation on mergers, consolidations and sales of assets; limitation on debt; limitation on dividends, stock redemptions and the redemption and/or prepayment of other debt; limitation on investments (including loans and advances) and acquisitions; limitation on transactions with affiliates; and limitation on disposition of assets. The Company is also subject to financial covenants which include a funded debt to adjusted EBITDA ratio (as defined in the Senior Credit Facility, with adjusted EBITDA generally calculated as earnings before, among other adjustments, interest, taxes, depreciation, amortization, and stock-based compensation) not to exceed 3:1 as of the end of each fiscal quarter, and an interest coverage ratio of not less than 3:1 as of the end of each fiscal quarter. The Senior Credit Facility is secured by substantially all present and future assets and properties of the Company. As of June 30, 2013, the Company had $139.3 million available under the Senior Credit Facility. The Company’s ability to borrow under the Senior Credit Facility fluctuates from time to time due to, among other factors, the Company’s borrowings under the facility and its funded debt to adjusted EBITDA ratio. As of June 30, 2013 and December 31, 2012, the Company had $0 and $5.0 million, respectively, outstanding under the Senior Credit Facility. As of June 30, 2013, the Company was in compliance with all financial covenants. </div>falsefalsefalsenonnum:textBlockItemTypenaThe entire disclosure for information about short-term and long-term debt arrangements, which includes amounts of borrowings under each line of credit, note payable, commercial paper issue, bonds indenture, debenture issue, own-share lending arrangements and any other contractual agreement to repay funds, and about the underlying arrangements, rationale for a classification as long-term, including repayment terms, interest rates, collateral provided, restrictions on use of assets and activities, whether or not in compliance with debt covenants, and other matters important to users of the financial statements, such as the effects of refinancing and noncompliance with debt covenants.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21475-112644 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 19, 20, 22 -Article 5 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.19,20,22) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false0Line of CreditfalseLine of CreditUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsDebtDisclosureTextBlock12 XML 99 R38.xml IDEA: Income Taxes - Additional Information (Detail) 2.4.0.8139 - Disclosure - Income Taxes - Additional Information (Detail)truefalsefalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_90_20130331_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-03-31T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20120630_0http://www.sec.gov/CIK0000353569duration2012-04-01T00:00:002012-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$eol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_IncomeTaxDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Income Tax Disclosure [Abstract]2false 2us-gaap_IncomeTaxExpenseBenefitus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsetruenegatedLabel1truefalsefalse55570005557000USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse16800001680000USD$falsetruefalse4truefalsefalse933000933000USD$falsetruefalse5truefalsefalse16500001650000USD$falsetruefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Article 4 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Income Tax Expense (or Benefit) -URI http://asc.fasb.org/extlink&oid=6515339 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 9 -Subparagraph (a),(b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32639-109319 false2Income tax benefit3false 2us-gaap_IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestmentsus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse-7312000-7312000falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse-4802000-4802000falsefalsefalse4truefalsefalse96790009679000falsefalsefalse5truefalsefalse-4721000-4721000falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetarySum of operating profit and nonoperating income or expense before Income or Loss from equity method investments, income taxes, extraordinary items, and noncontrolling interest.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(1)(i)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 false2Pretax income (loss)4false 2us-gaap_EffectiveIncomeTaxRateContinuingOperationsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.760.76falsefalsefalse2falsetruefalse00falsefalsefalse3truetruefalse0.350.35falsefalsefalse4truetruefalse0.100.10falsefalsefalse5truetruefalse0.350.35falsefalsefalse6falsetruefalse00falsefalsefalsenum:percentItemTypepurePercentage of current income tax expense (benefit) and deferred income tax expense (benefit) pertaining to continuing operations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 235 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.4-08.(h)(2)) -URI http://asc.fasb.org/extlink&oid=26873400&loc=d3e23780-122690 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 08 -Paragraph h -Subparagraph 2 -Article 4 false0Effective tax rate5false 2us-gaap_IncomeTaxReconciliationNondeductibleExpenseResearchAndDevelopmentus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse500000500000falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of the difference between reported income tax expense (benefit) and expected income tax expense (benefit) computed by applying the domestic federal statutory income tax rates to pretax income (loss) from continuing operations attributable to nondeductible research and development expense.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 12 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32687-109319 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 13 -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32698-109319 false2Benefit related to the federal research and development credit6false 2us-gaap_IncomeTaxExaminationPenaltiesAndInterestExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse400000400000falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse00falsefalsefalse4truefalsefalse300000300000falsefalsefalse5truefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe sum of the amounts of estimated penalties and interest recognized in the period arising from income tax examinations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319 false2Recognized net benefit from interest and penalties7false 2qdel_IncomeTaxReserveReleaseqdel_falsedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse35000003500000falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryIncome Tax Reserve ReleaseNo definition available.false2Income tax reserve release8false 2qdel_PercentageOfLikelihoodOfAmountRealizedUponSettlementqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsetruefalse00falsefalsefalse2falsetruefalse00falsefalsefalse3falsetruefalse00falsefalsefalse4truetruefalse0.500.50falsefalsefalse5falsetruefalse00falsefalsefalse6falsetruefalse00falsefalsefalsenum:percentItemTypepurePercentage of likelihood of amount realized upon settlement.No definition available.false0Realized upon settlement9false 2us-gaap_UnrecognizedTaxBenefitsus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse68280006828000falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse68280006828000falsefalsefalse5falsefalsefalse00falsefalsefalse6truefalsefalse90510009051000falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of unrecognized tax benefits pertaining to uncertain tax positions taken in tax returns.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Unrecognized Tax Benefit -URI http://asc.fasb.org/extlink&oid=6527854 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15A -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319 false2Unrecognized tax benefits10false 2us-gaap_UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRateus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse49000004900000falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse49000004900000falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe total amount of unrecognized tax benefits that, if recognized, would affect the effective tax rate.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15A -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6907707&loc=SL6600010-109319 false2Unrecognized tax benefits that would impact effective tax rate11false 2us-gaap_IncomeTaxExaminationPenaltiesAndInterestAccruedus-gaap_truecreditinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse300000300000USD$falsetruefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4truefalsefalse300000300000USD$falsetruefalse5falsefalsefalse00falsefalsefalse6truefalsefalse700000700000USD$falsetruefalsexbrli:monetaryItemTypemonetaryThe amount of estimated penalties and interest accrued as of the balance sheet date arising from income tax examinations.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 740 -SubTopic 10 -Section 50 -Paragraph 15 -Subparagraph (c) -URI http://asc.fasb.org/extlink&oid=6907707&loc=d3e32718-109319 false2Interest and penalties with uncertain tax positionsfalseIncome Taxes - Additional Information (Detail) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureIncomeTaxesAdditionalInformation611 XML 100 R23.xml IDEA: Intangible Assets (Tables) 2.4.0.8124 - Disclosure - Intangible Assets (Tables)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Goodwill And Intangible Assets Disclosure [Abstract]2false 2us-gaap_ScheduleOfIntangibleAssetsAndGoodwillTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Intangible assets consist of the following (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="100%" align="center"> <tr> <td width="45%"></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="2%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Weighted-</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center">June 30, 2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="10" align="center">December 31, 2012</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Average</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Useful Life</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Gross</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Accumulated</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Gross</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Accumulated</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom" nowrap="nowrap"> Description </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">(years)</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Assets</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Net</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Assets</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Net</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Goodwill </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">Indefinite</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">86,165</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,449</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">82,716</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">74,461</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,448</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">71,013</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Purchased technology </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8.3</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">57,030</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(25,371</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">31,659</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">52,670</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(22,308</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">30,362</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">7.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,852</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,483</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,369</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,322</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(2,007</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,315</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> In-process research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">Indefinite</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,270</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,270</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,570</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">—  </td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,570</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> License agreements </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4.6</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">49,778</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(33,672</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">16,106</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">49,378</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(29,386</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">19,992</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Patent and trademark costs </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11.9</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">14,562</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(4,078</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">10,484</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,012</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(3,887</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,125</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Favorable lease </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9.0</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,627</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">73</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1,700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(1,594</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">106</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Software development costs </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.2</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,891</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(563</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,328</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">3,262</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(391</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2,871</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total goodwill and intangible assets </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">222,248</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(71,243</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">151,005</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">194,375</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(63,021</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">131,354</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of goodwill and intangible assets, which may be broken down by segment or major class.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI http://asc.fasb.org/extlink&oid=14024403&loc=d3e13816-109267 false0Schedule of Intangible Assets3false 2us-gaap_ScheduleofFiniteLivedIntangibleAssetsFutureAmortizationExpenseTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The following table summarizes the expected future annual amortization expense of intangible assets recorded on the Company’s condensed consolidated balance sheet as of June 30, 2013 (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="68%" align="center"> <tr> <td width="85%"></td> <td valign="bottom" width="9%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center">Amortization</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom">For the years ending December 31,</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">Expense</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2013 (remaining six months) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">8,434</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2014 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">17,345</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2015 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,965</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> 2016 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,087</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> 2017 </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,781</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr> <td valign="top"> Thereafter </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">12,407</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total expected future amortization </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">66,019</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the amount of amortization expense expected to be recorded in succeeding fiscal years for finite-lived intangible assets.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 false0Summary of Expected Future Annual Amortization Expense of Intangible AssetsfalseIntangible Assets (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsIntangibleAssetsDisclosureTextBlockTables13 XML 101 R33.htm IDEA: XBRL DOCUMENT

Inventories - Summary of Inventories (Detail) (USD $) In Thousands, unless otherwise specified	Jun. 30, 2013	Dec. 31, 2012
Inventory Disclosure [Abstract]
Raw materials	$ 9,014	$ 5,582
Work - in - process (materials, labor and overhead)	8,647	4,686
Finished goods (materials, labor and overhead)	7,003	5,228
Inventories	$ 24,664	$ 15,496

- Definition

Carrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.

+ References+ Details

XML 102 R36.xml IDEA: Intangible Assets - Summary of Expected Future Annual Amortization Expense of Intangible Assets (Detail) 2.4.0.8137 - Disclosure - Intangible Assets - Summary of Expected Future Annual Amortization Expense of Intangible Assets (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_GoodwillAndIntangibleAssetsDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Goodwill And Intangible Assets Disclosure [Abstract]2false 2us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYearus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse84340008434USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount of amortization expense expected to be recognized in the remainder of the fiscal year following the latest fiscal year ended for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.No definition available.false22013 (remaining six months)3false 2us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonthsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1734500017345falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of amortization expense expected to be recognized during the next fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 false220144false 2us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearTwous-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse99650009965falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of amortization expense expected to be recognized during the second fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 false220155false 2us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearThreeus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse90870009087falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of amortization expense expected to be recognized during the third fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 false220166false 2us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseYearFourus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse87810008781falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of amortization expense expected to be recognized during the fourth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(3) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 false220177false 2us-gaap_FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFiveus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse1240700012407falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of amortization expense expected to be recognized after the fifth fiscal year following the latest fiscal year for assets, excluding financial assets and goodwill, lacking physical substance with a finite life.No definition available.false2Thereafter8false 2qdel_ExpectedFutureAmortizationExpenseqdel_falsedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse6601900066019USD$falsetruefalsexbrli:monetaryItemTypemonetaryExpected Future Amortization ExpenseNo definition available.true2Total expected future amortizationfalseIntangible Assets - Summary of Expected Future Annual Amortization Expense of Intangible Assets (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureIntangibleAssetsSummaryOfExpectedFutureAnnualAmortizationExpenseOfIntangibleAssets18 XML 103 R43.xml IDEA: Stockholders' Equity - Estimated Fair Value of Each Stock Option Award (Detail) 2.4.0.8144 - Disclosure - Stockholders' Equity - Estimated Fair Value of Each Stock Option Award (Detail)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure02false falsefalseeol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00pureStandardhttp://www.xbrl.org/2003/instancepure01true 1us-gaap_EquityAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Equity [Abstract]2false 2us-gaap_SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse005 years 6 months 11 daysfalsefalsefalse2falsefalsefalse005 years 6 months 26 daysfalsefalsefalsexbrli:durationItemTypenaExpected term of share-based compensation awards, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.D.2) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section D -Subsection 2 false0Expected option life (in years)3false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimumus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.440.44falsefalsefalse2truetruefalse0.460.46falsefalsefalsenum:percentItemTypepureThe estimated measure of the minimum percentage by which a share price is expected to fluctuate during a period. Volatility also may be defined as a probability-weighted measure of the dispersion of returns about the mean. The volatility of a share price is the standard deviation of the continuously compounded rates of return on the share over a specified period. That is the same as the standard deviation of the differences in the natural logarithms of the stock prices plus dividends, if any, over the period.No definition available.false0Volatility rate4false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimumus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.00860.0086falsefalsefalse2truetruefalse0.00740.0074falsefalsefalsenum:percentItemTypepureThe minimum risk-free interest rate assumption that is used in valuing an option on its own shares.No definition available.false0Risk-free interest rate5false 2us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRateus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truetruefalse0.000.00falsefalsefalse2truetruefalse0.000.00falsefalsefalsenum:percentItemTypepureThe estimated dividend rate (a percentage of the share price) to be paid (expected dividends) to holders of the underlying shares over the option's term.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2)(iii) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Dividend ratefalseStockholders' Equity - Estimated Fair Value of Each Stock Option Award (Detail)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureStockholdersEquityEstimatedFairValueOfEachStockOptionAward25 XML 104 R26.xml IDEA: Stockholders' Equity (Tables) 2.4.0.8127 - Disclosure - Stockholders' Equity (Tables)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_EquityAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Equity [Abstract]2false 2us-gaap_ScheduleOfEmployeeServiceShareBasedCompensationAllocationOfRecognizedPeriodCostsTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The compensation expense related to the Company’s stock-based compensation plans included in the accompanying Consolidated Statements of Income for the three and six months ended June 30, 2013 and 2012 was as follows (in millions):   <table cellspacing="0" cellpadding="0" width="92%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="80%"></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="3%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Three months ended June 30,</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Cost of sales </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.1</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.4</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.7</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.6</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Sales and marketing </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.3</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.2</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> General and administrative </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.2</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">1.1</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.6</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">2.5</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.9</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">1.7</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">4.0</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">3.6</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the allocation of equity-based compensation costs to a given line item on the balance sheet and income statement for the period. This may include the reporting line for the costs and the amount capitalized and expensed.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Compensation Expense Related to Stock-Based Compensation Plans3false 2us-gaap_ScheduleOfShareBasedPaymentAwardEmployeeStockPurchasePlanValuationAssumptionsTableTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The estimated fair value of each stock option award was determined on the date of grant using the Black-Scholes option valuation model with the following weighted-average assumptions for the option grants.   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="86%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Expected option life (in years) </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.53</td> <td nowrap="nowrap" valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5.57</td> <td nowrap="nowrap" valign="bottom">  </td> </tr> <tr> <td valign="top"> Volatility rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">44</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">46</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Risk-free interest rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.86</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0.74</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr> <td valign="top"> Dividend rate </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">0</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of the significant assumptions used during the year to estimate the fair value of employee stock purchase plans, including, but not limited to: (a) expected term, (b) expected volatility of the entity's shares, (c) expected dividends, (d) risk-free rate(s), and (e) discount for post-vesting restrictions.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (f)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Estimated Fair Value of Each Stock Option AwardfalseStockholders' Equity (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsStockholdersEquityNoteDisclosureTextBlockTables13 XML 105 R28.xml IDEA: Acquisition (Tables) 2.4.0.8129 - Disclosure - Acquisition (Tables)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_BusinessCombinationsAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Business Combinations [Abstract]2false 2us-gaap_ScheduleOfBusinessAcquisitionsByAcquisitionTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The Company’s preliminary allocation of the purchase price to the net tangible and intangible assets acquired and liabilities assumed is as follows (in thousands):   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="73%"></td> <td valign="bottom" width="10%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="10%"></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2"> </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" align="center">Weighted-average amortization period (years)</td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Acquisition consideration </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Cash consideration </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,000</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Settlement of pre-existing liabilities and working capital adjustment </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">(850</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net cash consideration </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9,150</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Contingent consideration </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,919</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net consideration at closing </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21,069</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Fair market values </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Other current and non-current assets </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">375</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Property, plant and equipment </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">179</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> In-process research and development </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Purchased technology </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">4,360</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">10</td> </tr> <tr> <td valign="top"> Non-compete agreement </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">700</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">5</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Contractual relationships </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">530</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">10</td> </tr> <tr> <td valign="top"> Patents </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">8,800</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom" align="center">12</td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Goodwill </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11,703</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Total assets acquired </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">27,347</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="2"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Accounts payable and other current liabilities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">701</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Deferred tax liabilities </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">5,577</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total liabilities assumed </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">6,278</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Purchase price allocation </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">21,069</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of a material business combination completed during the period, including background, timing, and recognized assets and liabilities. This table does not include leveraged buyouts.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 3 -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1486-128463 false0Allocation of Purchase Price to Net Tangible and Intangible Assets Acquired and Liabilities3false 2us-gaap_BusinessAcquisitionProFormaInformationTextBlockus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> The following unaudited pro forma financial information shows the combined results of operations of the Company, including BioHelix, as if the acquisition had occurred as of the beginning of the periods presented.   <table style="BORDER-COLLAPSE: collapse" border="0" cellspacing="0" cellpadding="0" width="76%" align="center"> <tr> <td width="80%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center"> Six months ended </td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="6" align="center">June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom">(in thousands, except per share data)</td> <td valign="bottom">  </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td style="BORDER-BOTTOM: #000000 1px solid" valign="bottom" colspan="2" align="center">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Pro forma total revenues </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">92,650</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">70,205</td> <td valign="bottom" nowrap="nowrap">  </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Pro forma net income (loss) </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">10,122</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(3,505</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Pro forma basic net earnings (loss) per share </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.30</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.11</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"> Pro forma diluted net earnings (loss) per share </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">0.29</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(0.11</td> <td valign="bottom" nowrap="nowrap">) </td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td height="8"></td> <td height="8" colspan="4"></td> <td height="8" colspan="4"></td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Total revenue included in the consolidated statements of operations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">188</td> <td valign="bottom" nowrap="nowrap">  </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> Net loss included in the consolidated statements of operations </td> <td valign="bottom">  </td> <td valign="bottom">$</td> <td valign="bottom" align="right">(228</td> <td valign="bottom" nowrap="nowrap">) </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr style="FONT-SIZE: 1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> </table> </div>falsefalsefalsenonnum:textBlockItemTypenaTabular disclosure of pro forma results of operations for a material business acquisition or series of individually immaterial business acquisitions that are material in the aggregate.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 805 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(2)-(3) -URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463 false0Schedule of Pro Forma Financial InformationfalseAcquisition (Tables)UnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsBusinessCombinationDisclosureTextBlockTables13 XML 106 R19.htm IDEA: XBRL DOCUMENT

Acquisition

6 Months Ended

Jun. 30, 2013

Business Combinations [Abstract]

Acquisition

Note 13. Acquisition


				Weighted-average amortization period (years)

Acquisition consideration
Cash consideration	$	10,000
Settlement of pre-existing liabilities and working capital adjustment		(850	)

Net cash consideration		9,150
Contingent consideration		11,919

Net consideration at closing	$	21,069


Fair market values
Other current and non-current assets	$	375
Property, plant and equipment		179
In-process research and development		700
Purchased technology		4,360		10
Non-compete agreement		700		5
Contractual relationships		530		10
Patents		8,800		12
Goodwill		11,703

Total assets acquired		27,347

Accounts payable and other current liabilities		701
Deferred tax liabilities		5,577

Total liabilities assumed		6,278

Purchase price allocation	$	21,069


	Six months ended
	June 30,
(in thousands, except per share data)	2013			2012
Pro forma total revenues	$	92,650		$	70,205

Pro forma net income (loss)	$	10,122		$	(3,505	)

Pro forma basic net earnings (loss) per share	$	0.30		$	(0.11	)

Pro forma diluted net earnings (loss) per share	$	0.29		$	(0.11	)


Total revenue included in the consolidated statements of operations	$	188

Net loss included in the consolidated statements of operations	$	(228	)

- Definition

The entire disclosure for a business combination (or series of individually immaterial business combinations) completed during the period, including background, timing, and recognized assets and liabilities. The disclosure may include leverage buyout transactions (as applicable).

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6996-128479

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7000-128479

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4922-128472

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4926-128472

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4934-128472

Reference 6: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1383-128463

Reference 7: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 2

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1392-128463

Reference 8: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1486-128463

Reference 9: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e6927-128479

Reference 10: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 5

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1497-128463

Reference 11: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1490-128463

Reference 12: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 30

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=7488404&loc=d3e7008-128479

Reference 13: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 20

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6910749&loc=d3e4845-128472

Reference 14: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 6

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1500-128463

Reference 15: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 805

-SubTopic 10

-Section 50

-Paragraph 7

-URI http://asc.fasb.org/extlink&oid=25497992&loc=d3e1524-128463

+ Details

ZIP 107 0001193125-13-312877-xbrl.zip IDEA: XBRL DOCUMENT begin 644 0001193125-13-312877-xbrl.zip M4$L#!!0````(`/:*_T(EQWD1J+$``(^C"``1`!P`<61E;"TR,#$S,#8S,"YX M;6Q55`D``U^`^5%?@/E1=7@+``$$)0X```0Y`0``U%U;;]M(EGY?8/^#U@^+ M76#+9MVKC$X/>&T$2&*ODY[IV1>#D6B;/1+E(:G$GE^_ITC)%BE*HFXT':`O M$8M2?:?.O4[5^>4O3Y/QX$>49O$T^7"&SZVS090,IZ,XN?]P-LM0F`WC^&R0 MY6$R"L?3)/IP]AQE9W_Y]=__[9?_0&AP9J.%E]S M/IQ.+@8(+7[BK^7L+@<#<4Y@ADN/;J:S9'0YH$L?N6D4YC!\,()Y7`Z(A2FR M)*+XF\4N+7IIL?];'CU]?$[C^X=\\%_#_X;!%D?FC<'-^?%`9_Y,6H['6^J)XNA@:9U-&L-PTF7+$ MRW=G<=,WPU!\\G=(<.;\H'U:&QHU#13DT7@S-\L>T&:9Y8J:!J],8`DOGZ7/S._.' M#;,?SM(4!'?=>_.GYD52?3%Z&CXTOV2>-/Q2G/R(LKSYE?)9PTO);-+,@J,\ MO3`K<@$CHC0>OKP`LK?]G6F":N_-\G0MK^L+>'H&4CH8%'(ZOLP*;KZ)[@:% MT%R:;_UPEL63Q[%A[>*S,!VFTW'43CR+-Q[2Z.[#F6%8M.#,\Z=LM(?TME<, M%R6LN;A=?HJ3Z.H.=.$HSH-P&(_C_/ES^!1/9A-GFJ;3GZ#?W?`1GN3/@^$T MR:.G_,;,.IJ.;Z]]A1E!\`=3;*'_M4`";K]^\VZM6\,_EL+6+'OH+DGT^1K/AW^X^M#F$;9 MU2PO;!J\LR-^:DG"*_BSXAN7H7_\$JQ@]SQ*`S_`*+")A9AT/.0$PD)"NUP0 M*@13^I;<\K-?*=46TXS\4O"_FC!&K"=L"4&9.ATGD((3R!$X M8?&F&V8/=C(R__'!@/P(Q^";9';NAFGZ#&_]-1S/HIT%`@2\E4#0%3)H:A%A M:85<#S/$F,.135F`7-^7$LC-?&'?`M7)+07&P%I)7:%$*SPU$AQ3%.K(5T6A M`33WI!VXW$5,,%A[*["1(XA&VJ=2:>W['B6@!:@RHJ"$JB)N+0@K(S]FV0Q< MT%YAE*TPEC.OPKL&*Q.!61^=>"G!(;Q,8K!">3J+]L9)5TQ4T_SM6?XP3>-_ M]6V5\-FOO*Z$-L]_"ROV%:AX`;J)'5O`O`[3J_1K#C'8J-!!UU%:O'LPW"7= M>OL8I;?MC&];_*!DK7,(=1K!K\.TB:_?*1VL%3JT@[5=Q(^LA(^CG<@6[;2/ M6[!QR8XT<:)7)OXQ@8@X^A8^^4_A)$Z*7,AUE(3C/`;!348?`0-0+K>'P_08 M"]'>Y;-\+_"QYR)'2XV832E2S*7(#QQ!`V;#[^E;<0NZEM84T(Z8J@2YRA^` M.6?)*'W^%(??C;,(;[E%1)R?#/ZJ"@Z8A5U?.4AKS,VZVLC&VH(@F2J@@XL9 M8["DQLTCFE?P;X107_X?\-DT?;9'?\ZRW*3>L@[7V*:PN)[-D2+<`[ZU.-*6 M=.%W7(=33]F^H\H`CZ^L\>K$J]#L$;C[L/+A^#J,8C,,HC>L@SL MZO>Y*-]$P^E]8MR)CR,8']_%YFT[RR((9880UH`:!BE?8GUX-IM$(V^NHT$S M+#W\,DV&G9/-YM(EV"%(>1#%,M^U()"S(,ZGA!(B_(`KSP1R<\IQ*2N4ZY(J M]73!&^K$MF;.I`$4P=78=YLJG%N#%^/Q1IS1%J-1_)RIND"MA5`%^WN2OO`+ M#'2B)+J+3ZCZ5W%*Y;G2P0K,NY*($;#QMB=]Y%M?Y'E@7FXB*TZJT;\71X,&\M8)KR\:`5UMTU7UIH8H* M5_MA.AY%:6:R63NGICO`Q\`]!47$5)5]5Z>^U>JY`"U.[H$*\']9/#(;I_#Q M@DY=8F]OO"@H*:QKBG@/<*?S"98^Z24%C4(01*J3F?^E3[9O#-Q$DS!.8*4. MW14Z*#!4CM2^\A!1V$$L4`1ISQ<0'3+'$8Y0@>0OE@-370\/=P-6)/8<%, MK^/+CTP(]FF:=2E&3#B261Y#MH;(D2D?.,%R,!(6%9+ZDNA`F<%@9\Y^I8Q5 M]5!K1%5"!,`G>?0I_F$#6'`?:&-;FMJ*:)=X9K`TJEEBPJJF=W=LM8PNA.+@>J;VZ(>OFR:_-69\@RW>4=`(SO+XN(]^PP[=L$Y+1N_"J0)R)X-C"ZR*\1B!5 MV#W*!K1UEF%E-1/59-^NX?NJ[0-QGB7Y,?<"3V'+06*WV/`5'-OB^]YJ)^,V MRRIOKYW]YMBOOX&NAD`7QF^,_!HAK@G]OSV$^=^FLW%ANX>Y?W<7#7,P9##D MQI28=L?3[3,;P-.%3](BL[$%WJJ1BLNHR2+++O\BC]>Q2F`;S0(:L3+!R/.Q3Y#C4@`Q)UFJ4U`9+@PV:#^ZQ-X5-#"`T7K5`];D?HIN^`.9O/Z/Q MC^@S$."AR^BXI7HR9)"4\0/44QUD/6>2Y6D\A,"QN?RP0]/L<\(#:GM(@G.) MF$,E4@*\3ZF`$1SN>L;=I(8D=;.\#4234NXASS<'3N5TCY)D7:B$QEPCZ(Y^ M)EFER=);8FN>^A@4.'V%\2%$:UMA7!:_F:V-@RN,%V4`0-P(7@""`I5ZZ]"8 MV(SR6L7-)@AK"FZZE86VB1584B8$JWD`KU,^Q!0:__7;SVG_+"`H1:W%(09P M#FW-4IOORAY*S6#\IZN[^3'`+BT$_./[E@9M2+%OV,!!-A,$!8[K>0[V.*%N M20L(5&@S`ZP'TIHONF7[]NEP9LHI0*^UYH)=A.&WM-M]D?:PC3\`?VIU)-N@ MG&X[MG/':0I#&O4P\T5-'*4.27R]@#N= MRH'U>(S2_/EZ'"8YC#!NZ^.DK^6@PD3K1XE3=B-&VA^(3)FD:_=)ZP#6V)V;\.?G M,(_2&&;3<[-C&46+UX1M:W$<(@%EP=0H2J_N@C@;AF/#-OT3!R",8K5JB",` MK?MH:Y1F+V-\!<(!K,)JWMEZ""588.\+,)F)B$N%V@$-EHC]*4R,D79F\=ALMA2B6ZG2 M>TP!XFDKS%93Z,2BU)&VC0CUJ#FR)9#CVQH%6OFV) M;(DLOR>@EY-H]%L*&NPF`MO7:=Z\964/,>X9>87<-.LE4-?&'$V3J[N%]P*V M*TR&ICQYFN79Q\1LQ!HS]N5%VYPX@[+GU2S<(,=T62'LC6U914;`&U??Q_%] MP1:%4IF/G7]]_^PO`4IPRMF2:MR*8@ER]<'57>WE_N$UFVO,TJ]PMR!8PFI< M,+/E^CD>1Z`(DPCL9EG55)3ZO2K,4V\M-!1YN4)R2UJ`5H.B"V2`M&VYB`?@ M60E,,&&PU$7=><4,[@JI0?$OGYL)LX?*B9E>JGIS#,.REJG0!DH#'P2S'.QR M@Y/>O\##I$"%A?7JRJ\%L02X$Q^G/;.W]'2,SU=9YAT]FYUDXRKIM*:SG;B; MTWY\;W$'2!5%7U((#*%)X76;=VCISEC%KAE;UNWU26]18%L._O4VQ815D8CE MFW5:.W2'D>C5/>H?E8BIEK!,]>LA9'I%N)E2>V>]5[>B8-B;T+6]4347/\K- M['C1GADOW/2J<][T37R]W16*+,G,+W*D"DJ+(#R^LU18LW0$V?Y4:/VDB M0-6>#CXS\,5^Z+_GYKKNM+BG>W&5DCF#4-[O]9K9.(P@IA!-$OB;8%0"/2B8 MF1T3-*ZBRI+41DH$!#%I4:0%H0AS6Q)J4^91#9%ID:"Q,*]0HBW(7A"'$LWI M*8@CYL2Q"']'Q`%!8=;I.8?.B4/>%>=4B7,RSF$+L3J$<]9E!=L-ZKY,(Y;5XO-C5YT;%F"2@!1Q2<6MIEAI8=B# M* M7283_%5+#9:<:&4Z9NR3S7(4P[[%$<@F1Z94!CG<=A#6@18@3TQ;WM&)5K_- M[&N4_HB'47'-KV.:_9AV.5&2E7L@TZ(U",2G/\-TE'V;YN%X^;F)3;Y,\[]' M^6N0^_I-Y4M%%/OM(4RN'LTK>Z;/#+DMJHQ7H.E^/`IZ"E[U"!(*@^QRST,V MX3:R5>!0)W!`G1<:C!9N0#TJ>S-Z=;5LYIZ.(RT14WJ__A*MELCT4#&F5N#. MEFB)-IN/&!?6H5XNUH]/FRSW:$VKUMORCWE)3@($(%%M<4+)? MI.5KW[,I%HCX'HB5##C2'G41%C[`@W^[UFN,4;]/<..M-[%*T)*H6"] M+0&N_TD/R#$CYH7>7!S<1.GO?'UW]7Z:");9>?W7!]FUL>*'Y)N/L5ELQ@3BD]YV6R94F:F[(+2*OH]+IO=0+"7>B4OSH;C:3;; MN>WZG!9++H=%]BMZM*CC*!)KF;\_RAVEJ0M9^K1)>JD1O-_\MK-A7H.(%Z"9V;`'S M.DROTO+41Z&-KJ.T>/=@N$LZ]O8Q2F]7X3>=:6F+GY?'H7`C^'68-O'U.Z6# MM4*'=K"VB_B1E?!QM--J"5-UZOLX3AN7[$@3-]Y';>(O'<3\IW`RSP1>1TDX MGK?-6YS*FC<<.RZHS3Z/[P4^]ESD:*G!_Z44*>92Y`>.H.`FP^_-CVO64RP[ M8FHH1OLZ2T;I\\$E:>WA[WGE`BF[2:F&"K1U$&H-`*?)_;'MWYSD$ M9EO.;3*IS9-OZCY4+O1[6,_B>D&YNIQK(:RYK=0>_3G+]BHN/$1F;0K"ZMD< M*<(]$HZOPQADV`T?XSS< M=?^E`UZE&F02PC):ZZK3//_F$X?S&R&[9].6&#'H':EJG4&:)[^VNVQOP9'B MMDJ^OIUL([+5EIR]5JCF4F1>:_2P"4*KKIL=XJ32[&QKA91G`UA7^DB[C"(1 M:-MR+.[C@+ZTU=06KR[FFODWGW&ZB8ITZGM@75ST6JAU)=R*8W,Y?J_96!3] ME]BJP6S1_?C@WM8=`&3F7AJM9#/L,&^XQ38'-BV)C$(S]QL<=?]K<2^=/?IAKC;J;SA@6D+S6GJM>>YK4VLG M2$8;7*QLK1'D M-ACUM4ZBJSL7QL=Y$`Z+:__**S*/N66Q0RY*.5+[RD-$80>Q0($"]WS068PY MCG"$,HUB"VE=35*T@;(MDNBM?C(MG?A*\\OFV9_BT&<7+G71Z9OAC2[F6B4\ M/QMIMJ47UV(,=^]MT4ER6*XDAP_I*]?!RI@S[4S6BOR/WTR^`R2F0A=;F#;Z M?2=O)M^%$!4I/UJ3HK=I)M\%7!.U*=R4Q]W83/[(O=$/,7FM>J.S\KZ.FLGK MH#EZ%VO8[+TU=>4\12'5(0A;%5+112$59HI78^ZW[=K=1?!A^C#PVFT=G73M M[B+L,&D4IH75N+^R4@IY_+[4AV!LU>&N*'[DI%8N_;9]J;O)ADB3[EQ)>+YA MY6LWL,TNMV:+"\[WJW8]?NOD#F19-/!Y#UHG=R#A)O,EU!HEUK9U\B&-:;M) M^)K]?L8$;O3\&[CX>(U7.^!>;KK>D&I\]G:-5SM@6G/S`E>DF6E;-EX]8OO0 M#I;8%%TS7/,?6[8//5U'RT,"GU8=+6E1:%]I8-?GCI:K]#A:1TMR](Z61VC= MV$'FTT2'"[[O4^_&0UB_5:^0XJ`>KK2UZF7OQBYV.DP8PH5<4@)OU[NQBY2( M.7ZBEA:^?>_&3I3:D5O8D;)M,5MF]1UUV<%=VSK09`:DT'1Y59N[MFU,E.R' MJ\.V",4-?:1^-*[KM@BON-^F+4+9$`#7=REW2?7]/WO7UMPVCJS?5:7_@/(D M4TF5J/"FFWWF5.FZFSV9.)-X9W?/RQ8D0A(W%*DE*2?:7W^Z&^!5DBW9EBS/ MR`,U8;=@Z#IIQ?C`G0C,VGPG-N#34$Z`9RS7/T#<]F>>#,\YQX228M0:N MB$WTY]IG#%OT+%S!)+MA[IUK/E&*_;0\:.!6)N.LP8PW^')DP-ID831-2S]C M!/!G80L&AKJU/_CUR77F%$Q`G3&;):_IO)7FV)";!D)NHLYTK/;>L*//KC,G MX4J+#G9TSE5E3L(#/(36L1X%QGIZC3DN<*"!G5/XU=F[R'\&"G,"IJ#"G`]V M\7-PH''^>))EMAP9.!"=88IB]L<-?'YE.05/6ICKW/_.C5-KRRE8@&?IS/.^ MCV63+4?%#:34!WICNOYR8OZ3,*6%>)+&N8;\)V$!;M:QS(>HBR//^#4VSTT#\W1J&,-="P6F9H];&&.N]/7 MFGUCU.UVK$Z[84J:IR!<0A):(*7,W)'KB;`/EF(6A`<[MS[/XJEK!'TL6Q6M/_'+Q M:_?SG]Y_U&ZN/UTR??G]BJD'O>N;F^M?Z=D%?H8?38'NY+O1]<<;$(%?WW_X MQR6[<1JE0+'\/UW MX^3+=]AI^F-YSPB:QQW!!S'CWJ/INQG^_49[_W$P_'ASR>S7.PF6[3R,Y)NY M0#8ON;]F;E2MN/YMX('?QER?W7(08U0KC[L+F@&&U5RUS6S!XQAW7TW#8,%B MZ(/%`?T?&V$QM!N$X%%Q6M-7802_IVRL+I"ILU^YSV<"YY:-A><*W.,4SWG, MN.=5*]%J,F?).4T/NO!6`AB4ZR-P#'$"E!&A,K!'M467F.H^30[`S$1B[$(MUB"^`<3B97.)TII*!:D=.03/NWN0#R\XTZ M`L;GT*.L!1C=&+='2?T5$0@(_JP?KA)&^\@ZZTZ$#WR>52O=$"9>SM;CKDQ,)\\W`FO#4+ M!=WBQ)9\+4WQF$?0-$A-M(08E@(S./(A$;@381UZZ0?CA MIYW^Q#^V,M'W21?:Z0,4^C'PBDB/Y]`J&!28EGG$((H!JN_00-0U^@=^&[G? M6?[#:N6>+VLP+&0.;I[TUF>H(WCTA(=@SJ2U`2H#.J`!*I-R_P^D,&%^N$XV MW+RL*64!!;AU'0'F&E8CD)W0G!Y?!Q`_`I2`X3P,/;! M0-?97T'F0BG$(ER05DR@'5C=\)_PO*`T-7R"'E;B"R1Z[^`@%OPK&`!R:]W) M%DN0_U8).`ATYRHJZWY"0:;YX"8@H\%%F$`;I.".BTR2-@&(S+T+KA^LOQY8 M);DFEVT+340NVVJ%'**IMT(!BH6TQ[(_G$P?=&()4B^(F+Q6PS/T"2E M(4%,X4$$2AC29+\T.U2M(+9HB`O,*\.H=]+91ZU)!XG_S,:(OC`\^-?*)^<8 M)UZM6STW^#/XF=]!/T"+(X(01CE8!"!JTQ5JD".B2>B.R>A5*QAT9=)M6'=/ M]3L5)!91V/8/;/A)N#?K>GC]I:<]BT-5MOX@G; MCJT-+'A()'W_!)O%3!QA6%1A/!D@:F+G1!""EZ+'B/ MB=5/7^88":6ZX0M:1T(Q!LLFC;GT:QV0LGS$5;"IC,PCKHSZ)\7$@N+:W5[H2,9FY=A0\7`<6N MTI>5Y$*8O5H(3:Z@;GIDILZ2HXN;G"EQ8K4$E5[B*C>C(<5N+.,L<#ZBK_C$ MPQ(2.<@B'4@=S.0<#3K%T?2)>B/IBUK(Q$UR6](43&"90T\%NW;`OD`TO"[W M@*&AKRB62QZR>(J+#WPU#G@(2]R;S$OH7XVN>]G/P=5;-$VQNH%!SE',"I,W ME^>"J27VZW<0M(/Y(X\^?WOX.)6(&/'@H>R\`'`CPW#D*2!C]UWF>RG/2% MWW+?YXEP&Z8)"C=PGE'`D:^!KH4#&4*X* M@OY@-9M+?@HTV:JCE-5JC8%/=T8&C3I(I'*F*8M`PROG!'8D$PJZDV.'LR5W M8>3S>%&189B"B0+$#Q`.4\ZAJ]XIIURB)*:B3E+_4RY:,)%FWB,-4[`V-N'1 M7"8.P5B`H*I(;RGQ9E1(%Q76ZB2SR^51=3+Q&PW0JQ!/)5G@[#01O@PO'!JO M52N')EDVW=Q[7=7270`*?CRYN6K@>JOXD/N0RO[L`3=SF9L']>UAP^@U!MJ@ M`8ZO;79'6K=OM[2N8?1:HV[;MNS1/RWH$Z$9K/Q5`-N'4<+%Q[_TT)JC3,&4 MDRW.Y5)[Z^R53])(='%%2"^3I)OAE^0J#@'UE M((M-9EE&N]$S>FVM8;6`6?:HI74:=D,;C/KFH-_4NT9O(#,H>7IUAVJX3B?^"8-HJM M8(/FZ*K="HDK+'7U6,&E,1QU&_J@H_6MCJ'9SSR-L?!ROTRN5>#/E] MAC!+KY'5/7"?Y0'LV8:-9`VZ+;W?[VF-4;.IV7W3U#JC85OKM(>CX;#;'EF- MOMHM91I6JU&ZNN7@@97P\1%G)4*\%?"[Q#%WG'0MHZ,W1UU-[R(:5J_7T#IF MIZ&U1Z8UU.V6/C);]YG"!0]GKJ_%P?*2+*'Z/0[B.%A<[K*#^&]MRL%575\> MLMW$J#-B3[62`=$<:@1S%#>W$7S%D+D:Q*P@MY?VZQT&<.\A2$%@>!ZL5+Y! MT^<)2GQ1:D1NWL#QC3E,,^X6C>2&BJ2,](7[;."*65"M3-5]`S)`2'Y1!!\% MGD.V\Q7$-WIF'-/"!+2F*F(0X;4W7J!&)KDK^$)W3`[Q>+VY,P,)KU8H<>#C MMA`9:>1HKV$V,$Z*9FGF!K=4?*>\G[=FKUIUG=(-V'TQY'$QY#`;KUD2>:O: M6;+#)"FES=TEAG"X-V62E,1RC)&-YEF*)*O=$)Q-$U`K:"/W3E86FJU9 M8+?=+WUV$RS="6O;NF;#DJ.09G"0P/=JY0LENH#-GP6P"@:P++:4[ M=W;4&!6+@1_$#EFJDCQ)"*#.TYIAM8(UL%CXVEKP4"H&O9.$_OE!&9V:#)T# MZ9,#FS"HC84J\\NO*9.SE+E0QN!O%LA.Y(55$E;-A$T"5R>DA"Y)H,, MTTO-`Z8JB/!PH=I0B0R5H"#WA;9L^*A@:29&BH/[/3.N(8 M+\X"99-0/I@P6XFD!X]B=?AOK``+<:_6^%^XN8J&#A02\;4D4<^S@R"99)'N MHI9@6B'5SJ3.64AGW!GG5RMW%6:+15*0U&1.BD)*]7_:K[9,DH<0'4[F)!.H MG[+FG)B#HNBYZE)@93.R^CL8#7SV%^ZO<`L<)H1(1M`@?*<=,^Y$;*1@,/^& MLTLS0":G9(BDT<+J!&6JTNX%[?8%[_WW]\.W&V;.#^(:FP??!(A1327[L0*S M!GWWZ3HT_'=B(*`)Y+P;,R<0]#'CXR@(QU+&$+0,UP,E$3GB"JR1B1_*$*'G MG13Z9;J0']`,C,]UT*67:?I2+G+!G41?4G&7!8GB7*`H%A>&?(4=9T9PL$"* M&H@%'K#II["E+FF2=O%EH<8AC1X:4MSKWY5\YML$P# MSPN^R<6>%#1:+;#2^1\AC6^J$M.5*DCX*-D\?Q90Y4NIN.2FLY$L[VGYK[B7 MM6B58#(<;,/![2@^>`14\0"CS3WR-**Y$/'=UO6-2Y6U8!6!-$9O+P]/`^S8 M)7[%B*5?WO_O4,Y.POB4AG+KBI.RA][UY\'PL]:__O"A^^D+-$'[GY:1N``W M!Q@3_G(!0C41GA>!XP`SD?Y>HOE7O[^Y3CS_Y:+9?GT!GB6X&[]<3&@+6$X* MXC#W;R?YI-UXG88/[V*G\,JM:DIZ_&DOG9U?/,'C=P4RP[OH*89+)+F&?%AD M?6&6[Q[B/DT^N'&<6IA$G[*SF[/T$$TUBJ%?WJS=%>P]G@EW-OG@.7SPP%5E MBJ%72HL1.GI;?:GCLF5_V2BJ?V)/?I*(E,Q8?F=DYBY.+T1J/3P?^6'C&0PZ M`$OX4[\_'(Y&%UM[CX-E[@^I"2\LE9HA%JD1_S`S7G6I%"S6=.-S@]3\VRFQ@+E=X+5V!,GL34/ M[>X08_..*G6YWQL5ZJ]VF:0Z',,+>2+.'0UOK#CL-S>PTN@/; M,IK]P;VP8OE-GN8I]DR68&:J%75R-�A7LK=YI,TKL%7:S'XW716"HW]->T M0816+'7"JL9PUXZL^T=[5LF)6"2J,&;D@;YSG^O]!?(]:]ZMYNM"J7Q'73WY MQ\'U\?;!]?'=%?4G>?PLW?Z_*,LWR\*1"),4KT2$4SZN*CS8VN=`XSZ):^\<4C8UB^VE%`U>M9YSBDS1Y3LPVST>? M'A?OJL77$]/XTJCK.@:\>0=$DP\?RCGI@R2^VMWNPCD$ML_RVA'4[HBO/2)O MFQ;05[VA& MJ/?#"!U/:N\O=9Z%U/XP0GL1<7]._BQF6#N/:#5P]RUW^L38\U9N:6W7KG:,U^K$W[3>?]QPC.8CI?_.*456M/ M87$?V]MS+T]_*&X]L*+^\'IPL;X\$./XF,A`IC&TAUU]I/4:C;YF-QJ6UNV/ M.EI/;_9&_6:[9_<;YX0,E,U4J\X^()`HGLONA\)Q8YJ1'4GO<\`'NO:KE>YJ M!I*0C<+0MZ'S%JZ_0+0=A9M"&!L(,$''QU\9MKX%]8=%PG<#L+)BLL)&HK7O MN!/Z8D)\RB"%V!OL]>?TL'K_ZHO\5C*4C=1[V1N#J[>U]`XENA:B6H$N=PRK M)<$AMC>Z8U0[3]&_,DP8+MLQRHVAR2/VUY,X*)RA;2-A>KO.NA&!7$B("83Q M2(!7RE=O^`1YZM`\9"@RKXP<+2[";T\%O98#&$+T8G4WCKRW(][)C(T+=Q#A M7-PBZ#D!R"17$>11,DH-!^!1N$A:F15U-M@@CDG:Z,XK!74C<7I9`M/+$*:W M6E$XO;>Y2S,25(Y=(^E&I)0/O;^CS(=-SBKB$="X@+8KX7<;N8N&\I@SM0Q0 ME]!MR0I+Q"T)@XNPPT4HW'JUZ#=DE-#FP'I4W)$4J"NI%@DD-O?DL@6#!:W`L(?[,N#86>DT.(EV!/4[H! MEH'Y"V,$VY)X:9G13F^0E'R"[[!I!+1'O"\?FZ9[\S;;9L6F[_1T2"^5HS)> M$]I_C%<=$$,12G&)J/_J4HP$BR@%8Z?+3O#.,5>DA"3(C`=[NJ?9UGFG"["Q MQL.J;77R"_DM=STR\P2,)^'@]O";BA8[N?,2812#,`R^52L9RN..B4HOZ=IR MD2I>'X86OB#C"#L9!V%4V[URR,Y)27(X?ZF?BE..B)]W*[*4SR?VK<"=5-<) M-#)GM@C45V-!#J1\!_^JE9+SM\\U"@0X2!=F+6!51].K[LM"?=AB^0Y%7]L1 M.1?#ZYZZRK6;6?M/83!")^&<=K`WK,&P:[7:6KN).*3&_[%WK;UM(\GVNP#] M!R+(``Y`:OA^)+L#Z#G70';BC3T3[/UB,%3;Y@U%:DC*CN^OWWZ0$O6R)%L4 MV50ML+NQ+;&[JZJ+U=55YQB$)TNU\?_8LM7MZF2@C'9\B2C@T.4M"V>.@+\0 M8W+\#,30U@9=?3"2%'78)\3DBF3K`T<:R`-M@#\T4DSY@`S$]I+M8R<@%+4C M$!$)5$:$_L8E(B)ON[IG(L@7?>JGD>&>V3BFQ3'8]R;;@;2B+]&#^`$,-+-F)"V M?)4@YGH!'IDQVE*F4#;O-51C@2+RL@126@0+S$8E*9-[?*A&^_81[-9BL;CC M[5K\3+B!"O;XEE"*(\ITF.90RB3@\TEG!T`T9 MTFE1L)2DB9Q42)R>$K9.D;Q0"\PSF;ZCN*CNH^V`4F6G%F3W[R6!D14G.)@/ MW'@I)"M:])I0Q16I+XDM>TS.I+STF.S[PEPG%.W58X18Y"'A=%:DU&NWHN\) MBA])L"3FZ8BB-+^H7\)Y$M92GT9)'(#+]PBWD=.K^B&I_Y4*)64.(5 M$WS$?$1&0T:HX?R_9SFU?>:Z"*PGE>I5-%CYG:6=0>YB%"TW@ M`V8'=;"LIR3'Q!P/%B,A]XM(FBE3\YR[[?D#EW'\7N'F'+>:06//X7"R6E'I``6]\3Z59[KYB%7#++8BK;`W(*%$_/ M\WFVJY"_HEM"4#)'47.S.M!VA!=,I]W:=LFPV8)PG."YE.HOI5QK+HE=5E&\ M:>HN78R^S&>V"Y/]JGR#Y-4RT9K5K^9W_OA.+\9+?O\6U&%,ZTK>:O M!9(SFEO%JL?*B24V'Z-K:BB%PSV]$"%IM9#M\LP#CS/6]2V,S/-7&!4N97)> MOS###Z3Q)CWRD\<569JQW.;LS30L)6P)1.R:L.3S,QU<)#AT9!PFV@ZWOGYF M??'$M7PX^T)>]7UV6_%Y$424U%LL.[JBR/V>9!GV0-('9E_J649?ZAJCKC[J MJ:JN]0^!`3=+H=+ZLL1F6`BM&.ZVG\Q=R"+6OZ![M-FXVK3'^+"^8?*5?0N: M\J]4TS=H.&@7KW1J8534?C3;VU!DY= M.*9%X5!3/5.9+2J'N"A-EWFS8=#SP;/0#>ZTS%E0]6=(BNW06+B/77*1DB'> M@?G^)+2OS[1K#OQ4B5&6 MQ1W!`FCYX%DX!N_T176/L;J>%\_0HBSKF11-M5NT<@C/^Y[4\7@$^QH.C64: M^J)20C_.=0SX.MY,P.*>>*5>GHW61H#3*C73I3K11JBXD`JM+'JM455YRZ#U*!W6C/8QT!R1WFO[4:9 MVZOX?X60[>Z.M1"QU/R-^Y/@$/4CTC\^,@5*PWI/KGQ>-Z4T4V2689(,\SX,6]0/%&. MQ^"FV$9/Z=F2H5FJI.LC2W(,W9`&H[XZZ)MR5^EE#&Y7QG_,?RG*H``\6-KR MMA'>Y;`!RX\;3J9!](S0-<%NN9K%W@/^Q%7@AG_E?9B%<4KJ5NE9MFR.NEB. M_:$IZ0-#DVQ#DR7#Z2JZ)JL#6SL$4N!TK4XH26FGVIC@@Q0[MRC@#(7#$:(, M_X@(>Z4/,`>PHJW:I-^)5@IDS?3D#[W`]7Y(6(41!6AB3UHTR$ZB,0H8`!#K M#)YWR3PA$F2@L>1F36ON0HFTKY@"T-&?LU'W[3VD\F$@L,TCWSN\B0;(]W;& MYW4*^8%\[VWJ.@O3J)X/CK^>$8Z%W9@^D9.0[^6A9AZ-!/X=P<_`8<0S@5?] M\&(44;=LS]ZK+O,F8^])&!UC=W=!F00"I\KHG:-F=]^>UTNS1^)M+,U/_14% M^)!$2X((S@>XI=*,5^>$U01\T7[JY(1SB+_0Z:N?_)#N"%3A,@81^*;2C%GN MV)R8,WBG/15J-@E,$!1"!&% M""1L'/$C8HB<[^6.L1#G$DQKD8T+S^RU8+%%?%<`)#P:(.'V;QSEUY4,>YX7 M9J]UC`!(>#KA`B!A>?Y?+#1%\8RZ:R^]^_.H^$;Y:%/MNT-36[4H; M"!Q1!B3"YJK7$`V;N_:?6O=C?XOB'X)$&"(D81I'A'FIW;J8^RA1"%Q\KJ+' M3$)1^8#<,5^U,+RU]=JBJ7,'.0!Z/ARH4#3WN,.KF9XY"[=&?N@G#P2J,")4 M2@6WUFZ!7SNMO5NB+','(@QZ?D6(IJHV;WIN4`MO$^`50&ZOD]LA)PV^?5VU M>/@X=C,AR]!8_2J&J#OVQWF<]+U3?;4`.&;ASZX7UR MA>*\-LCWNN%XX` MI-]N)?-.X9)"MR` MG\$-.&>90>KN:9F=SR@"IH2,B7J4E_U('4+J$C]6XEV5]F:E_3%75^U5Q..I M1Q9-A??+U7+]SMM-^#-*DH^YSW%Q/.41F"4AC0@_29SZGC]U"8,\CJV\64S1 MU!IJZ_7(5E]H%5O\AS,\WI];JK7"%^6*C\&_PF'=!Y!3R$[?#:.IM*`1^YH`-L/WH6C<.?M*>3LIA"2R+R^)FJO M(@Y?!)!$AB3RV9VN+JH.?B")#$ED2"(W[U5JV'"J@E,51Z;>A'E^IS8P:F_L&S4KVP=_5.8[51PM=L;V4.7MU,Y-_[D04$ M&\'5[4Z[5937PKDZGP0F/*JI[_-]L(Z+I-DYH8>`5@/Q\)7-,U0 M^)-V*[H3^BS53)=V[`4A0PGC`QQ3XE MM624W;/03Q-1T&5#=!1KRYA"8'UU MM?AY\.D#!;6?!50^>-P0I>T6A3E$XR1?6#8PF;0[Q7_\2;G/@V?AO=YQ;9:-,IXSH@GQYXH?^9#814A?;)?DC<1-DR.@[?LFX"_IT#\6I MBY^5BSTA!L7NDC-AT49FNC=S\Z)?QH/FWUTS.TH1GW2$+N,QV+85\-/QH@B3 M_'M#[LAS0H,83?!CR11F6+A9]_A&8Z%B+8B%`%K>Q^YD3PKX4[ENZLTD2D;" M%H+"A.J@[A[N)FORS^?;;J&?Y`?$K(1>#V[?RM08I._47)>?0O9R0HX(P6S, M;)D\Q/4\]ABB^CXV,I+(H:-. M:_E70!]2O<*NYZ\6KM1U%GMY#6'EM*;1<"J2&HN]2B*2,Q8[6/O963M_).5] M0M!(,E=NP%F)S=Y++.&::>^QY<[NIH\R&62/+WS0;*[9W37(H%D^-5LMY3QH MMCS-[F;:J)=FWU#`5?%N-CM0,>_N"9Y"Q9]X/%^(%*3`;$'Y#-`Q:!B4#&$ ME^>K8MYV<=U3';^C$,5NP&(-=TQJ1Y,T=DF;,@0(-M^#!(#:0& M4N-%:F]+#7/]?JVR9$'I.)R]5D&S^VH6+@";J5F]LQM9!#3+HV8U[LZQW!]R M%L@MIXBAWCI:?4)/D!O(#>1VC,/.*J[31F`,]21`$U'J!A1H?HX2(2R@)KSH M/L0?'J\@/A21'K:AC#"H&H+TD*%-),)[I8`U0N^\WI-$_?RK"QB2.<3%.OH- M06=9^TJ[E?W)?/%IJW@I%+)F2I!<'E'PW&FWJ#2$?86Q"GIQB"C4CK8B"O5P M49!X?XLHE([Q%E$(788*M15!A@IJ%A:DLDEJ!!EI/F08A1(!4)JCU>1KH4`T MYH;EB\+3@^\]"'["\$^\[$G?E]01/:)8<(6G#'Q5RL%7IRCVHS'%+5D&&U*+ M9O*,W#A'S'EYN>W6SO4*FY>[$/8#@_?,1>)8J?J7F]M,!VZR7\&8(-Q8"3PB@5R&1B'YO+ M1MB8O="[YCOH%?A"IW&C!+4K2:G@L7#N7#\F;Q\&*(5H'K_9"NO8>(U"=F3R*#,`U-HC$*YAA? M>`X468=\>W"293:8++"KR=/:\;-1D3SD78O[3(_!89KD(/.;!"#Q&-9@T MI0Y[%C@6`'$"$"=;3*-Z]`'^0!\X%C9`/1P2]@SS6#6+1@+_#A$HOW:+AIT? M7HPBN$T7UZ(XQN@8YU%Q?8Z:Y>T:K^Z%UG]%!%HW\--G(<;'*W!+Y5U45@MT M\0OXHN.JL]K+R;W5R5_H]-5/?DAW)!'FDT@7)6F[!;ZIY`8FFQ-S!N^T+^`! M)Z^;N@=(`__1QT\;0WA4LL7R8:[@?YJDS;J6'I!;JK6[*7;K12_!EF_1EN^, MZ<<8;[-#<[AK)Z$7Y3H*W)!A4,U1$53:Z:3%NC$U3V%M.&\B(\FD?-"H&PQJ;6A_Z3J6T:>0*U$B,,*$ M1N;%$&&$*?XB?Y8SM`>2:BL]21_9JN0,AJ9DZWJO9_9, M>V09M_@)[WXK;BMB6I15:3X?1LD4!,*=CV?J^;0HA\TZZ2R$LM_J5KCNYH1Y MEWFU0W\6Q_A?RPQY1Y.)TN_)JH,EH8]46=(M699ZPY$CZ<;0Z!IJ;ZAIVBZJ MNXPFE/(/$OXA88E*5/]E3B3:^W)S\^5?'P5YJ02WZ)[W)Y/,Y>,3AC@LC<2G MQ2R9T<_+"T1"]97M)Q0_LFW]7MY0?[2HTEJ4/J4O[>D!\M#D.XH+?U9$MM.I MFYMO=4H?E#Y$LP1_;6_^H*)4Z?MM78B?A"(3IKIW"<.66@1RTT5IO98*%PZI M=SBLAL$ZO(9A^S>.\NM*ACW/B^I-P>4^NW_E4K1.%0>-$^Y&#U>A@)NT4Y9] M<.[4<_K>>0W!VJ&L?*US6=31$,$WIL!C%YN\\F8V^:_NT[QXER\B#TX(XQU1 M5G8GL% M,SUS%FZ-"/SG`QH+]U$T3H2"6VNWP*^=UMXM499WE]?6S-Y!SZ$T535YDW/ M6P`XBIGJ.B)P9/D`FFY?3P9LL(DW=?8?<;0-'P:Y'1D18<=)@V]?5^DI5,6Q MFPE9AL;J5S%$W>$^-N?X';8`CCF),W[M<#5\BS5#G_/_)@BD;RR4F46^NQ;K![KG3!&GC_!)\Y_OKO\8[16 MR:(-NI;<[_CX;!KCS2C?ZO)]`'L_0HB_>32%<5Z_;/ MZ\'M%,6WZ$0UT1A:(-A5[-LR39U6=(5`XM"5K$H9%NVNEV=#(1%H;W[3>ZH MSD(2AR]P>_52ZH;W/K:8;I*@-.F&X]^C:/SD!T%)A4QX67;?,36IJSJ6I-O& M4'(L_`"CZRCF0#&LGF[7M)`I%U6[Y5)A"5DYTUHQTUD4$BFR?'`ED;X=9&1; M28]:3241#`O#\C1LDTIN3E[0\2TOBZ>SJ::JH_[E-(I\JMI`UC4`RJA"&1MK M"5E'284*`??V!I5V6;-/@_?3"R*M:.X@CIH]LIE"`'&`.,YFBT`0$8@X,\$ MW\.8L5.+%/D5!>JJI5KF]O MXD4!,IFG3=@$V;,K=!!]%:*?1''J_[^[RV'44@'\BOT/E'(G[2;('3P->!KP M-`"YL*54+2_AJT_`W,"FK\MPC.[\T-^$=+MC%M`5P4E7A&V*BFF`?INJWPM- MU'6G6OU^J%5VBV-EVJIH*=RU,,%FW;N;7A=U4P']-E6_U!E7W$8/SOA8FU41 M\Q)>CC9KK6&KKF:Q]T#@Q-NM%'D/(3Z!WC_#$:_,B*+#G06#E@]';[%$6=M- MP@&*YEW1%ZHA:E;%$623(HQZJ%531-.H^!`/^_<4CEH530L<=?,5?:&JHB;# M4;!A:M5D43-YAS*N^]U??Y9@J:&84-L$])8Z>?"G305>KX=A6QU(.S=?RZ9H M&]QY+]#S*Z(/4;HX]H!#8O/U;(J:"EZZ^7K&7EJ6*R:-`"]= M@I=6N*NWJO6MX64H91PWE%K5C;T'QA$]1H\HB*83%*9P.(0Z47@K'04F750A M0WT&>LYFH0I69/X![R'+3LB);%'=T@*/H5#3&::%H57V9`COOHD8E,#)L%Q35CI0_'0&:M9%@[\*>U#TX1&'+LI5AY80O,5;8@YG1KHN9HF%8M0")KOI+!19^'GK&+ M-IR*\SS@HH^?O>.NJ*/6=X77T5WZY,9(*'0JPEUA^79L="`UV7PM:Z+M`)AZ M\_5\89B`9=,PG6JBID)=X3GH685JCC/0\X56]:L8?/3Q&\7MJJ'&WWY)6!SR M^O)_AQ$!^3FF\(5U>VCX6W3V\\X3O^QU\]WY>R<\6O>?+G:1*ZYP88/.]V6 M-]J&#X/<3B"WJN?/E[1`;B`WV)T528NS.J.;*'4#X3XC3&;(>'Z8NN&]3XJ/ MW`71>IW3S95\K(;'N4HI[U15%=6J"0P;?EZOEJ#24K""(9O:#&TJAB+*,G=U MO+!=]V_?U47-`@4W5L$7IB;**F1.FZ%-15-$S>"N^PU2II4E%S1\@!U',WQ. M.\EY^;7#;?@P2(ZOQ,R9R`LD!Y*#/5JIO);"B5]3T@%9^'GL/Y*?_O'K+)'N M77?Z\=I[0.-9@+[<7/`3='(]>._W&"&!`_'47@F7]'=/]^A*+B] M&MJ*KDKX/SC^DZ5_8]$:M]G`[1?%M0J:7O!/&R/,G;I"04$[PQ_B#_V7O6I_;MI7]=\WH?\!DTIED1E)% MR9*EYK0S\NLVYS:/QNX]YUN&(B$)"46J!&E;_>OO[@+@0P_'+UF2C7YJ+)(` M]KT`]K<^?*#9!8DZS MVQL,>OWZ<;O?JA\TVZ?UWNGA:=T9'#<=I]<_.^@=*8JA8&JY7%`;O55/:M.< M7;]CI>W\@Y^RS?RC3Q<7GS[00P7UN^>&_H17*\@M-YQK/8-E]M])-HMY(*8B M=.,YY"U`+6(FBT8LF7`V2V-O`FR$QX3'61+A7ZN5D"2?9&A/#M*)7PO'S[RW)Z,;L-+9=) M]XX5DXY63LNUIHG,RX*1._[TQQ^#S^?P"0_FZ\XD?\6&4>SS^-=7("8>#P(Y MG+#GT0"EX7$R!RH4&YI7V3[=-+S+D;R[?TB6P2]RLTFM"T?GW56ZO^^1.YN!WG6ZJ?W[+`ZXWC! M]6-%5"@%V.>,6>L88@^M-V)([FSJ[RD_[8?WAG?E9)6\[+*4[.-.=K/6?"EU MW!O0F?!MO0C3\`V MOI2H9#>,8[_F;-LZVNAD8QIU#&]!Q*&Q,JQ./5'([]3ZS@M!V+>QAXT]MA][ M'#Y.[%&TD,Q%FQE$$NSG,[66VRV0<&K-KC62+]%(/H_+&=LPD_9TY,ZG(WB? M@F%G*0[V_!(O5J@*/GLLLBNF[#$%Y^$;NI^2"8^9E\:Q[DU6K8116,_^L!\U MH'L8$+R8ZIQ-1`,[?DKR.8YF/$[F-38+7*-6_.]4S.SIQZ8W(PYMD/T\/-/[ ML#Z+(X]+R6(NN1M[$Z5(!4ADF*C_P8JBY?W3S\#OM\CYBYH7%%@FO5MQQS+EULEJ1M4*S$/Z/Q$3L3LN>Z3[(:F=MI64ZW[O#&H=1.@@=7"36IA MK]:S'O,)]/`'T/=[YC)--;95SPSILOI!6B??\Y'.]8F#O8>WI/2P%P:M. M62'EU]7TUDQN\B;68:U]L.4>P7ML)DOOOY0+.@^/@`:>%Z60G+"9.W<-GD:$ MER^J%7/9HE!`9RW`1O?\]JXYS6ZJ_]:UZH2/>(SP,XE[72I`M?JSR9VX6N?0 M.E";9]@\8VL!R6-E'@63">F'PNRRMG.#MK-;:QV^D#89UG9:V[G](//AEO)S M"1T1S&2&G_A,+:4ME+,6TA;*[;2-O`LZ\NT1=!\)'CG#]!U@0*G0@$^O9]Q+ MN'\B+H7/0_^+FSP&(/(LC?G-\,=MI]8CP!_?=O5E8ALFP6!#$=)8)T)B03:L\/$ACD\' M\$.WTZXWVRKW:X2XK$&:&=T5 MX(2L'#$7(HS(3[V$%4H<5,V#%TVG//8$V(E_=+V^N1[*WN`'M7T!EA^_PV'8 M(+L^FOUR\NXMNQ+)I%HY$M'O/!#7H$@^C]G51'@3FI='\T($MZLH#7SX=UW/ M!687IE-8!HM&U;8.=QQ&,A&>U&28U]@0M1NXPXZ` M"G$PKU4K'W!MWB25/$EDX^Z2A^C43P8'KI9NT%(ABF5#SD%XU&D$+&T4Q;@\ ML"OP?U.1S$E"V.#\F%U$,^&Q7K-38\8Z$;JXL4^RP=[3FR'8-F0,O9F4!T68 M0$/UFH(5-UR9N<)GK_N-%IN*(,!G<2*NG-2T0,9\AI4_>&JR`B<+O_S:`:.= MO:X`!O6B9!&I$+F=0Q66@,J5!N"LRVI#!S0C6&I@@`QA?(UD2.)!V\Z@M%H5 M?9;.8`XH,`'0JL$&OD\4@'1AOK!R_0*\C?9<(18MP'&@F\&ICN)H6JV\[C2: MN8R;]<+[K\$FY@2@&8!L"A!6@]'H\3AQ18@W5?,BJI*!@;>Y3*)0PS;&\%.8 M<@9Z.4:(]V021^EX@M;+Z378Q82OG_45"!@5G8,^X52*N//5"M!&R!IS$YBV MT^B;:1LM@Q?`)`P5:T`.-6)SM3*-?![<7]5^A!9_"[#XKUH\#2;`!O9-[(=#6Q'@S4)E;T29#L:/'3W\-$?>]&77VQ'@R]C8XREC#]O18._V1>Q%S1=K).U%35LP;3L:V&.1G3P6L1T-MA00V(X& M#X@&=OR4Q'8TV-YFA.UH\$P\D^UHL'7@%[M3_FP]E.UH\,3:9#L:_(C*%I+9 M=C2P3NXY*J7M:&`UU78TV`=-W6OW:3L:;%X+;4>#I]%#V]'`JN;=[V'9C@8W M?_*Y7C&P][#V]!Z6[6CPY&;2=C2P%W2>/@*R'0UVQP+8C@:[X3YM1X/]U!_; MT<#F&3;/V&I`8CL:[*GMM!T-K.VTMO,)@TS;T6"_[L7;0KD7:R%MH=RM&;W8 MT6`'L+/!.DX);]>-N8*V3[S:BC=J3MGOAB->$PPU@H#NX3;FTV# M16F"L-D^4RM3O\EG^TB^.P612&,%'*90-&L*Y%BF0\G_3HE(>@$(OYU/..8> M(O`2K#Q^22;P9P-`AF4V&EW]1E^\`^J1407QU1'1^S`#(H_Y*.`>@8=S+8JX M0&2<3&!]?"P\4(&%W1DMI@'Z/0<+K`("$9U[TV\`W@ M)!`Z]1+B,<+")^XU:NTL`LE#_'I3D7$#/KHR`R*8:[4U`LE&:0(2L*HY0V$! MVDPJV.K2=_D()I2H+#6"MW'.&4SV+,*;/T*!S2]_73>*4*)5ZA:A=!9D+=.# M`F5W7J9*,.>9K0)/DJ.98P.51(P$G3FLT&`7J9SP>(KF!"POVB!)1Q5&=3,@ M<\U!PJQB(X+S7N!%M0(OR.SC:@I@:'1C`F5P%$QYT3II#/VBUJ=2+4$MJHA1 M[AAA;R.]+ MG*5A"SCVA=$3EU`>L2?+HN?`ETQC`J:!EV&U4K5:T+"0QBH96[7K2J?G6:V( MD`[N?/:ZV6CE\5W67R.D7]K+O^"*8S>4KF=`C"79)O3!W])PH3U(+BX%FP]C M!VGN%17A,=TGCJWQD<$^J,D\$*?X=/$,(,B'1U3,Y(1F;L]>-ID-3H->6 MYH&=*W`B;,4\7G8W"]4\@3!6T]!-?8$T!O."Q)RZ%"B'Z/%`&.@O)"%R0LJI M(HJALN[`3`A/Y8)4:,=W;+KX*-DJMB*J8:\*,5H./28NV`U/JT$>]`\A8@E# M90R5\::03_6A0./#_7MP]'FV?NBM[Z>PM,FA7^ELI_/#1H=]$6TBNNN%XRX2 MO_XK=[4Q"\T4SG,K3.L:9BM\L*(Z&YPV.8Q;3GC3NW;/28[+%O(.G3YN%OA' MX#@&!_E"($JXB?N[RO%[K[[41*E&/:)F22'6@B#0O75WDMT7HM:&A`@#RRW* MS68^N=/D;NV.FNXZH-OG++Q/\*(&QNZT2?)<;[9M]Y[DOAEX;O,OSF&X5]]!%Z$537JV\"2*I^_E9S_K8[<"]=9-IJQ#W3$'81WJ@QSJ_F2NZF20FJAG)X+*U>:; M5=;I/KYY;C8L5-)SX^F;9L/9UGI8ZV%WP,,^!:C0FJ?W+-56-?SZ9+AX)Y@NXK/5=X(7KG_:\&`#N]X] M6^+_4*=SS\>L9]PQ2[^IP MEMU:=FO9S3_*L`D_^^(2__6OGU-9'[ON[)>C5(J02WE,15-D0$^$Q,;H:]]^J%<;^E;WC2B$_C3ZKVB9Z9Q#ZYS`U,1*>&R8:_%.$X\]@K3W! M9?8EJKN'?WSAHU]?\2CX^OFTYQRTZO"?TW::]3^!@9VOYQ\Q6O+#>[ M[>;7YBLF_%]?"1_^U.PX_=;7DY[CM-NM=OWLS&G7#TZ/NO6CL[93/^SWSPY/ MFD?]PT[KJP,O_H8+U^M>$)[;U,\]-#(-]'7@CU'"F=-@Y^D482.H;+9`,I;3 MC!FB$<>&&9?O5)/2W>QJ2`1H#44I>/"$GZC"$(OZ/%7^A_3.BPQ+\45>9UB. M-/Y,A<\#+."-9U$1X@)^1G@'X0LW!O:Q-YB4YA7^Q^]TR6'^IY-W;PD&1$.` MS&(^6G`F^UB^F:NDF<>5;+#K_()#:UVTG$%LG\G]_?7YS6SS\/CL'_%/SZ&7PO MMX2HQR4)H%$&<2*\@!I:BJ4_W1>_V^#5"+&DD,LQ879S<&J(V"* MB0L1AR,KIUY8%SH)@)6RIVTJ79BJOK M*[I5(76ULOI]>AAK,FH(`Y*I?(.!Z+)1&E-?\,)4:EB"@.`T96B1,F#'C^T% MU8GGLHBC\"3*UC'G;JP+P$]`#J9#'A>F[M#46U1Z7TR$5D\&'V6#,`1)8%\X MF*8$,0[NK<'_6Q8<]DDE6"!NIJP:%H&X0W/V=^K&8&,(7&$"*$H=HH#<#^(NUV6KA1LHSH M52M*]M9R;P11%Q"*!$+AYL3@&@PZ`*K&LH"T^@797B$_2O1;950#L%7%B;$? MS$MR$'(_8W$^G1O4[-]I,"_(TLI9D-YQ1,="'T"JQL'9J9D`)6`@H$1A6"SS M0Q`3D!U"2T%-$J$&$%EA#TP1OIIR/IT2T$)&`9B*-RDHFOFIRZXX_RX7)G\/ MJ>MM-B!#WL5\PL%/@`*]-Q>]_\@N>N]Z6(:;/NHHG[@`TR>XIK_1FH'!]$KK MTV?^^KDEIU"M+'J%-4XE5P`"B]AE!O^E->74X/SL!5PC8BYWU)_K-XB@#!W-`*^:8^!;@]#XZGJ/@'#*7"F6A'Z MN9:7%V:01J&$O]._%(Z73Q!$*@]>0-[+VM?`PX6O-M@G##W!.-;'$?I)O`\* MW\SC0,85.A\&Z?B!;%U%$))D$DF>30)(8,Z[$!D.\D4*3I@'H23(?HR1?S2. MW:G4,'M8Q`HRK"P6CR^5>J0APGQP#76FHV"D@PCAX^"PYSEP8&T9-ZO&9#1* MKJC8N@`G1D`^\!&8BO>]KF"5"-PIE/I+,`?*)P@9KY83$=-;Q4RDW5@_O0Y! ML&;6AMJ>N-=(ZP\9514(%I&TB((5%D(1XC#D9)A-42.2$)8+WB&5IB<)88'/ M=-Z#4B42"*,#`:M5/B=6H0S2)`6+$NL-:1%[Z13D&+XL:Z6H!61&P0=A2*E@ M8BAI1G9,"4.J*,GN,$H3[?OBF-)2`JPJB#!;D#>:)\%/4E($$_0QCG)GF$," M"0E5D98'W$MC#ZDVH#:NV1RG[AQ1C$H@C+*@;SMH![\8\+0ON3KLC2G,L+04 MRJ-DF1G*802)#P9,34(@I$#2R"88FX7(;QE0)%9V$>;;T)A(S76#H2:U(**D MY.AV*#M%,$``I>G$:D:\J(JNE>1D$ZY=J,Y(:LP33+5U!F@1(I8IO.0%L0=PV3 M")'HSD,(\H9_H6,EG=&9A4!`?$Q0G)1=T2OZ"3.6\@J9N"EJJSD1&A0L@X;V MP6!<\GB^.`+0'VBH9HS8@\JBC#!:@;>&D1N#(7Q3W"DZ^W14WB7RD7%AOKVQ M@.2([9C)).-(BJ^+P\$GZ;$9;7Z`@TH,NE],H58(G@9/BG0\#B9;!=E92R.5U@6B'*LEE)?#/)<1-W$T$2F"3T7)=:N5J0!^)5%H-(#&5V@(M$DY0ZEZW6NT,QS5 MC/Q'F"^2-_T`$@B)$_L?,@5GH/V^AB:,C.>F@"1%`$B3CN.Q`B97.`N(MT'M M$LK#(6:*KNKHY&LL3+V`(^Z=)Q#Y3+ISHLSO[_\/3$0Z1O1(-U'>&.)NQ'8D M:0@-DBX?QV1USMU+-PQ=(]Q.JP6\/;EF,PAWR%%2M"(Y7>I!Q,R$`)&5`X-D M-,$`P<`8\VONI4448T6SS-34E"88@H,*XQC-W)Q@:#DZ4AK]N-UL(/!WIW-@B4 MD0/[\X]99&:`%(EA+(CV,E!7"G]9]@Y%/"X&:K&+.EY'-&4=C^CD2;^B8A^T M!F$=DG*4'PQY(+5"H%U%3TS&S4`9J0U6HER_D=5127^R)F&_.54KZ4Z!'`0Z MF6,+$R6=@I*`DI4(M@I05^AGRCS%W9=L/P`&Z9MO*J<%C,SY11X!J"MHGXK0 M0E&[*1H&$5#(E)0("5]AKF*^4?#5IB=>(=1;_L#Z_GD:C/"&+'A[0C9C8:BB:)$(`X10>*70D"G[#8>5@S.C]E%-`-[WFOV M:JQ$7U8@+\1J/A_A`?'BY##OR&>'HAJ6YTMA!051;JPD%+V-I]ZEOR&4O-XB M5UCXH!8JW09:R,+1*"'TEG532'6&I\]RS,J_45A3,M@_\M@Y\"S8@=BOX]3F M2O?4URATQ,H2RM@*1%!F>O&<[B;2ED075O39^(7,,\$Z?!/I(K=9D=GE(T>* M##CYC>:"WV@9,^@4?R"[>TMKN]J[(0`HCHWX3"6?UFSTBOYTR"F,\M/,<>0? M1=,MID,(FI6@@$U41UT2,]]L*59=';H4 M0QU<"]D,C/\*K1%B>+PL!"6/FPD8Q:W&!,CP MGD"F0U[&F%Y4XT(4DRPE/"4+#$2B.BE\+G9 M%8K'(C2V9J=S)Z#K!^(A$?U&GX:LHU,M=;>`*+1(,LA^%^]*Y)]G`_-8.26^ M!9F)K(O627+(EFY^KWP$]B?F1.=)ZHNHE+><_)?YPAV'8(S`W&MYBF*"2L^6 MFN@_T`8">``I(8[J>3,`%K/>)!)C(GG#G!?`IIJ6SRA2%TN=GQ^_>WJYBI3 MMF1+YJ)^F8EMLME=55U=7]+JL<89_?VVYQ!2V:'+@ M]IR6IU452])_$:PGCU7AWA-H%OYCLP3[PK,A[D>2"#.]NPX<2'PB-@UI&.73 M[A!=+3QY^7SN^%X*WG;9F8Z)]9'A!L>XFV2^% M8FB6"%?IZ]Q?SC3VFXJUIC$PZOIJ[KK0?KUE!^C,6U3<@:H=E1W5/+7>?W3> MK+M*^:153C?*?/7AFQ>[ M3&//H6\YH:_*DO'][V_3,VZ!;&=EN>&O9X+RR*TZ5$19%X>F,)E*JJ"J8TT8 M*>I
"(.1R+P&R]-E(:")`NB ME*^O:FKER?^3M,<=T>ZX7V)P#WZ]H13X&D>02@VGZ)A@*1^#H15"/E9GFC36 MIL)4TV5!E4=S8311#6$D26-C/C)5+/'?E>_2\.PW1=$ULR3D>ZVH3`Q:IH-U M147)_<$X.IG.%,54=4&-L/8^Y4F0*]KO&?I[ M\AM%>_\XSETN$(5'LREPZ0SZ/0>B\86($,G>4`H9B1OQ)6@D3FOT.!L%D46@ MUF`T6EL2;DT1L+Q"O4;I:]I`SY,&DC2"/'_O&1IEA7LT!Z^JKO`*TOD@MW:G M4)GG1R382:+%UP_DR0N(&7FDBI;F6'[#:W5LE&5CX+&\6_S5,,F%^8,D"N$/ MK)PH0H1:6%JMK&5P6CM.,0("=.=@P2'-R@-_[9,NYI[/V20)/7RRX)C2'G*S MH6+4+=3$XK_T>VG)(][[9C'U1ASDPI6D8.Z14A'MQ^)^KY@LR9%$'`2/)$^# M$`QSEJ>I$,5$("QECZ477I3$]UD2Z0Z9HQ55M[L):4$D^SV0TW0-I(``GE`' M1OZIERP%[^("5T99:A6`'>`O_F%YL144RF@5NIJ$'Z,5@LHF#P1M;3V@``NK MZZ`;J/"!T5.M01+ITF0,U[HGZ5<>)!S16C.LE1"46;G;$X?L`.&YI8)&29IJ M)H4XU<+B0C9`&S*REK=C,LRN'XA24?:E).AY--(_N?2&,T!HT')3XTW."LH3\WB%Z+JV'3#58 M-AK%PBC6W&#=O$!0S>*00#/MSL[=HZ1DA;/N+,4 M7`>0/$]RN`!C(CV`Q_*`CR'0SHLTL/XCE!W54M%E^ M$,L/ZJ!8L_P@EA_TS-C8Q6X&4:>WZG%D-Z-^6QP$=,7-KYQWCNWH_=!:W\1B7';SFB:5'`XHI822FT MO/!12#&#*1@!\6["ZA*7=GD^`':47%;\NZ1HUD,_(P[`E&G(L#1\>4IK*'9] M2%SQ.>Y.BF0$0"\9A@L-XR+/`YJ&5%'+"/J6%!!7P"FV1JOSKY(<.AS MA_M^'7TH2?#N7SZF2\K/IQ(IMD>`4R2Q+V53;H9 MQ5VSA>0Y(E&_1PK`MX78GD/Y>(0$A"V#K).L,;?D$!#G:+ MLU-XCR=ME@8$48K@,6%\3;!!P%]'DB8`VPR">R&)-&)!)47]">8\PLD6X1>-,EB\_#U5X2@%RE2GD%2P&0#S\H M85JNK3#:A)(E6YHDA]"I$P!$2!2Q[F'AF!Q9,`Y&)!L88&B20V%?S(:G4@8W M$HJ31$3:"@#,E&_H-NL^\_@\2MV0#',LRL)FK.V31\DZ]+`./:Q##^O0PSKTL`X]K$,/Z]##.O2\68>> MK5!HS]B2&U5J4.$SAEO$I-#SHH#P.7[('TF@/D=PPYKCX^-_H+G#*&\Z\9<3 M_IAC"ETD'H*_,"G_Q`?5*EX=P%S']WI4M-75QR5MDJF-I;$I:(HA"ZHZ-X2A MIFK"=#Z1IQ-='$GC*2UI$P>B:.J%FK8W(L.&\9_T+1W9V'2@U\;+P`<5:5WD M1\3A;P'B1)X-Y9DIS'1S(JA3=2:,)L9,T%55FXZ4R70D[]5V5*PIBS2WJ/'= MG+0HL;:8G^'2OP\3V$'H$0L'>*''2>ZEVW`$%B_.8\?_';G.3QX\6$YB#UHY MZTB5#&FE$%"XU62HZRQQ,/E%HC'`FB;6UXN,IQ;DJ!KZ_CFJXMXYJMHQ5XR]>?:G:@^=H/`'. M6()!34#!K2>[1[9+B.0C"5&6KU./W!QGR$:36V[.-FUZTMEE9MZ3AA%YY\MC MGVZGF&$VE'E=:UT=0@TZJ55<-41>%EFN,DLC6ZDB0_ M5B&QSDG[K;M9OW5VLAY4!TLB+\D55<'-UL'L9'VVLDVK^V1]:64;.U#K/B#8 M@=KI/VMQ9Q0[=PZMG<:"PRVS'>'HN#J2:04#8 MB=O6$X2=N)V\PBX<-XY(HBL[8=_ZA)6'[(3M%D_9"!6KEZK99XH.[1`&IG3M\'=M?@.0"1`N3A`)*2P-7`Q(PT_B/$6Z,9).L9`U7)I9EQQ8N,TILP](G>L@BEKZ[0`E(5%[EF$!`]7OW28=!SJ(M!CF/ M(.20IFP)*TBS06B8DG8;Y'+\KK0MV(`K2-D3JWXD#00P:Y]5O)JHF`T'\"@,@=E*1'N]*B"`B&?A)S.$PW#*U%)C!Y:;&[G0"@$*E: M/$7'^R7R2N6R>'@4V$Z(`-#$1OP&*B/YID"WM5VHH*8X#%`:O0EO".U[`/TK M&14^>HNW?$389]&/IU1;6<$//$ORY;R%UQ:HC,*VOD:V%8<$]-!).UD11>!% MCI!JG`2H8`^,.)X3!VK^ZQ0:CWP3LS8A?`)(%VW>4S88D<6M4G$CW$W8<%Z$ M]9E=?BM#^M`^2OG*",9E>6W[GQ9OBUN1@:Q4(""6T1->!,Y1(>::+B(HH*","`9'N;9K!0YJ[)3S#+$DTJ95B&Q)GXP/]8@H-@1E/ M>^H5`1RQ6"25XF0+PI46*[>D*T&*M);W]$H5#9:8;>=!#G@"!E:`7X\)/$J& M3(1U=G(6/X'O`A.!YEX>GD:B^4!2`6-PVW>A<]W*6M"]F2\:*_U=5DU@J-9K M]R&%:LQ4-Q8*JKOI>0VJ.T^CHN_"7BFR;`-X=!=@S0(Z1RIHNXH7STD#Z9$F M`/U0U5>1X+-4_6E#91,!3PZ`FT?&`D$,*F)@$E%+M/^"ZOM4/C,24;8382*0 MME4(3FD[NAPC=)$^P)4SQ%.,PP%7[OBX3V]8V@?R>=)O`T,%2NH51)8&2C7I M\5^TYY3V)KSH8QU>.%+R(Q'T1AAC2<]T/X$-OD;<8;3QA1TNZO4MEFA_^.1S7W3'4P5G&D^R!K$_>:-G$ZP\+H0#URG>7? M+0LU5]V[L4X"C?*T'FE"@*&=@2/E(($CRJ[&LZB%,2!)Y/6JCI?-#O2_J=YY MO0A_1F'X,7-6E=Q2VRYG'97U5P!0';3TKV:)/\4.4LUDMRIVJVK1 MK8HYD3MLYG3"B=PL:9\FB<7%:C4FP\<\5'FQ]2+!! MO`C#&"VF!!OADE0>DU="\L>OM!QSEM1I+@[0A)Y:/<4V]!=?YH\;T4]'ACB9 MC`5MKNN".I%E83B?F<+0G,UGLY$Y5[3)=^F[=/:;*FI#R2@THM][466B7'C8 M&+MU,(5'(1183IW0=OTP/@;\SF@V5\>B;`C#J3@1U)DY%\:ZH0LZMDG&NBE/ MI_BU?=O(OQ7ZCCK@Y1:1!ZOL]V_[2RI%V:G.&V+3)M@FSIAE#:8STIM MR^6O':UQE41Q[R)7=7O[]FU%KG(]?>;99]EGV_39+I5KOWD5=NIL$9XZB%Y/ M@5J)^OH:>$D\$OFW@)0P9M3!C"FR$:`R%1@B488TJ'%ZJYG_YNIM1%W('=Y/ M3Y"TIKDS-DM@@S`EYA!/P=HIO8S6?XV;DY48O@./3]=^"' M3SHR&4'WM%IM.UX!8&\286P363NF>#LG6VRSLLW:UZJ+Z MQ/US,;WZ_2.G#-=188!7>Z%".W!(R/4I>:HKT:2Y@*+G#\@*P@^MVX1=H/WS MP6Q&^F.1?N4'D?-?ZSF%T4@&M)?L7U#4.FIW@>Y,TS!-PS1-;39UTT%N_NW[ MBWO'=9MC,'>P".3"2_K%54#2/#.+5K;9/L4T?%/G)5UC_.TJ?\\57E6']?*W MF3V46\A,4VYC51[;K+M^W%!Y56\=M`KC[U[*F#6T[P8S#8E/4WA;M%F/6)'[ M^EO=91S82VCUV^]%R%YZ^`9Z^\"N>,>T*`:MDV#&Y;UGH1F\V+YJ:\;H_0T, M6>,5HRVHGRVP,)K!5D7B=:WF2SS;OV^AJ&5>-YBB[CZCSV695T1V%>P86Q61 M5W0&,W_<6^(D#C'5H*5%@%P2I0Z7SIKA4Q[5V3%@;N?N[S&6MI4328ENX65[&6EEJ7;]7H MJ.&%)ZP#WT9AR`4H1%9@+SG+6_1["W2'7'^]0E[$+H<@;1NO:(3)&OZ`@1N%UH^9@!O-Q']SRT'E) M9(JZ^XS&BEIABOH$&'TN8TZ;-6]IIJ@/KJB'_'#8NER"1D_9?LANAL<596G`DI].@,TJK[4OPYXQ>G^+0^7%NDU+9G`U2ZR MPHK4278Y/)@\#P>M"X0S+K]`:QDBXW/W^7PN\;K,;(Z.<=5@2&3=9S)3T:?! M9ZRBM6'-?AZFH@_OO6M=4D>C8X7?_)OHW@H05ZA49+'"X\NQ-F"NR>YS6>'- M(0-3[SZ?SS6=8=ETC*<*K\@LK_`4^"RS;(X3X/.Y4O=1S'3TX0O%S;JAQE\? M)"Q^\MO%_\X^0@_(ZDCA!NMVX?"VZ>TF'&__V,OGNW%W3OIK7GV]K&JN62'# M^]UNC_>UBH<9W=Z`;G7/OUW48G1C=&.[LR9JM2S/Z,J/+)>[31HF4V0\QXLL M[]:!Y",K;[3>9'=S+8\U\#I7:\L[699YN>X&AAV_K]?;H-*0,(.9-[4;W)0T MB1?%UN7QLNVZ>_FNRBL&8W!G&7RN*[PH,\]I-[@I*1*O:*VK?F,NT]J<"PJ^ MP"[\&-_3WN2^_-+/53S,*-)XN2Q'/1$O5[$W^UMKP' MSK+_+W8"M.`L+D+VTO-=__:!>/>!N_(![)YL#L]]; M.:[K^![/W2\=>PF#+\&TX9:-P#LH*0N[9"_'??(\,ML5F*7\4/P$]K%.`Y1=8M>24.R3^" M?@_^%D:!!3:LX#H>XE8H6OJ+`7>UQ!.I>@W_>H$B%*SPTXM^+PYAFC!.@.Z0 M%V,2WB(/!62NA`+KP%_$=A1R-BP&__;Z@32.V5@IK^!Q20T MMJ!+:+^'?JX)RZPP]&V'S/W>B8`Q>+D5K'4\VXUA%A;F5K^WAK'HN)"C#?\/ M+1>3`E@.2XF6`<*TQ:*W##GDP9M_Q![*-X,BXC5@"5/(9/$_9#IMPB#GYS.O MN4K9Z>!I3?P`,X](`7<> M(KRWO_@1XJ0/5.JJ)D*")=(_VU%LN1QL M'B(BF*]DYPZP?L"S?J`2P)?404:31Y&9[008._[OR,6CEU:72`S^Q.13^D3^ MN^FG#_1;H4,>M_#&Q`O$6BQVW0>\Y4,;$X+,@Z,D4AHO6&GS(5"6=Y4DK.8E M5\'*0;\'0U+MRZ7*%ZCM5'>9*I9N@-+$2NT:0>NI5'?F&[RHB^B4;'^%W[/Q M]]:@GLB/`59,;OI4\NV"ODK4+)7;&]]U_7NBF>$8Q<(9KU96@%<8DO=`W]E$ M0\=1C)EL>1Y(9FDBJ4[T;RK"@KD>3LZ;1%YS@1I^`HV/]14>8P%+\$C`E"+6/#Q]O$7[XN+_,B2!RCR7L$U?T4\BYR&VU M9@@I-^RBR=?/GT>7W_`0-B:YM0[1&7<-A`E^/1//.!NY;KBV;,R)[.>UM5BD M/]\[BVCYZYENOL_\27#@HJ#H-2G7)B6OF-K[7;T1Z2O#K6\[E%.]E>_O MP&YB8"UFH@>JI8)++]%14O;F-?QC5-AW9$+7V=3>TJ?Z8AZ^>.'SQ#ZB!BRV M;D!E39&-5MB&=77S9&?IN>_T/,E0"L+ M6PE8[K`]!C8/&-H?GCQF6,SJ11\W>55I>XRC<1)<0=!.2&HS*ADD@U?4UH71 MVZ>'*TC,I/A@4CSDAWK;A;AQ(EL!>,%$]H`B*]8-'GH*>K>"Q$R(#VCP&F;; MZR";);)72Q0@ZP;?FIG@'M/LE7E5;+WZ;6HZV@X1=E8-]?:JA51#;01&^CUK MTS7;/9U3JU-(UWE1:EU_G@ZIFA/('?IEX=S!3__Z)0Z%6\M:?[S(XIDC$LZ< M.J'M^B'>\5?H9S1V??O';_T>Q_TK?6&*KJ,++XR"&.*Y?R%("R#Y%1/_#GF6 M1]);O`B__!>Z^?4,^?_/WK7U-HILZ_=(^0^H-2W-2"$#%->,9B1LPRA'/9/L M)*US>8F(P0F[,7ASR;3__5FK"C!@.\:)[>`T^V%/V\%%K?NJJE7K"^ZO+5V4 M)1[^)Q)1X/\%U"OWMW>C>U$7[W'O65")<"]\XGSW]T^^"U\)BFA(]T.=Z()& M3%Y7;8F7-8'PABH17E1,32(FD4?$N-?OY4]_X$DO5^)+,/==/.=L9^X&?TO*B2IG-V(M3!^L(L@1DZ,1SC@O\J9]2=Y>QI\WB4MF45YX47+E?*&NF[6OKJUFF/JN'V3XR*TWSF(8VDNL[ZQHR8ZC M*1[79VP"5Q/+H6J37'OQ[9,3>^8TRH!?KU;H+/39KQ(<+?D$#!_[4R=(?O_$ M*TOZ3J3!T%(&0UXE"NC[0!/Y@:3J_$B3=9O(Q!;)X%Z$3#WWCCZ#'$(A)X M@1_!0"M"\I*_E54DU-QY5MU8'V46H'&6Q7@^*T5QQF,V#-KOL%IW M<@NJX#$3QZJ6RQ`>]!I%>M0_;5MQQ_V#A8!)7G=#'4A1I]:Z9H5R$[EV0:ND M*C(25LFH9;E*RPH40_I<*UQ94^52_&/K:A5AZVH5LL]JE?ZU!WCM#U$2I#9- MH3`=9DR%P99+["(17KED:>%0&T4?=Y7"8OIES/W*)DX=5_VK)2]&*7V?6I$? M56"W96@Y*G']$+:\5)EU6-7`E.)'M,CW9[O4L[W7]A^&[>^I[3L]%,C71($W M22_$Z%HFKL,G`*U)W,,!0.MW"RT0-QJ;_3NE M???,[R5;2'9S[4,OV>.4[.8R[EZRQRG9S2W^NB79-Y0K'21]N*E<"<7;G^6= MT(^92NRS?ND#:W$OXE[$O8B;(MY<@=B+^,A%O!DVM%LB/K[]BUM::T.S#WC? M-R_UP\<^]^CW,WH1]R+N1=RGES^NB(_-BKN^U?$G[?N7`\DX[M0/L7N:@]69 M?<*Q-ST6CTZ/>Q%O+>+^).6#BU@ZNI5P+^*M1;RY!T>W1+SFEAM](RM4[^(E MM[R.!@OGUQ31[/"*V^Y>MN+AGFL]UWJN'0O7WK8U?-3Q]3U+%L3SS;?'NQ56 M>\FVE6Q_`/@Q)2N?"[UD/Z1DR=&M8X]^D;/HJ'&('.JM;^M.ZMGSK>=;S[== M+'8V]]O96UN->O>.KPF^(8?*VEU'GI%ED>%`-GE!,@Q>UN&W`U$T>$N61JID M&J8I29M:;M100$% MVJTGSKM[1!-NXH=.B+@W,%S9NB/V*"124L-)2B-NZGSS2J"TO.3IWYG[R'[% M4,8F$]KYB+8*0M0NA/"B;6`J[8C.N,!W'K!=DN\E9Z8X,IW_7B M_"\Y;=C9)76^(Z__*KEZ>H)OIBRM:$H4Q3(,DFRHO$4U2H_Y1Z\P`=J$XIC%WM.$H6T_4H6N@P![/1D[,?C;`IZ MC$VDSG(=3+*`J1X#`@3^3^E?&'P8B@.T&NBL:K+S$&5,A\=.'-,N-RB0:D1@-;#@EU7UWWXT/$4GJ(6.V`&<>@851\)E-&H/@Z"OSQ?'<] MUU135HA%>&,D@8E(D$;GXX,HAJZ*HJ=\G#UQAT>E)AT5&X^LN0^Z\, M](^"%3+,NL*/TSO1#*LMXAR&JE40"L95TKD`]#L]68OH5W1VJCHBL)%I!.XM M"YP8K<69([:;>3OD[J*9/^9T03_C:OSE*NP%PZ6HK,KVSHK6<.#F<30: M<.'SG$XH0-1%^"HLDJ"\LQQ()8MS_-6U$ZNH?)(]))!5TA=$S"'AG`J8Q0*] M;6Y1MZ)=$,?01&M8L(@T M"M2$W@(S-,].:F9<-A5M@)$&2=3PT'BK(,PF3IZWL;EELUFA>2^`K]:LMX!" M!A7%1I]%[H-EBX6OZ33>*$5P+7!G7XYI!>XK?"Y:>BZQ[/3D9QPAER?%;%T% M:[OX.^*WMF#S,HPNAA8O"#;\;O$B[,CXKPRBT&T*BY"H^(,H2;]QH_^!E9#S M&((S`G>?ZQ,L&'#M4))*UQ@+?^"'$ZJ,D%_#*@HR9]!VWPL0'C7`EK,+%67! MNC!A]&E%O\ZZO;]BK*)NM^DDD2Z)V__5V5.NX2I8[KFJJ)`N&SNLC M?'T"Z985Y.\>_$AF6,005*1.<.1*/.R/%!XD\@V/[0L3=-%0;94$Y8"!-8" MBM#@S49*WJ`XPRS&I=K1J(X,_%&4UZO.6GH;#7LAY?N"OWYPQM_N%GV7_\+8 M&,QO$+X^*-/*_;%J15]C4]`5T1KPVLC4>%G`74/34GG3)J:N"\2T1).M*=6& M&FU%TS([@(]T%^C/*'*3O[W#FL]`MA1QH(SXD:)*O"R9-F\.98TW17&@V:8N M@RW=$Z3:$#7@29/NYN3KY,$7K&GOERA)S&?'#W"7Y2Z"2`O)T"WN+3U%`42% M9.`D$((.2?EP9.CR`&S!5F6=E\VAQ0\L`_NVCW1#(K*IZC8ZCD]_B(*BUR6^ M)5UUIA2:9#"Q^D"7H=,"B8%QP/4[R9!8P\AUTI9*(RJ#4.;(-475V,$;> MX=;?M>-WDF*B@Q(8#:MOS+M)5-&=GCUV25/*I).V+8(\1:E!V^KI-^.ABS>& M_(<,5G)%M_81-G@_L.*V-&60(A$;$6X]!75:K>]C4.9%%,20M_HP[&I&M[;# M1W.Q7NV@3FM@Q$2K<>---+[6\7=87PSF^L57NOZ5>I2'2V3MG_';<$A>D>-8 MBJ1`.C/BM8$ZX.4!T7A=U>&CKAK@*88C6U/N)8SV8G,=L33Q.EVE1BR8TT5? M1T4JJ&J-M!5SKQ-7Q#*S`B)R'4=V%$^=FCX),C#^W`L` M,P;>)$*%*/.[O_PPBOUT7@QJAFY]%`LXF<[_\M*GR+VL`!-UT`.*L-`W5*W) MK8/Q9$D8="]AY+'_7H;YWAVL*_%$B6&B=$_E(([P\#B-DC4V;J2FD2=%852/ M/E9^A-!%U8&U,$_T>M*XEH(7$L).$J=BG%0;"Z$78N&RL"_S@IN.9OPBW<21 M]`TJ6Z&BL5>%N>V--\OB\1,\>,`KFA$35[-@\TT-7@11V// M.#5]@-^ M7VYN?^V5"+'#CH0S)K!*I0-L7,]475VY*V7@%UF MK>]2AY,_3(](\^1K`QU+*2">`ERSBA%W,/\*_N`RM%D54=?W2XF$*;].FNEA M2Y(VF<---'<"?!""4E<7/:*"1K#!!)J$O.C*NZCH6$-!)%%_R7\WP:8G7AQ[ M;KDZSM4_WT;OHBA5)%*M*_,&,AJ+@941O8ND*@A$W%CUK)Y]0U7QQ#)T\3^8 M!SX[`>:*K+ZAJ?9=I)M`'J()1EW&VQ#5$+@7!.C10O>OHBUQAZ,5"%U4X(FZ MU->2L'J_L\/TB=+Z+<\U-*W8FHJSBK5W._2H=.M):+'?MIJHMMN.7>8!H9N. MRJ8(W""ES=JUZQL8.BY`&T=8&REIE7VRG>G.9Y\2KC^``?)2'5)+HIJGT*R" M'5SA:%&^WF%_)Z,_E]6ZZK](Q2:#O\+;<^7);]>7GQJ*7Y:T#::_EJ@6A3OY M)6[/O8NNB]M-.,JM-\[BPW.F98T&QL&Z7W@E<V21^6+=`TQNVMD.ZZRRM*N?5Y%WK3%K&**Q"T/1Z:='+ M5#0H+GS4:B7/A^PB:[)DFKPTDBWP+J$(3\@FL%KEJB8UF@DV4.+16>Y M>;S6CIHUI<#6=V<*-DJ^<=<6I&=%ER,4T7E=4L`I#57A#4&1^I`T5$]RH,M0- MEIKHN2KLCM`*XY;3OVMLQ^*71S`P`$T(\ZLY\/'O*"P^=+9<3Z0;[;(A+CBW M`THK?%M1_U:4O_T91PG6PAW:PEJ6\^$J2-<7?&E'287TFL(EBU9-)OP[O^#< M)4,3U:%J*);)&Z*H\A!])%[7@4&F!BIC#P1CI)*\7%FL6MK;R:SP['I1'.', M_-0)RJJ`P1P4$Y0,TIA6X.KKP4]=YP8CW@[8,O;TT&?HM"-I79.92.!5;.!97;H MQ24IA'>R+6>=GCS5]>=JM;IRM%M=552._*7CT$ M>7.P+GI*"Z:&5I$'HR4@<';M@T+=)$HO&Y( M$D]LS12TP5"`=3H3UK4H_&\^V^I,JHI)S^;G(*DO_AC%\RYK2BR:%FUP24-; M!R680G&C$TS9042Q;9C6.MIGQKYEXA;_B$#2!P^_LHCK1$ZGGSNT@; M"*C:4>F(KB9?_&]>X#]%D7LU8?6JZ)`PU?DZB\+%ALM!/*P@Z+HE@:8*,@TX ME@RAQ]3PX]`B0\,<2+FF"N=*:5>OH*;"C+P`J?#3;[]FVZ!)$@@90+2$,#$B M$#4$E1]8)ABCH5L*9!0CT\0,%$0)@RB$.9DK9E79>9_9],'+[Z:6-@G*=F- M&Z2NJ2JDR[_MUSJ42I*T--5J^E?T/AA@[P/P-WD%IUWT$=D)A:\C`6+YM5*X MQ&TF6J&ONJRL),!E0]N=T60+FJ2+8"ZZ!>HF:SHLI2 M2\._(TCQ1EB1.ZR2\7VY,BK";E-X[.^_;R_RS6]ZIH:;6VXS/-M(LW#*YN M1M8-/[SZ\L6\OH4A:$NE&9H_ZRI-UT=C+PB2F8-'%^7G&3;!RS__X[OIT^^? M-/5S"2HPIMVOJAWTZ\BEE9^TA2LH?K+V%SOY^EU>VP;C=0L`BDU0#(?$M$"- M`MT)::A?5H[76*%8=R%+'?!>\AAOY\2/Q=R1-_8P;%<8++XG@S^2I=1]<.'4 M\[[]7`E;M@25LG^I8X+Q@:VHTXR7NF-=6X+9-;*76O]-7D3P\3Q_^6+9$6X M!GF\?2(V+%O<+[K:O]S[L6/@3NU)W0.Z4_N7BV>**&\]@0;@TQL7#,>(W74D MXI7.5(,SEO/0M9.3HI M'UE2]37TG#CT7.X1^[.5.$B]]]JC5NN:=&Q:W4OY%7F6J&S&2>V8G#N=9UV6 M@%\4B(7B$?9^:H]9EB8>F_[V4MYZ%H:B')N4CRS'RN\7EV>'S7%,[^N.304T03LV*7M'O]=5?65>HU1#W5LONC827C>]S3]M^,7\))@66BT?`Z_0B>W\V?[> MMN+AGF]OY]O;EA/'[?W>]2A2.1.-?BOTPXI7/Y/DH]M!^D`QC8"W=*/L(?`. MXIQ?^[H.1K6/P;F:*O]**\$KGTM@W%97%FHW%?/KT%>3-;_"FS>+[FHW'G96 M&A==/;Z&?C=[",C2IS]DI7*S:A>$KKOAN;C"A&-<,\SVRE5([!U[D`M8+>]U MBK4+6%N34NM`X6;`)[R4]Z>'\`FS)W]\&4[PKC"]9+_S6S*62)0A&=B\+&J$ MEP>&QIN6,4"*B2E9`T$SAIMNR3"4S"IBU%6T_,8AWWD_=$%\%_+G MBA][%75W"YSTTQ,&_`(/^R$7A1X7>[,HSJ^I>(\4T9NC(+&(6C[.2ZL2+LK2 MQ'<]AA+^]?SV''\8>PD6Y+K<3Z)TKI5PYS^+\N=?%EQ$N/J?1.%<+AXX/?E9 M5*I/X`6>*'4"+B]_H/CE>*4'8=RG0.93PM'+L=S2]8/3$XK6CN_`[LB&G1>$SUY3F&>(?VU[#TO6MKV$I[W,-:Z^O_4B72]9>75";RE$H$U.O0H7+C94B)WUM M.&O<<+@M_2?]*N9^9=.FSK3^59B.>"@.>:U02$9U^^+2$O:OI?3A>ZL#'X+H_MP>SV^-@;SM"KRD;VI6QF MYY7L=8O:/9ZLMIZ$N/GTO+'CO%,>?.Y4/.K%>2AQ[BWB[9E:VM+IYDY@LBNMVX>C6TP].XW;ULQ<-;<:WGU:O2 M]3XVO=6929LOJ77"F_6QJ9TX-[?NZ(0XCSXX+8HV#N%QW_JV]PY/'XI;+Q;6 MO-^Y*3UK7G&00@^;SS@GAWCD8F_L^<_T0)*>*5?.DOWTZ?3_V;NVYC:Q;/T^ M5?,?NKKFE81]AZE,5X$0/:ECQZXDW:?RE)(M;'-:!@](B3V__NP%2`*$)(0` M;5VFIB9C6Q?6=:_+M]?Z6Z'KO+Z[6O5YR5^\\=__]@^7__6\4#_K+C\\%0@_(#_O(/C-_1E?[XYHYX"3)5&\BR9?'!?,[O(/SA M1:-'3[G5!V3SZH/*YZ]8?C`(G^^R34:P?W(`PU/'R=;!,+@=^>.O83JM^3;R MAJ]^G%]&^-8K7LQB8H"1C37#X:9&AP-=LXBN:Y1@@C$?NLQP4DB4P7+#QMN@ M<_/.B'2A^'R-P#"8RG=\C49!/+J?_SG^^/PB?[H)[%'LW\-X?7^2WVEXZT4) M.*U=AGY_\:+O,7QNO!EM9A*+,T>W-#R@5*-,%U+C3%N3OZ(#+#`>8CT=C:V_ M6\S%[I836S15LDF^.H&QY>3XR>MW+T=-E:2__H:1GFT\W9VD\CK+N^G'0'JX M6;+:17(Q_O(2>:/Q3?#G*/+!G4I3]U!31GPW,:58?T4Z%52@#9ZK8M%G'<^5 MC8V7;\FOM:Q'U&%884IUH)M\>$-.X(P32-^7$U)EH(&=JLQG/_YKB?[:)5(O9T^F58@IF?[1':BKQY+I,<]+H;@^7J5 M&OS($9??MI(N#(,C*%NV;+]E4$_X(%C4LEBWL/RLX^".-!I2V-W8C-@^][M* M!@D=,>E,F$%P=]M>)7\(I!&8E[2GR<+7OEAB<&1VQQ(,+-'G.W"/A",F)QVN M!`:.H.4&IR/@",&B2[.AP!&\NARX"42?:R9V!AH;&HYI$8O9F"V(-Q$KTKX+E7O75/ICTZJ.U"J82#85EHCO M06LIZ)7-.S>&F=,(8FYH%41X?(MU" M8F!CUTUU4,8NW##-G-_IBS6'$M")],966M)-_NC($\<=^=&?H\ELGZ.S M6F*-JHFUY2(:-_^6WE9%'`P^>72?CF>5^\Z(=_[U4_Y:=+G&.GT:-XRR7\'K]CGX"U)?CT;CMON4Q$T44\,Z@E;-O$W<YA-KOR'/32`((-#)5+G&%64`ZAE6$(W-)M1F0HZ%M<,-F0:M729 M`Q\YQG M_3OC4J#6)A,,(5/`%28(0K%NR`_@U*:@T;9FF4AR@LOLWS#TH3O0%]%KNJ>] M#7)48@RTM%:-H19C<%8-ZHHQ?9@'E-WU5<6H:QU)M?26EH[1XS(.>1)@NNH@ M:JD`R3+S6X1/SC:@UD@:F@:=.TYVQ)9A4J/Y,%?&2IL%^HP4(=;PSI[3'!:R!!AN M]V.'J2\A>Q]9S84V5]RJ)]F`'V^>P812 M7.I,OO?F)<.D[E0KK.E6JFJ#PC$L2V>N9EN2>LH(TR`PU;!A87M`7"JP^,[2 MX@+)P03K$U+AE^^V.Z2[71S25R]ZWJDR4V18,U^K)P$(O\;Y4[D[\AI;V6&/ M^9IV1O:QLW8#@.Z[@BVRMUYI'W25OV.HJZK^CIV^3H(2!\9C>L$8W)!*(1E) M@?@=AV1YZHO,_N1-`1(B;0=>,;;?9'H@,X;,/P>/%GCQ9*1SNRK?,+<=VF1[2I+>+4 M%D4;[J:%AKI--I2:Y1++,'1B#9&512$U[U!4 MTK3*CCA#@OX>AN-XQYN)>\N^IN<&J@T#&2MTEQ^^2-['I-L/=*<9UMRGJ$@B MDK:?@'27!*Y[_"*1BR,[?='5CAB9ONB39Z_4:FH6**QX]JTY6CQ/8:2X#T1R MS81,2E0C3&<%DFM3M`6876Z_J.BR,8;S#/$B![:24E\%,NM74?@Z7$7!.P@_ MHZ5(_.\C/P!EN`DD^.%K;_H4CI?G M@Y(>'X$N4(%1B5V],65%&A%$28Z7_OLQL+(1+Y^7`UX4U#DX.)%1\J%UB"G5 M,,(@+)ZV#6")O:D.U#*YP,62Q3H*5HHU:D="B$-%#4H>3*51 M*%IQ@E2-LK*?W$!%=;"3@&Y?9M']DWR]3.C"Y^#YP-PVCJ_W>TZY7^OLP:+J@;@A=(WT#"*JTQL"+U:$KZ+4-&M-C@8H7"_(-O M\UQSF/YG;P*(\MPV1!7U.0EA9(2_Q9&M)ZH4S7N!/+\FDEW6^-D/_#@!EO]0 M^2269Q5".BLV#[;04:MYXOK!*+A7OGE"`+V`I5FOG-8UB=IF$)_#M]$$7BC= MI*HA*&)2"^@6(R@3LM&9JZCJ<,O3,-!&#UX>[/7@19$W7N0JF0'8TCX>U*RB M0^R)N"B&9EOHJ-/T4I%6J;6$F<5@I/KI2[H*U_^#,?P#HDFD#U11$M>>Q>R2B+W)A-P:L'X>A3]Y4$"IO"1E3@KC(K$KR>AN@*E,'T( MKR]"K:%I7;%`Y3,'E)CQ7S-M8]!U5SS\!/HZ9SK=XP;5$E>/5ET@^51+R MR/\_\1*<3G"XTDK=@$9J@6YP7`I:MQ-30@SE_G+S<-`&:DWUAXHB)<4S<#,5 M70\FV!OG4F]T'1@^:6/<8RZE&3UG(ZQOO2#-5)-&4E_QWBHK]*'C#I$C&6!* M!E"+$,V@`Z(-79L3EUKR&\T4_++2/ZM-T%IN'"Q1K1OELB13+4UNVYBA)H/+ MLFKSS<.G<.IE4>'7\,M4ZHWUZ`7W.RT#Z,W!`?"/FNDQ5X^,',FKY\%MY+V, M_$515JI%P^#8/R9I]3Z#]>PF"9+\N\81KY M]_,`X@])C9KFC&%FJ!4>ZGAR?#$93<[M`)4>ZGQR?MD-; MX$A'CK7?R?%['2U-)LEKT)1CGUZ]=IJ:W*[(NIZ8G-X41>TYY.C63(Y&BD; M,':<;6>3HW?:+)24=M(0X.;!G07C].J.![/&O\SN8N\_,_GZ7+,;\![R0_S1 M)&O_-<$N$#WA"T*-:Y9BP`73A:Z90].4'!&N9EHRCV"N#!6Y_&A,4;H]=;&P MK4U2<\R['KW"7(CY!U_[$R^>AD&J:(GM98CLKZ%Z;'0X9X:PL#8P'5NRT3(T MTS"9YB)FF"8>##C*V&@4:ONM$UTT/QB>,)^=,-_1+>W43Q79V6U/+4&I$1H$ M50P)L]TAU64Z*M^%AU`!'VK64*:FS#$&7+>%Z7#[NTCJ-SH2FFYH^0VT-1ZT MRS&E))M22BI)DRDVDTF;#7-)=5B\A*1P95YA2#$SK`\LP[92X=YRA>;,%HC* M#1/&8K68S8?NP"0VURSA<(TZ`UTS#!MKMC`0YBYVB."+K6NM4#FI&CL\GTR\ MLU:NH;)!6;\^)]"RC[,+:9V*G#/@!D*X4I%U8@\88ES3'>F@*.*.9B)*I#&: M!J4#W1E:;KK-_I84-O'4%W+6XO"?[V91G$1550YL'[P:X3SUUAF-3<:S$$DN M%D(SF#1C:G*FF3J34:48,,NQ!FQ@9(NR%R-JFM*U!K(!ZT<"<'/S32;CM"LD MV9J]L?I3Z[/)U`LNK4EH4&<29C)UO9RD[$UFRW.:3;2UV=?NK%C<>$QS9W." MU_&@O9ELV8U1;-(BPO&08X(/(?E&4X*[F(.[COC6QN"2]L;@=C2*L`^M3R81 MUM7Z.I,(>ZZ^[\"CAN7VM)2UTJ3LH-[>S42X&EZDC8%PE:W<@PV$VY7HQO:3 M$&VP_N?!]48A`*+*5[PZGP;7&W7),#CYA@*!6X?!*3E/J3^-2,8I&?K*,(+# MC%-J89Y0?ZR#NX2X/`&YTW%"_=&63!-"N#0K:?TTH5;&JO1&'G2!*2DZ^AZF MJO1&GP%WU(G89:A*:U-$>B.2PP!R7/3V.\T0:3P]HC<2<3HA8Z.BMG^IOC?R M&%S%*&EIYU?J^_.A@'4SRP?KAGM4+=4E>R.0POSDTIWR'6J0;5V<[(U>`?O+ M2^'E(>]-[I\-UL/V)O>EVUCO6)%'JUF1_CBR]-&FLJ:VOO32Y M_UVH%C2\SE6H)/6?`U)K7(7JQ:![O,V0!L1MP&QZXDCGEQD2C3@FAG1]ER$! MLJEXNZ.:(=U?9DOR8N6K3OF5KM^U4>M-?(1&G[GI2+TH=OW_;%5\KVV[U>) M;ZU]GP&=!5>\?=^MUJ>+!&MJO;+M^UH\:AA+5%^H/;+N_48GTD;WGBC8O:]/ M=&/S@9L!IB@-M>NO>]\#A2C3_EV[]QG]8`KIU:$^57;(,)/:Z6C"YK9&92ZE M&=R0/QKP5'KE)&'EL5O')/0@,\`D"(2+3>)CQB3TH>>`21`$G1HF MH0_6D62O4[%'T0T!D]`#>239:EA<"-$;)J$'^@"3P(U2 MO[Y73$(/1'(XH4L[N/K$)/1`(F`2"!<;%;4K3$(/Y`$F(3EY^L>M?7YB$'@B4H8,P*=.5P"3T0*^`)D0)IG=X3,(^"4.]IF6"23#5QR3LPXF: MM3.Z[%VK!$SHPYL!,($QMK+.8QLP(7]]$G:;AH^!_U]O;,6+F9BMW1+=7PT0 M'W"3#2W-1(AKTAZP9AA4URPQ'`K7UDV'DS2#KKP>VHB^XASH^1W*V(M^P#JZ MW584]68(R6:F/(ICS:-W`%'9R^'5@:B@[^5IS#6F]58L!D\#M?D=\*%,HJ=O MN7)@$H]_?'Z1/]T$24D9U"/ML)0KIX?IGIC$XLS1+0T/*(49"$(SN6EK\E=T M@`7&0ZRG5\?U=SK*>-4M(WH\47L$!:49:2L(AWXXTCDH**TQ'Q%#N@8%(;5! M066&=`\*0D<-"EKRJVM0$*K&=+37R=O#Z^_!-2;XJXS1F*#-,$+USK:2(]J# MU'Z-L"\$5>*5VD@->V)(YP@JM`2S-N1(1F+R`(U)3#Y*?IB7J&+VD_S9'\-O M'GPO^B6^?Y(YR[]^?9I.7_[Y_OW/GS_?Q=[]N\?PQ_O!Q_^1(9W\#Y'A/S<_ MO%^^;?E1L?>83&WY\'H73<;^/[W7EXE_[T^O/4!-_#+VY5]C2=R_?EUP`>8J M?GU[\:Q7/_[UMP7\)-N]G:Q!3,##N7+^,:T>&CQ[D7?7B?^_`/[S-9M2.X MQ%B/27"Y)14@NO,26N$`4E)J%>=4*K_T%//#?WL3__7,I)8+MI04VIYQF?U6 M_0%%PSU;3YO/3904?UI%2Y;$P3NO(&I8V.WV%MDY2C--O8]7FAMKP^I?B2:NGQBF\+A.2,1-JY$(^3.]77LI14>"4R;EQ/<+A_P5TR M[F,2VB5WZR]W4U#\E]SM]*1YR=U.3J"7W.V8Q7?)W4Y$I&KE;BIPI[`:0RGN MR)05UY4SWQ=1=*;ES1JZ3X5.D#J"JY2R/@J*26=0(4EEH?G8#SU@&!3*D#!C8I M.[\#M/;7IKG,+)Z&SUX4Y^"?G\+@CWCQAW/3G4LKZ?3$>>DEG9Y$+\VDHY;? MI9MT0C)E6-!7TT2F8)`X46%"B9=R?`F_-GUM'$[\?1W]>?X3FJ,M*%5&)QT>53TN6;X*S]"5\ MF/XO6`Y MIHK>SV@DV%O)MK.5)3/T4SI<8G8P;S@(E*QA_C49C#ZJ19V>LYU4Z/C'Q76"D)>G)]$+\O*HY7=!7IZ03!D14"TB!E-[CZ$[NOC(Q.AZ8PAZW5DPCD%\YR0YM8#L"K!'SXUCN\#8FZN]'T@9 MRE?G!\3-?]>]N"[8]*,4W`5P?BR"N@!4CT98%Q#;$8GJ@DP[!ED)(M)&O*(^ M\"J,8\#Q2H?F!?>^)P7T:32=1=[-P_+7^12HNA,W"">3T5V8UFE.S#."")'. M.,&*FMO.,I36YS^#L5WY4_]QU#X:[5"2TA&$]*90MK$V]AZ:!!T?@]LHO/?B MN-KZ3D!XV*`"0[0H"$_..),#"(4P17OW'#R!WYT9^C MR5GMF%Z'@?>6HE&2`E);->/%ETK]D5F$M'N@Q8V\_\R6=K_RXH^!3!3C M*U`B=`KZDX.\J:DQ!T&;'4`6!Z\3]DDS6BE+Z%A1C[7'U=I>,BC4DZQ4TL_. M:;Y,66E311?=A/[$=2E/'Z7@+N7I8Q'49O22#T:45T:J<<@JTLC]21$>&FD'H6D+HW48Q7>942.DN*XS+TY MO"CRPVQ`,L+4H5)K$$6OH;0RVJ8)C&#Q?_\M*0`O^9;@!+8C" MCYS;)VD]1XR".[K#_BGVR74NL:]U[3=9P,W06^GA7VA@,!4T*2RI<)^L@#V? M^%-EA?)FD4@Z8AK$P@&#@9\8!]PR\#.K>(0\'&!U``C(`U)/=&$TH9(WP_$H M9W!H:XC_*P7*`5#1B?($0M":B6S5"!*M2_L3GGS!C,I("3+HE?HGUI4FI^BG\J M9(\@VZV_%PV8TF\AR;*[N`CRK[E=XA3]6(2U&5 M[)C=&]_TZVO8/>4B97P(N,^B"K.KO%O7]MYK^AE@.HY3BR/<5LS>[*@7K*.% M(V!T[TP_B!8-0!C6@B]?4$L#!!0````(`/:*_T)\U*0H2Q,``!T7`0`5`!P` M<61E;"TR,#$S,#8S,%]C86PN>&UL550)``-?@/E17X#Y475X"P`!!"4.```$ M.0$``.5=ZV_C-A+_7J#_@R\%#G?`Y;7;QVW0;>'-8Q$@&QNVM^W=ET*1Z)BW M,NF24A+WK[^A'I9DBQ)E22'I?MFL;3[F-QP.A\/A\,>?7Y;^X`DQCBEY?W1^ M%$KI<#RX=WPU])X#6!G>8?'EP./K70/SK#>"KWSY,[@9O3LX'@T40 MK"Y.3Y^?GT\8\](F3URZ/!T<'Z?=_1(3=C'X_N0-T);[94)#XET,WN:^NF0H M[M@#DBX&;\[.WQZ?_7#\]GQV]NW%V=N+LV__FR]-5VN&'Q?!X!_N/Z'PV7?' MHL9@GJ8%C[[^:A`7OGCAN%#A^6U:_/STMT]W4W>!ELXQ)CQP MB%NH*!HKJWK^[MV[T^C7N#3'%SQJY8ZZ$9<4"!Q(2XA/QVFQ8_'5\?D;X/3) M"_>.?A(=_LBHCR9H/HAHN`C6*_3^B./ERD='R7<+AN;OC_[PD!]Q_NS[MV>B M_C=7U`V7B`3I7X=XUR3`P?J6S"E;1M0?#43[GR>W!1A_A!A:BX0H2"3R5)0[ M56KRM"WA$ZCY^S0`Z1-]C.8WF,!P8<^PSF>8^0UI%^QT==$,'88 M:CH,#5H.%BC`KN-WC^D6U-L2#?T`,0(#_X3V![';5/_4MN1[>7O],&H')P"Y#)HR'.^P\8!\& M!G')UWLSH6$WG4J",)1@8]N]YJQIN!\0&_'Y3,!VHF!P_(D\^.4#(FB.6\FI M>A\=0KO#!$0<]OS`PFX'J+[E+NW.@+I?%M3W$./70%RP[MC&5&R_5TC""`*5 ME-=.$^2#8>_-:%3Z@W`0Y4N-?8?L+Y+=4=`K6ZYY@)>"AAL'LU\B:FVZW8 M$@=B?\^!Q$L:[7P1Z7ZOW;BC+I0/A^XN@?S<QLA.="#L>3(6N^D=;7%7['=;ZO@S` MV_D@J_;8-W:)?[3[@:[M2#?2CH=8L;O^93OQN?8[B2LZT8FP\VE;VU7?:*_0 M0]#G4,K:[QO7K@-2E.T3J7J/QF#O6)R;]MO_3*YV0?:AN%1[-`9[YRJM6;]] M\Z'"^]JG,FC8;=]_0V`>]JH%ZWOJ&^O&B9MUWH/Y6=U+[WZAD&," M'`8Q>\`DFEA]#JIB=V:@[EBA->HTX8";W4405Q$*G(`:B'@B#CO^5G3?82AY M3,#I%@5]DJ48(1Z1`$0`MPH=1YYYRHJBD?0;A?[/'?X0Q?^'_/C1<5:G0F1. MD1_P])OC^,+%>7(-X)ODZ]\3?R0?.VLQ/,GF*>W)=QZ0__ZHIO"I1KHGR$7X M25!SCP(UZDNK:,+`0N3E0G3N*7'K,,BK:,&P.34;.QCHNG16.'!\&?F2TEHH M3P(`RPG-A^3IH*M&E`MEFE&YNZ2(;WXOT>$;DRR`_W%0;2S1B[%G95U.8]O6 M=*&!B=0MH%R#.N1(7,@0=C7\$1O-)\>/+.W@TF%L#71'EIE$OM3J:D$%FP9* MHEUT)8#M8IU(53*<8Q'-&]T8*$9WE,E-714=/+Q"4&+0[FA<579DJ5*BE@X.YB2-" M-7;\LQ*NUE;3C*5:>1BB+>XH>9PAMA0G(+7:6U)8!]W106.B">K(+B^KC6IE M$9&5-H%R-::;L\:/66)YU!JN924U4;R"+7IR&P,T7$Z,J^5&I:8>1'2%6+`6 M5T<"($NHZ97PRW*BM6,76.IP'J^C\RX;X_(#` M5Y\-99C?'!#FHA\@P_CV@#!6^BTSR-\>$&0E,SR#_IT]T%7=+GENE.U=,_UM MD8&U%WB)KR1C@$5&5Q,&*+L<,TY89*4UYD3+H\V,2199=?O,E_HSH@TKWEAD M^NW#BNI`DXP-%AF!^["ARHN8,<$BJW`?)I25RL#;N80H[`6VX]LR-6BGT%=` M5CA0SM#;*>TEZ-4"-#+@%FV,%("WB=[*>&+1SDEM*DA/O#+,%FV9U!1\Z5E3 MIN$MDGLUO+L181E8BP1:T9*3A=MFF`].H%4.O3+X^W@!#+P+4$S\K97*W3SJ M.J*B>,#&4-OB0GF`8LD-2%*%HQ84TM//)^8;"(5^0VHRMB&"T'KC5:)_<8_ MH#DMY'7]A$FDWD"^$4,\B')TY5N)5>LG%"RH)\X)>'SI4AHN^'H4Z.,PT)T, M8Q)J98*>7DM\7Q%4BHX75923^051V#:BD/U*_2$?!I%O53SO+J. MEG@KD5`V210;61?RV+?2HEIH1CZT^0A,_.2P+TC(0C7;*RIHW>W(#*KB9G;+ M/+0R6D$%:=V^U6(#A#`HWMS(G(3U;)-:5UIFNHIGK MN:Z6'B0K$%L<31'XOX\B50;;NMPV1PI'H:J6!!S12TK90WC"J$L??RV^.I:< MU\+NW07%DCR]4@JV79MFF:AR2YX-0:4JVH,IJT8[3W&2M*"&0CE<:G*$"N: M,`-CX>%K15"[CUKK1A&%36Y4\CX#)6^A$VMPM\/B13F>WI1+`C[A8W8'IE29 M=]:L&2,XH6O'%_QNJD1V*FHZ@A=;BS&C3["G\CZL/W.AU]3-KP8-&(0O=B^U MP%?6@$'XU`W'!@T<8HB(1.O!E(S=""(3=S(_Q0/)L!0.1>+\[>0IBI6T)..) MJ>(WE$W0*GEN@U&OD.137E@G;V9HSO1R">'QM5CAO MDD<[:[BLU(01&!4C@NOK&8%&FF9'%9:\`4VIMUR$O.BX[);S$!9AM6T\W M&G%.$+T0VVRX&K2@)]AME6JT>9IVX$[,?V`^S/B*+&-U];0$D)5ZG&3!8^6% M]<:9[.&P+QSS-S#'K$RGT1.#2NUQ*V_+]\2@T@U9QB"+`G&:[S@W5V\K+$5) M4@'#C\CWXT43RUYR&_6P^5)O`UEY;[4=5UJ>O5EYZ[4=QQ1L,\EEV(.<7JJ. M$4F*$SMY4N$H+%/%*MM*21:QOQ9_*ATEDNQB?RT.502P%_.)'39;FG@`K,PR MUMR#O[5=*`_-MVC+U(X#:G%25E[N:L>8F@`;R;4O.[6)(DMD_BDK;X.UG38U M@9)6WA-KQY.6@7F2"V8'/:/4(L9:QKS:?XD>`Y=H5/)=:H@&],?>R*C->;5)BW M9$Y9S'4-U_LRNH4M'@:Q*3X7F]PT8^48L\X1,L MD(_H/EP^()80%*DX/@H#'CA$O'XW]/X7QAD>)/#V;K=9&[H-R'T6F@,\HFG+AKU5N^3HQGP_QW[KMI+HV+5%;<^(ZM71RN.; M/9>,/%<:ZF(K3W3Z8I.*6=(N8Z"F?6;NE,&\37".N(WK(7\LHBF!=O2+YE;(OXCB'BJ/D1H`J:FK.G+DK3J7O(5<,I95&KS+PJC&W,O!(&7F5SFQG MK6I;H(I1EU,7T(4B[G`G'E.#EA'L#M`=?A*'&$5R+ICJS]CW)11O?M9)6Y5P%,OHI/)VN7)$P'MNQL5? MB=U'Q?&+>OV.,@!Y:-Y6\;1I28\]5TGJ]8OKAV*[6#,;&C>CZ;&C71VICE"I MLE9S1DWUY@V<^H7'2E]B3&YU?MNOV5V8WTEPS9T)20.YP%B_T$.NQ'/^C;?E=>U:#X' M[D&L9\_(?T*?*`D6>VS>51HUGP\3M'0P3&\F7J7FH`?$&';"C/*6S>=(),0T M[(8)F\;LP#V#[KO1!UEKEB!_IMWAAK:TV$_-%C75G96RTK!J)_):O-I=:*PZ MA'DM-FWFH%6NC%?E3JR;K0HO>DW^Q&NV5?O=UV+/EKEO9211_@9J[JJ3Y&L= MYZ&[U]42NB2&A;R\#I/I,N0!T,&&WI-(45=#NZQT-V]^)8T#9Z!-O!NM(BNE MY4E[(8#)4.8$L)I]-96TX6@&P"3*IR'QV+H9_=(ZG4CQ9P(*ER#O(W-(D#PI M62;'I>7TOAQ9+0I9$H62>6K5'J`!X%HU:955WW2DRV79*E-]C[&N6-"MLL+W M@%ZWJEEE9N^+7[ZF6&E!Y^38Q!.B#7&;PZ'/A"&7/A+\)_*R/%A<*YW0*$HS M[IK'Q?P%IOA]>AMHS.I5PYV45SS`"\%T3<.9K\X M?@AR'>9JGF0<&#%L/B?<1T4?FK!;8S4F&>>)21W'T8ON, MBH>UG[`7.GYJH?%;$J?0&\W/ST;S&0T6.+H3I=(K'5)H^0FB)B9 MVF3K:0/S"-Q,MD]`*7P6?#6/RBB+GR;ES9!9(RVC>=0-NY6-+$]G)7S9]C1YU^$A2 M2*!\'C"):)]L;*M;3VS?Y]BI&4[X+5S"EU4/K?70D>W\2I/;@@F;^_&>$K?2 M1?6J)-C.X_JWBOOJS2+.I>&2I9CDUW[ZZDVK+Z!GX=MXSOI>O:Q,5OL*S->C MR"59<`]R-%2U25^CL?MT@$7OSEG*A&'C[',$J\R7^H,Z/C@BX?F#@5(^H51@+83 MJ)K)=BF5,Z$!S.+H)J]#-GG-9&H5H4;RM>B[,9^]M?0:R&5)8)J9+*XCUD#^ M;@X,S1=?.:$&\O4*/02FLW3W\$V4/1BJ#92*NE,X,SFN3+6!'*\X)C1=T*-# M0_%,L7A2U?AIN3E!S`@U=)4NV_CO@P8B8XY+9,>4DK'\^NO*-F69(L4)5,FY3@>/ES,4AQ%>#'X5X`CS%&,!V/TPBB;+0:7>$(HB6&PP2VA M7Q^1P/\SD/\?#N#3O\Y'MX.W;\X&@VD&!70>C9' M=#$81M%@)'N)P0@+S)]Q^&8Y:+1$=P`$I>+#40'#ET<>O6'\Z02F>7>R:GCT MQS\,LL;O7P0I=?CV;M7\[.1?GVX?@BF>H6-"18QH4.HH!ZOJ>O;33S^=I+\6 M6P,<8;QN7@3KQY/LQZRU(.]%.NCWT(MT^N=WI[+_ MGRY9D,PPC5?_132\HC&)%S=TPO@LA?YH(,?_,KHIH?%;0F"T=,O%R^U[(MN= M&`UYLBO@(^CYRT,,>U7.<3>Y)A06EZ#HGHGT`%U$2`@R(3AL"+_AH/O$X!YQ MW'09&HP<3W%,`A39Q^D&>.$,#Z,8]"WA]H9VDLB@HB)A..'9#9#?'$W>2!/%+9A@&@\#`*XDV*X M-^]91`*"Q3`,T\V*HAUXD94Y+:(N;$D3H>]F]PR(:X0IP"`N,?\80K;PR[6 M+:?;)\+G2)!@2,-+$B4Q#J_N'[K#MF(NBZC>T&#Q/K(%+[9 MP*%R7*LH@,SQ1!XC/!0"QT+*?V$283EA^9<=L#&>HD/$;.\RD]&[7*?5OKAZ MF<.-@\/K)(9F0TH3%`UGC,?D]Q0(^3L5G:[G[J!8)-0=B`S\(N%2>+@EZ)%$ ML#!8*#ZW)D+#::SN!"DH@19LGW/6#-P-$NOM\X6"[,1`X/@=A_#+.::@X.^T M3\WGL(C:+:&PQ2\X!A+:7:#ZD6W*G3$+ODY9%&(NK@"X>&%9QC0(MM^2]B#HE"Q7(B8S"<,U(OP?*$I@VUVA M8)JVO)M+*(;?$&]J++`RI54F%"8BY@L0O:C2>R>55A8"YWCQ%YZF"_&PUN$9DUX_@$$\/?DJ1V M,3*?P2):PP`@RRR1=K&I';@C)*)H:>B_F]PG/)C"+KGG),!C]AG'XY5>0,,M M%4N.`;(/_&1#@.\0I&X(EZO-]YQ=RU5:FZHM;P?#F>R89#^S6#+Z]0QKNZJ0 M!B@A8D;2E:*AUB0YQB_Q.2SFUX9DZ`@(GRFT^N`%I=;`=$VQ32.G_0VC MGL$9;F,$',O>0M?-TS6>*TOH(F=>]I=1.XE+#"TOIL%4W6-;OE6[7=;ZN3S` MU_HBF\[8->X*^ZC]A:Z=R#6FEI?8<+KN]_;2YMKM(=9,XA)#Z\>V=JJNL;W$ MCW&72ZD:OVN\M@V0LFV7F)K/Z`WNEK=STWF[/\EZ$V07C,MT1F]PM\[2FLW; M-1TTUM/:(>4,P2UT[A'$*0_`@><3':\HT@[1J@"6\X3KE1V;\E&"&HX9I M*!,8LJ]R*(LY&-G$V4`.@3*,+'"3[#*H?L.8=S.@_`)&&_(M)W`L&]@[.0> MI``"B'#EEN!*W;N,5S*TE`U-D'A,>5$BCI\0FI](N>,$1[%8?3G.=M82-F',R6,B0/,)D])ERDAW8= M)%B@YR5^QA&;RY^7H815*V1G8*LX?B(@'<>,`D=<9$IQNHNR_2-%YW\#)'=4 MBX[Q&/N'?/R-[0RY',/%F+SZA7QE/19GA M"U&Q["8C>(9A#MUG-,.72X6G*9:5H_B%Z1>!)TET2R:;;*-15ROW^R%$UUVUX\]J?Q`KNIM%[5*5Z?J=54@=EN M8ZZID"NS0UZF!VS>U=1+PY2937799P(D;ZGBK9'*N/C,:@R%]%Z?G^<"3PD_S'T6#.">,D7GPX>GLT M2`30@\TS!:(K>FZ8.VU2MJM[>47J-Z=GDM"'1S-KMH.<4F\/DU+-M=N<).]> M29*IS3E)?C@XDFAN\QSM'P\8[3J!+*?"GP^."NT5C)PJ?_D.J&*F,N8T^=_# MI(DEQF.24.3YIM9N'.*>%*6MT*4JDB1@O3 MMMFN4-B-Z\UW2A.8@]: M5@!T$79`8Q+*PGQ`_0<<)#Q5JJ]>@B@!&DA-HH3+%AZINJ6*1[`RM@M#XXZ0 MGR^J!]`X`KNL=Y`J+]-(S\<-0OBL*TKN#MK;,O!>@55:/=PF9<25X!W)S MM@%AL[%)_`UM0:N5II@][68U#? MWXIU]H8NY<]=+OM=1G*Q1C6@&M[X34?Q$--,UP6%K^;<-Q[&0UP;W*)M1G*# M\3UG\EV&ZN`JK<9AUM<-5A5RIOE.->KL`J^T#M?PB>,L3DZ[.M5MG4!-`FF" MHT^FD"O;6[FO[N$"R2JXC3D*\0SQK]7PU+6V`\WRY8)PC(,I91%[6FB`439V MFR"F$:W-LL%J!W@-SW/JK6FC-E=GPM5OE0/TT.Q*O@V]I0]A\[NB:J#\]"$J M?E>BV&WJD=LT<=W_3*MOB;JJSY33P M-\>R50Y46SM:3A!_TRW;;XJFQJ><&OZF6>Z0VE*G,_8AKLU"9H_6/>X\V&T_ M--"85?J0?K_S(="8R,;5T*#6X+#VU M-1ELEAW<,F7Z&/DZ_`]>;6^`;;!==D\&[2MAVF3(OO4Z2'=+E_`F(;:@R52$ MDU:[#6HZ?3\UJ%]K!;\&8U;`5_&*47,DJP;Q#,\MR\%KH*9OX26'&."8*9ZU M#OO:YJ\N^U>7_:O+_E!=]DWO9^=:IS]NWGZ:KK44J--S>FZR-EA]XTIMAVFR MKE<4OQ.;M5IZ&R=JB11FI*O^.PT+5L^3#A&+S[FLJ]!6^^%+Y2OR[K"+^>8 M`@Q.5UK>6G>3"[A_2.R-150^8C`"'JG5*3<:60E$S^APC8+ESE995VH:.TF6 M+T*ST!CU*AJZAU=KY*ELVD.8'97?N\2/\0T%D2M](EB6(A$/$?_@3B1 M5[0\1RK[MG%W][C!#8HY%K&$)WTC-LQ+L!MAIQW`/7ZKPE8@-EVP9TPUSR<9 M='2#SP3SK'XOH@&6%?`UV>JJUE9X_34&J1)%\C$8H;QL="W=I)'EU_6:A6?/ MVB2Q`/E1!@(JJ&G6UQ>L5OM41KA$1"Y_`[0J.ON"%XC[A*>2U:6&Z9KT]`6C MY5-4YXQS]@VVT`6:PR_QH@%JRB%\P7&$Y04.D.V"I6807_#4N3W4[:WPXUM& M0T;3&_@1T:]W$^#]DMO>,D0UN:DFW5Q0=[FEM2I,N8T3*&$_UD)9:F,GX5>: M/Z05N'S#RQ,A[WA0G=/:@3?T,Z-+>T-E-,R.@SDIAHWH$]:H9_GOSJ#3%^@N MM'#CO86;G1-VS_$S88F(@*W.80?@4%\QNJZ;2UR^4#''`9D0'&J52G7[7D/? M6"]6E4C'E#"^(>"&OR9"EMQ\)'&(1E)\JN(AIET[@W.E>4K)E8.VV0C2ZLZ= MP:J^C#6M+4*3UHC%83.@=)W\]99XYU$.]HZZL/5WAB?"_+88>`Z6ZC/A7KL M8%_A;?&Y-H\=I*N<,>YK\IB]S:4.C"@E4E>Z]IU'M)L%^K='L2\O7NDB+S;N M):UUH`^%DQK@6H>D?^)5(R15+OH<0?^DBD8(&OF\^M[ M.KW&IE7':OM6.:`1J@H[9M.2`#W!MN"]6V+XSG/98,O?N(7.=NZ!OW)`A7^R MB,^&T[T/9?+J,"H[Z/M0V:W6+UC.L*QSY[JO]VBF9V@=.E4H5]#'_1$TXBF[ MH]I&[W"2'Y&^(#ME$8`JKJ"]M.YYDB4QC-+!<;AZ8A*4'M#/8?V*>44*EZ)A M9Q>>T>$WQ,,QS*+QB);;N(#R:C:/V`+C!\R?28"KR?B9T6.1^N\H'L,!R&\9GSY2;93A8GN&8B#HG,^4M8I36X;3Q'-'LE6 M[3QW\!P6]?/GR/=/Z>+<3JFZ_2:[GA);[=W4?EFDI393[C!?EN$%#8K-9HRF M("K0,.CH!!]9$!&'0KY4?2-$(LW;=Y-TNXDO(#_P&RH]E^09#ZGBNKR/$%VZ M]0E],MC;W<[I)')TZ0U;'B]]#&EE6[>U@*J)/.1TZOA/JU,&L`CF3E'-7Z=9E]I%+;^D-S>0,%?'V-?TAT_:?6%;8@/LQ\\NG M/\K`FW4!'L?$KX>O5ZNSY5JU1=9\X%[1HW+-=4_/=C%3_RFV]U-\2&=5>;/F M5@0:2G&JMMQD)U.]TJSQ5(XJ*:32JA37<7B9<)"ZLV.1B>TE)6WU.DDJI"NC M^MN-YAWF&^)\NFQ:%M]N,._P+NI<5R^8!T1@I2S;?"!G^.;*.:BI3QS-ADD\ M95R:3K+H-QV.]9U=X#7F&(F$+U(0,Z*OZNXID-'U<.MHJK2/E[PNG3#WGOBF MG%#'BS"Z%J7[+!D]2E4^R_1W3A5E36![*EYUQ>"=:7N`J7(=T[ZED.)S@IU# MBBG$&Y_S]!Q22R?^^YS4URW).O:M^)PZV"UAM0*MSYF%'>\W`]^DS]F'>V!@ M!MJ=S[F*W5+(-*;*Y[S&;BFTIX@0G],H>TI@16"9SRF;/:5T?6B9SRFC'=]! M^_:+N<]3/0Q2;RK+'F=0>D9.^Q$;[G,B#GT1^I$\U*4;M_*FW`Y8[4.R\;[( MI(B!;)JTY4FB2X7B,\*15([&+&U=;:IY386Q^.`$")=WDP<48?U;RMOMO$T6 M6%*;R/)HF[I)6AUMB_VW20MH,(L+2GW$5!8V`*8R#&=PJH%M(&D$7>XU[5J; M]76!5?;BT3HY\':Y`IHT+ET/CS#0QC?I^QP$%H["K>`ZQ7#+3V&K7^)G'+&Y M!,WDC)CT=)MN8(>+F:4>V)S+"=5P!&,^P6)^0OPKCN'?)IN@MMN^(PXZNA^K MPP^L;K`##D78PZ(T=RJX,@J:!:`9W/-%]&NN(^<10F9Q93:1]B)JC,>;U=W$?8C(:HVVHL#D/O&@1`]J!)&K`"'OT MLO.V9>Q*Q&0F+_2U21[(B()IP3R:&@Z=OCX<)K!)%[!C/V(9YC&?DJ!0L,9" M%1O%&QW#()!1)`*V"2;/3$B!:1J5NWVOH;;WK]IG1+V*]HNJ'OBK;.:%@(J>6 MDK(L92DWYD-F`U.=/TT'-X;WE),IGZA<_>S$&%SK#'7M!BVH5IMWP_FBS)W. ME]5.96+#!_,[SL@JK#-],'T MO@/6.OFR#^;W%J@W,"TZ-\)W2('6"K7[I$>B=K&H;:KUJ<7C3?%:>?;P#6)JHY2T^>'O/31I3=*1GX=YX(8")"K!98 M:>^\T$N<&S@HYR2=<]0N](ZI]L4/5B;1%7)7B MAG.OPJL+LA>6^IZX(%W;[5Y-FR8DJF30_7E=O2/"U(B5[M]F-RA*4R7!K]TA M%4://GAVS9`J6%/<.VL;ONZMTV/*B7(E2CAG90U?]FZ%9F]>]9;U@$F<(49# MX+*2Z<#=0[#H+C'JG+"_XXB\J`V)&RU?40Q,2)8E7WU>:+9E@P&\P*_.U:#I MX`7\.J.VHK%[N)=;0LNC=3UZCX$C^W9:1?26H$<2`:O#8LET5+XI16LK7+&Z M*,4%BP`(EMT)PR>XC]4NM-;#V(&?+5`4+]);(Y!5%:K+-NK;NE-]C"6GM3JT M*1#Z%*.IT1%JA*JB=F!`$Y\4(YT"V/P:+Q)"R^I$H%FW3NC@!=.!*5MO5Z^ M4:.92Q,';"%O1B#EA>G<'FX-U9K;S+T7V"JB5[.S;7&-GJ] M!J3E;IHKP#E'[P!_I>CCW"'3>,-7JEOYH59;>]Q;[.VBVDIM:IJ7XL3*?8OE MXW>/T7(!.RSY-4MA'6.^9?39_MV.!1#-2?H0$XTY>4QB')ZG[Q4@NI`15W+C M2N3/4?!US!$5*(@+Q[]D)6PWDA4LEE4%[Q&/:9K5$6..Q:;Q0-O4"ARWB(:` MZ'E"(OG&YF<8V?RK2W3YBEKX>M M7@-NB%>YKT]8U;DZZOOYA,TGN`.GT6(D#WBT>DFW(6;58_B$Y?833H:H%3H> M&#ZN<@-4@.&X):C+:/I?N47A+\Q*Y1(*UN"[7S1]'2<>Q5L]MR M,_VB[M`X-U08AF9U206_3?#&UZ$TH=OD+=*K@W!K0]6^D;X[V1.Z(,IW^IN M*%W-?;#R-]\+C91EYT;^3DA0MN?UP>#;:I-7VX7<1V%TL:05YB?GM94Z0;29 M[Q%:LXZ@N(3H`1_IT^QO^;DO.;D?,\Y.9;J>B$QE0^8 M/0/#D)EO\07B?`%@5F%FV,E)I:N(/!%@AO(JO.,?.4OF(-WE;['5^<_,^[O` M;@W'.8H0E0_R81RG0`+1KPF%;P1%ZT3-"Y3)MW6NJ)V'=4N+1178.K.Z45?' M.*W_^7<"#(('T\6MC$#2;%W#SH[Q*ES=UQS_EM0DN)GT=(K1#9TGL4C)>Z:M MYJ;KX0L&[QIC\,X'#*IVAE;Z,>EYV`OU/`[K,.6IEM)&:W&>,#!'UT0M@$)MTL9$4Z+L;HHGI MI;A7&O`UYYRI5 ME##3GITS!S,Q;D_T\$*0:[Y%Z@S!=?38LHOY1`.S76&9!'YLA`;B5KV5LY(" M52;W/L2;MK(1UE'@W38%_(U-;&IA*SWEI[!?-0VS=1*Y4I1N7@-6#CM@Q0HV MCHS$KP$XUHKB5DXLTFC;+%<@*WI?",J3/QNC4#^20RS$S6P.?]W1 M1NEH\/DC8^$WDEMJ:U:K;A2KT%^PV2.AZ032$EDZT#IXM?V^5 M*[5Q`F7VQKP>RE(;%U"N(MG';,DS5JN.19KO(%=\Q4T42#0:P@6.(P0WF.9N MSG]W!IUVEQ1;>`^AJR((ZP=R*MBL.%\4_C)[;=-PF,-P\[O*7#.SA!VNGW]/ MP0U>6+N4_FL3D:_ZJ3W3HW[`?FI3XC60!/O@AFZZ9YJ).<[=RUTM?$LGN[]V MXEVI4*O&]:$RP>Y;P<#6XCXFT`M"F)MKW#L9S*2K+>VHR#=+HK]S$<),*6UF1+:),BG!V%>-LA0.,1- M`[N<>RW78L3=I"1?C!G(FF-`3#IRX>JXH?'J#Q!$8[&Z>-)Z\>N7/9KY.^U8 M4U:07$N2X5ORC+>`_2(M4MYP:&OE-9+1]U/5M7?+XU<.GB9NV6PAXT^[R6_`QOB?[8=9JN?N$557/*<2PVTQINO9[#QO)0M1HR!.4#3" M40JL>;6YIH>34@MJA?E\\0G]ROA%A$#STA0&:C""9QANF>_-4H93 M3O':-T>:CO+=8.HHRNB&+LV(.YW'IJ-XB&F#E6TSTG>'L;/]G#Y#($3UZYW: MF#^SOBZPDFHJF\UQC+=?'*U$1=/!34QN7`MRNYU5VA7^_(EO[D$.YWI5CD% M9_[F%+3=5[M%#N:4\3?)P(<3MXJHR>EUH,)V5[&:.>$.3PS?;RA23LGO0HRW M$PJ3$^UP1/W.XP_61'O;2[U`YT!:\SV-_;8/2:D[H&_BO.E#1NJN.Z`N9J4/ M":D6ML&&#\Q]]JF9ZZ)E@$`1\U9^:.>6>C,7AAOR>.'*,#@V.T0@E"EDY-1W M7N:A13ZAJ1?6T.^UO=^<;Y,]$:7Q0>Q;$F9.'C@,U[)V[/IQBJU:LGN$]3.+ ML1BS[8D?32_P8^TW.AQC@F;((1$HA M_:WQ0K8]$)B]VP\@ZRWL<5OA"_"6L&<,VA^_E$PO,( MVPG^^']02P,$%`````@`]HK_0OXPY7"I:P``3]@%`!4`'`!Q9&5L+3(P,3,P M-C,P7VQA8BYX;6Q55`D``U^`^5%?@/E1=7@+``$$)0X```0Y`0``Y;U[<^LX MDB?Z_T;L=\"MG=VNCK"K).I=,ST;LH]=[5F?8U_;U3US*VYTT!)DLTHB523E M8_6GOWCP30($*1()G_M'=_G89+Z8OT0"2"3^[7^_[[;H#?N!X[E_^6[XP^`[ MA-V5MW;T"?/=?%VBX_H/U=X MBWT[Q.C)?O=<;W=$M_8SW@;HUG%_?[8#?(;H_Z^1YZ+_O'BX1=8/0X1>PW#_ MTX\_?OWZ]0??7\?4?EAYNQ_1^7G,Z6]+B)7YRX-W<-<_H5'F5Y<^ MMD/R-%H3:7Y"UF`X.A_,SD?#I\'XI\'HI\'X_\D^[>V/OO/R&J+O5W\F#P\F MY_0-]/##PP\9]?X7>O3<@#R]V]ON$2VW6_1`WPK0`PZP_X;7/T1$MY&ZB!C3 M#?[R74;#]V=_^X/GO_Q(V(Q^C!_\[K__-\0?_ND]<'(O?!W%CP]__,_/MX^K M5[RSSQTW"&UWE7N1$JMZ=;A8+'YD?^5/!\Y/`:-RZZV8E10$1,(GZ+_.X\?. MZ:_.AQ:Q]`_OP?J[?Z<,_\WWMO@!;Q"3X:?PN,=_^2YP=OLM_B[ZW:N/-]52 M;'W_1_K^CRY^(=]R33DL*(?AE'+X']&OF9]]A^B3OSS<"!5:Y&CQEW[D0F[I M/ZB?YL3$[R%VUW@="TI?EYB+46>69D0I66^5([BE-O?\2L49K8T=/#."A^#\ MQ;;W/U)7_!%OPR#^S3EWYV%DY/\1_?H?R]6*("$D2+WWML[*P<'R.0A]>Q7& MW)B.?_E.X84?$_GI*SD-?!QX!W^%&YF$?YZ&4OQC^TQ?VFW)*S3\8/?\E\?O MD+/^RW?.^A\4I\.%]8^%-5_,YO\8_F/XW;^GM%!,#/T:D_M__XW+T:UJ(8E+ M^+9__:QV^BW]O/_9_BJ6D_Q8HV#TQ(\KCX2:?7B>^XP;W]LI^5+,WU.VR8]P MZ`GN[:/]O,67!]_';@URB@_K1TU!`D6/&HUFLTD.,0&*"*&($BA63M'*RFFU MYX0,0(;`L2I04:5],T3\L<9;YN>#Z6C`O)S^)J'_@%?8>:,LKHFDG^W?//_R M$(3>CGR>PH=1?Z]CWU][J\..:,\2E+9"J3G.<#@8C8>S?XQRGN,G=!']GFA' M*:-53/J'7@!2A?B>M,VC/Z6+*&'$**.$M-YHT)/&ENC[K@\8.2["[RL-LI9M5#;-E#0=2R"3$C0%-2U5+``'F[(24NM[:,"AN2+.,2ZRR#`87#KN/@FQ+OB8DHK$EH!IBZ7ZMKU;#9,QBA. M'7'RB-%'*0/$.:!?*0_$F("MV/=D!ZO"#N=M[:`/MV\[1-Y+>^^$MM"!!$_KQ'JU".H;;-8H@G%""%%*!,`HH@4$S@X4LPJ*[0FE M<\=%*[%BVM`F=[00WU_:P>N] M[[TY:[R^.!)D$\'O]K26S'%?EJO0>2,ZU=>S],%**SJ[EU\U/UU8X[B&)I4" M/7DHD8,MQD932BH*_2,5!L72H(LC':59,$@D0JE(\)4XT/:UBO8-/;H4'-G7 M)?9UN'V_WQ)9_DS_3'^YHE;>QU9^/B(OL:Z="/03;'SJ#^3YX-;3%P2)C%M& M'*\?7VT?7]#"6%I;BMV`)7E7[_1'X>Q"[66=T4M)(D6\C`?6/-X7BNDB1A@Q MRBA+&D6T@:)*]WJS.,'(G?-ZZ5566\PILLCQXCK_Q)43@9,5)UGVLZ==]2'7 M/?16OTMT!XUUC6";BU[JYNJFWFO':I>?L%]:BBS_77O]5H:Y8AW/8#H>6V-> MI_7T2J?$C`0**0W=!5FMQ>=!+1*=O0]17=5:?"LK?B@27T^I5(5_IR5110W; M#_$!7OWPXKW]N,8.']W)#\5!G?R*LZ1.?[VU7PI6+_]=P]!<8JJ:K0X7XUG& M4>GKB+ZOUU-/$]]2$[]O3Q4Z!O74:@U!DM',\N+=IKCT)AK_Y2_I3#ZEDBAG M((-%G'1F5UOO-N4%:J!G6]K?=R!,TVE7"9RS+K[=A1=DGKP.XVUP=WS8O! M\/K:\Q\/SP'^XT#B&3T5231]7;HTS=UA?^78VTBP=!I>G9UT0UI_3MN)W*H) MF;483`;1L07&F7KYAO".Z@N)3V\\'P4)>_)[SI\Y^*HH068U27LV#6"X8<9P M),13WBAFC@AWE+)',7]$!$`E"3*+G""Y/(#Q6(2]+OE:SL'6^`UOO3U+OVRI MA31-%SH-6)F91G?V!TG]W-!9.]L#$00_XM7!9^)XI9B2=W*WJX.VR3U8V*1OT7[*C@VW)X8 M+F"&^_Z[J_O'[_X,FNIUB<-<1MC9A_F`X>GB6$U@^>X(I[4].YL/Y-()(C\O67FAOI1AH+O.4;?)2PM%B+:@_BQ=;VRZJ M=NF;=661^8>T^VKC=E?C9'$N.@D#73?87@T>L!\?KYX>X1U86EE7UA'.H6L. M;^>>T>[.#<\QSX8%;^[U6+9:)&ZC0B8@1T?A?+R MID%O.AQ/JKS=D!A^BE8LE%_F7!^VYEKF5$(,P$?XK[:_?B)<9`MPN6=T^GZ6 ML7)I_V`4K^+3UQ%]'W8QJK46EK(6VKR\REURWEU2%L*K:3'O@QWBSWCWC'W! M=RD\I-&O\YQ5Q_V!-8M.[=+W$26`?N4D@#S[!#VL1`_6H7SKV6X@U4:7AU>[ M3M;%*[0&\G$GN-L4>O<>^?\_X??P@C#_7?SE5%[6BPD%B91];#`=)%AQ`KI[ M46S6?(S_\RNECAAY.!QUK;N5ZNYMT#TM!(DJI8#!UX$@*(4>@W!:T*/"B6TE'-6NWQ2E5FA M*<@X'1TJ8/UM`H>7?+(#!_+]^OKW=(ZX=<(H+Z2-9HL(#1%)E*&)8J+`6_;= MJFN)U#U3TU?;P*CJJ;G13\E4I@!/O.(H>AH89$W*OR:SJ01:D.N176@F1)$! M:Y0UKE:'EW;KEJ)$L,S@TF/9)\G.R$^!LV:=4#SWVG;\O]G;0['#2&LRVE/* MYC*JGG&9C\?3491W5OED.I^A#?W@;Y0N70-X\6!ZYIT:!M,91$M[]A?'@Y`N2/+CRE=$ MDO#XY-MN0,_6\3\KNT4])2.B>:V8J@X\',ZG"VE`#T*^9A\=!N?<4(8=>\:` MJ-ZQ362!'=`F+:)[QX9AP2ZKZXJ0".A%823X_'9P^2^_.N$K;R'`Q3`KXBD' M#'G04[,L8-P+;G9[\J\[EZ[&KI;N^A,_\%<\T=&=+RES_!AQ5%4=U17#^6@Q ML<3Q]HP'%Z\^N`1GB(M&[PQGPK&CY9%X%2?$/D*$[L?:IT?R(+;U76SKI7Y; M]Q'Y^S$XOV2%4>9WVC\G_AD?."Z?-/Y@`T33R'KB0-+H0QFRK'A;<]V+]!78 M!<9$#M52#VL4MV6M7HN[A;Z[I3,E)0N.-4H"+CN67+%F[3%O&D/P=.][UYZ_ MLTO'<6E(4/_LG^K\-:BN-Z?A2(\&_=,=*"9D)MHCZ93WP:R9;!U>BO>( ME?&(;V.2`N;CU/M;0'T!""UQGS5J7XLT,>^??6)H\H^-H[H87?6F`8LF%6(I M>N5\,%U,)6O-*5`9;<2)@Z];G*JP2F3J7>'&BP>G:FVEQV)]_(;=`Z9WN/"6 M1HZ+PE?,=LF\K;-F=U@$Q`DQO_S%V\07N9`'3%H6D&!9-KT7F=*P9./&9>,$ M_55M17Q#*F:D&56B*1_E&,]G2DC.,#&AT+U':_#:]M4K7A^VF)]MB8UP[;BV M2YMY9LUA:&HA4GQIK^L<'3Y%-UGX9T@;AW[V=GRAH;\B%)P;Q^I M<$MW?4>^H9]Y0M75.N1H0@CN3AW%E&,R'\VD<\=((L1$0JE,2:.5#,_XZ!V9 M<7&YV'8NDRS[&'P&HEOE'C-4W%-J*S<8 MV.C0?2B5CA\=?R7-(\S/GK?^ZFQ/],F$BKDC02RB(A1FT]ETTBJZQXQ,C=6M M#-$F_O9JB*ZB:2MKL`@I4\^PV%<$>8MXEK.3(TZNF2V6PX*F[49?B>56`44=YD.$2<.VU6=Q[S3Q8A*R\R MAHU:W9JL253C%GO*6@SU;;$%MYB+7^BVV$G1KV/#C5F1`Z/&KFOU-FA/7`C' M!LDLR[)%VZ^>_SO]_.^R.EO5OAR#<"?8\C8FHJN&J4<15^A20\Z:L\-4- M#$3Q^A1*`/.J!N(IS_T7@^*!IUQ<$34_Z3?F*L^[^K)(X^XGNN=A+7R^:E[6 MU'Z])5XUS*MOS#F5F@E)EIJHRITLYZ-2#50^M1(`^BQ%=*\W^#3*IOJPS2FQ MKM^[C1K/&/LP3^X6F+WG,P.0;&DEB(7H^P!C],4+,1J.0!:).PHITI2H@:6A M(N279/N\(_?)$/P`<3*55MG?%_/YX-10^24MF3$^7+8UT4D1LV\#=1XUVUI) MFC&>N^1_<0G0AXV8Y1!S2M`L&%ISW/R"3XR3E("Y<9%(I]SK93R82.*@&.2$ MAZDQK['Z+6)<7^IW%=$:VR`I>,\G>#;YQ=8C7%\^0*S*P+I%;(I-9LABUBAYI'Q<6@31C;^6G-FI/( M,(8`\`&OO!?7^2=>WZQ)K'`V#BM"YE=)1VV^ENXZ6Z\Z@K5%)\]@9/B@\;=6,570SR>+/@-P*F?\"C]S2T4% M.B=F_N=(EN%]>Q4>6/'\ELD7O#K[;R8(*\>'OJ*PVD?[Z&%8W""B;VX?-+0V M/ST_FE@SV?+[J4&T]P8%=-:L*U2V->\TG=_G"ETYU6\E*`IZ$.CX$'UM7K86 MD,5C_ERTR4H>:UPBTAM[`S9.^])-N3!].IC*MEU/#7P\5XR>C@NZZ,,FE:R8 M\1'Z&WW`/D+C360SO@3+WN]R#7/H:8QL]8PM7*:'VHKN.TC+-K)[_6P?/7V_ M]VDKOO!X3UR/JG=%GMWO]"Q>BWE_T-1>J)!B)CH>C,?%ECA=AMI8/L0$9(\E M(G[\19)NK!]W%V"DSM">68H&6"RSU$><"]1"OZ^9@?Q#?:"(&B_D5&I9KI[L MFYOY4;-.!>5E3&LBJW52C9.Q.,*`V5O]8D\K(IW:EZV()%W8]JP+FYWT[?J` M45`5KAW$/:4/84BD"Y;/`=L*4/?%]!78F)/(H7RMWV1>O"\M2P[]&A,TIS"R MG8Y66QT!,5QRQ!H@YBW3R?KB)>]EP#;':)]NO+XX$HY[VST^VJRWZBTFT?#" M7OV>N;6T:OV@)27=JW[MQ%2^17U`G)$OX$6,V"')B!-Z/I)_,EXHL*-6P%O* M#CT3?BA,&?Z@=QE.AU6&6:MD.*&+(XIX(\M'W_Z+@O?[.WPJ:+:N]J M3!Z4!%)/C^>C&+_!*P,H^R%#&2U#%--&C'@O8"7S:,=;7[F5C83ZTWV[-D`M:ED]ZI;4M4A MD\E&H2J;5:H;R9P(?,^#RNEDO92:=QGR9Q6.8< M4,P"Q3Q@EGEZL$T/J?JQ(I^OX[H_)E>S[3Z."B6NWL]F"76A,)TJW3*G#SJ MY.%D/)@NYAFDZL^;E$;/CO2,ALU(IS?Z/NL69!CRF@^<]F*-]"QAU.(H7::0FZ`;6&]M9Q>PW9'0>6$@^HQW MS]BO_";"A[6#6B2)JG-,IB,KNOV)T^)KG@DUW>N@SS.C#MU)C:NA73D_S M=DJ7REG"CR553@^JZV"4@EIJ#)!$V-L2M3S:5>8-+WV?!AT*ON@Z.Y)*W'M; M9R5J1ZS\NL[D6%$FY9V\^30J<\A11AG2**6-.'&@?+D/U2VIZJ`)H[!' M4]3CVW@D2[L8MC`=%)8]]S$D,MS;_IW_&-(KF=@"]CWV'U]M7[@?H_"F9M36 MB*,Z_@QGV7'8)RE8`:N`:VA+-00`E<@#!6"J-(L1(+H)@H,Z@**G(<'#15#-H2:S MZ4@,'$[+$-"T4$P,&$>H&1A8\IXF!4K&%$:`Y.X0!B%)O$EJJOHULZ]`PB4C MA_*\(SGX5(69#$%#@--613%Z/+F.8!"J\$,ICHJ6`0:3M&RM^!@,:!I5.D^F M\TD%4"!+T4[1I`(/__+#8#"LFMO\*YH,S@:#03E!^U^(17;,\9C8;LM]89(B3V>$5WPK:5.Y<` ML!37O%5]""#X[7W\BMV`V(V7Z?`M0_[_"LN/:J_KA:N23,JIU&"4[N.EE.,R M,TXU_H\1BXW=JV$U?_^U@L"D'O5VKIP`8?JQH+"YX%\\T=O$WXE4;+0";:R MTJW9NYJ162N0\DK;=)JN>3"R**9;ZN4,5#O6G]X,CXFZ:TS&/(_UO4$K+P@# MT'*R5JY;!*6:N6`0232G#:]9`P\G^/T"NZO7G>W__LG;V4ZQV%/Y-:TXE,NB MWAYBN(@AF*&(*$F4T$2_LD9?4A3\U%\Z!3,),9>#LFHBW?'7$= M6#F1AOQZP74K+&`.X$;14`)U05#F[5'BJ'6X61C(#;/?;I M+^P7/%3]X-E7(&&6D4/9Z49C,<12>FAH"+;:JL@32'N+`[IH$Y$P"D05?B<% M4-$20.`)R,1QS82Z"?$ND(]050_K!4R%!*H+`XOQ+,W^4CJ($8(>@4[5RVJN MET:D2)RL@!&1'DW60_:6+,EI5?D;VH^L2L51/0HYGPV'T^C<:N;BL!S%?M?KJ@#? MN8)#0`5K#K-VJ*7\_C<#3K4J82X]VEIO&IB!,PCO-K01#DE_\R/)L,AV?TO^/1G/S7.EN,%VR_F_PXGTWSF]S` MNVZ5/ID?4LO&-``^R\RG4'.#W!MPL,J*H7Q(I4#$EF M[`P+'*F,@*+F4'Y/3Y]=O>^Q&T@Z%Q0>T^SU6=[*B@U!-*K9@FN&^6L=LKI67FK@U.ZZ"8U M!L@`F)7H*-O"+3^H<]`K<5<=$<9C:U`%C2/LMNUI^E2@0::/ME%.Z$RY\:U: M=WCOEV_15CT*AH!FVY?CZ60BP`#LMNRI.E7CP(3M6(ECB;'0^38LOW([TUBF MK^)@%`*U M5NAR/+JG&SR>>[=A%_?=/6^CUMJ22"1\!6BD$LFC?&7C;#*Q\N/6GI.DVQ?\ M-D\OH0HSCG6C8P[N$4FZX\3OYDRIPHURW>AI*7Y+Z#&P#GS%`5%J'9`YVR$( MO1WVE^LWFV@<1'**IAB"IW7.W*I%:-"0(ADT.2$44T(1*:#96P=Z63F]]C[> MVT>P5%'1PW+S-XD-.AHR.8,;=@3$>2MMR8J>TC\P%D50C)]#:SX8Q#3HI(,&$(QE=:YC'ASG',1JX8%4NV%CCN%4M@7(-=W*#`J5CTH5%'>AE-==+UQ@E=[+L\"2Q`SPZ MZIIWBIX&PT?SWI2+\4``$/`^G%VHQC!R2ZOYO`WB91'FX$+:6%.F/10R;EP" M3Y9B7=B!$SSN?6RO[]R_V;Y#KZ1^L$-ABR/EUS5C1T4F]:@<][EE8$I)(T8; M<>+HSD4Q>43I0[5"ZD5]!K@+NCGE`VU.MW78(OB430./QAN7?&P-+"8`A4B:5887$C=;,\6,1V@$0(O]'AR7Z/CHU>8!=OG#JDB-X" M0(Q`%.5#\8NXIT7B8-&U'81D?,`9141A(=2%IGQE_94\B)'CHG6LMPIG,6)!X(Q*Q*QHH^.4EB+(W`'!6(8;JX8[!>#XK M8(R"BY.C0Q-L06)7&N:'J011YRNQ.YZKF$`DWJG`&5B&\%`;>_C ME<.J+,C/6TQ_6+HJ;0&57M4*N7IYE.3[P"QQ>7D-Y):+P<9V`$\B@W(G) MFD77C6I8A/A5`]@#*W1.&IK$)-%R0\T3',.*,.B[SJIJEC1 ML_[#:OV7(/K+RR3[,X)5:816/J"EPK(-UI/BR\9F[+\]0RP*/Q9_CWW'6U^3 MWQ4W_^3/:FK0(!1`O9/!L(B[J)4!)X88-?T=&KI1S&JCF(X6#;5.%O=HD-M! M-QIHDP@U+*1/@B`A8:_J+L/%;%R-`];2PP@4M%.J$@-RI?0CH.18U?Z?MX`^ M[^>X$_?IJ7Y.L^?GF*N[R+P8_Z/X"->=YW2%K*8*Z?3X2F_D3( M2CX+^[-FWZ8\&WA`,933U^'\N+'PEI+P.GTVZQ)%5TW4@UAHN[)]UW%?`H*7 MQU>[]M24\'&-"VTB&93O\)P/HS.#,24:X1"C!7YXJA/EK%;*Z5IJJW.Y[%*; MU!PFX(46T*\4OR5_%A`I3`#E0T93:RB$":-D!D*:*Q4?Y'!6Z/NM%P1_1CC6 M<$\T#"C57G1[P_ZSU[=V0Z8>K2UQ>#E7HA,Z1\^B[P8%_AQ^9,A/#6$,[!N. ME?EWH,-`PX%E-)S$6:$H'!@W=K;7,Q,AW`H@_60<@IJ,H66SF("H3\[V$&+1 M_:6BIP%1%(F@?EAI,1/B)Z)E!FS:*!;M[;(7S1]46WTZV;"Z%G\_J+!0P),L M(&3-85`H:#B\%M^"#PW-AY[IH"Y$&#?(GJ)K+FH8/]`*W%(!6<8-MG7=/\3/ M`Z*J:9N,T6`Z%L]@X9N`=*-?='??;G\(D\N-O[]E`W!9:Y/@)&T1(K<-"(0V M&WZW>G*^AIZ]OO3[", MM21(Z:.4`1`*^S&`E3<`+=V'[AK2W(-SB&QF)Q"(;AUVHSN](/#._]GW#OMK MS[^V'?]O]O:`[_:L&DI\8Y_Z^SH!JBJ4\SAP. MDI\8K7]/)V+KA%'UTO$X;FX:DT01S=R)-]`CI-TJRR"Y7*W\`]%Q;Q^)#%M6 MONU'>IMP-;6RD^:PIV0G2,P]8O_-6>%XB1BOZ:2"&)O7$&^9!.Q>FP>\\EY< MYY^LYY#CK5E'AUO!C=A]<0'`BJP+"6L37SB?HCR1(-UT((K)"H%0*>F-4 M*D=^+Y[[A M@*[A?;7]=?#DA?8V^W>JRQ;Z%$%^GI&K"-Y\LM$;[+-'H;28ZHK)'JTA0 MZ]P?XENQ48`;O#:N)XL"H8=H,YSHJ\4]1LF/0>BM?O\FP[]J5-(R$BAYP+P4QF_U0#>UOX=!&L6H9$GMNO'C]05H4)/ M5"Y^5M`(G`HC;>0D?AXBTA6%4"X8G2_FQ>B4"2#`S9RZ48_?NY"%KQ%]G&H= MKA)[E9;H_\`P;]5RB=W0M[1_%-:H9-CK1YO)Y,<5A@5%).!@D9[7:Q&NNCS_$KW MR;MZ66E=OOV`7VC/3=L-O]B[JMXJE8]I]>X\;W67&.7SHY0,HG2@_/L$;:QF MVNCS\&HGRKMXA=X@TV8FS-^=-7[`;]@]X,_V;YX?W[1=6VNE^+;.*;6:2,HS M4*LP*E#**"*-&&V4W*)N0+E3#]HSF$7DSIJJK&TVWLR/@?!R)? MW1G5_$,Z`9?CK%P@-TJJ8]C[\*=-VZMA*:NA#0V5+I-S^K*Z(+[]OL)!\&2_ M1W='71,UJA>FK^,KZ9;T;!"K9Q9]R9-HZD3.*8(J[Y\,1E';2,Z.'8V+&"+* M4;R-E7!%*5L@<&JSE)6Q%#U*]QQ9BN*+GQ2/2G>S6T^@4.\"0;G(<+*MS0XD MT?'!3@-)%4TC`TF%H,K'9B;6O&4@2;CV%D@6W$@N?F%G7LRPU?C;C242$+6+ M)2)C=W+)25SLNURO6?&HO7W`SN[Y0$8=?JTR*QAX\AYP@(FY7I?N^A.9"FR] M/?US=+MEP9\Z)*S[6I1.I%:$PF0V(5/(4:[DVD[X(C_+.%NYX4>\V9F\=]-*OI--LR9+.6+(E)YJ[]K!7 M3-=&P8ZT'()J&=+2MMK(U9&JT[2`$<<*;[C"=LUMEEIC32T,2W%$;J!.8\1G M9XN#T'/QO7VD:`P(UP,-62OLO-G/6TPO';ESI2%#F094!%$54-G_QK0#23Z@ M[&(>M/,!8T*]\,#&Q9@-.M*+9\@S0)E6/W;(AYR$!XJ9(,X%I6SX!3R$$6#Z MU(\MDGYNMGO\4Q#%)1YW65I$B>.RKR#'112CX+&J:3@HA:Y&9M4?R9Z^>B<[ M!:5A="0C`BIZ[6`\GI>FDNJ1+/SJF1S)&MNA;20CC$R/9(UM<5HD&W^,2)8) M!^TB66Q6B.7YI/77A4T^*#U\@G'(^H(Y[DNTCV!O'\E'8[/02YL7^M?5GYQ, M5N,B_:FR*E_-,9]$UR=DVLI%/!%CBF*N*&&+$KXH9FQ`-8M6DUEYDYT);'9V MFM%T+>5W!;CL:GXGGP,V^ARK1'^B$;+6!26O@D01L3S*Q2OSX:P<*8ZB8/$K M(PX>"CK2NP3WYS:*ZX=SO0=70[;&;,"P3'[\JX-]NNQ\O*6+SI(6NHHOPT!3 M(I%RJZ+98E`%SLR_$N*(40=MG-N#\B6$IOK"M\=MYKL"2-99"AB4G[$=''PV MEE_[^(\#=E='-40*WX2!HT@<57>J M`@!*;02*OD].L-IZ5+B@IO);^@H$WBKD4+YG9#Z8EX"6H0=>)=Z9DE9K);6C M2^**E;`2F<84/-5=221_!QA13:_NL:;6;"B'%/CU1-WI6415)KZ;!B7II43U M%@$%TXV[/X0!RU6'TB8[LC<@@%060WF)<#::EF#$R46SKR%PLYVNE"Q-NSB] M,R4UM2-*[(J5>!+8QA0TC1JC:60&FD;-'&TQ'Y4'I1R:1@:BJ8V2-6B2JPF) MIE$S-(U,05/5E.Z3M[.=8JU"DSWUPUP&]"K=RDBA[4G<% M<+48RC6=L_%LR.M\(T)H0RFQ:XTUU_!VHT M"G!):F*ODTRCJZZ559:VRCV-2J]JQ[%<'E4WG0T6DRQRMT+@"W#'H;M*9=09WG`_NW3^\F!+VMI(G+EE&I8"O3QMKR0>;EAG@&/4!S M35YH$K8T\5\KC8,5QST1XPE/ZA&F4+BO'\K\5N-7K&/;4H# M'N8G(4)U3%:QH/E!X0M^#Y^^XNT;_NRYX:NP)O8THL:&AJ*DRL/>S#HA.E"N MB+-%G.]'"!`GV8K%"*A#JMU"HWV`J+2@^3'B`=-UP#7V[S;73K"RMS3&=>)2 MU92-C1:5XBJW99U;X_8A(V&-[C:(,V?IQ4<('*>;+8X>(_2]SXC1XVR!\XYV M#$=__CA!18JE]I%%;&+SPPO+F(B/=N)K"3%C@T@LH3(`QM-A^[C!IR"$W4<( M%*U,$\>&V<<)`D6/;X_[G,4^!M2?"/MNEA]2:D:#G8FH[-)#:W$BVAF_CP+W MYL:)\3[]6'C/N?UI@$]M]D$07VH`=AHML]&NVO1I,9K/YM-3L:Z["Y8^P\0X MGWPPG.?;6YUN+\,P?G'DUTIM[2"0':)O0,$,/!?%4G76X7RJMA1(#]KS2\2#8.V*=:@F_R!X'SXA(K;)T5':C6*,2K5]?;>B\@M_&>YN"*,!99 MSC`D_^Q[08OAF+]F!EJ9+*I>N1@OU/#)J!J'Q^:Z,@2RUR+-#$5\'5WJ-G(]Y:#H$M M]1ZQ@>_OF!Z_($J?H^4;]NT7G-46?4]W&ZIKJ"!'_98JYR_.W%(%-V18S]Y. MU^!XRLD&(/9^]C2;8,AL<(]]QUM371V7Z,I..J/@L-]OC\A^\3'O(O/5"5^Y M&SS%"WD.#M"EY^\]W^"3=>68IA:B"R:%"-0_DR3KU@N"._>3$_"PX+EW&SZ" M"'Q$_H[&T"P51/D\IS6(^E!3U>[QKP&=$/M)'K-L!BZQ8K@L9($;M[VP_)#P%) M63'Q@N*2E_11W:V1!'*HMMZ93Z?6F/=&BGUH'Y$BTQ5.2W.+I$XTRD6#F!2* M:0%T2.I$*ZOB._TI_5!@'9)J<).T2)(9`61(];SU5V70J*7X3:&!K([?5O]QUJ^BMY)YFY1;M`&@;7`M.G!L_L]I!(HR,X,4U^K2( MJ^9"HF8T`+"J))AR#\QA?(EFXF`TFRUO/*4LP&\QZL\0N0C!TML3#*$;D8V< MO@JVZO:$Q+:LWC'_#``VFU3WC>GU[P7L`=8LME?!4E-!-QZ$]8AE32']^6:W MMVD_L4RW/_XK.A&[K??U^OR".LF[[`N71* MH#%F:%1+&77C4;2HP\GRO4I*&*7RH51`Q"5$T=-,1A0+F:P#19EU@2`7%7%9 M4498F#3`U*_!BQM\'-KOR.$V_)YDIGT5L-1-Y$TU$ULK^)Y2_'-LIF?NFR&5 M`7)\``B@V1%&]Q>#&Z,>0S)L4D%J5CI$3VN/_241E*_+FD\&N3B=4`)?I.A" M,ZN%9GK1+'2U,O*J36$`2FXI)X)_25L#V1MP:,F*H>Q7@^%$@)B8'&B+@JY4 MK(:.@HI`^*ER0@F&2G8Q"$?2@UGR=^"QU.R^M^%B,*Q%$^CQJN[4K$.4`:>F ME!Q2`57`)Z*2#%1YSTKVAG9,58JA7,D^LJPNE+1:JNB7BQ)G;", M)+%=#,'1$WX/+PC+W]4_;_H*+)(2.90O\)[-)E(H48J(D30'3.VT+*#)A'4. MN=O50"=O!5#LX.#>=M9U'S!Z"@(AG+5J\!V/AR50X`!1$L`8:*$'<_M+.WA% M>_(J._`6K?D9LMA7\I]*O\]H#NKJ5^_VSG%9!GB/77L;.CC@-1%\]6^U\@^X M%@J*5""@HB::J@N.K-FX-+YD6*"$1UQ2%.V"<#;`<.O!%M$H%*E)JX?VB078 M@.6]N,X_\1JY.$3/V,4;)T0474F%?#X&?`282PZJM;$H,,R9 M(!?\R]3[2>YI&-AF16AP4\ZB`I[\^%E$"QR#K15C6+N(P:60X+972[W*JY,O M-LY\,IH./(L_%4"4J(*.(!J43`"*>AJ7W96S=5B`^N*Y:[P^K$):TIQ\]?9T[;?N4[>F"Q%)V@JK?"QEL2BG_GFF*,BA\Q6B#U^R8G1_;AZ8.ZY016OEX;4AT.!5BE7'DI"_0 MR7'5V8$H)S!IP)\POR_-^YRM?(. M;AC;!![QJ%'SGMXQ7RZ,\NT[B_DL00XCA6*:9$Z/8JHH(@LV8'>HK14= MJ^"*[<6*:1QBU3RR,(0JV,0L@)'1'CMOK3"6>=4(F*7RJ!=J3\8J2$LI`TYT M.]9ZG(.<+]40'G5E-U4#7L$ZQF"/KK_GMMT:#W,""M!(K!9+?3`8UP"2TL^? M[C%O&.S`!O&`R-3-KK09.SC*/;H6K1*;F0':J]U^ZQTQS959L';L9S)'IDON MRJXA(0$*6[%+P_A7Q,A/F:RC0 MFU"-O5N.X!KKF0%A>C#,)=R:8#;[#BA(,X(H)WJSS*&L,BHS%,U):UNK&>WB M2%6"PU>%Z\D!5;2#&0B*CFBZ+Y?VW@GM;7TUO"H!4&R)I%*^XV8R'DF`EI!' M$7T3BN?[,`$O@WPE#V+:G3#JK\V&OVTZ(OQD%C3K?%J.4ZG=#`%M^(K]1,XV MB:N8`BQL16(I7X(SGMZ[GG\[ZU< M=T#XUGEW#7ZE!NQJ.[/`]-['M$X\VDZE-5M,C$MN:_+/+YX;_Z/J5HK.R`)L MDYXJLZ)C3T?3>=3@.&*1S+R8;WM2;^<#E^8&R+J-(PY\L<5BQJQ&A,>'B!W[ M#>&>_AODLA`8NXU/\BK(W>&NXE!V)[D3VYN1*3UX1UY%VW0]OO0B:%Y4E$9Y M`6LZGDJB0D+6M"7WD_3-+=CY,26SQN14E_WM)&3-6B(FLX&4_BZJ^8D?#B45'W2=W)2O\6&1IE$>5L1(-AHL7. MQ!`LLR"IR&I[6-.9:MI"/&,:N\8TFI*04T)')N]H;6685$,J[L4QO0A:VORJ M&16M24@CT93[W#BF+M"'+9Y5G_FL/+F.-\*S&%"9ZU67I_/:IH; MTD"`7\61N>;FF<9DS(%X23;E>I?Y<*&,\:O2$`?5=;9'8\37LM/CJW4CO,'X M%CI]`X!7&])`A*=QZ(N]PS6=]YI3,@?G5>(I-X0S0 M[%V`E0LEP10GH,/QT!K.D[4*1IKM!:3$489ZWX4.LN6)'M0>&J)VW1&W/G2W MNM%=UR)#(R1GEQ743:NN\VKM: MIS0*`JGWX)XE!]M11%?830/XVOGN%8]`>;Z/%!>VR3#A_OE&3IR?AZC:#0:; MHKM!Z[LJU[^I%9>UXJ@ZYV"6EF#++HHUH-5RMSI;E3K#HD[9/?.84S.,"8AC M%Y:J+^HKO0R(NVJ)5-UPNA@M1-!CE+6MVC?%7@=Z\RMWF9;&K]8W\6$9,B5F M,P&<7W#8%IJ5KP("LTH>Y>JVR60B@B7=7#(5E"?K7!P1[6CAW,7`7=O4W52& M/J%]@+"GU*H9L!5SF_;"H_G"2M/)'KLH-SDJ>X(BXYPF6*R)1C#4MSDVI8TQ MET-Z^T;F$0#G;G)?Q<2:+`J>#7GG1DL%*B_%2K@Y?Y*]\$,1LDASLC*BA#!LKA3U3(BFN#O$W<=I*D-HXI?0_$ MGI6'@<`*H'!H<,F?^`T(<+2^`<]:#!:+(D:,NN.O&PVMEAIJQXWJ%7]RLQB" MHOK%:,DKL#AJ?/G==#&7`LF`9>>.E,QAR93Q1GF)N<8(H,BY=EPG>,5K.JFG ML_R[3=2>N38[D[P)@2.Q..IET.GELS&<8JILN8HO8=UMXH[BT.E<1RHS<"6* MOC!%O]_91`['WI(\C[`G,QUVTOP-^Z_87O_9"/S5NVXE#&NL!HI&(D[=1Z>/ M0."+\%7VJMEP7`32E^IU4(UH::J`RIASNOCU9SY:BC\U<_1B.B^$4(P`JE4;ZH:C(IK640HBBA:MAPV(W"_'H_HF8R`AJ!G%JG MK,23W"2@*/N[Y_^>5#PU@IGD30B MT\Z-YR@N\/L(Z6>]`U="LL9T4)CD"Z*\&7J\82#Q@LK'-:.O2@;U"]3'@Q1R MG%+C!V,G:Y:_BYJW\H<&C@8& MPDSSCD]X[^.5(SQFTN1UW4=@&LBFVGYN-A]%9^\H<1:(GR/R[.YC;X/L3,.7 M=8:%YA,Q?2D_3)2GA?8Q^7A(SG:[R;(`.!/3EP&LRJ]_5O?YP<[(M`!X)CS'8QI>=BJI_5.%17"J"\DS:>1ZDQ(X-2.L"'7$[7BB^[ MVF^>3_OD(789HA$'6*3>E1VIQ38``\75^][Q&3@_$;0.91^O^*AN2!3X*_O. M;)I#1$H&43IH"(B'4U3B+3&)(ZWIMIJ,'M/6T])\@.Z]_2GK#6BJ3:I7!H+1:+*%%E MGN,E5)-,)6Z*O.>D=>>G'>N:B0(IU3@MC7MD1Y0ALM&.U;6:?%JXW%,9F6G* MJ68HL$$UJ"E-*SRD>R`-FI9G3>:#408\`7C)V0EJ6,IJ:!T@2RY3&AH#\.HQ M+L;=YA8'`<;J)63U[VE'@$0896\:#?.@(&,()VI635FW"EM50R@\>A2:3H35R*)^8^`L7DI,*;(5 MQ2Q-Q(G"%)MTJBHK0'FB++/W.+$5Q"!#^4\("S76!CI%+\UA3L56)D*N+IE3 M?=T@"#:^-S"Y.5@!BO#981_:\X'O9GEQU(D8@1(-EKFD,F(B40=O`G6AGI=IA M9*OII@\U-4Z7!XW,'#"8\ME<4TCU;<))N(*RP0&WAR'I2JYC,%H)?>&W9M-[ST=GN2/;BI/REX1L7+ MP!`M2Z1\28`H, M9PH^%:NL%-X$1F;+@J7);#:2P]*4JJR.=6:(?.1#8T'E,WI@[N!3Y<%+M-1= MM@Z(IQ=P]8?"S_:[LSOL+CS?][Z2(?S2WI._2/;4&I``QJ5(+N4D;V#5`#3B M@!(6*.9A#E([L8($LJ9AM,ZAZ\`JM9TWV]FRTP(?;:):[_5UX*XQIRGP?J*?IX&7\.>!0)L9SKU<$I-4DWYQ$\=^VY[*CNL^W^ M?K?98/^!9,RWGNU6;U(HOZ;]1$*]3*I-#JSA>!"=2&!$>;M@2I6X%2&+?#HW MW%+"NH\B=*SD,*-D0A4QLHC218PPT&9-+QI'!307=P^@VS1-T9<>.E"T!\C` MZKDO3]C??<+/X1>BN[P\IOIAG4-JI03*'9;'PTF"GQ=$"2%*":6D@$;2T]6R M$K78B;XUH00Z:DK]*C=DBG6'`4007'IN2+)>[*X<'%P*DH"(:ODOM)\90WBA'XD2ZL5#\,B9M&2PZC6=)EJ,*E0%=33M=+"!4# M5E&D3B9%2-OUDS[0$0U^GSRZ0JKT(?-O@.$D)X:R4PVGHTJPI.D-)V@$9-JK M6)G!G:GH"`.?2B\48ZAL&`@@?;9_\_S+0Q!Z._)=)1.HB@6)'Y<<;M(O%0,]4#O1"!4$^EP2%'KMSCH;E(B!F!R("8(B2="3AV)9V(G?DC0H%0=@FP+8I#RR M>KN][1[_%*2>>9[Q3+!MCMZ"7+(ITH_U81(;IHGT?%C^&:WI3(:Q>E(<[S/& MD(<]^M5>"4M5"7WY2X6SY%.7HJX@/NVX]3Z=>T:G3V<9JR[56XM)-)>-7H?V MZ=9*6*I*://I*F?)^71)UVXR<4[VG@P(-!-]P:Q]-!U/@@>\PLX;73BZ)J+F MIP.5N4!+4MJSZG9R-FA!'O7UC/UKGW"*VH\S7B1-CIDAZ@MHQV:\JYB?[N18 M@U5RH2/E%+6EYU9)F2'*#176`2!R7`V6L4[W%[@\][00DF:S)]@99'PGF?;Q ML^W_CL/K@[N6-S<0/*QSQ*^40'G4'$UB_%(ZB!-"C!)T%G"Z8E8+Q;1E!E(W MRZ4(8D-`X..+O2,0SH%5NNW/6>'UQ_"7`ZQOWVG%M=T4;E(A6NEL0 MT(DF9:E4P_5L'$]!:>-X2AS%U&G!'*5/[R%,./2^/%K7PZTG$TQC$ZRH"0Y4 M[0V),IM$;UNJMS98-O;K'$Z;VX]M!&[R/G4!4?O'C"6-S%0%X2%=( MI3HP+:R%I0#EA(.I8_.I)A",S4ZBM]%CL\2O%0`LLIW9P&TW-LL(&0GDQJ/0 MV)JT!+2I8W-75N%7%G_YV]7CD_ECLX+'MX.VJ6/SW1[3-DCMQ^8J`O"0KI!* MN4W`?*0R-B<<3!V;3S5!?FS>QR9X/B(O4=WHX5GBV@H8%IG/;.RV&YYEA(S$ MW@[8)P_.-N_)VF!ZF$'M" MYAF]P$P9*S>YFHZF*>;X^X@2`(-12QVL6`>'O0\VR+<4/QG'O]^25__=JAJ'BQ64IK71HE-U\]'"F-W$AG#,1@L5 M\X#,)3R:!.UQB!4OHY2\H'-V()1"O0%)?"572LN<^R@[TL^*]#N/%4PNI33B M!$>]\^4R=KE-@-"3[([RV<35^Y[>_BG^K(+G]6*G6@CU]5EKFD`GW1V.IM(1 M,:!)Z9>X']\)7[",LUDDC5N2N5H"*Q`Q&(:5N"[OV/1.0T[12:C9>U",( M?BNZ4W7YSC.#T_<1GF2[4^"XDNXT*UFFJ]G?+T%RIE=\!4?EF"Z!1>D@[.(L2J,[)%Y/%;!A!D]&@W1=P3$4W-D_3 M8IC1XFZ#$BH0F#Q-$TOP/>"0*()!"L-*C4'2T4B2![SW_)#N_#SB%S:C%.5" MXA=T)J!"*513L<5LOBB"(*6&8G)`"6R5]\3GDVB"=E>WCOU,;RQU,)F(R>X!K'E))V:DDBA74B:KY7SQ*R*(,A31 M)>3]@!VJR2^YCA3<1K2.[)!WB%>OKK?U7H[D#RNZ5@::A:FY9@Y<]6:"PU@0 MX#"HO6*S^EGMB"H(H-S>9[(8YX#$Z(!?KWFZ3IF5<9?NU7(2R&8TX4$B\*TR M-JIL``:)")<9I+*KGI[P>WA!>/\N^YJU[^J&3)U`JLG.=#0>9B$4T*65'%PH*EZ;`EX2D;J9*5;Q$X`*K5W=*^#UPFDO`Q+)@\C MOBS.G2H.W-N4J.;%\6Y5JPD4<"&B!UW-BPV-`)3RX:__8+$T7OJ,;0")!E+K7#Y>J/@^/C]0.VMU=!:(?%]]M5`-M7UD_%@ M,!SS9;`,]>Q=72&AC^R(`?()!X09"\VK8[TI/RPJG[G"C=)',0-$.2#.`F#) MK#<#6$4#Y#\Y@2W:V"NV&0RVE-8"UX2T).^SC;C4;#K$:$ M&DK)09ZEZDJ]#+CSWPNMO`"X^%`14ID!4FH3N/%07IB;?T;[R->P5'5JC0=Y M4)@PQ+51PE)50N]8)BFM+>O:T:AUI(/#W>:+%V+R#]Z#[I$FDLL7[*Z.U0&H M[B7]8UB-1(K>,:%EI/%(QDC2`SPN(8KVG"IM1\CR;&0SPMJ'MBX5'685O=L@ M2A1%5&D/2D87<<+=ZKG@>KKXA?9XE`QUG:H[;O!A`4<]14AF!C\5*\&,@4RR MX-KS'_">>,>K'>"[3:;'I3"TU[ZH=;2LDT9YZWL8US7%-!$ABE*J%(;9UJ]0 M(VNG"K/A-B444.QE>[KJCBU]?==Q"SWU91BJ4,RG'4H6ZC(7">[<6TRY/&^= ME[H1O^)AH-RC+(ERRT$R/"UR20=Q'!=M*37D)>1@,HU3U9 M5YRLW+CNHT%G$6(P%;,'@2T@LX8G+UK>OC@$CHL#$E&_8)+FT':K\<)W3617 M(@&02:C(I;RC.I^,"S@CN7M$!:4,$&VO3M,+VL,U9@*;7W1NAN32%M:HEH`D M<-;L3*K^0-/_)Q_S*ECR:N!0#6FZ<>%X?\5;Y_T,N9C-<9@A;,G7UIV`-$%U M52JB;$GDZ&DA0A)H\8?;;3E7`P!I,=V:`(3C9'W\<&H-M@6*8Z&%!K/5N*6+GQ MNIF])W4I=YM;YW>2@[QZWOINL]QY!S>D]2G./_'ZE[WG/N(PW.(*5+:GHWW. MWT)(U:GE?#Q(E@/2,B[BI=N$$?V7S5BQ:C;*"QWV=)4IX:9[M:!W@PP+!B$3 MF901_1=GA6)>B#)#*3>(C?K>C1(MK%:[`-S:PPFA(%V6:&N\;J*9YU/LWVT^ MX0WVR8PBN6GGDM9&W+BK[6%-+_>E%_'P^M_*_/Y$8MKC6EM)E2M/AHMQU,HU MXD5CV3KBAC;)/52\!,6)&-(SGBYY-M^:1'>,TV.<8=8X)*[%W#*7=#%^*&9( MKQ)GMQ!%QNEC,J46[_08R&KI/08TMNDFMJ0Q\B2#@\S8_$A2MG=T;_MW/MNG M7O_-WAXPB?F/K[8ONKU$\66=,S4EB51G*-8DOI4AHCY-M)2\H/02&!2+DBA7O4^2$L<"!#E%E)(T`78GJ5D-MX#K:4OUA`&; MR"?%(*NTCRG@N@F"0R-@12\`@XI+H1S8%Z.Q%%"%$B.4#]($.5] MKPY`&9N8`IZ[0QB$MKLFN6Z#CYM]"QA&&5&42]>'8TN*I0Q-G&B?_\L-@ M,*R:._TKFIP-!H-RGO>O=(T$1^,5\OPLQI`=HO\XD+^.!F>(.A#;*?N$5^PX M"AH-V6\MZ+RIEY(UHFCZM*+R2*% M*"6:W$9)MZ5SC;=!>Z%TK;*553FZGI(?H\UW_X-ORMW`:PO`4S(8#!"]%<;K MX)HH2G-=FQA!Z91*[7M:05@CC*H_SA>+9,K&22)*$\5$#3FBTJFZ5DY=ZO!L M(&3JFG2(0]51\\A3L90YN.,Y\2_N&OLW+MT#=MYHO&"_OK`#O+ZDM["[`=O% MI!4MT48'O7>&JG.W9X4]C?RF*Y[@>.]($>6BJOG24R802H=AXSOZ$ MF%PH*QBK1(MW.-F-2"Q+CX0S*>!`V)L%JZO=?NL=,>9!"27G!_>$`"_^WD<" MFQ>P.D9X?;#K\BM!!\I'>TLT:ESIVH`"4!"K$4LYG1Z,)U4AB9*GX4A?M6N; MR-*E$2J2&MH)+:"&($G-QGDG8=>$"45CYQ8A7L5Z0/BMEN@+E@!6_(I>A`KE M4/3&\6`^'2:0%(*/GD\#`V`W.EI9'<_86!SFB\K9T`R,MEI7+,!+;IMNZBVC M]*6N>V#-P]KK)462J%:T3LA**YT[$:M(8Q:-46*W>AFY74S MI#6B&I;2^D&I+3H%-CV?N7=">YO$CXOC#>LY3JL52_<%R;Y<4U)00:&AG*K^ M-YQ/QE8^9/!SOHQ7.M*@YR.M@.7L#+@;3(M9G?-\I2*\K@R^Y!39=#VO'YC/2KN>9I_0[;>-FH6.!O/A/.>Y MH/U.VRJ0]=Y/WLYV7'C_%7'%3\K([BADIXD3!>,'W`0^LXJ MQ'R-^!?7J3[:UPE=W0EJ%T(KYA[#P6PVB4XS)VQI\B&\TY"?8LUNOOH)>UZT MA`Y4`,W9JWZ;#?,V([FL^"I<=M8YN^>6LH_VV)@``*FM?KM9W?L:6-[;9=A* MDN#./DE'D=G9/1^("]&0E1[ZIB+<^]YO>!5^PF]XZ[$LG1YKK/:RID3TQ]R& M$JHZ_7`R'<_C`)OAD;T`B;GYGK-!ZY0/.R>K/9#V:HAAV1"9IA$L3D9L4(8/ M.U$-$AU[-8;5WBL`0U[+>)");VV,VGTP>\!;>KKSR2,!%!/U7Y?N.L,YJH2L M=0M%,J`!34U&Y>:JTY$UJPII/F=#6[7[$2.VNY9UWJAV%C*J]6&-BK@6L:&= MO&)&;$,U&]7'I^9!DD MB>6I(:\=5=`(V$IDQ56<^6(RL"KB84"\/&:*[`#9Y-_QM,?P$-F_NCS>QQW>-[>>^_*$_=TM M;9Q\M[DDW],1%:#5OZ=S[;Y.&.4CD]9L$L>&?7(MP091HHA218PLVSIFA*$: MH':L6W[YXF,>&L15 M:VW(Z$]I&LNH.L98B_$TSF$$X\8JRP?9"2/MB4J_1ACFC%#,-W)\4,H(LF:N M;XM8);J8\6HP'LQH`@TP8NE>R MC,E,J(9-%Q03=W6;&(?F,PINFX*K9W;SSQ72DAB[H2IR.=9:"S8@+BANX MJS+VX$>S:%^;71WDLO_0@M`W>TL'6_&WE[^F%WM2691[(`QF:5X:%T#P>\+< MZ(<,53#,=:>K5="5WY)%E[A6WF[ON9A?$+PO-&0!1J"2NQ;@5V\S6.RQ\]5U MXUW%LR`HRPB@&M]'BU$96KR=`?@8=J)611`%M5KIQTJ%>U4#I&@$&%2$MN/B M]97MNX[[$BQ7J\/NP+;W/N&-LY*LU=:^J!4O==*HQNK)>#*,P<-IHI@HRE!% M$5DH('6JKI53%T=$8=&DZI9Y:"F9!09G;]@]8-HQX&??EJ5ZQ>>THJC`7/T6 MPE%2!\=(\/X7G`@41$[1A2&"=FBQW>.?`O1"*2"?DX3%A<"-\C"H4AW0ZZ/- M2];IQMLZJ^,3?@\OMN(N=_7OZ4>%6!C5#&9LI37V'"49FH@31;]2LHC1!-'E"0OO:&_#(YG]WSHKNHPA*\,3 M/:M])UH@B&J-Z&PPF<;[S9P46U;=I7GU'A*>`@0V>E]W>&@BG*H3+B:+651FRWH%;BE]]$P8 M(.+]NS/D<1YHX_GT'(W#+^+%,1_-P:0_$PP3$S#ZB#+@M7$1"T1X(,Z$%LHE M;``B3W]6X%U6Z;MKEC1P=_#$+6BU!)@VJ$Z"3F-C0230B9`4>4]DRAS8K+[V M$PY6OL,$EG1$47U;8_JM*)+J1&XRFLV+$&5!*D,:96B#MEOI0W=+KON9HO*Z MDOV&_IR="S2QGDE0_=GW@B#NR]K0,_+O&@#3G$#J=WK$4V@)2!EE="]ITPT' MT/9:,WA>VRO:2^"(`F\+>OE=(Q=5P5[9,"8A[]9Q\4V(=TU1E[YG`.(2891[ M="V&@UJT_4K)(D;7L,&PG;XUPV"MOM`(++FJ"OKRIC()>9\]-WS='A_HK'4; M'[1IZ`C5-`Q`9*5@RLNRD_C(E<1;(PZ(LT`Q#[.`>KH9&&CYK'HO41$:FU)G M5L&IV%(F8?:+O<.\(5Y#1\B\:``Z4VF4-P-'PW$M)"E9:<-`.""VU+AVYEBK M,C0PRQZK@L:"N8R"(`Y;3A2S;YH`PE0RY.`R!KW-NX*1*L"L8R"3S=DXH5A,:8SF'5$%7:ATH7%4?]J]Z0C-FFIW!MJ:3108A4"?-3U7`4E-` MIY]7G/D6:0GFPU&]T<^>MP[$MY%5/JK;JPO\E2?>T\4DZ]YQ_2.C`W?IV,DJ M,8=_\NARB2^IT]/J\`)O*GE^E=X=5;VXGQS\XL4;$.)^+((G]5>R5(FA6JHP MFD]'T[AFQ46,$MI$I+07I)RNR3"O2;*-!-C\I`NUK.H/!-_!1`Z73.&(T`8@ M`]<*N[;O>/(:`+C7O/#_%:GI'5O:9S0*N113GU&0VCE@DQ19221#%- MZ)2N2V6MK+)G](AVK*VOHJVVX5#11W-#HXJ=(`'WBQOL\2;U<_7%P M?+R^=EPGQ+?.&U[?D*30?7&>MWA)K^"^.'ZV?_/\RZT=!-+%N9-H:H7?"8*J MC@B+B15O9$7L:$%RS!!QCHBQ1"E/Q)C2FR`96\3X`J\!:K.6E;.65[+6NJ-T%P!J&S%.:$\@6O!.N,>-=NZQSR[JN[`#9T4; M+SK;`VTV+R@-;TM%^T)Y8Q%5UVCG4VL^CA;1,S$@Z31%^$2W:#).O"Y1BHAGVJ%FL[]DH5B]&T;/4WSI0I-L`[:RK-\Y5S7':4#`VOC7( MZ(?#X6@VF[:-;3U.<4X/:RW,T#*D0K=%RT@&-\D[(0HT#V"F3.U4Q%2? MW36C!C+!:R2B>FUDU2JQDL,SAD;-]/JS$`L)W`1VQ@17]X]F3--:@:%ZIM;< MB,!Q8+??>D>,'['_1F;=LP6A@8(-QUCWE!,.SX>WX3H5(]J>J8WT<.F0W3CM%P M/JR:E74>-@W*W@`-G?173.P7WZ;TD%ZX:Q9R,2QCZLDL)]$:.]"WU:KFR\1*E>8%`B^'R-\_=N&OGS5G367YJ+X?.\E?T7`D)(N(Y!<-CQN\(:)EC= M.&'P MX&VWUYZ?Q'+U`-B8($A\:RJE\J+G;%91%YWE1L+/.XKY(A.]NU5L+* M*!&8T<"NREMR""@I"^/46T+S9>FN/]O^[YBNQ10N+B]](^$+6MU=)(6JV\RG MT[C%(Z?%MB43:G%-#A00.E$OLRY)C_7M8EJPN*ASN#Q(I(8P"S'R%L1UKQF! MGD9=>4?6;&0I8`BZ!W&7VHH@94;G84775$-8Z\[#HCX>V'4\_]+':R>,VXDO MU[\=`C+7OGIVPK7]0">)A:_8Z%7MG3O4Y%+M-#-<#,=Q.R)&&:T8Z:1M_!FR M(^KHZN+FZ=,2^92^[G;_?6@]S&C-2:=W`"P3I1EUQ,A#=.7H0W%+K+C@<\/U MX&B&X+3Y1@.[]19J;ESR<7$07GIOV+=?<*-@4_VR">&F4C+5AC#CR6@PDP<< M)Z*/5A$#8T).!YK+@DY,'L7TC0H['2@O#3R"SVY4Z)$B6AI\Q-;K+?Q(KB,2 M/VU"@&ETZ\UP,!J/1KF(4L15KY.!1@&DC6:RB`%Y55%'ZDEB@@%7%M7"2@KZ M?N8SCWAU(&R:@5WV$@SF)1*IIK/3Z6@\ST$_X$2+205([M"9@MD($!$U+Q)T MIJU5_SE-"0P*2"S$ASHK@2PO5I8:B9:VJA_6N918*8'R*O5X%B_""ZKZ@)8, M3]>*`X>U5.&U M[,M%1!D9$1,242FC4JX`<3G)4U$#*9/B#O!W8)'L@L]A(8*O7R?8-QNE9I M]7OGDC43H$".8EU0I`Q_`E%U,A6^WW:\[_9[L@$A)GEN1V9E`P):4[-NJ%G? MXL)I___'0X=R=(,86]2\XD,-/HGHF4KSN`/3)WHJ$[OK!Z)BUWA4YOL1!@M5 M991KG*?)LMG)@T#F3$;V)$O292N6CV[6?;2@WHO=6;!.K.(+K&)\W&T*[$[B M::,/`A8GG^LU>VZBV1/V=T.9;_?#4'=D[$4+Y>-FHUDV),J/X281L>H0;EU` MI&*A(6`DA+VS@:C[QT7';'M!W\&#XJ]HK@4#?O[*-],NO@W M;TO(T!TA&N(_.ZZS.^QT#OG5`GST!+)2*U4XCV?CJ:Y,,A64Y9(H$O4;RBE/ M_Q0LLF8,]4VFE])`T'N>*?Y('S[2/CC![]<^QG$UGN8X*V/_4:.L1"?E=C&C MZ;CG&$NE1%3,M,CV&PNQ77T'OO=&B)UOJ+F2JMQO*M`JQ('>PFS=A_I00?96 M<-%[AX0_0F"\;7;#-YDECA>=+5#"78,.9#^W2-URAU&_=RGPTF?4>(+_)2B,-WZ5A/5'P M;<=AO25#WUIAD+`1+^_&2^1;NFO:D_*+O07QG6D_E$/=S6 M=.OF_T_E8>V%6#];*A)TLSIH^_)M;5X4&\VA3>A[UR-"&T6\MN8'"6LAB:XL M3!\",N$/@KB5X?+=$_H##0R093OT;!F\:Y#3`[%]%#:V)&2A,)[9VH6 MFE4*==(&617ORV&OUA2@(+K;7-K!Z_76^QHLGX/0MU=AW3>M>@4"0A5RJ+>G MFTR+"+K;($H/,8+$TR*2T`@Z54LKKZ770$OMF)(X8R6D1+8!1M2UX]KNRK&W M]U[@L)%6&5GB5V$0)I1'N?1ENAA5("VABV+")B&N&ZW+R&NL-0`":YU7@$2Y MS4`1^;C"KDWFZBH)8NY9",QE!5"O+UL,BR"+Z9B1![;6*KJ+J587[4BIZJNB.A MW/E/4F9*E>'7'@892G]"6*B3/A"(O"F/@$K]S7#_VI1,^`(H')HF(I/A?"J$ MA0$I5R?Z647]8HS\9!9(Y)F4U!1F@.:+%^)/3K#:>L'!K[_=2?E]4$@)A%*^ M]WIHS<0(H\112MV$:YIZ,4`%!,5#+QP":QQ8#DB9G<#P>1,$![S^=/`=]X5O M2+*%_$!XOYQX!M2.FF[L-A=1N7II/,BFD(AS0IQ57+?`F4DOD(2J^])@'0;S M2V^W\]RHM,#A1G)<1`#IXA5;U/CJA*\(QR;B#^YC$^T)'_"HT!XVI1C1TN3& M18RT:QE[C.W\22M0VQ$S)5X()53?GAI,5<-%IB,%N3C+:;1HJ(GDK'!HQ9!RK%#_@&,"QWLCW?Q64SLKYP` M"UN"-B=D2LBHE$[YB-IT.E<-%]F;D^DIZXB5@9'B=),(H\3Z@%'H(1Q1+54S M&AL&I&A0#@%BRX+!GTLCO[FO])QN\&:9JU]H;@VRV(SN+`>^BN\D;;(%;PKJ M:`5.E1^5<%'2',SM'W`\=[GWO1??WBT/X:OGTSN8ESOOX$K7D.M?U@V06HE4 MP_=D-A]G49,21A%EE))&G#8@E+K5F^&+OX?L-]O9LEO8#^X:^RR7#5B)KI^: M9,^9@H-/V9M+B%0S(`A,#_O]EFVVVMNX(NC&W7C^SE8IOU%\6R=0U4123K3& MX[@^($,X+01#&=KPFT(]Z,Z7IW^YO[^]^GSUY6EYBS[=/%[>WCW^\G#UB.ZN MT>7R\:_H^O;N[^CFR_7=P^?ET\W=%]CMHV8^G4-K`PMVSG& MZUQK\:U.XH=UW^8DE$3UVI^%-1M/^"U.*:UDI7.M^>ZFCM09%M1)B$'>U-21 M;BP.I`J%J9;@]S+58BBYCTEN"XCQ-]D+JQEIR\]I'%-+S%5'D*$5[PNEF[?@ MH^1IVEB-M-$UY`G=*#NX52O>WNL#O/KAQ7O[<8T=[O#DAZ*?DU_]X\FWUX[[ M\GCC>J62U@1[SR:ZIL^4(T"5S!1_,A?D:PT#`Z!=W[=!]N>=#B-=7MN\2 M9`?++>.(UT_>O>V'SLK9VW07D]V7Z80.%NV?MZ6F$7XM151-11:S670V*,<( MQ9Q0P@H]>2C'#*7+&0XCFB9Q1B M6^GXK<"RX)NUV,L:JY.5PU]<3$CC-6N;\X#?L%MJ!"9^3O=Z8940BGXS'\WG MT4IA3"5JVN1S.IK7"D]699A3A3?OBN@`+`^>K(XE_C)@*X(R;"2+@4+-8<8_ M'Z^\%Y=N"3[9[Q?8Q1LG%"?`U4]K'?4J15`?#*:S&`DI(40HH9A4+V#8LSJA M*[=FM#M=-S;.$3YT&'NVR0LK,M(%=';Y'P<7H]'@#%%7Z%')QY",I7VK.:%J M7N`7QW7+FG["*[:ZCD9#IJT%LU+0A9Y6R55#XJK/$E?5EYU((T<^,1$;PJ"@ M1]R&+F&P6M[#EB:"UT3C1QR&?&LV^+L3OI+GR1^B.@KI6D&7/.`#;#O!%7U] M/!C4AF642(`2$1"5`66$0%0*Q,5`&3G@YB]@QF0#02$M;% MD!1QCP\)T)<2`8Q*1OHT'LM=4A/Y>!NOMJPB\]#+*5E"LY<9!S@JM82;0CAJ M8WSCX]`]$=OO)PJ)2)L:@P3R*H-H.+1:1R#&^Z/&GRX,)XX^>V::#QQ[:B#6 M.O+(S&Y0W'EZM<._>X?M^F:WMU?AU69##[&_8?)(]HYT-0>L(P8?6VHD5`7% M=#(9UT43R@HQ7H@S0PDW]N"#X%X^L/#1I6WD2RTHI+;YRFSC<-O@Q#;T0>@[ M"T\#BT+,4+$U2)0(\-WF*@B='9%"F&?D']*)ZAQGY9K/^23>L2&S][L-2B@` MX:^]%E:LA5>CA3:D5#I,#@%E;2$\NW!1R9<#7=2.-G1Y@=7=(0Q"FZWV+]>_ M'8*0KF((/F%;:AJQTE)$]=9S5I10E^XRXJSBXTC###:7L8!"HPS8,JHPF M'=7,J((X$0196)]B0F/P?[<12=S$<214H/$N%DVY#?%\,)'CG`RH8J@;A.^. M;)%>8AN@0\#[^:PC_??$'/SH\\K>K@Y;5DL#TWZW3Q-,<^X0W\*VBBJNN6F\ M3+@_CPUD7.RK#P"U,:_&I@;%NI*`%W;@K)KYCX`&?)RK%DRYO=\L;D\DB7(5 MB0QC8E2,Z\`.51'NF5+1&-^(4L\>E`&&5N,`]RQR!.#P)L>\0G"3F).#/E+Z MEM`C_R;_(C_06]O)/_X_4$L#!!0````(`/:*_T+B3^!AYS4``#CW`P`5`!P` M<61E;"TR,#$S,#8S,%]P&UL550)``-?@/E17X#Y475X"P`!!"4.```$ M.0$``.U]6X_C.);F^P#S'V)S@,4LL'GOZ=DJ=,W`<]+@2'1 M-BMET:U+9+A^_9*2;$DV[Z),F?9+=V68I,[Y2!Z>&P__]I^OR^CB!28IPO$O M;SZ^^_#F`L8!#E$\_^7-M\>WH\>KN[LW__D?__Q/?_L?;]]>3*<7USB.813! M]<5_!S"""KB\F"4QAG(&,#'=QC^+OSR"%__N"_F]X0?[TWY?3 M^XM/[SY>7"RR;/7S^_<_?OQXER3A9LQW`5Z^OWC[=O.]7TO*?K[XZ[M/A+C& M+U.?/WS^^<-?_E^S M-5ZM$S1?9!?_&OPOTOC#O[VE/2ZF[Z;O&DS^SXM''*>D]7(%XO7%*(HNIK17 M>C$EK"8O,'Q7#1I5[%X02./TES<-#E^?D^@=3N;OR6<^O]\T?///_W11-O[Y M-46M#C\^;YI_?/_?7^\?@P5<@KYQ4*"D0.`%MP7]U]M-L[?T3V\_?B)(OWM-PS?_03_XMP1'<`IG%P4-/V?K M%?SE38J6JPB^J?ZV2.#LES?_"&%4(/_AKY\_T/[_;_01S>Q!G* MUG?Q#"?+@OHW%W3\;].[%AO_R!$9K5A$6;4DW]-V[Y6&?-^5\"GI^?LC6?V0 M?F,\NT4QF2X$H@E.$?W$5032%,T0##7I5QSTD!Q,0`)UIT%CY&P!,Q2`R#Y/ M=T2^+>$HRF`2DXE_@>9,[`_5/[4=<6>/UQ_:5R!=W$;X1WH7ARB!069.^OY0 MG:F]1FD0X31/X&.^7()D/9X]HGE,EF$`XFP4!.24RW>,TO0%)3`A()S!Y7)#E89=KP\\=DN%+D*)@%(?7 M*,HS&-Y,'OOCEO$MBZS>Q2]D[^#$^MJ5#MP/$]LMT_B;#1Z8XUIE@>@<<_0< MP5&:PBRE&EV81Y!^L/U+!VZ4/]$C8[97F[A%X1A&9&)AR_FP,@N9G MK*X$JB@1R]:^Y)0,W`\3V^7S+2:Z$R8*QY\P)+]9LF:*+E?()XG8+5`06/MV1:O)E\[(+N/((+I$Z9&[`L* MR=E]19H3"9H0N_;F-8!I.IY]_#">/>$,1%-(U-%!`NR2B8)"N`3?H#9T\8NB,,]$XN.070? M\I,-!;Y'DOH!KC:;)PF^I;.T=55;7@Z*7[+CDGW`&17TVR]L_:HI=4"EE(8Z M=$>`%KHDG^!K=DDF\[LF##T1,62$-G\8!%);8OI&;-?):7_!\+_@C+>T'4MO.Q/H_`C+CFT/)D*G^J?V_:IVN^TRK\U`'ZM3[+J%_OF MG>,?M3_1T@^YYM3R%"M^KO^U7?E<^]W$@H^XY-#ZMI5^JF]NK^%SUN=4\L;O MFZ]]!R1MVR>GZE\<#.^6E[/N=_O?R6(79!^"2_6+@^'=NDC3^V[?.`B\KWT* M`\W/]HU"X:HEMOL]).IAKU)0_J6^>=TZ<>N/]Z!^BK_2NU\H3U%,$";+[!G% MQ<;JA>A!07I`N.0)F*7?Z7?MYA+7E!`:"!4 MM3Y;>,!QTIZ"ZJM%BGT*@W=S_/(^A.@]G17Z'V_+JPP?JP3[?R%_^GU$/AW2 MS]]&8+X9+@+/,/KES?[O[WNGI[*);LFD@.CO$"0W<7A-9H]!&K>I'I7["Y?^ MY??=Z1DQIF?T3`Y'0'.16\3I]^\?UPT9)5H3F"`=534J MZY:'H[%$AK]`V>T.1]\3&59`5O%S_]24J_Z*?#"A`:D0OOY?N&:0Q6YW,/J( MBH?CPN8IO.3I.,_H+2EZ@XU/K*C3H2B_11%,KLC*FN.$CVN[U:%HF\(YHB(N MSA[`DK46F MJA;O5\6EF;?!`D5;#6*6X*7)&;*A!C-V^05.B!E?7,S\^.'#FPO"R`R2TS.\ M+WGF$EI0F<$DA45+VA/AA%#PRYM/;R[RE#")5V4NPG'"M*/_U#A].N/$6DX[ M9UZ-U^X_5_SG@U\>([+6K(?CI#MK_$=FR7+5I$23VCM;\AA39J#5[? M*O[?WN^Z1'MUE"H6K3`V&F<@?2[@R-.W4(HRS=_&77A*S^_'N5(IE. MP)IZC"LQL&-/2AJ;&[O=Z9["`*(72LT#S-2H9W9QQ$.2P[!Q:_`!QX&,!WX7 M)SQL$_DG`!&ZKL`*96#7(2%K[83RZDXRF]#F+6$7=''\\IQ&[NB4;+E6&^=4 M*H&ZV]9**(81M-O&X#/R7RDY.)+JU"E3Z=9L9+N.YHH;(J;L,M08T,6ZHA5X M:"(%^3^:6?0"HB*U(KL"2;(F=!>A>,XZ4^OKA"M^E@B/%T$/5QQ4"J9P"G:; M6=D7U8*WF M@I>;Y2K":[BYI-\@3#PG\GXNN/F"A8HE"AEPL$&QN'WB[<2RGFH"KM M-D1>)`JRV^"QZ%/`2IVW4,/DL>11@:GMM:UA\ECL* ML`@#4S5*?F58:Z.D9/[7:/F59ZTOD7BXF"14#_]DTXT`-*$2>:QKW/Q*K+:" M&\=37F/F5V9U%\R4XX=;\#[Y:?D;@]-+$\KJ='S4]'O@IXX MW;E&SD_=OPMRHA!:C9N?QD$7W(3IC#5P?MH+78`3M:YQ\]-RL*0AR(68PJ21_^EHZQ`PQH?%L5!]$1T\89'V020'Q M`F8H((2ZO5Q+:!DG!=EA(1CJ^+ES6HQGEV8(LC3_K6>1SLM=C M$!SA"4\^O5*G5Q?SE$J2@_?W>%V\-N74KY[Q6WBMI&*OGO';6+&+E[HJ3_<%#@EH\'7 M\L@6P1.)-S\C\=9`VY=MOKHV+0'&$6Q].SS=>5W*I+111,BE8=`7Z*06ZY+& MK/\$9=QZ][(>1SF6=')CV*<$4GJA,'W$$=\5T6[EBE(:,JKN2O"+W.TT&P*M M$J.)V]Q)#;/*[;TY\"]!B@(.X>RV0Z#Z&D5YQO4<\%H[J;(&8YB`B$S_*%RB MN'@R@$JU:C%P.)#UYRFM^2H*Y-3<@+S>%4EIJ27<(83V,@J_HKB MXI@ALA"2@X->BF^/4H83OD*B287TIEU:IHAR4#DD!>X0WIZ%$K'":^V.\*M!D#\E7:X-_D&#Q+3.NQ6VLVK7:;@"_"]PIL& M6@?U;'?5*N5ZC7TO(*>SD]N>TV[%XKQ:/9Q(9K>R<5ZM'6[4U/<2<1H8 M:7JD?"\4UQTYOM?2]SIQR@&8W?JR[*B>[RERAG#MA&O-4N)^*E&*X;PHX^(? M3H)09K?KP,=Q=7,OB7``%S9;_OVF1TTM*Z_5PX/LE&$?;L+I.EQHQMT.HG7T M;R/\([TCIW<""4HNTG##/_+*<'["4QC@.$!%G?K:)'K"E-))@E\(3^'E^EM* MZUIN_4.C@.S^LAR)Y,7Q/CYU?@[[:+CZ_=.`^"(&&Z)NHR"A%=.N8?G_6NQQ MAK#SN/8"Q'.BJ3;\8579P!T29:U=/DBME[(HZ^6&$W(,!*@X!,A_1[`X2F,5 MW4*IJY-$[]<`$DD+7BM@J2MUX]V!X15>4M0+\JIK-4VYRTL'[S3FL%%@G#Z= M46"-Z21U'J"8GKOC^!JEJ^KRU'@FO(,C[N,T-9J*/<2[LK#;RA&EK=BJY&\P59X1A<,@ON:O,HF"(8?"X>61*AZEF MGV%PL3TWJLIS<@^!Z@`#X8\6EMW2:+(0^2-8TQU=7E42JA&-)HXN^K"<).K*NL8`P^9/=NM& M?Z`!\5M&K3K,)VN`8?-G-I^B@0;$K[H9J3'`L/DSF\^A>7O[OEC)T33H^4X# M!,IB3[67+>H"\AWU3:S:RPIU1(4H0RP/.(.5/O&$B]#+B#Z)M&81)^_DI"9B M255ZBY,I7.5)L*`/?,P:16PX2U*AHTVLTW&\]_8(%V-&8Y?8/N%1\(\<)?"R M>B$$IN4KC-3M7_["K:"I,\0@>%2LM"/O-PANR.%!CHML/8E`8171\$QQ(:2^D]+NYKLG.@UEA8\I#/.@=,PW_0:-[WQ;X;A>*E-R("9K^H MUT/>[^*$AWRUB@J*0+2AZ"Z>X60)5,H[*_9VF<359TY0^X5AE>BZ[TFZAT); M$NOU/\OW4$#SA+/OCP0=3FQ(THM\O^I\**`[YLB87:8^)HFB'Z#=N9NID#YA M=MGNE%%LA?K-[N'Y#Y\TR_0$KN&9PF8E"<#LJI[_"U,C5:Z&T-MJ'58!%.5Y MU5CZ6>#+-I;[>2XU@MY6^["]G7EYE364?A8&LPVE(&VNAM+/.A_FV4+;XUP0 MP:S1TZD%=:I#]-(#L@*P0 M5]L"^=E72\?>(21*6:IQ]-6?9F=)ZB1(UYCZ6=#0//F6=;RKI-V8E8CT8)5V MQ528?&962O*,*B/=S:PZY`E"J9.]Y7LY23N0ZESU\+T,I?DU`I7:G2;E]X^B M2KH=V/J)(/M>S]\.]CK./]]?BK8F!)1O7/GZ3H#FG:&MW6DG47B+ZE_\BGUH MWG6JK7G3-/(:2#_#<"H)P&9;FR$T/_NU&"UC*%S/-89^'N66,!1*VAI#/P]O M70SU"O'5Z/EU4-M%;Z\\8PV;0;;\JI@+0EF2G2!XOW]JPF<062OANXD'[A[2 M!4_YPDL-GI\1,U7@E+7&6MOS,U%=%S"I\5(#YF?&G^;=,E;9_K)TD>]/FW8" M:J=:Y.'>-CUPK?%KE`813O,$/N;+)4C6X]DCFL=HA@+JP"_3:_06M M(:Q<&1\M*83CV6T>A^4%%/)UG#SFSRG\1TZ69^.)8)J-!),`@:BZILDM:F1U M:"@YIZ1,Z7,\Z5=(G^'AS!NWN94YHA<,J.^MWJE3B);/.9%!RP+& M(K&;NO2%KSGOSY"=@:WR^!5%Y#C#,=S$=,M55-^-^CNA9!P+V5$>X_"4/_W` MG2FG8[C8$Z50BEA":2.W/G+VAU)7=SPQ!>WE^BOX`R=7$4C3T2OBB6R=$0;& M84W=`UC":[P$B%=-0G>487'Z+86S/+I',UYA4J6N5J3%5_"*EOERWFAI?BR7>: MKU7L;#[QN^V62[85<[//QT M.YJ8WULW9`_'LN_.N$YX6W,[',Z-=X0HZQO5G5(ISW#N6OJ^YT::PBE07GQ/ M?NP.F4QW[9;LZ"^"YG:<]\4(K2&J9M6;51T\$3PM>?N]KSMH;D.\KS?8 M\:!2<\>:E0L\IKL[=G"4A5W,+N`>SVHT"-2H+49.%,1W;XEA6*A5D94;(S>[ MMWP\X%GQ8BHNS_W5O4'W@Z]KTSJ\>B)XB^\!`':6&T8+X>3E^+2$2YK>@"1& M\9QFYA=WO(:3%A9G*$01$3,O\!$&>5)X_FY>@R@G&%#708N7/3X*WPPOW\K* MV$Z2S;I1?KEF#R!(=.CSB\-!4)H)(>WFY%W[W84I3ISD-G<;C"WJG`GS[-AM MK03(ZT-G;^6"%`74"*2S3@NHLG,X34D2%S/BX.4.$JV6_G MU/[K7U*W=!VI6//=M%$5[*W8^O[2\CZR:``31U;['C64':];OZ*N&/9U*W8\ M4>7R3%O]]S4;H\/I;Q%E\2'EK<.B(_C&N^3LH6#@.&;3BXFH(N%E MV\%0K0E[N\\0N*A6L2+]F]8#HEQS!G9[N>!DIXX@D^YV&^=4CEX`BLHRT8WB M\`LU?W5&&S:EXM^B/XX+;;W&XB:"1TZO:'J.H^")-\)B`)$,!6A4E MKVJ=BL.SZ6B#X5P\I<(N+GCX#=*0)Q%@+S`!<_B04U.X(J@0<.DXS](,$+KC M>5UYD\.>Z6B#X7P\XU&KP[%@E`%QND><2.[JC3%T+X>B#N:KM6T#JCUUR7=' MHY*^KE+>V=-$.VU\C!4'_]_F[;;65)3K;HEVPZ]0J(V@YB'9*3?L*!(^M1'D MN&',GJPX9J0XGH2^2O\?X=F@@)#8N#*[D7;,1X#NHE+S.W2[IG9\QX`"BJ8' M@U:FI=[FANEZ'2]3'/W.@M!TC*^<4:(&U"5 MS`U-Z\9K/AS7$[.I"S_:EI`:6DFT2-3#[1O>4D[:56=9DW4X[]@0=LZV"FWC M;TXWCMU%Z((#>H\E7<#P"\9A^6XDO:N:O'"#0RH]G7)$2)&13ILXI7$*?GPE MYD^"0*0'.K^C4WY^P\GWN[AX\#'58TC0\QB%LV!B?0]DF$(F6CN^QS-,,1-) M;=_]6*:8%>="MRI*.G:90WVI?1VUS@K=>\K8P9%1IF(2$Q#/LA]@CUKA91RU MOBX.PBNBD>,E3(J**F1BTP5:BD\#F,& M`PV,7_^K=7])^$F*TFX#X^5>\@Y&#^]?G*NI6^.4;ZQ).@V+#Q=5X>WP1#7( M'RB*.'1O?W9)VRC>6P+*CA>],5QR*1+*[38NJ;Q;K@"M?](XR\L_48>D(/== MO;^52^QW1(N>=55INHSDQATC)%51K]$=98"_>]''57F!3,![-TH&-* M*^T*8M=[+,-/+QMPH>@53A&M3')J`*:[$N[TJD.;(L?U-IA=8#D%42=S&7>Z MT.*Q`%0U,FO\_'P:Q^@I!U.G80VFSO6#4]C&^GZZ&DN3RP='O;%EQ?)EIKGO MR5(6WAD0YFGXGCAE`3^!U\SW]^DZ;UR!A\_WA^ILK#RVE]GW!^ILR#RUC#O? M;_T9)1.PWTR6>Y9]]Y8:1IHU5,/3]$)WB/6VL54*H/I^(T$_%J2Q0$_Z,243 M/(T>IO)VI_>&Y?V)U7;>\](,Y79UTT?$N'O!CCY+.KF(J//?YF-RP&WN+F-7 M]N`EDP^EKL/*0CZ!FPNW`"6_@BB'M0#09Y(UR,#XW/.JGF\U#"U+T>?;`'YG MW)>N.&EVF[3Y.;_MG-]V+/9&#X%XYEGLNT_A0)E)IQ?"$Z(GLZ5..'2GL.ID M]L\Y="?UJ"H\4'^.W?'`X^M;OH?OSD&G8W"9GEWY9_>S+??SMD3AS>L*TM=M M;_.,[O$XSD'45&/H[W':N2H/YP;7SM?WO\NZR27O-"P_2\H@<30CZ^;O$"2W MI(.^=TDZXO`1>"#+^ND'C%[@5QQG"P,/HLJ@P\=A"JD^$M(ZS;=DNX*(SJ$5 M,-@C#Q^18A'CW`X(V\&.@^\G\GD[\J`>[4@X_X'M\4W&.C&_]#%:#58$I>^> MO`.CO'\L^^[L.S#`6UGGNS/0!:[EZ>F[H]`!LJ4^YKL3\<#`[AB!9R\C!UU5 M5T&WNP%'435YG"U@Y<5DD?A"X@#&>V\UE:J&VT&)\B0,='^(P6\5BYP*Q9@-96-!2B&3]+) M&1]Z#`R4\SA,UGKSP>UC95=^B\EY'&[\6RPJM@[R'=KV&Q="90IWXU<,\!D>HCO M%FP'U/AGK>^&:0?0Q'!Y:X8V!-)@+K+=S&8PH%K*EK@IR.`5)II+G*-X/E[! MI*RFPM$>-09P4YAY\U[W+5F]++(N(9F`YMQ\17&Q@.YBL@MAFA6>E^8H-V2N ML_57F"UP2%^@DKVN>C@*W"%,Z-9X+Y/?PRD'-Z]@B>)B4B:0[$TJH$J_6SD- MY0DIXTIQE"%SRLXC,AW%,:<%$9T3Q09BVGA1O*_$#298&'SPN$RK;^T&%-_01G;D**I[) MNUX%)H\92#*O-!0["^_LF5(!U?0L,'->>>QUM76*G'U8*K`2A:J;MZJ4G3>Q M\B)T9IN00>%X=D480]E@$FPNR9*FUK6P"N5.(SLW(0H<;D%095K=7F'Q6V93)Y6_X7.F;"1S&KNB^RXF!.3TT"4;!Z6/1+*` MHKD0-J)W(2MP)!W#/'SGGLP05'L@K M_`)CP,^A4^CHAI_R'+U%,;W`<(73Z@53#A/LUE:D_2TD1SR(;O,X3+G'C:BE M"_R:!_96B!I1F(Z?.1'#35^@Z%J\TZI>]U18A.OP9;C,Y#X>OF=87* M,/VU0.BJ]!P*1U^)!;?,EYRZ(PA+(N7`H& M&0J?HE+I_/96Y/$]CD,<%R?P,XB_CV=$]E-I>X]!S'YC1;F;"W2K)2TT8MIM MG%!)UJ.4RE8;.ZFDM*H"K5W=/N'ICJ!G/+'CHSRD]]$><%SY,YCO!'4H>8YM6TWFT(@4]EM77BJ MU?R,[3?&=31N7\LFZ./&]33X&KM3AZBK"N9K:%^S MQ;MB)O9P^YH^KBG:E/587Y/%+>#%T:=]31OONB_9D1E?L\/M')0BG^KA\L*/ M$3E&Q*<&[-05?]5@4HV87W:`/"6D55&.F8CA^]M9HO23G6-1Z"RIUY!?EI`! M3C*`_-)(M0#B91K4X/BE3&F!HQ3VJY'R2Y%218J7&KG%Y9.?=]1"B!-8V(!T7D8[4>P-,)].&AB9G7+(US_=P+27V+"W7O:? M.?88B78\M8G%3F90K=OXY>I61:.=@52CX9=+5CGEH_W2;N-"RIOEJL(KR%\A,D+"B`;Q@=<5-V#84%O^D1+ M@S=_IPD!#SC[.\RFV_N2Y?726YQ4?Z+M>,GL!R;"*YSKD M!`NR>(BYB9=+'!=0[-,UIL&T\*[9%^HT^J[Q]Y6D4 M2274JI.-MD[=(LGKLCJ+?4A'GB'^KS/ MV/X&T7Q!S_$R*ZKXD:9YW@*4_`JBO3?ZAD??4.'[&#[V*?]BKW9*V]'7%(U:D'L(3BZVQ]?,K-722B=U'%$X;7>4+T MQW*"2P6T919-*CV]4#>YMY7,1ALO,`E0RGT# MRV`@9_S69B8QN.8)6%95^_XD,JS(2!7Q*._L@J\G6D`O3]8%B27HHX"H7`EW MPD0]7$9*F/[H5H2D%\'N>RR7[49J1YZL&;V^@VG=/]!ZP[B]`;Q/:NH53!L6 MF_\I+_;LVG8"FIE.Y>O=;X=HM^\7[A[#L3X>JN]WTD1 MVAN^7GKO>9TK!%!]O1A_`(&M8/3[>HV^7W15$^-\O7+?+[H'2@GR]8;_D4X. M)RO1UVH"1SI+\IQ&7ZL9]'Q>'SI(ZGL)A6.8IEWGCZ>5"`8V%?;3AKR_R7/4 M$^C_-;T^\SZ86L5^5KGOQ4(.!3$G>?AP5RL'=`^.85)/843-[B=$*Y)M;XNN"K?NMS>C[ZO5HK@-JJHQX`X$*:, MBOLXNJD#B0JP($OD&K[`"*\H82IK2Z6GVUL\=J24VHT>F]]R@AJ,(OJ0<1Q^ M!);FPSUWO?\*&V,E)0$W].:C M-,V7FZ3R%:2.^FOT0J8S#FEQ9]N7CY6_ZPS-9SE7SSIC1RGA^[4I M170/)$-\=PT<&&VA1/'=H>!H9;=UM<.Y()S9$7=QF!.,UZ,X_`+I'9#5`@6- MLL(6:@USWJL>!0&]8I(2(^P MXDUB=DH'LZV;#([BJF#YJBT5.9C6)O/:QCF>M0@1"E1^>RNS\(#C;^D6$6;: M`K^=$_QR^FGJ[:6O8M")?83S(I&6!R"_@YO`I?K]NZ^K!Y.H54,J@E7S$HR'MGIN^#,@:N/".\]9^8@<:QJ[_U?YHB)-"??DVH,8--P1OF> M6F.*GK&)YVOM'B.7`B<=V%S_]5UGX;LV6N*0;XC[#I#4!['=P6SW@/?%G^Q9 MF6)K8M<".:7L09O(LG:\]X]W]X2E\F%_$OF4LL.Z<*$\8=*,1HAS$&TQOXMO M7@.8IN/9QP_C65$DJ0+41:;E.9QW#N?UR$.*(Q06!!7"03P+K,;#H%NV%]C- MK01B-G)C'+,OCW(:6?WVTP\L_W;=Z!PZ/LW0\7@%J?"I=0EAR(C7^AS@.N(` MUT$OV1<4B%\5:[5Q\UA2=1WL,D^)&$G3#7""HU#<9UBQ,N-@HI^!BW,PT1`U M@:*X@Q5'-3L]C/A;CGL0GZ-@YZCT.?#@BT?N[#?N$5GF@73V'9OA*=&"-[!^ M.L-Z_"YY1PBSK,%MN)+A1/,]LT4-D(9GS_=D%25+O%URJ(7@X9049T$M^DX6 MRDI0XI`<@E0*$8T"P;2_>WV7"/\7C-`KW\.\T\*%&V>S9HH'VM("B>JM-O&S M]O)^0^&&[X[BM;;B#&<,OEUW&57#R*(M%=S&^PB,)6(PC)T02030DNZ6>_+1 M>?$%0:B$V]A-F(N[VVN1(*G!HS>&I:!4DA23NOTR.RJUU\H%QOY=6`Q\B]X+MK6&ST M",]!P7G@?:Q1'3:NMN9]_+##TCJI<)6"_5Z+>+Z+T?>8C0Y,1E;\X6XL.@OJ MW$.0PO%S5"V='@LT+@M::2E==B'&YN]V7,%@A8HWYN,L0<]Y!L/+XI%/$*]I MUBG=,I3Y2Q!\?TI`G!)KCS++;C62%B^J=C@E(LKBX'U:6;V61R6MJA8Y[ M$(>$TRX1Y@5ES+SY=Y\4;J-21+-4"`!Z%.=RK.X%6M4YF$\+D%5NK'`* M07239OO/(VAWMT(O%1"U="#2K7HU_!8GY8,C$ABU^KNZ'5,0^-P6?]PZ)(^'=.F$?2Z=/?(W@'-^"H'AA@1^? MY+1T:M\Q]9O=VV,"U'V/*F@>O2K(-27*J<(GC,TH*@6^1VJTL.MDCOL>SK&Z M"EL'J.^1'OTUJ&4\^A[HT8>O[1]?4!MD/1\ M1[Z78M?'3\MG7AA"]7'LV%@Z$5J8'A:!L*^RZHA[MC.BAJJT[(` M^!>F5>U^[[-NK$%W[R:_Q%GF4HUH[D24U M";LXY>$N7N596BR1C\*2L:(>0^'@LS8'GX?``6MU"S4XE9Y#X2C=%TC:O/'' M<,IEJ1$PU`8U!F7=G;R7C&.X_@J2[S"[S>-07$6:TWAH-XM-[U[[&24ZW[W6 M*L&J:U,T\5,7%+[#:,MX:56UE)BMOF>TV,34QNU2`U_W"TR>\?'@+#]N.MMA5H+ZTWHA-D`^/D,(`]`TT/)_]O2>IX^ M)KIJ]O7I:)52UZ(,Q3V_R\E@)W!BL9R.GH`R] MSZ=2*D_7V=AZ+YCCS#M+;DIWN-H MY)S1GY59D(_DD(OT;KDB_QK'ER!%`:VQ@R)ZP^L&)#%!/IW`Y'%!9+,];I6_ M.)!=)/A.S MMU@&(%VT-K2(7F$_EVND09@LZT'8Q4ET$[RB9;X4!S5;;9Q0B6(YE:TV+JC< MW`QXPI7]BGW,?FI<53?V M7=/9L[::<+6,G9-`HFW9M>(Z;0>![W4T9&BTG3K>E\4PM*FU$L.\S;VQ@5Y# M3GF?>MC3:FNH(2=1O:"YT;;:_'C64O.?,#$VG\C:HO%]HDG=$8*J?Q!+-$LW M>ECQ=,;VJ2V]0+8=M]Z&DEMR#F7P'KW`/6)_@VB^('K@B)AK8`Z_I7"61_=H MQG/Q=1KRP.&FZI&JQB2,@@#G<99.P!J4D[?[(EJWT)31%\]!N"$%X3I0.`$H M?,*/,,LB`A>\(2R19@]; MS4_QE.CM\\>^TB8)7L$D6T\B4+!&[PT7#^H=8-WQOWU$J&YD#I/#?36F[Z\- M!+D#)L#QW@RDKQ.0T7(036%4?F&!5NRZ'2H]G!14X1O]E^NOX`^<7$6`6(^" M4E$:(PR,P[V(G#IK==>!\50C+GWP27<4%YS>Q2&<=5ZCNJ,,D%.->349R0W' MQ?LC:87JG6UP57U!3#RQ7,X/XCP4Q6!!W<)!=G4I+;;1SY'OJA($NV;IKK'OXG3"> M>YJK<1JRGQEAO4$G#PB972'XJ80VAG/ZVHQ?X';-]?8SM^96=;V MNR!8Z/M+1K8P[,\1[_L[2!9%0A_N>M_?5AH"_`K1SWH:/"U:U$4.&5WD^>CG M11[3]=PMQ[!&U<^;/4.0$IN\G1KKLQEG(`K,LDEKT/V\(SZ$!2Y/M*IGX6P> M]C4+G&5O8D+B#$1GP+6R.K:`?S*Q-X\:<%&PX4`"\MO)\KL>SD`PS26)F)&^2&^A\@Z),VTL57*1/&]>(]^PH%B M_'9_?9_0;6<3++7EQ0G=AK:\-AO*_:G=AZXQ)>+OEM;GWCX38ERON[>JN!L2 M=\O;%-5O)$G@RL,,I`(PC\BJPD]W;C<#]791N?KNEP2G*?G'#*E6KV;U[)M* M8F[?46L(WI-OCK(L0<]Y1D7)$YX`V1T@H_$&LLY2)L7JRXO3?VC<38DJ%^^5 M@-?IZ=6EER-(JU2:3=_5<9N@[6QPWQUD%J"3Z!N^^\AZ1'"KQ?CN)U/%4$N+ M\MU59@LT!:7N<%G0![;V'G`&TR>\_^AC2J572NV]QKS&X2.:QVB&`IKR54;` MR7Z=X`@%B(Q#Z+@D>LYW-_6N=LF1J$""#DZ4N"YXOR?Q4WLZRS"[ZN<$2(Q30#_@6.DH26WJ0+;9=6 M#F?*W=WPMB3[PF MS="2R#F>:VJGT=$=2[#T,/'06YZ;O#0G<; MJBH(A_-9#$8;WW5Z.;6B=XF1*-CSAQ&(]YNU4YWPP`QOU,T(%O++-9CK:L6Q%8[1.<*/>Q41_(JMV7><:.3WT M&/1(-JJHAYL":0)$E5D8QJY3F(UV`J2(]?/N:@'B[B0\_CU62_@M9=6U4,T# M4-+]B/:>.B0GN0_;Z<,#.>P:UPGY%$JVIMX8;@Y$.?@\L2/OZ7*+&LU?^\!4 M@.:\7UFXN#L^3V/7;LX3++JZ<9MGE,XE3C+T9[$\;EY7,$ZAUC%LY1.NU9"= MM^?B[5UQ;8U$=:2CEGQ&T/D>4+.&JIU->[@XW&`.GJ)PS'Z%&4,MD7.I1?J1 MMHQ0Z^-"_FV_+CGM]MNYW&5!>"@8]$A=A?P>;KP/`D2561B&UJTP&VWO@HCU\^X:B#_A M^/=8;`1[<\NL)W@[KV&S]E` MCL4V*9+=RFGL8J/R(%0A?!A;3(Q\3W!K?.8$R MF4J"9.E8[49.3CEE$#F'FG)_IXE6S-EH'5OJ.)RW&A\=AYF0Q[+AZCR^Y2K" M:P@?8?*"`KC)Y8,AO50"X[3<(-L2X>-97W23'I'M[_ON46O)K]Z MS&E$-)Z`U0(%C=*!=H-=ZE]C1+W4.Y\]]/;"7QI3=H(*GC(Z M[A2\6F)6UR,WI6<)X7A)4+]<3^&*QO_C^2.&HY(>.O/0@0Z/_I>'9/'RD>BI.S)$JR7W<:N=B0\DJ=CX7:7=3\EDVI^>-R('&G5M'4#=9P:%J.HI7&]2)$XY5XO]RW?B7 MNMM-8ZAC$DIF6/D>&C,5[8F:A$```J[```1`!P`<61E;"TR,#$S,#8S,"YX[)/W[Z\Y\^_$^K MA89#=!LR1H*`+-$O'@D(QY*@,7X.63A?HI$W(W/\-_2(!?%1R-`OU\,>>GUZ MCM!,RL5EN_WUZ]=3SOU4R*D7SMNHU4H+^&>LRB5Z=_H:M#'>#,.(^9?HPGAT MPPF60(U\4.(2O3X[OVB=_=BZ.!^?O;D\N[@\>_-_)G6X6'(ZG4GTROL!B,_> MMA0'&IX.3PVK_HI&(1-`/5]@MD2=($!#Q270D`C"GXA_F@@5VE@$-+TY!/VU#$>?N73[VX4D[^_"<4TUX^/_*`YCC4DY3GHDV9D)AYQ&`)*/MB MX5"O59V;A118$K7.W[]_W]9O#>I(M*88+S+Z"1:/FCIYT8XK]QPJ-\\EEPLB M2MGTFW*^WWT2Y%3[/:+P2#N#8CA[=W%FD#,`)YJ7F^]+WE8EM8&H!52$4\]D MW^*7DRSRY(-[I-'QJ)R_+:\&+.(?&MHDU>:MX M7Q=X?4++V>!%>6GDV9N5LZ@WY3R4/1$AR[GB=^5\0BYX.9=ZHWC.#1Z)^93( M!SPG8H$]XN08$'GFA,G[D,]OR01'`6CY>X0#.J'$/T%82DX?(TER!!%;D?RD MI'S`C(52QQ#]MWJR6%`V"9,_X8%J*)<\#,@8O`6I'Y^'W4TZRB00MA5=^S;T M(J5E^C]F_AV35"Z[4`*?ZW)/$/6O3IPH,YU2K7PRH8QJ[<_/SE$+I>SF3Q"% M8EG($/:AO2YA77@$$;S/?M*_/1QX4:`9>_!WPIQ0V!@7'&(FDS4X5YIMYDN> MIN#L!;,1**M=JS^YIPRB,,7!(!1:DYL`"Y%XF$)M"`R_.C+8P8->#66"X/=- M_V'4[W5O.^.[6W3=Z74>;N[0Z.>[N_&H06XGY`88HJJ<$4FA:BK#J+FW8/G& M'4OT*J?.#PVVV['MPO!T3CJ!))R!!4^D',0BF1VUMS;41F/X[]/=`R#6OT?] MP=VP,^X"08-7#;P<6F`YSQ8$W]5!L&F!U1&]P6)V'X1?19?YE!-/EH-8)+/C M]Z,[?C>=T<_HOM?_5],"-^'U$$HBQF'6EV4U*ZZQH*(_&1@F=9@_HE,&79R' MF>QX>MI"V700!M2C((<\R^L@]+X82+]0`78?^;L:V5+A!:&(.%$.$\WGF"]1 M.$%&`6A5`DJ+:#RELJ?<8EQ&Q* M'P/2$8)(41_1[7+LP)X7@4U%HEAF`V]E>/LP1.4W.BQ0_T@#4J]HS;Q5B M!_;U.K!:'DH$(D-B`W"-]JOF/&/\7+_A6@38@;THME@E2ZWK-%C6P/*6/,JZ M,&[BM2/X9AU!J`JB1DLWG/A4-AA6QG`DH=9G8>`3+NZ`7RX5;5U4W:79<7Y; MF``9@O\7Q:(;M&M$7S\2DB]AHOJ1A%..%S/J&>LE54.QJS0[VN^*<3D6K%=U M5J*;E9V=P(<)YIQ*_1,0NPEUXH`PE36HV]XKBK2[P8\E,^)4NO:$G/S&`2H[ M0(]@041_TB,P/:D=X[=+L<-<2&YI@:C_&-!IT[3K(7N/*?\G#B(#CHIS)KL$ M.Z*%5)82AK0T]`G`A8>JC`;7ZDGL2,``5Z@X^TB9-JENLW44947Z=2&9U?'` MJGCYN('WFZY1I`]>?*TB*\CN&H5TF/N:!7J5_FH6)O>X?#'&CX&C?VR388>^ MD#!S7S[7=.H@+R#&#OX)4FU;'VCP?=%%SHJP>PJS8YV(0%76/1H M,'^YU8\*@#N*LJ-=2,-M7`EI4'^9)9%*37RK&#O:)6FXU?)(`_`WR+%70+NJ M3#OTA=1;6;Z]<8%OD'BOU."KR;2[0"$MYY"$;SSBI5,[%=RADD"[+Q02>D:: MI\%\ZWFHK.:2%$A_8LVT='Q?:XF#XH&IO8BR@GU1R.E52-R`9V0EY@/#+9&8 M-AO-'9S$2);T)RI3LIZ,X>X11FK-*2ALI;=C;4WM-2U\KWAF M_;OQS`)G*;D=S9+4G8FFT>OG,K@-FNYHYG.LZH,8?A00!5+^31%89TX[QH6$ M73$]VT*I]!CJ0OJV`;PNX(XQV87)#G-)IJX(]]Z@TZ![][P@'HQ?[B,) M9!W&(AQTYB&7]#_:4/6>B3H-?_<2[)Y32/25!HA55Y#J@6)%4*P),E5!B2Y- M.-G1W38LV6QXO.Y*%;GM;E)(!FY>^+$N"C7@N\>:9/7&>6B_A=X.<"'#EUOK M:3J/O0*:1?7/C!,OG#+Z'^+#FVO"0,VR7L&=U0KSFY+#ISF8C4AO%J#>H[2( M!G1WT*%S--V5\H93M?,?>W^Y"S M)+O3%+*"&YPF*\X\W*$FB%!DS(/B0I$NM?&2*B-%^SX.Q_E`'2%VWRC))F[? M$M)T12_O$2,4*8.HZL.4.BH:G9_]1?VG=4*)4HWC55IR MWG2>UW470C5^N\-4.Q'"&W#W`&XV5#1. MY3HA[,YHA]GQI'`#]A[`-O9L.F&\E=X*[5O;T>`&SSWC&02AE^SJ&D3J@[2^JCQ M(6B$4I7T\*"X')FJI5\W2U6[.N)JH\J`A^H2"IQM3'>+-(X"[&Y3R)'FW<;< M[P*E(%T,RLKY_QJ/U#_J,ITAF2!]3\ZENBCFZD30^2*`Z6+\#'-/\=MOV&DO M>+@@7#6D=BHV%5#@SE_IHWUKK?X2K5(),TXF5R?J,IU6>CG*K\!Q^CP/4A)) MI2KE9B5'+81\$7]#.`A.VH=K>1Y&!\.!H<3PVTS,D=@=X$<2.)H,M"4F]Y2$ M([%VO9D[&`TL)4:;'_`HL_U#V[S8!_[*7_SS`4P/N42L]!*B#;=SH?@"L%[2 M]5I8U%^ME*^E'K7.7[5?_YNUU4,.X[JZA& MR![J:6*[%6X'8-23JKALNV;-JDX97_K';HJ47-KFIHG)F/W56HFIKLO:37!. M:J0\ZL=.%;%^IYQ3Z1F3_K53^<7;Z9PT,-B2WSMIL7[;G9,.&9/^U5JQF^4G M]]]I!:Y.DA.(8D@\0I_4*=1['LX_X=]"GJT'Q',-U9?^ZD8>#PKT7967\Y#! M\)\ONY+,U8CY!.%'(3GVY-7)!`>ZT]>$,!B@H3_6K'&')]-7CSA0W=_5B4\> M*3QE-`A4V51@MTL(I%+K!;OCM$W],^#QG7^ZQ:8Q(F?:DLJKZ_N0^8GY<_\2'>=<())'?(Z!3MXS"V&NFEPGF`(6:BB4[ MBCN>I$]&9B*Q=D\2=P9\55$OAO@U#7\F`7W^1.:/A!NUL/XB-B:^.?32#^>8 MEH(>*_+"F*<'T(W9=[8^(^&7H#Z)B\O2R:9E=;A?K/%Z>OO2/;9^O'5M=.M.U>B>T%)0X16N$B> M?;_@6V)KFET#"4+`'Q.ZQ<-*&8[4HU);'HB,]S^K,\J=Y.Y<5=PXC*_'J5!CH=3O MEQ7K9;NXHPI9IJGE@\3,LB2D;*DO5R''%&HJV/>0A=[=ZLF4\\>J*NCT:U6- MYCO6MC7,3H1U?2"D$XJW+/##NVA.XCXZIDO\`SE2CV"ON$&+ZC$@?(F M/:XD_K4^+H+94NV#57:KG7'7V/MBS%6,"JTKX!C&]CI'>+QNKR8T84HVK.%\*",TB'W M'GM)\.E!_%+*F#,>"XWI@J`W=!G?SY(X+AJ;JDT32EX>0Y>>Z#U0'ZC07SW+ M;TXN6KB9\CC,C5IT(89HF@/%?:WI+X_RX;<++`U$]BJDA72LHR(>;'Z-*JV%W:471<799L MN28]M8.D>&P%!C&1[JC-CBI75?4$',.X>^M'!(JC/W>6`QKY5;P&V\E0@R<7 MT67Z_/N%PAYF*F%Z'='`AVI_('K;0^:GMV3!B4?7';T2UQ%TT&O3>VU//@5@ M&N]`?`PMNAP&Q` MJ3]>])'C\EF7VX;#%Y!]%#WD)^C_,JJ<0MZ>$?[]QQK8[)PU3MI,>VB`JG?'.Z&(5 MV,8S+-,EZ2'!P9U0UW$9=E;BVBW\[=E:F7S$9\RQ3^:8?RFV)AO1(;6I)+W4 MGZC+TY*U8/6A15"_H[X=M,S9M)7V*'KQ-*769YL7P"PTQV&C,<#HT2\DH+,P M]&&PD:01U1B,^)\7(8LWOLWS6T_JL1]2(TU7+F\)#-2A7K,12+QWG7E!Y*L4 MA27SLX.,(YCSI;MD_3'Q9BP,PNFR&,4VTQQ4$$O4A'EHO,-'?9I3KQQ=+P$E M@$9AMN&:@)RAE24<0SYT2/S(BSUYP]A"->2N$)$JN3^!*1N,5-4JA#ZL\9G1 M7+/8C[CCJ#ACC7(5$I5Y`Q[^1CQI+%*NG4RJP7M`X7.WU=X_[MINSC*QVHW9 M$5FKJ%E--84=2:V5V7`3*L%A7'QGRDE<#X5.J!;W(75/PW")`[G46Q(]!5N) M*VPD.88XJ3;/KG;.$CZ//W9WW+5$XW9=R$3X3#>,S% MS`T\AVUH,2!9B`XJ*&D]1P0F7<1WLLE*>TBFK6;1V<2Z8)*%YI!,^1&HL0`` MCZ,(`!$`&````````0```*2!`````'%D96PM,C`Q,S`V,S`N>&UL550%``-? M@/E1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`]HK_0GS4I"A+$P``'1`Q0````(`/:*_T*2?7*80B```/01 M`@`5`!@```````$```"D@8W%``!Q9&5L+3(P,3,P-C,P7V1E9BYX;6Q55`4` M`U^`^5%U>`L``00E#@``!#D!``!02P$"'@,4````"`#VBO]"_C#E<*EK``!/ MV`4`%0`8```````!````I($>Y@``<61E;"TR,#$S,#8S,%]L86(N>&UL550% M``-?@/E1=7@+``$$)0X```0Y`0``4$L!`AX#%`````@`]HK_0N)/X&'G-0`` M./<#`!4`&````````0```*2!%E(!`'%D96PM,C`Q,S`V,S!?<')E+GAM;%54 M!0`#7X#Y475X"P`!!"4.```$.0$``%!+`0(>`Q0````(`/:*_T+RO>8F:A$` M``J[```1`!@```````$```"D@4R(`0!Q9&5L+3(P,3,P-C,P+GAS9%54!0`# I7X#Y475X"P`!!"4.```$.0$``%!+!08`````!@`&`!H"```!F@$````` ` end XML 108 R15.htm IDEA: XBRL DOCUMENT v2.4.0.8

Industry and Geographic Information
6 Months Ended

Jun. 30, 2013

Text Block [Abstract]

Industry and Geographic Information

Note 9. Industry and Geographic Information

The Company operates in one reportable segment. Sales to customers outside the U.S. represented $12.7 million (14%) and $10.4 million (15%) of total revenue for the six months ended June 30, 2013 and 2012, respectively. As of June 30, 2013 and December 31, 2012, balances due from foreign customers were $3.0 million and $2.8 million, respectively.

The Company had sales to individual customers in excess of 10% of total revenue, as follows:

 Six months
ended
June 30,

 2013 2012

Customer:


A
 15 % 15 %

B
 11 % 9 %



 26 % 24 %



As of June 30, 2013, accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $2.0 million while, at December 31, 2012, accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $22.4 million.

X

- Definition

Industry and geographic information.

+ References

No definition available.

+ Details

Name: qdel_IndustryAndGeographicInformationTextBlock

Namespace Prefix: qdel_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Details

Name: us-gaap_TextBlockAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 109 R33.xml IDEA: Inventories - Summary of Inventories (Detail) 2.4.0.8134 - Disclosure - Inventories - Summary of Inventories (Detail)truefalseIn Thousands, unless otherwise specifiedfalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20130630_0http://www.sec.gov/CIK0000353569instant2013-06-30T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_0_20121231_0http://www.sec.gov/CIK0000353569instant2012-12-31T00:00:000001-01-01T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 1us-gaap_InventoryDisclosureAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Inventory Disclosure [Abstract]2false 2us-gaap_InventoryRawMaterialsNetOfReservesus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse90140009014USD$falsetruefalse2truefalsefalse55820005582USD$falsetruefalsexbrli:monetaryItemTypemonetaryCarrying amount, net of valuation reserves and adjustments, as of the balance sheet date of unprocessed items to be consumed in the manufacturing or production process.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section BB Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.BB) -URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)(4)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Raw materials3false 2us-gaap_InventoryWorkInProcessNetOfReservesus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse86470008647falsefalsefalse2truefalsefalse46860004686falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying amount, net of reserves and adjustments, as of the balance sheet date of merchandise or goods which are partially completed. This inventory is generally comprised of raw materials, labor and factory overhead costs, which require further materials, labor and overhead to be converted into finished goods, and which generally require the use of estimates to determine percentage complete and pricing.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section BB Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.BB) -URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Article 5 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)(3)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 false2Work - in - process (materials, labor and overhead)4false 2us-gaap_InventoryFinishedGoodsNetOfReservesus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse70030007003falsefalsefalse2truefalsefalse52280005228falsefalsefalsexbrli:monetaryItemTypemonetaryCarrying amount, net of valuation reserves and adjustments, as of the balance sheet date of merchandise or goods held by the company that are readily available for sale.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)(1)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 5 -Section BB Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SAB TOPIC 5.BB) -URI http://asc.fasb.org/extlink&oid=27011343&loc=d3e100047-122729 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 6 -Article 5 false2Finished goods (materials, labor and overhead)5false 2us-gaap_InventoryNetus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalsetotalLabel1truefalsefalse2466400024664USD$falsetruefalse2truefalsefalse1549600015496USD$falsetruefalsexbrli:monetaryItemTypemonetaryAmount after valuation and LIFO reserves of inventory expected to be sold, or consumed within one year or operating cycle, if longer.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.6(a)) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 330 -SubTopic 10 -Section 35 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6386567&loc=d3e3927-108312 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section 45 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=28358313&loc=d3e6676-107765 true2InventoriesfalseInventories - Summary of Inventories (Detail) (USD $)ThousandsUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureInventoriesSummaryOfInventories25 XML 110 R22.htm IDEA: XBRL DOCUMENT v2.4.0.8

Inventories (Tables)
6 Months Ended

Jun. 30, 2013

Inventory Disclosure [Abstract]

Summary of Inventories

Inventories consisted of the following, net of reserves of $0.5 million and $0.6 million at June 30, 2013 and December 31, 2012, respectively (in thousands):

 June 30, December 31,

 2013 2012

Raw materials
 $ 9,014 $ 5,582

Work - in - process (materials, labor and overhead)
 8,647 4,686

Finished goods (materials, labor and overhead)
 7,003 5,228





 $ 24,664 $ 15,496





X

- Details

Name: us-gaap_InventoryDisclosureAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of the carrying amount as of the balance sheet date of merchandise, goods, commodities, or supplies held for future sale or to be used in manufacturing, servicing or production process.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation S-X (SX)

-Number 210

-Section 2

-Paragraph 6

-Subparagraph a,b,c

-Article 5

+ Details

Name: us-gaap_ScheduleOfInventoryCurrentTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 111 R15.xml IDEA: Industry and Geographic Information 2.4.0.8116 - Disclosure - Industry and Geographic Informationtruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:001true 1us-gaap_TextBlockAbstractus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Text Block [Abstract]2false 2qdel_IndustryAndGeographicInformationTextBlockqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00<div> Note 9. Industry and Geographic Information The Company operates in one reportable segment. Sales to customers outside the U.S. represented $12.7 million (14%) and $10.4 million (15%) of total revenue for the six months ended June 30, 2013 and 2012, respectively. As of June 30, 2013 and December 31, 2012, balances due from foreign customers were $3.0 million and $2.8 million, respectively. The Company had sales to individual customers in excess of 10% of total revenue, as follows:   <table cellspacing="0" cellpadding="0" width="76%" border="0" style="BORDER-COLLAPSE:COLLAPSE" align="center"> <tr> <td width="88%"></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> <td valign="bottom" width="5%"></td> <td></td> <td></td> <td></td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="6" align="center" style="border-bottom:1px solid #000000">Six months ended June 30,</td> <td valign="bottom"> </td> </tr> <tr> <td valign="bottom"> </td> <td valign="bottom">  </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2013</td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" colspan="2" align="center" style="border-bottom:1px solid #000000">2012</td> <td valign="bottom"> </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> Customer: </td> <td valign="bottom">  </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"> </td> <td valign="bottom"></td> <td valign="bottom"></td> <td valign="bottom"></td> </tr> <tr> <td valign="top"> A </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">15</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr bgcolor="#CCEEFF"> <td valign="top"> B </td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">11</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">9</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> <tr> <td valign="top"></td> <td valign="bottom">  </td> <td valign="bottom"> </td> <td valign="bottom" align="right">26</td> <td nowrap="nowrap" valign="bottom">% </td> <td valign="bottom"> </td> <td valign="bottom"> </td> <td valign="bottom" align="right">24</td> <td nowrap="nowrap" valign="bottom">% </td> </tr> <tr style="font-size:1px"> <td valign="bottom"></td> <td valign="bottom">  </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> <td valign="bottom"> </td> <td valign="bottom">   </td> <td valign="bottom">   </td> <td> </td> </tr> </table> As of June 30, 2013, accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $2.0 million while, at December 31, 2012, accounts receivable from customers with balances due in excess of 10% of total accounts receivable totaled $22.4 million. </div>falsefalsefalsenonnum:textBlockItemTypenaIndustry and geographic information.No definition available.false0Industry and Geographic InformationfalseIndustry and Geographic InformationUnKnownUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/NotesToFinancialStatementsIndustryAndGeographicInformationTextBlock12 XML 112 R20.htm IDEA: XBRL DOCUMENT v2.4.0.8

Summary of Significant Accounting Policies (Policies)
6 Months Ended

Jun. 30, 2013

Accounting Policies [Abstract]

Basis of Presentation

Basis of Presentation

The accompanying unaudited consolidated financial statements of Quidel Corporation and its subsidiaries (the “Company”) have been prepared in accordance with generally accepted accounting principles in the U.S. for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnotes required by accounting principles generally accepted in the U.S. for complete financial statements. In the opinion of management, all adjustments considered necessary for a fair presentation (consisting of normal recurring accruals) have been included.

The information at June 30, 2013, and for the three and six months ended June 30, 2013 and 2012, is unaudited. For further information, refer to the Company’s consolidated financial statements and footnotes thereto for the year ended December 31, 2012 included in the Company’s 2012 Annual Report on Form 10-K. Operating results for any quarter are historically seasonal in nature and are not necessarily indicative of the results expected for the full year.

For 2013 and 2012, the Company’s fiscal year will or has ended on December 29, 2013 and December 30, 2012, respectively. For 2013 and 2012, the Company’s second quarter ended on June 30, 2013 and July 1, 2012, respectively. For ease of reference, the calendar quarter end dates are used herein. The three and six month periods ended June 30, 2013 and 2012 each included 13 and 26 weeks, respectively.

Comprehensive Income (Loss)

Comprehensive Income (Loss)

Net (loss) income is equal to comprehensive (loss) income for the three and six months ended June 30, 2013 and 2012, respectively.

Use of Estimates

Use of Estimates

The preparation of financial statements requires the Company to make estimates and judgments that affect the reported amounts of assets, liabilities, revenues and expenses, and related disclosure of contingent assets and liabilities. On an on-going basis, management evaluates its estimates, including those related to revenue recognition, customer programs and incentives, reserve for uncollectible accounts, inventory valuation, intangible assets, software development costs, stock-based compensation, restructuring, contingencies and litigation, contingent consideration, and income taxes. Management bases its estimates on historical experience and on various other assumptions that it believes are reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates.

Revenue Recognition

Revenue Recognition

The Company records revenues primarily from product sales. These revenues are recorded net of rebates and other discounts which are estimated at the time of sale, and are largely driven by various customer program offerings, including special pricing agreements, promotions and other volume-based incentives. Revenue from product sales are recorded upon passage of title and risk of loss to the customer. Change in title to the product and recognition of revenue occurs upon delivery to the customer when sales terms are free on board (“FOB”) destination and at the time of shipment when the sales terms are FOB shipping point and there is no right of return. The Company also earns income from the licensing of technology.

The Company earns income from grants for research and commercialization activities. On November 6, 2012, the Company was awarded a milestone-based grant totaling up to $8.3 million from the Bill and Melinda Gates Foundation to develop, manufacture and validate a quantitative, low-cost, nucleic acid assay for HIV drug treatment monitoring on the integrated Savanna™ MDx platform for use in limited resource settings. Upon execution of the grant agreement, the Company received $2.6 million to fund subsequent research and development activities. The Company expects to receive milestone payments of $2.5 million in 2013 and $3.2 million in 2014 and will recognize grant revenue on the lesser of the amount recognized on a straight-line basis or the amount that is non-refundable through the end of the agreement, which is December 31, 2015. For the three and six months ended June 30, 2013, the Company recognized $0.7 million and $1.3 million as grant revenue associated with this grant. The Company has included $0.9 million and $2.2 million of restricted cash as a component of prepaid expenses and other current assets and as a component of other current liabilities as of June 30, 2013 and December 31, 2012, respectively.

Collaborative Arrangement

Collaborative Arrangement

In July 2012, the Company entered into a collaborative arrangement with Life Technologies Corporation for the development of molecular assays. ASC Topic 808, Collaborative Arrangements, defines a collaborative arrangement as an arrangement where the parties are active participants and have exposure to significant risks. The Company is accounting for the joint development and commercialization activities with the third-party as a joint risk sharing collaboration in accordance with ASC Topic 808, Collaborative Arrangements. Payments received or due from Life Technologies Corporation totaled $3.0 million in 2012 and $1.1 million in the six months ended June 30, 2013. The Company expects additional payments of $0.8 million to become due through 2013. The reimbursement represents approximately 50% of project development costs based upon mutually agreed upon project plans for each molecular assay. The reimbursements are recorded as a reduction to research and development expense in the accompanying consolidated financial statements, to the extent that they are less than related expenditures for research and development activities subsequent to the date of the contract. The Company recognized $0 and $1.1 million of such reimbursements as a reduction to research and development expense for the three and six months ended June 30, 2013, respectively. In connection with the collaboration agreement, the Company also entered into a manufacturing and supply agreement with Life Technologies Corporation, which provides for margin sharing.

In March 2013, the Company entered into a six year instrument supply agreement (the “March 2013 Agreement”) with Life Technologies Corporation for $0.8 million to sell Life Technologies Corporation’s QuantStudio™ DX diagnostic laboratory instrument for use in the infectious disease field, along with the assays developed under the collaborative agreement.

X

- Details

Name: us-gaap_AccountingPoliciesAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for basis of accounting, or basis of presentation, used to prepare the financial statements (for example, US Generally Accepted Accounting Principles, Other Comprehensive Basis of Accounting, IFRS).

+ References

No definition available.

+ Details

Name: us-gaap_BasisOfAccountingPolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for collaborative arrangements.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 808

-SubTopic 10

-Section 50

-Paragraph 1

-Subparagraph (c)

-URI http://asc.fasb.org/extlink&oid=6931272&loc=SL5834143-161434

+ Details

Name: us-gaap_CollaborativeArrangementAccountingPolicy

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for comprehensive income.

+ References

No definition available.

+ Details

Name: us-gaap_ComprehensiveIncomePolicyPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for revenue recognition. If the entity has different policies for different types of revenue transactions, the policy for each material type of transaction is generally disclosed. If a sales transaction has multiple element arrangements (for example, delivery of multiple products, services or the rights to use assets) the disclosure may indicate the accounting policy for each unit of accounting as well as how units of accounting are determined and valued. The disclosure may encompass important judgment as to appropriateness of principles related to recognition of revenue. The disclosure also may indicate the entity's treatment of any unearned or deferred revenue that arises from the transaction.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 3

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18780-107790

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18726-107790

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Staff Accounting Bulletin (SAB)

-Number Topic 13

-Section B

-Paragraph Question 1

Reference 4: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 605

-SubTopic 10

-Section S99

-Paragraph 1

-Subparagraph (SAB TOPIC 13.B.Q1)

-URI http://asc.fasb.org/extlink&oid=27012821&loc=d3e214044-122780

Reference 5: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 235

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6367646&loc=d3e18823-107790

+ Details

Name: us-gaap_RevenueRecognitionPolicyTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

X

- Definition

Disclosure of accounting policy for the use of estimates in the preparation of financial statements in conformity with generally accepted accounting principles.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 9

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6143-108592

Reference 2: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 8

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6132-108592

Reference 3: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 275

-SubTopic 10

-Section 50

-Paragraph 4

-URI http://asc.fasb.org/extlink&oid=6927468&loc=d3e6061-108592

+ Details

Name: us-gaap_UseOfEstimates

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 113 R35.xml IDEA: Intangible Assets - Additional Information (Detail) 2.4.0.8136 - Disclosure - Intangible Assets - Additional Information (Detail)truefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_31_20130331_0http://www.sec.gov/CIK0000353569duration2013-03-01T00:00:002013-03-31T00:00:002false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20120630_0http://www.sec.gov/CIK0000353569duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$5false USDfalsefalse$eol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$6false falsefalseeol_PE8142----1310-Q0005_STD_365_20111231_0http://www.sec.gov/CIK0000353569duration2011-01-01T00:00:002011-12-31T00:00:001true 3us-gaap_FiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Finite-Lived Intangible Assets [Line Items]2false 4us-gaap_FiniteLivedIntangibleAssetUsefulLifeus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse006 yearsfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse003 years 6 monthsfalsefalsefalsexbrli:durationItemTypenaUseful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.No definition available.false0Expected life for amortization of distribution rights3false 4us-gaap_AmortizationOfIntangibleAssetsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse20220002022000USD$falsetruefalse3truefalsefalse17190001719000USD$falsetruefalse4truefalsefalse37860003786000USD$falsetruefalse5truefalsefalse34370003437000USD$falsetruefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe aggregate expense charged against earnings to allocate the cost of intangible assets (nonphysical assets not used in production) in a systematic and rational manner to the periods expected to benefit from such assets. As a noncash expense, this element is added back to net income when calculating cash provided by or used in operations using the indirect method.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 28 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3602-108585 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 45 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6388964&loc=d3e16225-109274 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 30 -Section 50 -Paragraph 2 -Subparagraph (a)(2) -URI http://asc.fasb.org/extlink&oid=26713463&loc=d3e16323-109275 false2Amortization expense4false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse7false USDtruefalse$eol_PE8142----1310-Q0005_STD_31_20130331_0_931868x927273http://www.sec.gov/CIK0000353569duration2013-03-01T00:00:002013-03-31T00:00:00falsefalseDistribution rights [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_DistributionRightsMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Distribution rights [Member]5true 3us-gaap_FiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Finite-Lived Intangible Assets [Line Items]6false 4us-gaap_FiniteLivedIntangibleAssetUsefulLifeus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse006 yearsfalsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaUseful life of finite-lived intangible assets, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.No definition available.false0Expected life for amortization of distribution rights7false 4us-gaap_FinitelivedIntangibleAssetsAcquired1us-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse800000800000USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of increase in assets, excluding financial assets, lacking physical substance with a definite life, resulting from a business combination.No definition available.false2Acquisition of distribution rights8false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalse8false USDtruefalse$eol_PE8142----1310-Q0005_STD_0_20111231_0_931868x929029http://www.sec.gov/CIK0000353569instant2011-12-31T00:00:000001-01-01T00:00:00falsefalsePatented technology [Member]us-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_PatentedTechnologyMemberus-gaap_FiniteLivedIntangibleAssetsByMajorClassAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Patented technology [Member]9true 3us-gaap_FiniteLivedIntangibleAssetsLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Finite-Lived Intangible Assets [Line Items]10false 4us-gaap_FiniteLivedIntangibleAssetsFairValueDisclosureus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5falsefalsefalse00falsefalsefalse6truefalsefalse2880000028800000USD$falsetruefalsexbrli:monetaryItemTypemonetaryFair value portion of assets, excluding financial assets, that lack physical substance, having a limited useful life.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 820 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=25499696&loc=d3e19190-110258 false2Assigned licensed technologyfalseIntangible Assets - Additional Information (Detail) (USD $)NoRoundingUnKnownUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureIntangibleAssetsAdditionalInformation610 XML 114 R1.htm IDEA: XBRL DOCUMENT v2.4.0.8

Document and Entity Information
6 Months Ended

Jun. 30, 2013

Jul. 25, 2013

Document Document And Entity Information [Abstract]

Document Type 10-Q

Amendment Flag false

Document Period End Date Jun. 30, 2013

Document Fiscal Year Focus 2013

Document Fiscal Period Focus Q2

Trading Symbol QDEL

Entity Registrant Name QUIDEL CORP /DE/

Entity Central Index Key 0000353569

Current Fiscal Year End Date --12-31

Entity Filer Category Accelerated Filer

Entity Common Stock, Shares Outstanding 33,904,942

X

- Definition

If the value is true, then the document is an amendment to previously-filed/accepted document.

+ References

No definition available.

+ Details

Name: dei_AmendmentFlag

Namespace Prefix: dei_

Data Type: xbrli:booleanItemType

Balance Type: na

Period Type: duration

X

- Definition

End date of current fiscal year in the format --MM-DD.

+ References

No definition available.

+ Details

Name: dei_CurrentFiscalYearEndDate

Namespace Prefix: dei_

Data Type: xbrli:gMonthDayItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalPeriodFocus

Namespace Prefix: dei_

Data Type: dei:fiscalPeriodItemType

Balance Type: na

Period Type: duration

X

- Definition

This is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.

+ References

No definition available.

+ Details

Name: dei_DocumentFiscalYearFocus

Namespace Prefix: dei_

Data Type: xbrli:gYearItemType

Balance Type: na

Period Type: duration

X

- Definition

The end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.

+ References

No definition available.

+ Details

Name: dei_DocumentPeriodEndDate

Namespace Prefix: dei_

Data Type: xbrli:dateItemType

Balance Type: na

Period Type: duration

X

- Definition

The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".

+ References

No definition available.

+ Details

Name: dei_DocumentType

Namespace Prefix: dei_

Data Type: dei:submissionTypeItemType

Balance Type: na

Period Type: duration

X

- Definition

A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityCentralIndexKey

Namespace Prefix: dei_

Data Type: dei:centralIndexKeyItemType

Balance Type: na

Period Type: duration

X

- Definition

Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.

+ References

No definition available.

+ Details

Name: dei_EntityCommonStockSharesOutstanding

Namespace Prefix: dei_

Data Type: xbrli:sharesItemType

Balance Type: na

Period Type: instant

X

- Definition

Indicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.

+ References

No definition available.

+ Details

Name: dei_EntityFilerCategory

Namespace Prefix: dei_

Data Type: dei:filerCategoryItemType

Balance Type: na

Period Type: duration

X

- Definition

The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher SEC

-Name Regulation 12B

-Number 240

-Section 12b

-Subsection 1

+ Details

Name: dei_EntityRegistrantName

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Definition

Trading symbol of an instrument as listed on an exchange.

+ References

No definition available.

+ Details

Name: dei_TradingSymbol

Namespace Prefix: dei_

Data Type: xbrli:normalizedStringItemType

Balance Type: na

Period Type: duration

X

- Details

Name: qdel_DocumentDocumentAndEntityInformationAbstract

Namespace Prefix: qdel_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

XML 115 R41.xml IDEA: Stockholders' Equity - Additional Information (Detail) 2.4.0.8142 - Disclosure - Stockholders' Equity - Additional Information (Detail)truefalsefalse1false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$2false USDfalsefalse$eol_PE8142----1310-Q0005_STD_91_20120630_0http://www.sec.gov/CIK0000353569duration2012-04-01T00:00:002012-06-30T00:00:00iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$3false USDfalsefalse$eol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares0iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$4false USDfalsefalse$eol_PE8142----1310-Q0005_STD_182_20120630_0http://www.sec.gov/CIK0000353569duration2012-01-01T00:00:002012-06-30T00:00:00iso4217_USD_per_sharesDividehttp://www.xbrl.org/2003/iso4217USDiso4217http://www.xbrl.org/2003/instanceshares0iso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$1true 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Share-based Compensation Arrangement by Share-based Payment Award [Line Items]2false 4us-gaap_StockIssuedDuringPeriodSharesRestrictedStockAwardGrossus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse121375121375falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesTotal number of shares issued during the period, including shares forfeited, as a result of Restricted Stock Awards.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 false1Common stock issued in conjunction with the vesting and release of restricted stock3false 4us-gaap_StockIssuedDuringPeriodSharesStockOptionsExercisedus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse405917405917falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNumber of share options (or share units) exercised during the current period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 210 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.5-02.28,29) -URI http://asc.fasb.org/extlink&oid=6877327&loc=d3e13212-122682 Reference 5: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(1)(iv)(2) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 6: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 false1Common stock issued due to exercise of stock options4false 4us-gaap_StockIssuedDuringPeriodSharesEmployeeStockPurchasePlansus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse2473324733falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNumber of shares issued during the period as a result of an employee stock purchase plan.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SX 210.3-04) -URI http://asc.fasb.org/extlink&oid=27012166&loc=d3e187085-122770 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 false1Common stock issued in connection with employee stock purchase plan5false 4us-gaap_ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptionsus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse49000004900000USD$falsetruefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryThe total cash inflow associated with the amount received from holders to acquire the entity's shares under incentive and share awards, including stock option exercises. This item inherently excludes any excess tax benefit, which the entity may have realized and reported separately.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 14 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3255-108585 false2Employee stock purchase plan, net proceeds6false 4us-gaap_TreasuryStockSharesAcquiredus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse3836038360falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:sharesItemTypesharesNumber of shares that have been repurchased during the period and are being held in treasury.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 04 -Article 3 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 505 -SubTopic 10 -Section 50 -Paragraph 2 -URI http://asc.fasb.org/extlink&oid=6928386&loc=d3e21463-112644 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation S-X (SX) -Number 210 -Section 02 -Paragraph 29, 30 -Article 5 false1Repurchase of Common stock shares7false 4us-gaap_PaymentsForRepurchaseOfCommonStockus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse858000858000USD$falsefalsefalse4truefalsefalse33870003387000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryThe cash outflow to reacquire common stock during the period.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Glossary Financing Activities -URI http://asc.fasb.org/extlink&oid=6513228 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 230 -SubTopic 10 -Section 45 -Paragraph 15 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=31042434&loc=d3e3291-108585 false2Repurchases of common stock8false 4us-gaap_StockRepurchaseProgramAuthorizedAmountus-gaap_truecreditdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse5000000050000000USD$falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryAmount of a stock repurchase plan authorized by an entity's Board of Directors.No definition available.false2Amount available under the share repurchase program9false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse19000001900000USD$falsefalsefalse2truefalsefalse17000001700000USD$falsefalsefalse3truefalsefalse40000004000000USD$falsefalsefalse4truefalsefalse36000003600000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false2Share-based compensation expense recognized10false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValueus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse9.199.19USD$falsetruefalse4truefalsefalse6.516.51USD$falsetruefalsenum:perShareItemTypedecimalThe weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (d)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false3Weighted-average grant date fair value of stock options granted11false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse5false USDtruefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0_929038x924898http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseStock options [Member]us-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_EmployeeStockOptionMemberus-gaap_AwardTypeAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Stock options [Member]12true 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Share-based Compensation Arrangement by Share-based Payment Award [Line Items]13false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse10000001000000USD$falsefalsefalse2truefalsefalse11000001100000USD$falsefalsefalse3truefalsefalse23000002300000USD$falsefalsefalse4truefalsefalse21000002100000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false2Share-based compensation expense recognized14false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptionsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse61000006100000USD$falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse61000006100000USD$falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryUnrecognized cost of unvested options awarded to employees as compensation.No definition available.false2Total unrecognized compensation expense related to non-vested stock options15false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse002 years 7 months 6 daysfalsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaWeighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Expected weighted-average period of recognition for unrecognized compensation expense16false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGrossus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse529134529134falsefalsefalse4truefalsefalse621705621705falsefalsefalsexbrli:sharesItemTypesharesGross number of share options (or share units) granted during the period.No definition available.false1Stock options granted17false 0truefalsetruefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalse9false USDtruefalse$eol_PE8142----1310-Q0005_STD_91_20130630_0_929038x923936http://www.sec.gov/CIK0000353569duration2013-04-01T00:00:002013-06-30T00:00:00falsefalseRestricted stock [Member]us-gaap_AwardTypeAxisxbrldihttp://xbrl.org/2006/xbrldius-gaap_RestrictedStockMemberus-gaap_AwardTypeAxisexplicitMemberiso4217_USDStandardhttp://www.xbrl.org/2003/iso4217USDiso42170USDUSD$nanafalse0Restricted stock [Member]18true 3us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardLineItemsus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse00falsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Share-based Compensation Arrangement by Share-based Payment Award [Line Items]19false 4us-gaap_AllocatedShareBasedCompensationExpenseus-gaap_truedebitdurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse900000900000USD$falsefalsefalse2truefalsefalse600000600000USD$falsefalsefalse3truefalsefalse17000001700000USD$falsefalsefalse4truefalsefalse15000001500000USD$falsefalsefalsexbrli:monetaryItemTypemonetaryRepresents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 1 -Subparagraph (b) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5047-113901 Reference 2: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section S99 -Paragraph 1 -Subparagraph (SAB TOPIC 14.F) -URI http://asc.fasb.org/extlink&oid=27013229&loc=d3e301413-122809 Reference 3: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (h)(1)(i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 Reference 4: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Staff Accounting Bulletin (SAB) -Number Topic 14 -Section F false2Share-based compensation expense recognized20false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1us-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3falsefalsefalse001 year 6 monthsfalsefalsefalse4falsefalsefalse00falsefalsefalsexbrli:durationItemTypenaWeighted average period over which unrecognized compensation is expected to be recognized for equity-based compensation plans, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (i) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false0Expected weighted-average period of recognition for unrecognized compensation expense21false 4us-gaap_EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedShareBasedAwardsOtherThanOptionsus-gaap_truedebitinstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1truefalsefalse16000001600000USD$falsetruefalse2falsefalsefalse00falsefalsefalse3truefalsefalse16000001600000USD$falsetruefalse4falsefalsefalse00falsefalsefalsexbrli:monetaryItemTypemonetaryUnrecognized cost of unvested share-based awards, other than options, awarded to employees as compensation.No definition available.false2Total unrecognized compensation expense related to non-vested restricted stock22false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValueus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse23.1823.18USD$falsetruefalse4truefalsefalse15.4515.45USD$falsetruefalsenum:perShareItemTypedecimalThe weighted average fair value at grant date for nonvested equity-based awards issued during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false3Weighted-average grant date fair value of restricted stock granted23false 4us-gaap_ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodus-gaap_truenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalse3truefalsefalse6899468994falsefalsefalse4truefalsefalse132205132205falsefalsefalsexbrli:sharesItemTypesharesThe number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan).Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher FASB -Name Accounting Standards Codification -Topic 718 -SubTopic 10 -Section 50 -Paragraph 2 -Subparagraph (c)(2)(iii)(1) -URI http://asc.fasb.org/extlink&oid=6415400&loc=d3e5070-113901 false1Restricted stock grantedfalseStockholders' Equity - Additional Information (Detail) (USD $)NoRoundingNoRoundingNoRoundingUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DisclosureStockholdersEquityAdditionalInformation423 XML 116 R21.htm IDEA: XBRL DOCUMENT v2.4.0.8

Computation of (Loss) Earnings Per Share (Tables)
6 Months Ended

Jun. 30, 2013

Earnings Per Share [Abstract]

Basic and Diluted EPS

The following table sets forth the computation of basic and diluted EPS for the six months ended June 30, 2013 (in thousands, except per share amounts):

 2013

Basic net income per share:


Net income
 $ 10,612

Less: income allocated to participating securities
 (32 )



Net income allocated to common stockholders
 $ 10,580



Weighted average common shares outstanding — basic
 33,658



Net income per share — basic
 $ 0.31



Diluted net income per share:


Net income
 $ 10,612

Less: income allocated to participating securities
 (31 )



Net income allocated to common stockholders
 $ 10,581



Weighted average common shares outstanding — basic
 33,658

Dilutive securities
 1,058



Weighted average common shares outstanding — diluted
 34,716



Net income per share — diluted
 $ 0.30



X

- Details

Name: us-gaap_EarningsPerShareAbstract

Namespace Prefix: us-gaap_

Data Type: xbrli:stringItemType

Balance Type: na

Period Type: duration

X

- Definition

Tabular disclosure of an entity's basic and diluted earnings per share calculations, including a reconciliation of numerators and denominators of the basic and diluted per-share computations for income from continuing operations.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef

-Publisher FASB

-Name Accounting Standards Codification

-Topic 260

-SubTopic 10

-Section 50

-Paragraph 1

-URI http://asc.fasb.org/extlink&oid=6371337&loc=d3e3550-109257

+ Details

Name: us-gaap_ScheduleOfEarningsPerShareBasicAndDilutedTableTextBlock

Namespace Prefix: us-gaap_

Data Type: nonnum:textBlockItemType

Balance Type: na

Period Type: duration

XML 117 R1.xml IDEA: Document and Entity Information 2.4.0.8101 - Document - Document and Entity Informationtruefalsefalse1false falsefalseeol_PE8142----1310-Q0005_STD_181_20130630_0http://www.sec.gov/CIK0000353569duration2013-01-01T00:00:002013-06-30T00:00:002false falsefalseeol_PE8142----1310-Q0005_STD_0_20130725_0http://www.sec.gov/CIK0000353569instant2013-07-25T00:00:000001-01-01T00:00:00sharesStandardhttp://www.xbrl.org/2003/instanceshares01true 1qdel_DocumentDocumentAndEntityInformationAbstractqdel_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalse1falsefalsefalse00falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:stringItemTypestringfalse0Document Document And Entity Information [Abstract]2false 2dei_DocumentTypedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse0010-Qfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:submissionTypeItemTypestringThe type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word "Other".No definition available.false0Document Type3false 2dei_AmendmentFlagdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:booleanItemTypenaIf the value is true, then the document is an amendment to previously-filed/accepted document.No definition available.false0Amendment Flag4false 2dei_DocumentPeriodEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse002013-06-30falsefalsetrue2falsefalsefalse00falsefalsefalsexbrli:dateItemTypedateThe end date of the period reflected on the cover page if a periodic report. For all other reports and registration statements containing historical data, it is the date up through which that historical data is presented. If there is no historical data in the report, use the filing date. The format of the date is CCYY-MM-DD.No definition available.false0Document Period End Date5false 2dei_DocumentFiscalYearFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse002013falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gYearItemTypepositiveintegerThis is focus fiscal year of the document report in CCYY format. For a 2006 annual report, which may also provide financial information from prior periods, fiscal 2006 should be given as the fiscal year focus. Example: 2006.No definition available.false0Document Fiscal Year Focus6false 2dei_DocumentFiscalPeriodFocusdei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00Q2falsefalsefalse2falsefalsefalse00falsefalsefalsedei:fiscalPeriodItemTypenaThis is focus fiscal period of the document report. For a first quarter 2006 quarterly report, which may also provide financial information from prior periods, the first fiscal quarter should be given as the fiscal period focus. Values: FY, Q1, Q2, Q3, Q4, H1, H2, M9, T1, T2, T3, M8, CY.No definition available.false0Document Fiscal Period Focus7false 2dei_TradingSymboldei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00QDELfalsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:normalizedStringItemTypenormalizedstringTrading symbol of an instrument as listed on an exchange.No definition available.false0Trading Symbol8false 2dei_EntityRegistrantNamedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00QUIDEL CORP /DE/falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:normalizedStringItemTypenormalizedstringThe exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false0Entity Registrant Name9false 2dei_EntityCentralIndexKeydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse000000353569falsefalsefalse2falsefalsefalse00falsefalsefalsedei:centralIndexKeyItemTypenaA unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.Reference 1: http://www.xbrl.org/2003/role/presentationRef -Publisher SEC -Name Regulation 12B -Number 240 -Section 12b -Subsection 1 false0Entity Central Index Key10false 2dei_CurrentFiscalYearEndDatedei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00--12-31falsefalsefalse2falsefalsefalse00falsefalsefalsexbrli:gMonthDayItemTypemonthdayEnd date of current fiscal year in the format --MM-DD.No definition available.false0Current Fiscal Year End Date11false 2dei_EntityFilerCategorydei_falsenadurationfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00Accelerated Filerfalsefalsefalse2falsefalsefalse00falsefalsefalsedei:filerCategoryItemTypestringIndicate whether the registrant is one of the following: (1) Large Accelerated Filer, (2) Accelerated Filer, (3) Non-accelerated Filer, (4) Smaller Reporting Company (Non-accelerated) or (5) Smaller Reporting Accelerated Filer. Definitions of these categories are stated in Rule 12b-2 of the Exchange Act. This information should be based on the registrant's current or most recent filing containing the related disclosure.No definition available.false0Entity Filer Category12false 2dei_EntityCommonStockSharesOutstandingdei_falsenainstantfalsefalsefalsefalsefalsefalsefalsefalseterseLabel1falsefalsefalse00falsefalsefalse2truefalsefalse3390494233904942falsefalsefalsexbrli:sharesItemTypesharesIndicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.No definition available.false1Entity Common Stock, Shares OutstandingfalseDocument and Entity InformationUnKnownNoRoundingUnKnownUnKnowntruefalsefalseSheethttp://www.quidel.com/taxonomy/role/DocumentDocumentandEntityInformation212

Large accelerated filer

Accelerated filer

Non-accelerated filer

¨ (Do not check if a smaller reporting company)

Smaller reporting company

Document and Entity Information	6 Months Ended
Document and Entity Information	Jun. 30, 2013	Jul. 25, 2013
Document Document And Entity Information [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 30, 2013
Document Fiscal Year Focus	2013
Document Fiscal Period Focus	Q2
Trading Symbol	QDEL
Entity Registrant Name	QUIDEL CORP /DE/
Entity Central Index Key	0000353569
Current Fiscal Year End Date	--12-31
Entity Filer Category	Accelerated Filer
Entity Common Stock, Shares Outstanding		33,904,942